Isoxazoline-substituted benzamide compound and pesticide

ABSTRACT

An isoxazoline-substituted benzamide compound of formula (1) or a salt thereof: 
     
       
         
         
             
             
         
       
     
     wherein A 1 , A 2  and A 3  independently of one another are carbon atom or nitrogen atom, G is benzene ring, etc., W is oxygen atom or sulfur atom, etc., X is halogen atom, C 1 -C 6 haloalkyl, etc., Y ia halogen atm, C 1 -C 6 alkyl, etc., R 1  is —CH═NOR 1a , —C(O)OR 1c , —C(O)NHR 1d , phenyl substituted with (Z) p1 , D-14, D-52, D-53, D-55 to D-59, etc., R 1a  is C 1 -C 6 alkyl, etc., R 1c  is C 1 -C 6 alkyl, etc., R 1d  is hydrogen atom, —C(O)R 15 , —C(O)OR 15 , etc., R 2  is C 1 -C 6 alkyl, —CH 2 R 14a , C 1 -C 6 alkynyl, —C(O)R 15 , —C(O)OR 15 , etc., further when R 1  is —CH═NOR 1a , —C(O)OR 1c  or —C(O)N(R 1e )R 1d , R 2  may be hydrogen atom, R 3  is C 1 -C 6 haloalkyl, etc., R 14a  is cyano, —OR 25 , etc., R 15  is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 4 alkoxy C 1 -C 4 alkyl, C 1 -C 4 alkylthio C 1 -C 4 alkyl, C 3 -C 6 cycloalkyl, C 2 -C 6 alkenyl, etc., R 25  is C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, —C(O)R 32  or —C(O)OR 32 , etc., R 32  is C 1 -C 6 alkyl or C 3 -C 6 cycloalkyl, etc., Z is halogen atom, cyano, nitro, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, etc., m is an integer of 0 to 5, n is an integer of 0 to 4, p1 is an integer of 1 to 5. The pesticide containing these compounds.

TECHNICAL FIELD

The present invention relates to a novel isoxazoline-substituted benzamide compound and the salt thereof, and a pesticide characterized by containing the compound as an active ingredient. The pesticide in the present invention means a pest controlling agent applied for harmful arthropods in agricultural and horticultural field or livestock farming and hygienic field (endo-parasiticides and ecto-parasiticides for mammals or birds as domestic animals or pets, or hygienic pest- or unpleasant pest-controlling agents for domestic or business use). In addition, agricultural chemicals in the present invention mean insecticides, acaricides, nematicides, herbicides and fungicides, and the like.

BACKGROUND ART

Conventionally, as to isoxazoline-substituted benzamide compounds, it is known that N-(2-alkoxyiminoalkyl)-4-(5-substituted-5-substituted aryl-4,5-dihydroisooxazole-3-yl)benzamide compounds, N-(2,2,2-trifluoroethoxycarbonyl)-4-(5-substituted-5-substituted aryl-4,5-dihydroisooxazole-3-yl)benzamide compounds and N-(2-pyrimidyl)-4-(5-substituted-5-substituted aryl-4,5-dihydroisooxazole-3-yl)benzamide compounds, and the like show pesticidal activity, particularly insecticidal and acaricidal activity (see, Patent Document 1). However, there is no disclosure on N-substituted-4-(5-substituted-5-substituted aryl-4,5-dihydroisooxazole-3-yl)benzamide compounds and N,N-disubstituted-4-(5-substituted-5-substituted aryl-4,5-dihydroisoxazole-3-yl)benzamide compounds having a specific amide substituent according to the present invention.

In addition, as to other isoxazoline-substituted benzamide compounds, it is known that 4-(5-substituted carbamoylmethyl-4,5-dihydroisoxazole-3-yl)benzamide derivatives, 3-(5-substituted carbamoylmethyl-5-substituted alkyl-4,5-dihydroisoxazole-3-yl)benzamide derivatives and 4-(5-substituted carbamoylmethyl-4,5-dihydroisoxazole-3-yl)benzamidine derivatives have platelet glycoprotein IIb/IIIa fibrinogen receptor complex competitive activity or factor Xa inhibition activity or the like, and can be used as a thrombolysis agent or a therapeutic agent of thronbo-embolic disorder (see, for example Patent Documents 2-5), etc. Further, it is known that other specific substituted isoxazoline compound can be used as a production intermediate of HIV protease inhibitors (see, for example Patent Document 6). However, there is no disclosure on N-substituted-4-(5-substituted-5-substituted aryl-4,5-dihydroisooxazole-3-yl)benzamide compounds and N,N-disubstituted-4-(5-substituted-5-substituted aryl-4,5-dihydroisoxazole-3-yl)benzamide compounds having a specific amide substituent according to the present invention, and further the usefulness thereof as a pesticide is not known at all.

On the other hand, as to 4-hydroxyiminomethyl benzamide derivatives, N-(arylmethyl)-4-hydroxyiminomethyl)benzamide (see, Patent Document 1) and the like are known. However, N-substituted-4-hydroxyiminomethyl benzamide derivatives and N,N-disubstituted-4-hydroxyiminomethyl benzamide derivatives having a specific amide substituent that can be used as a production intermediate of the pesticides according to the present invention are not described in any documents and thus novel compounds.

-   Patent Document 1: WO 2005/085216 Pamphlet -   Patent Document 2: WO 96/038426 Pamphlet -   Patent Document 3: WO 97/023212 Pamphlet -   Patent Document 4: WO 95/014683 Pamphlet -   Patent Document 5: WO 97/048395 Pamphlet -   Patent Document 6: WO 99/014210 Pamphlet

DISCLOSURE OF INVENTION Problems to be Solved by the Invention

The development of pesticides for controlling several pests such as agricultural and horticultural pests, forestall pests, or hygienic pests, etc. expands, and a number of different agents have been practically utilized to the present.

However, recently, pests acquire resistance by the use of pesticides such as insecticides or fungicides over long term, and thus control by the insecticides or fungicides that have been conventionally used becomes difficult. In addition, a part of known pesticides has a high toxicity, or some of them start to disturb native ecosystems due to long-term persistency. Under the circumstances, it is expected all the time to develop a novel pesticide having a low toxicity and a low persistency.

Means for Solving the Problems

The inventors have eagerly investigated in order to solve the above-mentioned problems, and as a result of it, they found that novel isoxazoline-substituted benzamide compounds of formula (1) are extremely useful compounds having excellent pest controlling activity, particularly insecticidal activity and acaricidal activity, and having little adverse affect on non-targeted beings such as mammals, fishes and useful insects, etc. Thus, the present invention has been accomplished.

That is, the present invention relates to the following aspects (1) to (17):

(1) An isoxazoline-substituted benzamide compound of formula (1) or a salt thereof:

wherein A¹, A² and A³ independently of one another are carbon atom or nitrogen atom, G is benzene ring, nitrogen-containing 6-membered aromatic heterocyclic ring, furan ring, thiophene ring, or 5-membered aromatic heterocyclic ring containing two or more hetero atoms selected from oxygen atom, sulfur atom and nitrogen atom, W is oxygen atom or sulfur atom, X is halogen atom, cyano, nitro, azido, —SCN, —SF₅, C₁-C₆alkyl, C₁-C₆alkyl arbitrarily substituted with R⁴, C₃-C₈cycloalkyl, C₃-C₈cycloalkyl arbitrarily substituted with R⁴, E-1 to E-50, C₂-C₆alkenyl, C₂-C₆alkenyl arbitrarily substituted with R⁴, C₃-C₈cycloalkenyl, C₃-C₈halocycloalkenyl, C₂-C₆alkynyl, C₂-C₆alkynyl arbitrarily substituted with R⁴, —OH, —OR⁵, —OSO₂R⁵, —SH, —S(O)_(r)R⁵, —NH₂, —N(R⁷)R⁶, —N═CHOR⁸, —N═C(R⁹)OR⁸, —CHO, —C(O)R⁹, —C(O)OR⁹, —C(O)SR⁹, —C(O)NH₂, —C(O)N(R¹⁰)R⁹, —C(S)OR⁹, —C(S)SR⁹, —C(S)NH₂, —C(S)N(R¹⁰)R⁹, —CH═NOR¹¹, —C(R⁹)═NOR¹¹, M-5, M-20, M-40 to M-43, M-46 to M-48, —S(O)₂OR⁹, —S(O)₂NH₂, —S(O)₂N(R¹⁰)R⁹, —Si(R^(12a))(R^(12b))R¹², phenyl, phenyl substituted with (Z)_(p1), or D-1 to D-65, when m is an integer of 2 or more, each X may be identical with or different from each other, further, when two Xs are adjacent, the adjacent two Xs may form 5-membered or 6-membered ring together with carbon atoms to which the two Xs are bonded by forming —CH₂CH₂CH₂—, —CH₂CH₂O—, —CH₂OCH₂—, —OCH₂O—, —CH₂CH₂S—, —CH₂SCH₂—, —CH₂CH₂N(R¹³)—, —CH₂N(R¹³)CH₂—, —CH₂CH₂CH₂CH₂—, —CH₂CH₂CH₂O—, —CH₂CH₂OCH₂—, —CH₂OCH₂O—, —OCH₂CH₂O—, —OCH₂CH₂S—, —CH₂CH═CH—, —OCH═CH—, —SCH═CH—, —N(R¹³)CH═CH—, —OCH═N—, —SCH═N—, —N(R¹³)CH═N—, —N(R¹³)N═CH—, —CH═CHCH═CH—, —OCH₂CH═CH—, —N═CHCH═CH—, —N═CHCH═N— or —N═CHN═CH—, in this case, hydrogen atoms bonded to each carbon atom forming the ring may be arbitrarily substituted with Z, further when the hydrogen atoms are substituted with two or more Zs at the same time, each Z may be identical with or different from each other, Y is halogen atom, cyano, nitro, azido, —SCN, —SF₅, C₁-C₆alkyl, C₁-C₆alkyl arbitrarily substituted with R⁴, C₃-C₈cycloalkyl, C₃-C₈cycloalkyl arbitrarily substituted with R⁴, E-1 to E-50, C₂-C₆alkynyl, C₂-C₆alkynyl arbitrarily substituted with R⁴, —OH, —OR⁵, —OSO₂R⁵, —SH, —S(O)_(r)R⁵, —NH₂, —N(R⁷)R⁶, —N(R⁷)C(O)R^(9a), —N(R⁷)C(O)OR^(9a), —N(R⁷)C(O)SR^(9a), —N(R⁷)C(S)OR^(9a), —N(R⁷)C(S)SR^(9a), —N(R⁷)S(O)₂R^(9a), —N═CHOR⁸, —N═C(R⁹)OR⁸, —C(O)NH₂, —C(O)N(R¹⁰)R⁹, —C(S)NH₂, —C(S)N(R¹⁰)R⁹, —Si(R^(12a))(R^(12b))R², phenyl, phenyl substituted with (Z)_(p1), D-1 to D-65, when n is an integer of 2 or more, each Y may be identical with or different from each other, further, when two Ys are adjacent, the adjacent two Ys may form 5-membered or 6-membered ring together with carbon atoms to which the two Ys are bonded by forming —CH₂CH₂CH₂—, —CH₂CH₂O—, —CH₂OCH₂—, —OCH₂O—, —CH₂CH₂S—, —CH₂SCH₂—, —SCH₂S—, —CH₂CH₂CH₂CH₂—, —CH₂CH₂CH₂O—, —CH₂CH₂OCH₂—, —CH₂OCH₂O—, —OCH₂CH₂O—, —OCH₂CH₂S—, —SCH₂CH₂S—, —OCH═N— or —SCH═N—, in this case, hydrogen atoms bonded to each carbon atom forming the ring may be arbitrarily substituted with Z, further when the hydrogen atoms are substituted with two or more Zs at the same time, each Z may be identical with or different from each other, R¹ is —C(R^(1b))═NOR^(1a), M-5, M-20, M-48, —C(O)OR^(1c), —C(O)SR^(1c), —C(S)OR^(1c), —C(S)SR^(1c), —C(O)N(R^(1e))R^(1d), —C(S)N(R^(1e))R^(1d), —C(R^(1b))═NN(R^(1e))R^(1f), phenyl, phenyl substituted with (Z)_(p1) or D-1 to D-65, R^(1a) is hydrogen atom, C₁-C₁₂alkyl, C₁-C₁₂haloalkyl, C₁-C₆alkyl arbitrarily substituted with R¹⁴, C₃-C₁₂cycloalkyl, C₃-C₁₂halocycloalkyl, C₃-C₈cyloalkyl arbitrarily substituted with R¹⁴, E-4 to E-10, E-24 to E-29, E-31, E-32, E-35, E-46, C₃-C₁₂alkenyl, C₃-C₁₂haloalkenyl, C₃-C₆alkenyl arbitrarily substituted with R¹⁴, C₃-C₁₂cycloalkenyl, C₃-C₁₂halocycloalkenyl, C₃-C₁₂alkynyl, C₃-C₁₂haloalkynyl, C₃-C₆alkynyl arbitrarily substituted with R¹⁴, phenyl, phenyl substituted with (Z)_(p1), D-52, D-55 to D-58 or D-59, R^(1b) is hydrogen atom, C₁-C₁₂alkyl, C₁-C₁₂haloalkyl, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₆alkylthioC₁-C₆alkyl, C₃-C₁₂cycloalkyl, phenyl or phenyl substituted with (Z)_(p1), R^(1c) is C₁-C₁₂alkyl, C₁-C₆alkyl arbitrarily substituted with R¹⁴, C₃-C₁₂cycloalkyl, C₃-C₁₂halocycloalkyl, C₃-C₈cyloalkyl arbitrarily substituted with R¹⁴, E-3, E-5 to E-10, E-24 to E-29, E-31, E-32, E-35, E-46, C₃-C₁₂alkenyl, C₃-C₁₂haloalkenyl, C₃-C₆alkenyl arbitrarily substituted with R¹⁴, C₃-C₁₂cycloalkenyl, C₃-C₁₂halocycloalkenyl, C₃-C₁₂alkynyl, C₃-C₁₂haloalkynyl, C₃-C₆alkynyl arbitrarily substituted with R¹⁴ —N═C(R^(17b))R^(17a), phenyl, phenyl substituted with (Z)_(p1), D-1 to D-4, D-6 to D-13, D-15 to D-23, D-25 to D-37, D-39, D-40, D-42, D-43, D-45, D-47, D-50 to D-64 or D-65, R^(1d) is hydrogen atom, —C(O)R¹⁵, —C(O)OR¹⁵, —C(O)SR¹⁵, —C(S)R¹⁵, —C(S)OR¹⁵, —C(S)SR¹⁵ or —SO₂R¹⁵ R^(1e) is hydrogen atom, C₁-C₁₂alkyl, C₁-C₁₂haloalkyl, cyanoC₁-C₆alkyl, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₆alkylthio C₁-C₆alkyl, C₁-C₆alkylsulfonyl C₁-C₆alkyl, C₃-C₁₂alkenyl, C₃-C₁₂alkynyl or benzyl, R^(1f) is —CHO, —C(O)R¹⁵, —C(O)OR¹⁵, —C(O)SR¹⁵, —C(S)OR¹⁵, —C(S)SR¹⁵, —C(S)NH₂ or —C(S)N(R¹⁶)R¹⁵, R² is cyano, C₁-C₁₂alkyl, —CH₂R^(14a), E-5, E-7, E-9, E-24, E-27, E-30, C₃-C₁₂cycloalkenyl, C₃-C₁₂halocycloalkenyl, C₃-C₁₂alkynyl, C₃-C₁₂haloalkynyl, C₃-C₆alkynyl arbitrarily substituted with R^(14a), —CHO, —C(O)R¹⁵, —C(O)OR¹⁵, —C(O)SR¹⁵, —C(S)OR¹⁵, —C(S)SR¹⁵, —C(O)C(O)OR¹⁵, —SR¹⁵, —S(O)₂R¹⁵, —S(O)₂N(R¹⁶)R¹⁵, —SN(R²⁰)R¹⁹, phenyl or phenyl substituted with (Z)_(p1), further when R¹ is —C(R^(1b))═NOR^(1a), M-5, M-20, M-48, or —C(Rb)═NN(R^(1e))R^(1f), R² may be hydrogen atom, C₁-C₁₂haloalkyl, C₃-C₈cycloalkylC₁-C₆alkyl, C₁-C₆alkyl arbitrarily substituted with R^(14a), C₃-C₁₂alkenyl, C₃-C₁₂haloalkenyl or C₃-C₆alkenyl arbitrarily substituted with R^(14a), when R¹ is —C(O)OR^(1c), —C(O)SR^(1c), —C(S)OR^(1c) or —C(S)SR^(1c), R² may be hydrogen atom, halomethyl or —CH(R^(14b))R^(14a), when R¹ is —C(O)N(R^(1e))R^(1d) or —C(S)N(R^(1e))R^(1d), R² may be hydrogen atom, C₁-C₁₂haloalkyl, C₃-C₈cycloalkylC₁-C₆alkyl, C₁-C₆alkyl arbitrarily substituted with R^(14a), C₃-C₁₂cycloalkyl, C₃-C₁₂halocycloalkyl, C₃-C₁₂alkenyl, C₃-C₁₂haloalkenyl or C₃-C₆alkenyl arbitrarily substituted with R^(14a), when R¹ is phenyl, phenyl substituted with (Z)_(p1) or D-1 to D-65, R² may be C₁-C₁₂haloalkyl, C₃-C₈cycloalkylC₁-C₆alkyl, C₁-C₆alkyl arbitrarily substituted with R^(14a), C₃-C₁₂cycloalkyl, C₃-C₁₂halocycloalkyl, C₃-C₁₂alkenyl, C₃-C₁₂haloalkenyl, C₃-C₆alkenyl arbitrarily substituted with R^(14a), —C(O)NH₂, —C(O)N(R¹⁶)R¹⁵, —OH, —OR¹⁷, —N(R¹⁸)R¹⁷ or —N═C(R^(17b))R^(17a), or R² together with R¹ may form ═C(R^(2b))R^(2a), or further when substituent Y is present on an adjacent position, R² together with Y may form 5- or 6-membered ring together with the atoms to which the R² and Y are bonded by forming —CH₂—, —CH₂CH₂—, —CH₂O—, —CH₂S—, —CH₂N(R⁶)—, —CH═CH— or —CH═N—, in this case, the hydrogen atom bonded to each carbon atom forming the ring may be arbitrarily substituted with halogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkylidene, C₁-C₆haloalkylidene, oxo or thioxo, R^(2a) is hydrogen atom, —OR^(1c), —SR^(1c), C₁-C₆alkylsulfonyl, —NH₂, C₁-C₆alkylamino or di(C₁-C₆alkyl)amino, R^(2b) is R^(1b), C₁-C₆alkoxy, C₁-C₆haloalkoxy, phenoxy, phenoxy substituted with (Z)_(p1), C₁-C₆alkylthio, C₁-C₆haloalkylthio, —SCH₂R^(14a), C₃-C₆alkenylthio, C₃-C₆haloalkenylthio, C₃-C₆alkynylthio, C₃-C₆haloalkynylthio, —SC(O)R¹⁵, —SC(O)OR¹⁵, phenylthio, phenylthio substituted with (Z)_(p1) or di(C₁-C₆alkyl)amino, R³ is halogen atom, cyano, C₁-C₆alkyl, C₁-C₆alkyl arbitrarily substituted with R⁴, C₃-C₈cycloalkyl, C₃-C₈cycloalkyl arbitrarily substituted with R⁴, E-1 to E-50, C₃-C₆alkenyl, C₂-C₆alkenyl arbitrarily substituted with R⁴, C₃-C₆alkynyl, C₂-C₆alkynyl arbitrarily substituted with R⁴, —OR⁵, —S(O)_(r)R⁵, —N(R¹⁰)R⁹, —N(RO)R^(9a), —CHO, —C(O)R⁹, —C(O)OR⁹, —C(O)SR⁹, —C(O)NH₂, —C(O)N(R¹⁰)R⁹, —C(S)OR⁹, —C(S)SR⁹, —C(S)NH₂, —C(S)N(Ro)R⁹, —CH═NOR¹¹, —C(R⁹)═NOR¹¹, M-5, M-20, M-48, —Si(R^(12a))(R^(12b))R¹², —P(O)(OR²¹)₂, phenyl, phenyl substituted with (Z)_(p1) or D-1 to D-65, D-1 to D-65 are aromatic heterocyclic rings of the following formulae, respectively

Z is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxy C₁-C₄alkyl, C₁-C₄haloalkoxy C₁-C₄alkyl, C₁-C₄alkylthio C₁-C₄alkyl, C₁-C₄haloalkylthio C₁-C₄alkyl, C₁-C₄alkylsulfinyl C₁-C₄alkyl, C₁-C₄haloalkylsulfinyl C₁-C₄alkyl, C₁-C₄alkylsulfonyl C₁-C₄alkyl, C₁-C₄haloalkylsulfonyl C₁-C₄alkyl, C₃-C₆cycloalkyl, C₃-C₆halocycloalkyl, —OH, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylsulfonyloxy, C₁-C₆haloalkylsulfonyloxy, C₁-C₆alkylthio, C₁-C₆haloalkylthio, C₁-C₆alkylsulfinyl, C₁-C₆haloalkylsulfinyl, C₁-C₆alkylsulfonyl, C₁-C₆haloalkylsulfonyl, —NH₂, C₁-C₆alkylamino, di(C₁-C₆alkyl)amino, C₁-C₆alkoxycarbonyl, C₁-C₆haloalkoxycarbonyl, —C(O)NH₂, C₁-C₆alkylaminocarbonyl, C₁-C₆haloalkylaminocarbonyl, di(C₁-C₆alkyl)aminocarbonyl, —C(S)NH₂, —S(O)₂NH₂, C₁-C₆alkylaminosulfonyl, di(C₁-C₆alkyl)aminosulfonyl, phenyl or phenyl arbitrarily substituted with halogen atom, when p1, p2, p3 or p4 is an integer of 2 or more, each Z may be identical with or different from each other, further, when two Zs are adjacent, the adjacent two Zs may form 5-membered or 6-membered ring together with carbon atoms to which the two Zs are bonded by forming —CH₂CH₂CH₂—, —CH₂CH₂O—, —CH₂OCH₂—, —OCH₂O—, —CH₂CH₂S—, —CH₂SCH₂—, —CH₂CH₂CH₂CH₂—, —CH₂CH₂CH₂O—, —CH₂CH₂OCH₂—, —CH₂OCH₂O—, —OCH₂CH₂O—, —CH₂CH₂CH₂S—, —OCH₂CH₂S— or —CH═CH—CH═CH—, in this case, hydrogen atoms bonded to each carbon atom forming the ring may be arbitrarily substituted with halogen atom, cyano, nitro, C₁-C₄alkyl, C₁-C₄haloalkyl, C₁-C₄alkoxy or C₁-C₄alkylthio, when R¹ is phenyl substituted with (Z)_(p1) or D-1 to D-65 and Z is present on an adjacent position of R¹ bonding position, Z together with R² may form 5- to 7-membered ring together with the carbon atom to which Z and R² are bonded by forming —CH₂CH₂—, —CH₂O—, —CH₂S—, —CH₂N(R¹³)—, —CH₂CH₂CH₂—, —CH₂CH₂O—, —CH₂OCH₂—, —CH₂CH₂S—, —CH₂SCH₂—, —CH₂CH₂N(R¹³)—, —CH₂N(R¹³)CH₂—, —CH₂CH₂CH₂CH₂—, —CH₂CH₂CH₂O—, —CH₂CH₂CH₂S— or —CH₂CH₂CH₂N(R¹³)—, in this case, the hydrogen atom bonded to each carbon atom forming the ring may be arbitrarily substituted with halogen atom, cyano, nitro, C₁-C₄alkyl, C₁-C₄haloalkyl, C₁-C₄alkoxy or C₁-C₆alkylthio, E-1 to E-50 are saturated heterocyclic rings of the following formulae, repectively

R⁴ is halogen atom, cyano, C₃-C₈cycloalkyl, C₃-C₈halocycloalkyl, E-5 to E-50, —OH, —OR⁵, —SH, —S(O)_(r)R⁵, —N(R⁷)R⁶, —N(R⁷)C(O)R^(9a), —N(R⁷)C(O)OR^(9a), —N(R⁷)C(O)SR^(9a), —N(R⁷)C(S)OR^(9a), —N(R⁷)C(S)SR^(9a), —N(R⁷)S(O)₂R^(9a), —C(O)OR⁹, —C(O)N(R¹⁰)R⁹, —Si(R^(12a))(R^(12b))R¹², phenyl, phenyl substituted with (Z)_(p1) or D-1 to D-65, R⁵ is C₁-C₆alkyl, C₁-C₆alkyl arbitrarily substituted with R²⁴, C₃-C₈cycloalkyl, C₃-C₈cycloalkyl arbitrarily substituted with R²⁴, E-3 to E-10, E-24 to E-32, E-35, E-46, C₂-C₆alkenyl, C₂-C₆alkenyl arbitrarily substituted with R²⁴, C₃-C₈cycloalkenyl, C₃-C₈halocycloalkenyl, C₃-C₆alkynyl, C₃-C₆alkynyl arbitrarily substituted with R²⁴, C₁-C₆alkylcarbonyl, C₁-C₆alkoxycarbonyl, phenyl, phenyl substituted with (Z)_(p1), D-1 to D-4, D-6 to D-13, D-15 to D-23, D-25 to D-37, D-39, D-40, D-42, D-43, D-45, D-47, D-50 to D-64 or D-65, R⁶ is C₁-C₆alkyl, C₁-C₆alkyl arbitrarily substituted with R²⁴, C₃-C₈cycloalkyl, C₃-C₈halocycloalkyl, C₃-C₆alkenyl, C₃-C₆haloalkenyl, C₃-C₆alkynyl, C₃-C₆haloalkynyl, —CHO, —C(O)R⁹, —C(O)OR⁹, —C(O)SR⁹, —C(O)NH₂, —C(O)N(R¹⁰)R⁹, —C(S)OR⁹, —C(S)SR⁹, —C(S)NH₂, —C(S)N(R¹⁰)R⁹, —C(O)C(O)R⁹, —C(O)C(O)OR⁹, —OH, —S(O)₂R⁹, —S(O)₂N(R¹⁰)R⁹, —P(O)(OR²¹)₂ or —P(S)(OR²¹)₂, R⁷ is hydrogen atom, C₁-C₆alkyl, C₁-C₆alkyl arbitrarily substituted with R²⁴, C₃-C₈cycloalkyl, C₃-C₆alkenyl, C₃-C₆haloalkenyl, C₃-C₆alkynyl, C₃-C₆haloalkynyl, —CHO, C₁-C₆alkylcarbonyl, C₁-C₆haloalkylcarbonyl or C₁-C₆alkoxycarbonyl, or R⁷ together with R⁶ may form 3- to 7-membered ring together with the nitrogen atom bonding them by forming C₂-C₆alkylene chain, in this case, the alkylene chain may contain one oxygen atom, sulfur atom or nitrogen atom, and may be arbitrarily substituted with halogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, oxo or thioxo, R⁸ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆alkenyl, phenyl or phenyl substituted with (Z)_(p1), R⁹ is C₁-C₆alkyl, C₁-C₆alkyl arbitrarily substituted with R²⁴, C₃-C₈cycloalkyl, C₃-C₈halocycloalkyl, E-1 to E-50, C₃-C₆alkenyl, C₃-C₆haloalkenyl, C₃-C₆alkynyl or C₃-C₆haloalkynyl, R^(9a) is phenyl, phenyl substituted with (Z)_(p1) or D-1 to D-65, R¹⁰ is hydrogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkyl C₁-C₄alkyl, C₁-C₆alkoxy C₁-C₄alkyl, C₁-C₆alkylthio C₁-C₄alkyl, cyano C₁-C₆alkyl, C₃-C₆alkenyl or C₃-C₆alkynyl, or R¹⁰ together with R⁹ may form 3- to 7-membered ring with the nitrogen atom bonding them by forming C₂-C₆alkylene chain, in this case, the alkylene chain may contain one oxygen atom, sulfur atom or nitrogen atom, and may be arbitrarily substituted with halogen atom, C₁-C₆alkyl, C₁-C₆alkoxy, —CHO, C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R¹¹ is hydrogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, phenyl C₁-C₄alkyl, phenyl C₁-C₄alkyl substituted with (Z)_(p1), C₃-C₆alkenyl, C₃-C₆haloalkenyl, C₃-C₆alkynyl or C₃-C₆haloalkynyl, R¹² is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy, phenyl or phenyl substituted with (Z)_(p1), R^(12a) and R^(12b) independently of each other are C₁-C₆alkyl, C₁-C₆haloalkyl or C₁-C₆alkoxy, R¹³ is hydrogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxycarbonyl C₁-C₄alkyl, C₁-C₆haloalkoxycarbonyl C₁-C₄alkyl, phenyl C₁-C₄alkyl, phenyl C₁-C₄alkyl substituted with (Z)_(p1), C₂-C₆alkenyl, C₂-C₆haloalkenyl, C₃-C₆alkynyl, C₃-C₆haloalkynyl, C₁-C₆alkoxy, C₁-C₆alkoxycarbonyl, C₁-C₆haloalkoxycarbonyl, phenyl or phenyl substituted with (Z)_(p1), further, in case where Z is present in an adjacent position of R¹³, the adjacent R¹³ and Z may form 6-membered ring together with the atom bonding them by forming —CH₂CH₂CH₂CH₂—, —CH═CH—CH═CH—, —N═CH—CH═CH—, —CH═N—CH═CH—, —CH═CH—N═CH— or —CH═CH—CH═N—, in this case, hydrogen atoms bonded to each carbon atom forming the ring may be arbitrarily substituted with halogen atom, C₁-C₄alkyl or C₁-C₄haloalkyl, R¹⁴ is cyano, nitro, C₃-C₈cycloalkyl, C₃-C₈halocycloalkyl, hydroxy C₃-C₆cycloalkyl, C₁-C₄alkoxy C₃-C₆cycloalkyl, E-10 to E-12, E-19, E-24 to E-29, E-31 to E-33, E-44, —OR²⁵, —N(R²⁶)R²⁵, —SH, —S(O)_(r)R²⁷, C₅-C₈cycloalkenyl, C₅-C₈halocycloalkenyl, —CHO, —C(O)R²⁸, —C(O)OH, —C(O)OR²⁸, —C(O)SR²⁸, —C(O)NH₂, —C(O)N(R²⁹)R²⁸, —C(S)OR²⁸, —C(S)SR²⁸, —C(S)NH₂, —C(S)N(R²⁹)R²⁸, —CH═NOR³⁰, —C(R²⁸)═NOR³⁰, —C(═NR²⁹)OR²⁸, —C(═NR²⁹)SR²⁸, —C(═NR²⁹)N(R^(29a))R^(28a), —C(═NOR³⁰)N(R^(29a))R^(28a), —C(O)C(O)OR²⁸, —SO₂OH, —SO₂NH₂, —SO₂N(R²⁹)R²⁸, —Si(R^(12a))(R^(12b))R¹², —P(O)(OR²¹)₂, —P(S)(OR²¹)₂, —P(phenyl)₂, —P(O)(phenyl)₂, M-1 to M-48, phenyl, phenyl substituted with (Z)_(p1), naphthyl, D-1 to D-4, D-15 to D-17, D-21 to D-23, D-52 to D-58 or D-59, M-1 to M-48 are partially saturated heterocyclic rings of the following formulae, respectively

R^(14a) is cyano, nitro, —OR²⁵, —N(R²⁶)R²⁵, —S(O)_(r)R²⁷, —CHO, —C(O)R²⁸, —C(O)OR²⁸, —C(O)SR²⁸, —C(O)NH₂, —C(S)OR²⁸, —C(S)SR²⁸, —C(S)NH₂, —C(O)C(O)OR²⁸, —Si(R^(12a))(R^(12b))R¹², —P(O)(OR²¹)₂, —P(S)(OR²¹)₂ or phenyl, R^(14b) is C₁-C₆alkyl or C₃-C₆cycloalkyl, R¹⁵ is C₁-C₆alkyl, C₁-C₆alkyl arbitrarily substituted with R³¹, C₃-C₈cycloalkyl, C₃-C₈halocycloalkyl, E-1 to E-50, C₂-C₆alkenyl, C₂-C₆haloalkenyl, C₃-C₈cycloalkenyl, C₃-C₈halocycloalkenyl, C₂-C₆alkynyl, C₂-C₆haloalkynyl, phenyl, phenyl substituted with (Z)_(p1), naphthyl or D-1 to D-65, R¹⁶ is hydrogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkyl C₁-C₄alkyl, C₁-C₆alkoxy C₁-C₄alkyl, C₁-C₆alkylthio C₁-C₄alkyl, cyanoC₁-C₆alkyl, C₃-C₆alkenyl or C₃-C₆alkynyl, or R¹⁶ together with R¹⁵ may form 3- to 7-membered ring with the nitrogen atom bonding them by forming C₂-C₆alkylene chain, in this case, the alkylene chain may contain one oxygen atom, sulfur atom or nitrogen atom, and may be arbitrarily substituted with halogen atom, C₁-C₆alkyl, C₁-C₆alkoxy, —CHO, C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R¹⁷ is hydrogen atom, C₁-C₆alkyl, C₁-C₆alkyl arbitrarily substituted with R¹⁴, C₃-C₆cycloalkyl, C₃-C₈halocycloalkyl, E-6, E-8, E-10, E-25, E-26, E-28, E-29, E-31, E-32, C₃-C₆alkenyl, C₃-C₆haloalkenyl, C₃-C₆alkynyl, C₃-C₆haloalkynyl, —CHO, —C(O)R²⁸, —C(O)OR²⁸, —C(O)SR²⁸, —C(O)NH₂, —C(O)N(R²⁹)R²⁸, —C(S)OR²⁸, —C(S)SR²⁸, —C(S)NH₂, —C(S)N(R²⁹)R²⁸, —S(O)₂R²⁸, —S(O)₂NH₂, —S(O)₂N(R²⁹)R²⁸, —P(O)(OR²¹)₂, —P(S)(OR²¹)₂, phenyl, phenyl substituted with (Z)_(p1), D-1 to D-13, D-15 ro D-25, D-30 to D-37, D-42, D-43, D-45, D-50 to D-64 or D-65, R^(17a) is hydrogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy C₁-C₄alkyl, C₁-C₆alkylthio C₁-C₄alkyl, C₁-C₄alkylsulfonyl C₁-C₄alkyl, C₁-C₄alkoxycarbonyl C₁-C₄alkyl, phenyl C₁-C₄alkyl, phenyl C₁-C₄alkyl substituted with (Z)_(p1), C₃-C₆cycloalkyl, E-1 to E-50, phenyl C₂-C₄alkenyl, di(C₁-C₆alkyl)amino, phenyl, phenyl substituted with (Z)_(p1) or D-1 to D-65, R^(17b) is hydrogen atom, C₁-C₆alkyl, C₁-C₆alkoxy, C₁-C₆alkylthio or di(C₁-C₆alkyl)amino, or R^(17b) together with R^(17a) may form 4- to 6-membered ring with the carbon atom bonding them by forming C₃-C₅alkylene chain or C₄-C₅alkenylene chain, in this case, the alkylene chain or the alkenylene chain may contain one oxygen atom, sulfur atom or nitrogen atom, and may be arbitrarily substituted with halogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, —CHO, C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R¹⁸ is hydrogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy C₁-C₄alkyl, C₁-C₄haloalkoxy C₁-C₄alkyl, C₁-C₄alkylthio C₁-C₄alkyl, C₁-C₄haloalkylthio C₁-C₄alkyl, C₁-C₄alkylsulfonyl C₁-C₄alkyl, C₁-C₆haloalkylsulfonyl C₁-C₄alkyl, cyanoC₁-C₆alkyl, C₁-C₄alkoxycarbonyl C₁-C₄alkyl, phenyl C₁-C₄alkyl, C₂-C₆alkenyl, C₂-C₆haloalkenyl, C₃-C₆alkynyl, C₃-C₆haloalkynyl, —CHO, —C(O)R¹⁵, —C(O)OR¹⁵, —C(O)SR¹⁵, —C(S)OR¹⁵ —C(S)SR¹⁵, C₁-C₆alkylsulfonyl or C₁-C₆haloalkylsulfonyl, or R¹⁸ together with R¹⁷ may form 5- to 6-membered ring with the nitrogen atom bonding them by forming C₄-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom, sulfur atom or nitrogen atom, and may be arbitrarily substituted with C₁-C₆alkyl, C₁-C₆alkoxy C₁-C₆alkyl, —CHO, C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R¹⁹ is C₁-C₁₂alkyl, C₁-C₁₂haloalkyl, C₁-C₁₂alkoxy C₁-C₁₂alkyl, cyanoC₁-C₁₂alkyl, C₁-C₁₂alkoxycarbonyl C₁-C₁₂alkyl, phenyl C₁-C₆alkyl, phenyl C₁-C₆alkyl substituted with (Z)_(p1), C₃-C₁₂alkenyl, C₃-C₁₂haloalkenyl, C₃-C₁₂alkynyl, C₃-C₁₂haloalkynyl, C₁-C₁₂alkylcarbonyl, C₁-C₁₂alkoxycarbonyl, —C(O)ON═C(CH₃)SCH₃, —C(O)ON═C(SCH₃)C(O)N(CH₃)₂, phenyl or phenyl substituted with (Z)_(p1) R²⁰ is C₁-C₁₂alkyl, C₁-C₁₂haloalkyl, C₁-C₁₂alkoxy C₁-C₁₂alkyl, cyanoC₁-C₁₂alkyl, C₁-C₁₂alkoxycarbonyl C₁-C₁₂alkyl, phenyl C₁-C₆alkyl, phenyl C₁-C₆alkyl substituted with (Z)_(p1), C₃-C₁₂alkenyl, C₃-C₁₂haloalkenyl, C₃-C₁₂alkynyl, C₃-C₁₂haloalkynyl, phenyl or phenyl substituted with (Z)_(p1), or R²⁰ together with R¹⁹ may form 5- to 8-membered ring with the nitrogen atom bonding them by forming C₄-C₇alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom, and may be arbitrarily substituted with C₁-C₄alkyl or C₁-C₄alkoxy, R²¹ is C₁-C₆alkyl or C₁-C₆haloalkyl, R²² is halogen atom, cyano, C₁-C₆alkyl, C₁-C₆haloalkyl, hydroxyC₁-C₆alkyl, C₁-C₄alkoxyC₁-C₄alkyl, C₁-C₄alkoxycarbonyl C₁-C₄alkyl, C₁-C₄alkoxy, C₁-C₆alkylthio, C₁-C₆alkylamino, di(C₁-C₄alkyl)amino, C₁-C₆alkoxycarbonyl, phenyl or phenyl substituted with (Z)_(p1), when q1 to q8 are integers of 2 or more, each R²² may be identical with or different from each other, further, when two R²²S are present on the same carbon atom, the two R²²S together may form oxo, thioxo, imino, C₁-C₆alkylimino, C₁-C₆alkoxyimino or C₁-C₆alkylidene, R²³ is hydrogen atom, C₁-C₆alkyl, C₁-C₆alkyl arbitrarily substituted with R³¹, C₃-C₆cycloalkyl, C₃-C₆alkenyl, C₃-C₆haloalkenyl, C₃-C₆alkynyl, —OH, benzyloxy, —CHO, —C(O)R³², —C(O)OR³², —C(O)SR³², —C(O)NHR³³, —C(O)N(R³³)R³², —C(S)NHR³³, —C(S)N(R³³)R³², —S(O)₂R³², —P(O)(OR²¹)₂, —P(S)(OR²¹)₂, phenyl, phenyl substituted with (Z)_(p1) or D-5, R²⁴ is halogen atom, cyano, C₃-C₈cycloalkyl, C₃-C₈halocycloalkyl, E-1 to E-50, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylthio, C₁-C₆haloalkylthio, C₁-C₆alkylsulfonyl, C₁-C₆haloalkylsulfonyl, C₁-C₆alkylamino, di(C₁-C₆alkyl)amino, —CHO, C₁-C₆alkylcarbonyl, C₁-C₆haloalkylcarbonyl, C₁-C₆alkoxycarbonyl, C₁-C₆haloalkoxycarbonyl, C₁-C₆alkylaminocarbonyl, di(C₁-C₆alkyl)aminocarbonyl, phenyl, phenyl substituted with (Z)_(p1), or D-1 to D-65, R²⁵ is hydrogen atom, C₁-C₈alkyl, C₁-C₈alkyl arbitrarily substituted with R³¹, C₃-C₈cycloalkyl, C₃-C₈cycloalkyl arbitrarily substituted with R³¹, E-3 to E-10, E-24 to E-32, E-35, E-46, C₃-C₈alkenyl, C₃-C₈alkenyl arbitrarily substituted with R³¹, C₃-C₈alkynyl, C₃-C₈alkynyl arbitrarily substituted with R³¹, —CHO, —C(O)R³², —C(O)OR³², —C(O)SR³², —C(O)NHR³³, —C(O)N(R³³)R³², —C(S)R³², —C(S)OR³², —C(S)SR³², —C(S)NHR³³, —C(S)N(R³³)R³², —C(O)C(O)R³², —C(O)C(O)OR³², —SO₂R³², —S(O)₂N(R³³)R³², —Si(R^(12a))(R^(12b))R¹², —P(O)(OR²¹)₂, —P(S)(OR²¹)₂, phenyl, phenyl substituted with (Z)_(p1), D-1 to D-4, D-6 to D-13, D-15 to D-23, D-25 to D-37, D-39, D-40, D-42, D-43, D-45, D-47, D-50 to D-64 or D-65, R²⁶ is hydrogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxy C₁-C₄alkyl, C₁-C₄alkylthio C₁-C₄alkyl, C₃-C₆cyclloalkyl, C₃-C₆alkenyl, C₃-C₆alkynyl, C₁-C₆alkoxy, phenyl or phenyl substituted with (Z)_(p1), or R²⁶ together with R²⁵ may form 3- to 7-membered ring with the nitrogen atom bonding them by forming C₂-C₆alkylene chain, in this case, the alkylene chain may contain one oxygen atom, sulfur atom or nitrogen atom, and may be arbitrarily substituted with halogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy, —CHO, C₁-C₆alkylcarbonyl, C₁-C₆alkoxycarbonyl, phenyl, phenyl substituted with (Z)_(p1), oxo or thioxo, R²⁷ is C₁-C₈alkyl, C₁-C₈alkyl arbitrarily substituted with R³¹, C₃-C₈cycloalkyl, C₃-C₈cycloalkyl arbitrarily substituted with R³¹, E-3, E-5 to E-10, E-24 to E-32, E-35, E-46, C₃-C₈alkenyl, C₃-C₈alkenyl arbitrarily substituted with R³¹, C₃-C₈alkynyl, C₃-C₈alkynyl arbitrarily substituted with R³¹, —CHO, —C(O)R³², —C(O)OR³², —C(O)SR³², —C(O)NHR³³, —C(O)N(R³³)R³², —C(S)R³², —C(S)OR³², —C(S)SR³², —C(S)NHR³³ —C(S)N(R³³)R³², —C(O)C(O)R³², —C(O)C(O)OR³², —SH, C₁-C₆alkylthio, C₁-C₈haloalkylthio, phenylthio, phenylthio substituted with (Z)_(p1), —P(O)(OR²¹)₂, —P(S)(OR²¹)₂, phenyl or phenyl substituted with (Z)_(p1), D-18, D-21, D-25, D-30 to D-35, D-50, D-52, D-55 or D-56, R²⁸ and R^(28a) independently of each other are C₁-C₆alkyl, C₁-C₆alkyl arbitrarily substituted with R³¹, C₃-C₈cycloalkyl, C₃-C₈cycloalkyl arbitrarily substituted with R³¹, C₂-C₈alkenyl C₃-C₈cycloalkyl, C₂-C₆haloalkenyl C₃-C₈cycloalkyl, E-1 to E-50, C₂-C₈alkenyl, C₂-C₈alkenyl arbitrarily substituted with R³¹, C₂-C₈alkynyl, C₂-C₈alkynyl arbitrarily substituted with R³¹, phenyl, phenyl substituted with (Z)_(p1) or D-1 to D-65, R²⁹ and R^(29a) independently of each other are hydrogen atom, C₁-C₆alkyl, C₁-C₆alkyl arbitrarily substituted with R³¹, C₃-C₆alkenyl, C₃-C₆haloalkenyl, C₃-C₆alkynyl, C₃-C₆haloalkynyl, phenyl or phenyl substituted with (Z)_(p1), or R²⁹ together with R²⁸ may form 3- to 6-membered ring with the nitrogen atom bonding them by forming C₂-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom, sulfur atom or nitrogen atom, and may be arbitrarily substituted with halogen atom, C₁-C₆alkyl, C₁-C₆alkoxy, —CHO, C₁-C₆alkylcarbonyl, C₁-C₆alkoxycarbonyl, phenyl or phenyl substituted with (Z)_(p1), R³⁰ is C₁-C₈alkyl, C₁-C₈alkyl arbitrarily substituted with R³¹, C₃-C₈cycloalkyl, C₃-C₈alkenyl, C₃-C₈alkenyl arbitrarily substituted with R³¹, C₃-C₈alkynyl or C₃-C₈alkynyl arbitrarily substituted with R³¹, R³¹ is halogen atom, cyano, nitro, C₃-C₈cycloalkyl, C₃-C₈halocycloalkyl, E-5 to E-8, E-11 to E-15, E-19, E-20, E-24 to E-29, E-33 to E-39, E-44 to E-46, —OH, —OR³², —OC(O)R³², —OC(O)OR³², —OC(O)NHR³³, —OC(O)N(R³³)R³², —OC(S)NHR³³ —OC(S)N(R³³)R³², —SH, —S(O)_(r)R³², —SC(O)R³², —SC(O)OR³², —SC(O)NHR³³, —SC(O)N(R³³)R³², —SC(S)NHR³³, —SC(S)N(R³³)R³², —NHR³³, —N(R³³)R³², —N(R³³)CHO, —N(R³³)C(O)R³², —N(R³³)C(O)OR³², —N(R³³)C(O)NHR^(33a), —N(R³³)C(O)N(R^(33a))R³², —N(R³³)C(S)NHR^(33a), —N(R³³)C(S)N(R^(33a))R³², —CHO, —C(O)R³², —C(O)OH, —C(O)OR³², —C(O)SR³², —C(O)NHR³³, —C(O)N(R³³)R³², —C(O)C(O)OR³², —Si(R^(12a))(R^(12b))R¹² —P(O)(OR²¹)₂, —P(S)(OR²¹)₂, —P(phenyl)₂, —P(O)(phenyl)₂, phenyl, phenyl substituted with (Z)_(p1), or D-1 to D-65, R³² is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkyl arbitrarily substituted with R³⁴, C₃-C₆cycloalkyl, C₃-C₆halocycloalkyl, C₂-C₆alkenyl C₃-C₈cycloalkyl, C₂-C₆haloalkenyl C₃-C₈cycloalkyl, E-5 to E-8, E-24 to E-29, C₂-C₈alkenyl, C₂-C₈haloalkenyl, C₃-C₈cycloalkenyl, C₃-C₈halocycloalkenyl, C₂-C₈alkynyl, C₂-C₆haloalkynyl, phenyl, phenyl substituted with (Z)_(p1) or D-1 to D-65, R³³ and R^(33a) independently of each other are hydrogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₈cycloalkyl, C₃-C₆alkenyl, C₃-C₆alkynyl, C₁-C₆alkylcarbonyl, C₁-C₆haloalkylcarbonyl, C₁-C₆alkoxycarbonyl, C₁-C₆haloalkoxycarbonyl, phenoxycarbonyl, phenoxycarbonyl substituted with (Z)_(p1), phenylcarbonyl, phenylcarbonyl substituted with (Z)_(p1), C₁-C₆alkylsulfonyl, C₁-C₆haloalkylsulfonyl, phenyl, phenyl substituted with (Z)_(p1), D1 to D-4, D-6 to D-13, D-15 to D-23, D-25 to D-37, D-39, D-40, D-42, D-43, D-45, D-47, D-50 to D-64 or D-65, or R³³ together with R³² may form 3- to 6-membered ring with the nitrogen atom bonding them by forming C₂-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom, sulfur atom or nitrogen atom, and may be arbitrarily substituted with halogen atom, C₁-C₆alkyl, C₁-C₆alkoxy, —CHO, C₁-C₆alkylcarbonyl, C₁-C₆alkoxycarbonyl, phenyl or phenyl substituted with (Z)_(p1), R³⁴ is cyano, C₃-C₆cycloalkyl, C₃-C₆halocycloalkyl, E-5 to E-8, E-24 to E-29, C₁-C₄alkoxy, C₁-C₄haloalkoxy, phenoxy, phenoxy substituted with (Z)_(p1), C₁-C₄alkylthio, C₁-C₄haloalkylthio, C₁-C₄alkylsulfonyl, C₁-C₄haloalkylsulfonyl, phenylthio, phenylthio substituted with (Z)_(p1), —N(R³⁶)R³⁵, C₁-C₆alkylcarbonyl, C₁-C₆haloalkylcarbonyl, C₁-C₆alkoxycarbonyl, di(C₁-C₆alkyl)aminocarbonyl, tri(C₁-C₄alkyl)silyl, phenyl, phenyl substituted with (Z)_(p1), naphthyl or D-1 to D-65, R³⁵ is hydrogen atom, C₁-C₆alkyl, C₁-C₆alkylcarbonyl, C₁-C₆haloalkylcarbonyl, C₁-C₆alkoxycarbonyl, phenylcarbonyl or phenylcarbonyl substituted with (Z)_(p1), R³⁶ is hydrogen atom or C₁-C₆alkyl, m is an integer of 0 to 5, n is an integer of 0 to 4, p1 is an integer of 1 to 5, p2 is an integer of 0 to 4, p3 is an integer of 0 to 3, p4 is an integer of 0 to 2, p5 is an integer of 0 or 1, q1 is an integer of 0 to 3, q2 is an integer of 0 to 5, q3 is an integer of 0 to 7, q4 is an integer of 0 to 9, q5 is an integer of 0 to 6, q6 is an integer of 0 to 4, q7 is an integer of 0 to 2, q8 is an integer of 0 to 8, r is an integer of 0 to 2, and t is an integer of 0 or 1. (2) The isoxazoline-substituted benzamide compound or the salt thereof as set forth in (1), wherein G is an aromatic 6-membered ring shown in any one of G-1, G-3 or G-4 or an aromatic 5-membered ring shown in any one of G-13, G-14, G-17, G-18, G-20, G-21 or G-22

X is halogen atom, cyano, nitro, —SF₅, C₁-C₆alkyl, C₁-C₆alkyl arbitrarily substituted with R⁴, C₃-C₈cycloalkyl, C₃-C₈haloycloalkyl, C₂-C₆alkenyl, C₂-C₆halolkenyl, C₂-C₆alkynyl, C₂-C₆halolkynyl, —OH, —OR⁵, —OSO₂R⁵, —S(O)_(r)R⁵ or tri(C₁-C₆alkyl)silyl, when m is an integer of 2 or 3, each X may be identical with or different from each other, further, when two Xs are adjacent, the adjacent two Xs may form 5-membered or 6-membered ring together with carbon atoms to which the two Xs are bonded by forming —CF₂OCF₂—, —OCF₂O—, —CF₂OCF₂O— or —OCF₂ CF₂O—, Y is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆alkyl arbitrarily substituted with R⁴, C₂-C₆alkynyl, tri(C₁-C₆alkyl)silylethynyl, —OR⁵, —OSO₂R⁵, —S(O)_(r)R⁵, —NH₂, —N(R⁷)R⁶, —N═C(R⁹)OR⁸, —C(O)NH₂ or —C(S)NH₂, when n is 2, each Y may be identical with or different from each other, R¹ is —C(R^(1b))═NOR^(1a), M-5, M-20, —C(O)OR^(1c), —C(O)SR^(1c), —C(S)OR^(1c), —C(S)SR^(1c), —C(O)N(R^(1e))R^(1d), —C(S)N(R^(1e))R^(1d), —C(R^(1b))═NN(R^(1e))R^(1f), phenyl, phenyl substituted with (Z)_(p1), D-1 to D-5, D-7 to D-17, D-21 to D-45, D-47 to D-63 or D-65, R^(1a) is hydrogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R¹⁴, C₃-C₆cycloalkyl, E-4, E-6, E-8, E-10, E-25, E-26, E-28, E-29, E-31, E-32, E-35, C₃-C₆alkenyl, C₃-C₆haloalkenyl, C₃-C₆alkynyl, C₃-C₆haloalkynyl, phenylC₃-C₆alkynyl, phenyl or phenyl substituted with (Z)_(p1), R^(1b) is hydrogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxyC₁-C₄alkyl, C₁-C₄alkylthioC₁-C₄alkyl or C₃-C₆cycloalkyl, R^(1c) is C₁-C₆alkyl, C₁-C₄alkyl arbitrarily substituted with R¹⁴, C₃-C₆cycloalkyl, E-5, E-6, E-8, E-10, E-25, E-26, E-28, E-29, E-31, E-32, E-35, C₂-C₆alkenyl, C₃-C₆haloalkenyl, C₃-C₆alkynyl, C₃-C₆haloalkynyl, phenyl or phenyl substituted with (Z)_(p1), R^(1d) is hydrogen atom, —C(O)R¹⁵, —C(O)OR¹⁵, —C(O)SR¹⁵, —C(S)OR¹⁵, —C(S)SR¹⁵ or —S(O)₂R¹⁵, R^(1e) is hydrogen atom or C₁-C₆alkyl, R^(1f) is C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R² is C₁-C₆alkyl, —CH₂R^(14a), E-5, E-24, C₃-C₆alkynyl, —C(O)R¹⁵, —C(O)OR¹⁵, —C(O)SR¹⁵, —C(S)OR¹⁵, —C(S)SR¹⁵, —C(O)C(O)OR¹⁵, C₁-C₆alkylthio, C₁-C₆haloalkylthio, phenylthio, C₁-C₆alkylsulfonyl, —SN(R²⁰)R¹⁹, phenyl or phenyl substituted with (Z)_(p1), further when R¹ is —C(R^(1b))═NOR^(1a), M-5, M-20 or —C(R^(1b))═NN(R^(1e))R^(1f), R² may be hydrogen atom or C₃-C₆alkenyl, when R¹ is —C(O)OR^(1c), —C(O)SR^(1c), —C(S)OR^(1c) or —C(S)SR^(1c), R² may be hydrogen atom, when R¹ is —C(O)N(R^(1e))R^(1d) or —C(S)N(R^(1e))R^(1d), R² may be hydrogen atom, C₁-C₆haloalkyl, C₃-C₆cycloalkylC₁-C₄alkyl, C₃-C₆cycloalkyl or C₃-C₆alkenyl, when R¹ is phenyl, phenyl substituted with (Z)_(p1) or D-1 to D-5, D7 to D-17, D21 to D-45, D-47 to D-63 or D-65, R² may be C₁-C₆haloalkyl, C₃-C₆cycloalkyl, C₃-C₆alkenyl, —C(O)NH₂, di(C₁-C₆alkyl)aminocarbonyl, —N(R¹⁸)R¹⁷ or —N═C(R^(17b))R^(17a), or R² together with R¹ may form ═C(R^(2b))R^(2a), R^(2a) is —OR^(1c), —SR^(1c) or di(C₁-C₆alkyl)amino, R^(2b) is R^(1b), C₁-C₆alkylthio, C₁-C₆haloalkylthio, —SCH₂R^(14a), C₃-C₆alkenylthio, C₃-C₆haloalkenylthio, C₃-C₆alkynylthio, C₃-C₆haloalkynylthio or —SC(O)R¹⁵, R³ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxy C₁-C₄haloalkyl, C₁-C₄haloalkoxy C₁-C₄haloalkyl, C₁-C₄alkylthio C₁-C₄haloalkyl, C₁-C₄haloalkylthio C₁-C₆haloalkyl, cyano C₁-C₆haloalkyl, C₃-C₆cycloalkyl or C₃-C₈halocycloalkyl, Z is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylsulfonyloxy, C₁-C₆haloalkylsulfonyloxy, C₁-C₆alkylthio, C₁-C₆haloalkylthio, C₁-C₆alkylsulfinyl, C₁-C₆haloalkylsulfinyl, C₁-C₆alkylsulfonyl, C₁-C₆haloalkylsulfonyl, C₁-C₆alkoxycarbonyl, —C(O)NH₂, —C(S)NH₂ or phenyl, when p1, p2, p3 or p4 is an integer of 2 or more, each Z may be identical with or different from each other, further, when two Zs are adjacent, the adjacent two Zs may form 5-membered or 6-membered ring together with carbon atoms to which the two Zs are bonded by forming —OCH₂O— or —OCH₂CH₂O—, in this case, hydrogen atoms bonded to each carbon atom forming the ring may be arbitrarily substituted with halogen atom, R⁴ is halogen atom, —OH, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylthio, C₁-C₆haloalkylthio, C₁-C₆alkylsulfinyl, C₁-C₆haloalkylsulfinyl, C₁-C₆alkylsulfonyl or C₁-C₆haloalkylsulfonyl, R⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₃haloalkoxy C₁-C₃haloalkyl, C₂-C₆alkenyl, C₂-C₆haloalkenyl, C₃-C₆alkynyl, C₃-C₆haloalkynyl or C₁-C₆alkoxycarbonyl, R⁶ is C₁-C₆alkyl, C₁-C₆haloalkyl, —CHO, —C(O)R⁹, —C(O)OR⁹, —C(O)SR⁹, —C(S)OR⁹, —C(S)SR⁹ or —S(O)₂R⁹, R⁷ is hydrogen atom, C₁-C₆alkyl or C₁-C₆haloalkyl, R⁸ is C₁-C₆alkyl, R⁹ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₈cycloalkyl or C₃-C₈halocycloalkyl, R¹³ is C₁-C₆alkyl, C₁-C₆haloalkyl or phenyl, R¹⁴ is cyano, nitro, C₃-C₆cycloalkyl, C₃-C₆halocycloalkyl, E-5 to E-8, E-10 to E-12, E-19, E-24 to E-29, E-31 to E-33, E-44, —OR²⁵, —N(R²⁶)R²⁵, —S(O)_(r)R²⁷, C₅-C₆cycloalkenyl, C₅-C₈halocycloalkenyl, M-1, —CHO, C₁-C₆alkylcarbonyl, —C(O)R²⁸, —C(O)SR²⁸, —C(O)NH₂, —C(O)N(R²⁹)R²⁸, M-11, M-28, —C(S)OR²⁸, —C(S)SR²⁸, —C(S)NH₂, —C(S)N(R²⁹)R²⁸, M-14, M-32, —CH═NOR³⁰, —C(R²⁸)═NOR³⁰, M-5, —SO₂N(R²⁹)R²⁸, tri(C₁-C₆alkyl)silyl, phenyl, phenyl substituted with (Z)_(p1), D-1, D-2, D-52, D-53 or D-54, R^(14a) is cyano, —OR²⁵, —N(R²⁶)R²⁵, —S(O)_(r)R²⁷, —CHO, C₁-C₆alkylcarbonyl, phenylcarbonyl, C₁-C₆alkoxycarbonyl, tri(C₁-C₆alkyl)silyl or phenyl, R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³¹, C₃-C₆cycloalkyl, C₂-C₆alkenyl, C₂-C₆haloalkenyl, C₃-C₈halocycloalkenyl, C₂-C₆alkynyl, phenyl, phenyl substituted with (Z)_(p1), naphthyl, D-1 to D-4, D-28, D-52, D-53 or D-54, R¹⁷ is hydrogen atom, C₁-C₆alkyl, —CHO, —C(O)R²⁸, —C(O)OR²⁸, —C(O)NH₂, —C(O)N(R²⁹)R²⁸, —S(O)₂R²⁸, —S(O)₂NH₂, —S(O)₂N(R²⁹)R²⁸ or phenyl, R^(17a) is C₁-C₆alkyl, di(C₁-C₆alkyl)amino, phenyl, phenyl substituted with (Z)_(p1), D-52, D-53 or D-54, R^(17b) is hydrogen atom or C₁-C₆alkyl, R¹⁸ is hydrogen atom, C₁-C₆alkyl or C₁-C₆alkylcarbonyl, R¹⁹ is C₁-C₆alkyl, C₁-C₄alkoxy C₁-C₄alkyl, C₁-C₆alkoxycarbonyl C₁-C₄alkyl, phenyl C₁-C₄alkyl, phenyl C₁-C₄alkyl substituted with (Z)_(p1) or C₁-C₆alkoxycarbonyl, R²⁰ is C₁-C₆alkyl, phenyl C₁-C₄alkyl or phenyl C₁-C₄alkyl substituted with (Z)_(p1), or R²⁰ together with R¹⁹ may form 5- or 6-membered ring with the nitrogen atom bonding them by forming C₄-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom, and may be arbitrarily substituted with methyl or methoxy, R²¹ is C₁-C₆alkyl, R²² is C₁-C₆alkyl, C₁-C₆haloalkyl, phenyl or phenyl substituted with (Z)_(p1), when q2 is 2, each R²² may be identical with or different from each other, R²³ is —CHO, C₁-C₆alkylcarbonyl, C₁-C₆haloalkylcarbonyl or C₁-C₆alkoxycarbonyl, R²⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³¹, C₃-C₆cycloalkyl, E-6, E-8, E-25, E-26, E-28, E-29, C₃-C₆alkenyl, C₃-C₆alkynyl, —C(O)R³², —C(O)OR³², —C(O)NH₂, —C(O)N(R³³)R³², —C(S)N(R³³)R³², —SO₂R³², —S(O)₂N(R³³)R³², —P(O)(OR²¹)₂, —P(S)(OR²¹)₂ or phenyl, R²⁶ is hydrogen atom, C₁-C₆alkyl, C₁-C₆alkoxy or phenyl, or R²⁶ together with R²⁵ may form 5- to 7-membered ring with the nitrogen atom bonding them by forming C₄-C₆alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom, R²⁷ is C₁-C₈alkyl, C₁-C₈haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³¹C₃-C₆alkenyl, C₃-C₆alkynyl, C₁-C₆alkylthio, —C(O)R³², —C(O)N(R³³)R³², —C(S)R³², —C(S)OR³², —C(S)N(R³³)R³², phenyl, D-21, D-34, D-35, D-50, D-52 or D-55, R²⁸ is C₁-C₆alkyl, C₁-C₆haloalkyl or phenyl, R²⁹ is hydrogen atom or C₁-C₆alkyl, or R²⁹ together with R²⁸ may form 5- to 6-membered ring with the nitrogen atom bonding them by forming C₄-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom, R³⁰ is C₁-C₆alkyl, R³¹ is cyano, C₃-C₆cycloalkyl, C₃-C₆halocycloalkyl, E-5 to E-8, E-11, E-19, —OR³², —OC(O)R³², —OC(O)OR³², C₁-C₄alkylthio, phenylthio, C₁-C₄alkylsulfinyl, C₁-C₄alkylsulfonyl, C₁-C₄alkoxycarbonyl, phenyl or phenyl substituted with (Z)_(p1), R³² is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³⁴, C₃-C₆cycloalkyl, C₂-C₆alkenyl, phenyl, D-1 to D-4, D-14, D-52, D-53 or D-54, R³³ is hydrogen atom or C₁-C₆alkyl, or R³³ together with R³² may form 5- to 6-membered ring with the nitrogen atom bonding them by forming C₄-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom, R³⁴ is E-5, C₁-C₄alkoxy, phenoxy, C₁-C₄alkylthio, phenylthio, —N(R³⁶)R³⁵, phenyl, D-1, D-3, D-52, D-53 or D-54, R³⁵ is hydrogen atom, C₁-C₆alkyl, C₁-C₆alkoxycarbonyl or phenylcarbonyl, R³⁶ is hydrogen atom or C₁-C₆alkyl, m is an integer of 1 to 3, n is an integer of 0 to 2, q2 is an integer of 0 to 2, q3, q4 and q5 are 0, and q6 is an integer of 0 or 1. (3) The isoxazoline-substituted benzamide compound or the salt thereof as set forth in (2), wherein A¹ is carbon atom or nitrogen atom, A² and A³ are carbon atoms,

G is G-1,

X is halogen atom, cyano, nitro, —SF₅, C₁-C₆alkyl, C₁-C₆haloalkyl, hydroxyC₁-C₆haloalkyl, C₁-C₆alkoxyC₁-C₆haloalkyl, C₃-C₈halocycloalkyl, —OR⁵, —OSO₂R⁵ or —S(O)_(r)R⁵, when m is 2 or 3, each X may be identical with or different from each other, Y is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R⁴, —OR⁵, —SR⁵, —NH₂, —N(R⁷)R⁶ or —C(S)NH₂, when n is 2, each Y may be identical with or different from each other, R¹ is —C(R^(1b))═NOR^(1a), —C(O)OR^(1c), —C(O)SR^(1c), —C(S)OR^(1c), —C(O)N(R^(1e))R^(1d) —C(S)N(R^(1e))R^(1d), phenyl, phenyl substituted with (Z)_(p1), D-3, D-8, D-10, D-11, D-13 to D-15, D-17, D-22, D-35, D-52 to D-58 or D-59, R^(1a) is hydrogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkyl C₁-C₄alkyl, C₃-C₆alkenyl or C₃-C₆alkynyl, R^(1b) is hydrogen atom or C₁-C₆alkyl, R^(1c) is C₁-C₆alkyl, C₁-C₄alkyl arbitrarily substituted with R¹⁴ or C₃-C₆cycloalkyl, R^(1d) is hydrogen atom, —C(O)R¹⁵, —C(O)OR¹⁵ or —C(O)SR¹⁵, R² is C₁-C₆alkyl, —CH₂R^(14a), E-5, E-24, C₃-C₆alkynyl, —C(O)R¹⁵, —C(O)OR¹⁵, —C(O)SR¹⁵, —C(S)OR¹⁵, —C(S)SR¹⁵, —C(O)C(O)OR¹⁵, C₁-C₆haloalkylthio, —SN(R²⁰)R¹⁹, phenyl or phenyl substituted with (Z)_(p1), further when R¹ is —C(R^(1b))═NOR^(1a), —C(O)OR^(1c), —C(O)SR^(1c), —C(S)OR^(1c), —C(O)N(R^(1e))R^(1d) or —C(S)N(R^(1e))R^(1d), R² may be hydrogen atom, when R¹ is phenyl, phenyl substituted with (Z)_(p1), D-3, D-8, D-10, D-11, D-13 to D-15, D-17, D-22, D-35, D-52 to D-58 or D-59, R² may be C₁-C₆haloalkyl or C₃-C₆alkenyl, or R² together with R¹ may form ═C(R^(2b))R^(2a), R^(2a) is C₁-C₆alkoxy or di(C₁-C₆alkyl)amino, R^(2b) is R^(1b), C₁-C₆alkylthio, —SCH₂R^(14a), C₃-C₆alkenylthio, C₃-C₆alkynylthio or C₁-C₆alkylcarbonylthio, R³ is C₁-C₆haloalkyl or C₃-C₈halocycloalkyl, R⁴ is —OH, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylthio or C₁-C₆haloalkylthio, R⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl or C₁-C₃haloalkoxy C₁-C₃haloalkyl, R⁶ is C₁-C₆alkyl, —CHO, C₁-C₆alkylcarbonyl, C₁-C₆haloalkylcarbonyl, C₁-C₆alkoxycarbonyl, C₁-C₆alkylthiocarbonyl, C₁-C₆alkoxythiocarbonyl, C₁-C₆alkyldithiocarbonyl, C₁-C₆alkylsulfonyl or C₁-C₆haloalkylsulfonyl, R⁷ is hydrogen atom or C₁-C₆alkyl R¹⁴ is cyano, C₃-C₆cycloalkyl, C₁-C₆alkoxy, C₁-C₄alkoxy C₁-C₄alkoxy, C₁-C₆alkylthio, —S(D-52), —S(D-55), C₁-C₆alkylsulfonyl, —NHC(O)R³², —NHC(O)OR³², C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R^(14a) is cyano, —OR²⁵, —NHC(O)OR³², —S(O)_(r)R²⁷, C₁-C₆alkylcarbonyl, C₁-C₆alkoxycarbonyl or phenyl, R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³¹, C₃-C₆cycloalkyl, C₂-C₆alkenyl, C₂-C₆alkynyl, phenyl, phenyl substituted with (Z)_(p1), D-52, D-53 or D-54, R¹⁹ is C₁-C₆alkyl, C₁-C₆alkoxycarbonyl C₁-C₄alkyl or C₁-C₆alkoxycarbonyl, R²⁰ is C₁-C₆alkyl or benzyl, R²⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxy C₁-C₄alkyl, benzyl, C₃-C₆alkenyl, C₃-C₆alkynyl, —C(O)R³² or —C(O)OR³², R²⁷ is C₁-C₆alkyl, C₁-C₆haloalkyl, —C(O)R³² or —C(S)OR³², R³¹ is C₃-C₆cycloalkyl, C₁-C₄alkoxy, C₁-C₄haloalkoxy, C₁-C₄alkylthio, C₁-C₄alkylsulfinyl, C₁-C₄alkylsulfonyl or phenyl, R³² is C₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkyl or phenyl, p1 is an integer of 1 to 3, p2 and p3 are an integer of 0 to 2, and p4 is an integer of 0 or 1. (4) The isoxazoline-substituted benzamide compound or the salt thereof as set forth in (3), wherein A¹ is carbon atom, W is oxygen atom, X is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, —OR⁵ or —S(O)_(r)R⁵, when m is 2 or 3, each X may be identical with or different from each other, Y is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, —OR⁵, —SR⁵, —NH₂ or —N(R⁷)R⁶, R¹ is —CH═NOR^(1a), —C(O)OR^(1c), —C(O)N(R^(1e))R^(1d), phenyl substituted with (Z)_(p1), D-52, D-55, D-56, D-57 or D-58, R^(1a) is C₁-C₆alkyl, R^(1c) is C₁-C₆alkyl or C₃-C₆cycloalkyl, R^(1d) is hydrogen atom, —C(O)R¹⁵ or —C(O)OR¹⁵, R² is C₁-C₆alkyl, —CH₂R^(14a), E-5, C₃-C₆alkynyl, —C(O)R¹⁵, —C(O)OR¹⁵, —C(O)C(O)OR¹⁵ or C₁-C₆haloalkylthio, further when R¹ is —CH═NOR^(1a), —C(O)ORO or —C(O)N(R^(1e))R^(1d), R² may be hydrogen atom, R³ is C₁-C₆haloalkyl, Z is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylthio, C₁-C₆alkylsulfinyl or C₁-C₆alkylsulfonyl, when p1, p2 or p3 is an integer of 2 or more, each Z may be identical with or different from each other, R⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl, R⁶ is C₁-C₆alkyl, —CHO, C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R^(14a) is cyano, —OR²⁵ or —NHC(O)OR³², R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxy C₁-C₄alkyl, C₁-C₄alkylthio C₁-C₄alkyl, C₁-C₄alkylsulfinyl C₁-C₄alkyl, C₁-C₄alkylsulfonyl C₁-C₄alkyl, C₃-C₆cycloalkyl, C₂-C₆alkenyl, C₂-C₆alkynyl, phenyl, phenyl substituted with (Z)_(p1) or D-52, R²⁵ is C₁-C₄alkyl, C₁-C₄haloalkyl, —C(O)R³² or —C(O)OR³², R³² is C₁-C₆alkyl or C₃-C₆cycloalkyl, n is an integer of 0 or 1, q3 is 0, and t is 0. (5) The isoxazoline-substituted benzamide compound or the salt thereof as set forth in (4), wherein

R¹ is —CH═NOR^(1a),

R^(1a) is C₁-C₆alkyl, R² is hydrogen atom, —CH₂R^(14a), C₃-C₆alkynyl or C₁-C₆alkoxycarbonyl, R^(14a) is cyano or —OR²⁵, R²⁵ is C₁-C₄alkyl, C₁-C₄haloalkyl or —C(O)R³², and R³² is C₁-C₆alkyl. (6) The isoxazoline-substituted benzamide compound or the salt thereof as set forth in (4), wherein

R¹ is —C(O)OR^(1c),

R^(1c) is C₁-C₆alkyl or C₃-C₆cycloalkyl, R² is hydrogen atom, C₁-C₆alkyl, —CH₂R^(14a), E-5, —C(O)R¹⁵, C₁-C₆alkoxycarbonyl, C₁-C₆haloalkoxycarbonyl or C₁-C₆haloalkylthio, R^(14a) is cyano, —OR²⁵ or —NHC(O)OR³², R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxy C₁-C₄alkyl, C₁-C₄alkylthio C₁-C₄alkyl or C₃-C₆cycloalkyl, R²⁵ is C₁-C₄alkyl, C₁-C₄haloalkyl or —C(O)OR³², and R³² is C₁-C₆alkyl. (7) The isoxazoline-substituted benzamide compound or the salt thereof as set forth in (4), wherein

R¹ is —C(O)N(R^(1e))R^(1d)

R^(1d) is hydrogen atom, —C(O)R¹⁵ or —C(O)OR¹⁵, R² is hydrogen atom or C₁-C₆alkyl, and R¹⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl. (8) The isoxazoline-substituted benzamide compound or the salt thereof as set forth in (4), wherein R¹ is phenyl substituted with (Z)_(p1), D-52, D-55, D-56, D-57 or D-58, R² is C₁-C₆alkyl, —CH₂R^(14a), C₃-C₆alkynyl, —C(O)R¹⁵, —C(O)OR¹⁵ or —C(O)C(O)OR⁵, Z is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylthio, C₁-C₆alkylsulfinyl or C₁-C₆alkylsulfonyl, when p1, p2 or p3 is an integer of 2 or more, each Z may be identical with or different from each other, R^(14a) is cyano or —OR²⁵, R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxy C₁-C₄alkyl, C₁-C₄alkylthio C₁-C₄alkyl, C₁-C₄alkylsulfinyl C₁-C₄alkyl, C₁-C₄alkylsulfonyl C₁-C₄alkyl, C₃-C₆cycloalkyl, C₂-C₆alkenyl, C₂-C₆alkynyl, phenyl, phenyl substituted with (Z)_(p), or D-52, R²⁵ is C₁-C₄alkyl, C₁-C₄haloalkyl, —C(O)R³² or —C(O)OR³², and R³² is C₁-C₆alkyl or C₃-C₆cycloalkyl. (9) 4-Hydroxyiminomethyl substituted benzamide compound of formula (2) or a salt thereof:

wherein A¹ is carbon atom or nitrogen atom, J is hydrogen atom or halogen atom, W is oxygen atom or sulfur atom, Y is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R⁴, —OR⁵, —N(R⁷)R⁶ or —C(S)NH₂, when n is 2, each Y may be identical with or different from each other, R¹ is —C(R^(1b))═NOR^(1a), —C(O)OR^(1c), —C(O)SR^(1c), —C(S)OR^(1c), —C(O)N(R^(1e))R^(1d), —C(S)N(R^(1e))R^(1d), phenyl, phenyl substituted with (Z)_(p1), D-3, D-8, D-10, D-11, D-13 to D-15, D-17, D-22, D-35, D-52 to D-58 or D-59, R^(1a) is C₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₈cyloalkyl C₁-C₄alkyl, C₃-C₆alkenyl or C₃-C₆alkynyl, R^(1b) is hydrogen atom or C₁-C₆alkyl, R^(1c) is C₁-C₆alkyl, C₁-C₄alkyl arbitrarily substituted with R¹⁴ or C₃-C₆cycloalkyl, R^(1d) is hydrogen atom, —C(O)R¹⁵, —C(O)OR¹⁵ or —C(O)SR¹⁵ R^(1e) is hydrogen atom or C₁-C₆alkyl, R² is C₁-C₆alkyl, —CH₂R^(14a), E-5, E-24, C₃-C₆alkynyl, —C(O)R¹⁵, —C(O)OR¹⁵, —C(O)SR¹⁵, —C(S)OR¹⁵, —C(S)SR¹⁵, —C(O)C(O)OR¹⁵, phenyl or phenyl substituted with (Z)_(p1), further when R¹ is —C(R^(1b))═NOR^(1a), —C(O)OR^(1c), —C(O)SR^(1c), —C(S)OR^(1c), —C(O)N(R^(1e))R^(1d) or —C(S)N(R^(1e))R^(1d), R² may be hydrogen atom, when R¹ is phenyl, phenyl substituted with (Z), 1, D-3, D-8, D-10, D-11, D-13 to D-15, D-17, D-22, D-35, D-52 to D-58 or D-59, R² may be C₁-C₆haloalkyl or C₃-C₆alkenyl, or R² together with R¹ may form ═C(R^(2b))R^(2a), R^(2a) is C₁-C₆alkoxy or di(C₁-C₆alkyl)amino, R^(2b) is C₁-C₆alkyl or C₁-C₆alkylcarbonylthio, D-3, D-8, D-10, D-11, D-13 to D-15, D-17, D-22, D-35, D-52 to D-58 and D-59 are aromatic heterocyclic rings of the following formulae, respectively

Z is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylsulfonyloxy, C₁-C₆haloalkylsulfonyloxy, C₁-C₆alkylthio, C₁-C₆haloalkylthio, C₁-C₆alkylsulfinyl, C₁-C₆haloalkylsulfinyl, C₁-C₆alkylsulfonyl, C₁-C₆haloalkylsulfonyl, C₁-C₆alkoxycarbonyl, —C(O)NH₂ or —C(S)NH₂, when p1, p2 or p3 is an integer of 2 or more, each Z may be identical with or different from each other, further, when two Zs are adjacent, the adjacent two Zs may form 5-membered or 6-membered ring together with carbon atoms to which the two Zs are bonded by forming —OCH₂O— or —OCH₂CH₂O—, in this case, hydrogen atoms bonded to each carbon atom forming the ring may be arbitrarily substituted with halogen atom, E-5 and E-24 are saturated heterocyclic rings of the following formulae, respectively,

R⁴ is C₁-C₆alkoxy or C₁-C₆haloalkoxy, R⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl, R⁶ is —CHO, C₁-C₆alkylcarbonyl, C₁-C₆haloalkylcarbonyl, C₁-C₆alkoxycarbonyl, C₁-C₆alkylthiocarbonyl, C₁-C₆alkoxythiocarbonyl, C₁-C₆alkyldithiocarbonyl, C₁-C₆alkylsulfonyl or C₁-C₆haloalkylsulfonyl, R⁷ is hydrogen atom or C₁-C₆alkyl R¹³ is C₁-C₆alkyl or C₁-C₆haloalkyl, R¹⁴ is cyano, C₃-C₆cycloalkyl, C₁-C₆alkoxy, C₁-C₄alkoxy C₁-C₄alkoxy, C₁-C₆alkylsulfonyl, —NHC(O)R³², —NHC(O)OR³², C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R^(14a) is cyano, —OR²⁵, —NHC(O)OR³², —S(O)_(r)R²⁷, C₁-C₆alkylcarbonyl, C₁-C₆alkoxycarbonyl or phenyl, R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³¹, C₃-C₆cycloalkyl, C₂-C₆alkenyl, C₂-C₆alkynyl, phenyl, phenyl substituted with (Z)_(p1), D-52, D-53 or D-54, R²⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxy C₁-C₄alkyl, benzyl, C₃-C₆alkenyl, C₃-C₆alkynyl, —C(O)R³² or —C(O)OR³², R²⁷ is C₁-C₆alkyl, C₁-C₆haloalkyl, —C(O)R³² or —C(S)OR³², R³¹ is C₃-C₆cycloalkyl, C₁-C₄alkoxy, C₁-C₄haloalkoxy, C₁-C₄alkylsulfonyl or phenyl, R³² is C₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkyl or phenyl, n is an integer of 0 to 2, p1 is an integer of 1 to 3, p2 and p3 are an integer of 0 to 2, p4 and p5 are an integer of 0 or 1, q3 and q4 are 0, r is an integer of 0 or 2, and t is an integer of 0 or 1. (10) 4-Hydroxyiminomethyl substituted benzamide compound or the salt thereof as set forth in (9), wherein A¹ is carbon atom, W is oxygen atom, Y is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, —OR⁵ or —N(R⁷)R⁶

R¹ is —CH═NOR^(1a),

R^(1a) is C₁-C₆alkyl, R² is hydrogen atom, —CH₂R^(14a), C₃-C₆alkynyl or C₁-C₆alkoxycarbonyl, R⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl, R⁶ is —CHO, C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R^(14a) is cyano or —OR²⁵, R²⁵ is C₁-C₄alkyl, C₁-C₄haloalkyl or —C(O)OR³², and R³² is C₁-C₆alkyl. (11) 4-Hydroxyiminomethyl substituted benzamide compound or the salt thereof as set forth in (9), wherein A¹ is carbon atom, W is oxygen atom, Y is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, —OR⁵ or —N(R⁷)R⁶,

R¹ is —C(O)OR^(1c),

R^(1c) is C₁-C₆alkyl or C₃-C₆cycloalkyl, R² is hydrogen atom, C₁-C₆alkyl, —CH₂R^(14a), E-5, —C(O)R¹⁵, C₁-C₆alkoxycarbonyl, C₁-C₆haloalkoxycarbonyl or C₁-C₆haloalkylthio, R⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl, R⁶ is —CHO, C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R^(14a) is cyano, —OR²⁵, or —NHC(O)OR³², R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxy C₁-C₄alkyl, C₁-C₄alkylthio C₁-C₄alkyl or C₃-C₆cycloalkyl, R²⁵ is C₁-C₄alkyl, C₁-C₄haloalkyl or —C(O)OR³², R³² is C₁-C₆alkyl, n is an integer of 0 or 1, and q3 is 0. (12) 4-Hydroxyiminomethyl substituted benzamide compound or the salt thereof as set forth in (9), wherein A¹ is carbon atom, W is oxygen atom, Y is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, —OR⁵ or —N(R⁷)R⁶,

R¹ is —C(O)N(R^(1e))R^(1d),

R^(1d) is hydrogen atom, —C(O)R¹⁵ or —C(O)OR¹⁵, R^(1e) is hydrogen atom or C₁-C₆alkyl, R² is hydrogen atom or C₁-C₆alkyl, R⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl, R⁶ is —CHO, C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R¹⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl, and n is an integer of 0 or 1. (13) 4-Hydroxyiminomethyl substituted benzamide compound or the salt thereof as set forth in (9), wherein A¹ is carbon atom, W is oxygen atom, Y is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, —OR⁵ or —N(R⁷)R⁶, R¹ is phenyl substituted with (Z)_(p1), D-52, D-55, D-56, D-57 or D-58, R² is C₁-C₆alkyl, —CH₂R^(14a), C₃-C₆alkynyl, —C(O)R¹⁵, —C(O)OR¹⁵ or —C(O)C(O)OR¹⁵, Z is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylthio, C₁-C₆alkylsulfinyl or C₁-C₆alkylsulfonyl, when p1, p2 or p3 is an integer of 2 or more, each Z may be identical with or different from each other, R⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl, R⁶ is —CHO, C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R^(14a) is cyano or —OR²⁵, R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxy C₁-C₄alkyl, C₁-C₄alkylthio C₁-C₄alkyl, C₁-C₄alkylsulfinyl C₁-C₄alkyl, C₁-C₄alkylsulfonyl C₁-C₄alkyl, C₃-C₆cycloalkyl, C₂-C₆alkenyl, C₂-C₆alkynyl, phenyl, phenyl substituted with (Z)_(p1) or D-52, R²⁵ is C₁-C₄alkyl, C₁-C₄haloalkyl, —C(O)R³² or —C(O)OR³², R³² is C₁-C₆alkyl or C₃-C₆cycloalkyl, n is an integer of 0 or 1, and t is 0. (14) A pesticide containing as an active ingredient one or more selected from isoxazoline-substituted benzamide compound and the salt thereof as set forth in (1) to (8). (15) An agrochemical containing as an active ingredient one or more selected from isoxazoline-substituted benzamide compound and the salt thereof as set forth in (1) to (8). (16) An endo- or ecto-parasiticide for mammals or birds containing as an active ingredient one or more selected from isoxazoline-substituted benzamide compound and the salt thereof as set forth in (1) to (8). (17) An insecticide or acaricide containing as an active ingredient one or more selected from isoxazoline-substituted benzamide compound and the salt thereof as set forth in (1) to (8).

Effect of the Invention

The compound according to the present invention has an excellent insecticidal and acaricidal activity for many agricultural insect pests, spider mites, endo- or ecto-parasiticide for mammals or birds, and exerts a control effect sufficient for pest insects that acquire resistance against exiting insecticides. Further, the compound has little adverse affect on mammals, fishes and beneficial insects, and has a low persistency and a low impact on the environment. Therefore, the present invention can provide a useful and novel pesticide.

BEST MODE FOR CARRYING OUT THE INVENTION

Active compounds used as the pesticide in the present invention are the compounds of formulae (1) to (8) mentioned above, and the compounds of formulae (9) to (13) mentioned above are generally novel production intermediates used for the production of these active compounds.

In the compounds included in the present invention, some compounds have geometrical isomers of E-form and Z-form depending on the kind of substituents. The present invention includes these E-forms, Z-forms and mixtures containing E-form and Z-form in an arbitrary proportion. In addition, the compounds included in the present invention have optically active forms resulting from the presence of 1 or more asymmetric carbon atoms, and the present invention includes all optically active forms or racemates. Further, in the compounds of formula (1) according to the present invention, some compounds wherein R² is hydrogen atom are present in tautomer, and the present invention also includes these structures.

The compounds included in the present invention can be converted to acid addition salts for example salts of hydrohalide acid such as hydrofluoric acid, hydrochloric acid, hydrobromic acid, hydriodic acid or the like, salts of inorganic acids such as nitric acid, sulfuric acid, phosphoric acid, chloric acid, perchloric acid or the like, salts of sulfonic acid such as methansulfonic acid, ethansulfonic acid, trufluoromethansulfonic acid, benzene sulfonic acid, p-toluene sulfonic acid or the like, salts of carboxylic acid such as formic acid, acetic acid, propionic acid, trifluoroacetic acid, fumaric acid, tartaric acid, oxalic acid, maleic acid, malic acid, succinic acid, benzoic acid, mandelic acid, ascorbic acid, lactic acid, gluconic acid, citric acid or the like, or salts of amino acid such as glutamic acid, aspartic acid or the like, according to a conventional method.

The compounds included in the present invention can be converted to metal salts for example salts of alkali metal such as lithium, sodium, potassium, salts of alkaline earth metal such as calcium, barium, magnesium, or salts of aluminum, according to a conventional method.

Hereinafter, concrete examples of each substituent shown in the specification are described. In the specification, “n-” means normal, “i-” means iso, “s-” means secondary, and “t-” means tertiary, and “Ph” means phenyl.

Halogen atom in the compounds of the present invention includes fluorine atom, chlorine atom, bromine atom and iodine atom. In the interim, the indication of “halo” in the specification also means these halogen atoms.

In the specification, the indication of “C_(a)-C_(b)alkyl” means straight-chain or branched-chain hydrocarbon groups having carbon atom number of a to b, and includes for example methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, s-butyl, t-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1-ethylpropyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 1,1-dimethylbutyl, 1,3-dimethylbutyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)haloalkyl” means straight-chain or branched-chain hydrocarbon groups having carbon atom number of a to b that a hydrogen atom (hydrogen atoms) bonded to carbon atom is (are) arbitrarily substituted with a halogen atom (halogen atoms). In this case, if it is substituted with two or more halogen atoms, these halogen atoms may be identical with or different from each other. Concrete examples thereof are for example fluoromethyl, chloromethyl, bromomethyl, iodomethyl, difluoromethyl, chlorofluoromethyl, dichloromethyl, bromofluoromethyl, trifluoromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trichloromethyl, bromodifluoromethyl, bromochlorofluoromethyl, dibromofluoromethyl, 2-fluoroethyl, 2-chloroethyl, 2-bromoethyl, 2,2-difluoroethyl, 2-chloro-2-fluoroethyl, 2,2-dichloroethyl, 2-bromo-2-fluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, 2-bromo-2,2-difluoroethyl, 2-bromo-2-chloro-2-fluoroethyl, 2-bromo-2,2-dichloroethyl, 1,1,2,2-tetrafluoroethyl, pentafluoroethyl, 1-chloro-1,2,2,2-tetrafluoroethyl, 2-chloro-1,2,2,2-tetrafluoroethyl, 1,2-dichloro-1,2,2-trifluoroethyl, 2-bromo-1,1,2,2-tetrafluoroethyl, 2-fluoropropyl, 2-chloropropyl, 2-bromopropyl, 2-chloro-2-fluoropropyl, 2,3-dichloropropyl, 2-bromo-3-fluoropropyl, 3-bromo-2-chloropropyl, 2,3-dibromopropyl, 3,3,3-trifluoropropyl, 3-bromo-3,3-difluoropropyl, 2,2,3,3-tetrafluoropropyl, 2-chloro-3,3,3-trifluoropropyl, 2,2,3,3,3-pentafluoropropyl, 1,1,2,3,3,3-hexafluoropropyl, heptafluoropropyl, 2,3-dichloro-1,1,2,3,3-pentafluoropropyl, 2-fluoro-1-methylethyl, 2-chloro-1-methylethyl, 2-bromo-1-methylethyl, 2,2,2-trifluoro-1-(trifluoromethyl)ethyl, 1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl, 2,2,3,3,4,4-hexafluorobutyl, 2,2,3,4,4,4-hexafluorobutyl, 2,2,3,3,4,4,4-heptafluorobutyl, 1,1,2,2,3,3,4,4-octafluorobutyl, nonafluorobutyl, 4-chloro-1,1,2,2,3,3,4,4-octafluorobutyl, 2-fluoro-2-methylpropyl, 2-chloro-1,1-dimethylethyl, 2-bromo-1,1-dimethylethyl, 5-chloro-2,2,3,4,4,5,5-heptafluoropentyl, tridecafluorohexyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)cycloalkyl” means cyclic hydrocarbon groups having carbon atom number of a to b, and can form 3-membered to 6-membered single ring or conjugated ring structure. In addition, each ring may be arbitrarily substituted alkyl group in the scope of the indicated carbon atom number. Concrete examples thereof are for example cyclopropyl, 1-methylcyclopropyl, 2-methylcyclopropyl, 2,2-dimethylcyclopropyl, 2,2,3,3-tetramethylcyclopropyl, cyclobutyl, cyclopentyl, 2-methylcyclopentyl, 3-methylcyclopentyl, cyclohexyl, 2-methylcyclohexyl, 3-methylcyclohexyl, 4-methylcyclohexyl, bicyclo[2.2.1]heptan-2-yl and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)halocycloalkyl” means cyclic hydrocarbon groups having carbon atom number of a to b that a hydrogen atom (hydrogen atoms) bonded to carbon atom is (are) arbitrarily substituted with a halogen atom (halogen atoms), and can form 3-membered to 6-membered single ring or conjugated ring structure. In addition, each ring may be arbitrarily substituted alkyl group in the scope of the indicated carbon atom number. The substitution for halogen atom may be in the ring structure moiety, the side chain moiety or both of them. Further, if it is substituted with two or more halogen atoms, these halogen atoms may be identical with or different from each other. Concrete examples thereof are for example 2,2-difluorocyclopropyl, 2,2-dichlorocyclopropyl, 2,2-dibromocyclopropyl, 2,2-difluoro-1-methylcyclopropyl, 2,2-dichloro-1-methylcyclopropyl, 2,2-dibromo-1-methylcyclopropyl, 2,2,3,3-tetrafluorocyclobutyl, 2-(trifluoromethyl)cyclohexyl, 3-(trifluoromethyl)cyclohexyl, 4-(trifluoromethyl)cyclohexyl and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkenyl” means straight-chain or branched-chain unsaturated hydrocarbon groups having carbon atom number of a to b and having 1 or more double bonds. Concrete examples thereof are for example vinyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 2-butenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 2-pentenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 2-ethyl-2-propenyl, 1,1-dimethyl-2-propenyl, 2-hexenyl, 2-methyl-2-pentenyl, 2,4-dimethyl-2,6-heptadienyl, 3,7-dimethyl-2,6-octadienyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)haloalkenyl” means straight-chain or branched-chain unsaturated hydrocarbon groups having carbon atom number of a to b and having 1 or more double bonds, which a hydrogen atom (hydrogen atoms) bonded to carbon atom is (are) arbitrarily substituted with a halogen atom (halogen atoms). In this case, if it is substituted with two or more halogen atoms, these halogen atoms may be identical with or different from each other. Concrete examples thereof are for example 2,2-dichlorovinyl, 2-fluoro-2-propenyl, 2-chloro-2-propenyl, 3-chloro-2-propenyl, 2-bromo-2-propenyl, 3-bromo-2-propenyl, 3,3-difluoro-2-propenyl, 2,3-dichloro-2-propenyl, 3,3-dichloro-2-propenyl, 2,3-dibromo-2-propenyl, 2,3,3-trifluoro-2-propenyl, 2,3,3-trichloro-2-propenyl, 1-(trifluoromethyl)ethenyl, 3-chloro-2-butenyl, 3-bromo-2-butenyl, 4,4-difluoro-3-butenyl, 3,4,4-trifluoro-3-butenyl, 3-chloro-4,4,4-trifluoro-2-butenyl, 3-bromo-2-methyl-2-propenyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)cycloalkenyl” means cyclic unsaturated hydrocarbon groups having carbon atom number of a to b and having 1 or more double bonds, and can form 3-membered to 6-membered single ring or conjugated ring structure. In addition, each ring may be arbitrarily substituted alkyl group in the scope of the indicated carbon atom number, and further the double bond may be either endo- or exo-form. Concrete examples thereof are for example 2-cyclopenten-1-yl, 3-cyclopenten-1-yl, 2-cyclohexen-1-yl, 3-cyclohexen-1-yl, bicyclo [2.2.1]-5-hepten-2-yl and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)halocycloalkenyl” means cyclic unsaturated hydrocarbon groups having carbon atom number of a to b and having 1 or more double bonds, which a hydrogen atom (hydrogen atoms) bonded to carbon atom is (are) arbitrarily substituted with a halogen atom (halogen atoms), and can form 3-membered to 6-membered single ring or conjugated ring structure. In addition, each ring may be arbitrarily substituted alkyl group in the scope of the indicated carbon atom number, and further the double bond may be either endo- or exo-form. The substitution for halogen atom may be in the ring structure moiety, the side chain moiety or both of them. Further, if it is substituted with two or more halogen atoms, these halogen atoms may be identical with or different from each other. Concrete examples thereof are for example 2-chlorobicyclo [2.2.1]-5-hepten-2-yl and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkylidene” means straight-chain or branched-chain unsaturated hydrocarbon groups having carbon atom number of a to b that are bonded by double bond. Concrete examples thereof are for example methylidene, ethylidene, propylidene, 1-methylethylidene, butylidene, 1-methylpropylidene, pentylidene, 1-methylbutylidene, 1-ethylethylidene, hexylidene, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)haloalkylidene” means straight-chain or branched-chain unsaturated hydrocarbon groups having carbon atom number of a to b that have 1 or more double bonds and are bonded by double bond, which a hydrogen atom (hydrogen atoms) bonded to carbon atom is (are) arbitrarily substituted with a halogen atom (halogen atoms). Further, if it is substituted with two or more halogen atoms, these halogen atoms may be identical with or different from each other. Concrete examples thereof are for example difluoromethylidene, dichloromethylidene, 2,2,2-trifluoroethylidene, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkynyl” means straight-chain or branched-chain unsaturated hydrocarbon groups having carbon atom number of a to b and having 1 or more triple bonds. Concrete examples thereof are for example ethynyl, 1-propynyl, 2-propynyl, 2-butynyl, 1-methyl-2-propynyl, 2-pentynyl, 1-methyl-2-butynyl, 1,1-dimethyl-2-propynyl, 2-hexynyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)halolkynyl” means straight-chain or branched-chain unsaturated hydrocarbon groups having carbon atom number of a to b and having 1 or more triple bonds, which a hydrogen atom (hydrogen atoms) bonded to carbon atom is (are) arbitrarily substituted with a halogen atom (halogen atoms). In this case, if it is substituted with two or more halogen atoms, these halogen atoms may be identical with or different from each other. Concrete examples thereof are for example 2-chloroethynyl, 2-bromoethynyl, 2-iodoethynyl, 3-chloro-2-propynyl, 3-bromo-2-propynyl, 3-iodo-2-propynyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkoxy” means alkyl-O— groups wherein the alkyl has carbon atom number of a to b, and includes for example methoxy, ethoxy, n-propyloxy, i-propyloxy, n-butyloxy, i-butyloxy, s-butyloxy, t-butyloxy, n-pentyloxy, n-hexyloxy and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)haloalkoxy” means haloalkyl-O— groups wherein the haloalkyl has carbon atom number of a to b, and includes for example difluoromethoxy, trifluoromethoxy, chlorodifluoromethoxy, bromodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2,2,2-trifluoroethoxy, 1,1,2,2-tetrafluoroethoxy, 2-chloro-1,1,2-trifluoroethoxy, 2-bromo-1,1,2-trifluoroethoxy, pentafluoroethoxy, 2,2-dichloro-1,1,2-trifluoroethoxy, 2,2,2-trichloro-1,1-difluoroethoxy, 2-bromo-1,1,2,2-tetrafluoroethoxy, 2,2,3,3-tetrafluoropropyloxy, 1,1,2,3,3,3-hexafluoropropyloxy, 2,2,2-trifluoro-1-(trifluoromethyl)ethoxy, heptafluoropropyloxy, 2-bromo-1 μl, 2,3,3,3-hexafluoropropyloxy, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkylthio” means alkyl-S— groups wherein the alkyl has carbon atom number of a to b, and includes for example methylthio, ethylthio, n-propylthio, i-propylthio, n-butylthio, i-butylthio, s-butylthio, t-butylthio, n-pentylthio, n-hexylthio and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)haloalkylthio” means haloalkyl-S— groups wherein the haloalkyl has carbon atom number of a to b, and includes for example difluoromethylthio, trifluoromethylthio, chlorodifluoromethylthio, bromodifluoromethylthio, 2,2,2-trifluoroethylthio, 1,1,2,2-tetrafluoroethylthio, 2-chloro-1,1,2-trifluoroethylthio, pentafluoroethylthio, 2-bromo-1,1,2,2-tetrafluoroethylthio, 1,1,2,3,3,3-hexafluoropropylthio, heptafluoropropylthio, 1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethylthio, nonafluorobutylthio, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkenylthio” means alkenyl-S— groups wherein the alkenyl has carbon atom number of a to b, and includes for example 2-propenylthio, 2-butenylthio, 2-methyl-2-propenylthio, 3-methyl-2-butenylthio, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkynylthio” means alkynyl-S— groups wherein the alkynyl has carbon atom number of a to b, and includes for example 2-propynylthio, 2-butynylthio, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkylsulfinyl” means alkyl-S(O)— groups wherein the alkyl has carbon atom number of a to b, and includes for example methylsulfinyl, ethylsulfinyl, n-propylsulfinyl, i-propylsulfinyl, n-butylsulfinyl, i-butylsulfinyl, s-butylsulfinyl, t-butylsulfinyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)haloalkylsulfinyl” means haloalkyl-S(O)— groups wherein the haloalkyl has carbon atom number of a to b, and includes for example difluoromethylsulfinyl, trifluoromethylsulfinyl, chlorodifluoromethylsulfinyl, bromodifluoromethylsulfinyl, 2,2,2-trifluoroethylsulfinyl, 2-bromo-1,1,2,2-tetrafluoroethylsulfinyl, 1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethylsulfinyl, nonafluorobutylsulfinyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkylsulfonyl” means alkyl-SO₂— groups wherein the alkyl has carbon atom number of a to b, and includes for example methylsulfonyl, ethylsulfonyl, n-propylsulfonyl, i-propylsulfonyl, n-butylsulfonyl, i-butylsulfonyl, s-butylsulfonyl, t-butylsulfonyl, n-pentylsulfonyl, n-hexylsulfonyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)haloalkylsulfonyl” means haloalkyl-SO₂— groups wherein the haloalkyl has carbon atom number of a to b, and includes for example difluoromethylsulfonyl, trifluoromethylsulfonyl, chlorodifluoromethylsulfonyl, bromodifluoromethylsulfonyl, 2,2,2-trifluoroethylsulfonyl, 1,1,2,2-tetrafluoroethylsulfonyl, 2-chloro-1,1,2-trifluoroethylsulfonyl, 2-bromo-1,1,2,2-tetrafluoroethylsulfonyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkylamino” means amino groups, which either hydrogen atom is substituted with the above-mentioned alkyl group having carbon atom number of a to b, and includes for example methylamino, ethylamino, n-propylamino, i-propylamino, n-butylamino, i-butylamino, t-butylamino, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “di(C_(a)-C_(b)alkyl)amino” means amino groups, which both hydrogen atoms are substituted with the above-mentioned alkyl groups having carbon atom number of a to b that may be identical with or different from each other, and includes for example dimethylamino, ethyl(methyl)amino, diethylamino, n-propyl(methyl)amino, i-propyl(methyl)amino, di(n-propyl)amino, n-butyl(methyl)amino, i-butyl(methyl)amino, t-butyl(methyl)amino, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkylimino” means alkyl-N=groups wherein the alkyl has carbon atom number of a to b, and includes for example methylimino, ethylimino, n-propylimino, i-propylimino, n-butylimino, i-butylimino, s-butylimino, n-pentylimino, n-hexylimino, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkoxyimino” means alkoxy-N=groups wherein the alkoxy has carbon atom number of a to b, and includes for example methoxyimino, ethoxyimino, n-propyloxyimino, i-propyloxyimino, n-butyloxyimino, n-pentyloxyimino, n-hexyloxyimino, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkylcarbonyl” means alkyl-C(O)— groups wherein the alkyl has carbon atom number of a to b, and includes for example acetyl, propionyl, butyryl, isobutyryl, valeryl, isovaleryl, 2-methylbutanoyl, pivaloyl, hexanoyl, heptanoyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)haloalkylcarbonyl” means haloalkyl-C(O)— groups wherein the haloalkyl has carbon atom number of a to b, and includes for example fluoroacetyl, chloroacetyl, difluoroacetyl, dichloroacetyl, trifluoroacetyl, chlorodifluoroacetyl, bromodifluoroacetyl, trichloroacetyl, pentafluoropropionyl, heptafluorobutanoyl, 3-chloro-2,2-dimethylpropanoyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkoxycarbonyl” means alkyl-O—C(O)— groups wherein the alkyl has carbon atom number of a to b, and includes for example methoxycarbonyl, ethoxycarbonyl, n-propyloxycarbonyl, 1-propyloxycarbonyl, n-butoxycarbonyl, i-butoxycarbonyl, t-butoxycarbonyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)haloalkoxycarbonyl” means haloalkyl-O—C(O)— groups wherein the haloalkyl has carbon atom number of a to b, and includes for example 2-chloroethoxycarbonyl, 2,2-difluoroethoxycarbonyl, 2,2,2-trifluoroethoxycarbonyl, 2,2,2-trichloroethoxycarbonyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkylthiocarbonyl” means alkyl-S—C(O)— groups wherein the alkyl has carbon atom number of a to b, and includes for example methylthio-C(O)—, ethylthio-C(O)—, n-propylthio-C(O)—, i-propylthio-C(O)—, n-butylthio-C(O)—, i-butylthio-C(O)—, t-butylthio-C(O)—, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkoxythiocarbonyl” means alkyl-O—C(S)— groups wherein the alkyl has carbon atom number of a to b, and includes for example methoxy-C(S)—, ethoxy-C(S)—, n-propyloxy-C(S)—, i-propyloxy-C(S)—, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkyldithiocarbonyl” means alkyl-S—C(S)— groups wherein the alkyl has carbon atom number of a to b, and includes for example methylthio-C(S)—, ethylthio-C(S)—, n-propylthio-C(S)—, i-propylthio-C(S)—, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkylaminocarbonyl” means carbamoyl groups, which either hydrogen atom is substituted with the above-mentioned alkyl group having carbon atom number of a to b, and includes for example methylcarbamoyl, ethylcarbamoyl, n-propylcarbamoyl, i-propylcarbamoyl, n-butylcarbamoyl, i-butylcarbamoyl, s-butylcarbamoyl, t-butylcarbamoyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)haloalkylaminocarbonyl” means carbamoyl groups, which either hydrogen atom is substituted with the above-mentioned haloalkyl group having carbon atom number of a to b, and includes for example 2-fluoroethylcarbamoyl, 2-chloroethylcarbamoyl, 2,2-difluoroethylcarbamoyl, 2,2,2-trifluoroethylcarbamoyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “di(C_(a)-C_(b)alkyl)aminocarbonyl” means carbamoyl groups, which both hydrogen atoms are substituted with the above-mentioned alkyl group having carbon atom number of a to b that may be identical with or different from each other, and includes for example N,N-dimethylcarbamoyl, N-ethyl-N-methylcarbamoyl, N,N-diethylcarbamoyl, N,N-di-n-propylcarbamoyl, N,N-di-n-butylcarbamoyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkylaminosulfonyl” means sulfamoyl groups, which either hydrogen atom is substituted with the above-mentioned alkyl group having carbon atom number of a to b, and includes for example methylsulfamoyl, ethylsulfamoyl, n-propylsulfamoyl, i-propylsulfamoyl, n-butylsulfamoyl, i-butylsulfamoyl, s-butylsulfamoyl, t-butylsulfamoyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “di(C_(a)-C_(b)alkyl)aminosulfonyl” means sulfamoyl groups, which both hydrogen atoms are substituted with the above-mentioned alkyl group having carbon atom number of a to b that may be identical with or different from each other, and includes for example N,N-dimethylsulfamoyl, N-ethyl-N-methylsulfamoyl, N,N-diethylsulfamoyl, N,N-di-n-propylsulfamoyl, N,N-di-n-butylsulfamoyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “tri(C_(a)-C_(b)alkyl)silyl” means silyl groups substituted with the above-mentioned alkyl group having carbon atom number of a to b that may be identical with or different from each other, and includes for example trimethylsilyl, triethylsilyl, tri(n-propyl)silyl, ethyldimethylsilyl, n-propyldimethylsilyl, n-butyldimethylsilyl, i-butyldimethylsilyl, t-butyldimethylsilyl, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkylcarbonyloxy” means alkylcarbonyl-O— groups wherein the alkyl has carbon atom number of a to b, and includes for example acetoxy, propionyloxy, butyryloxy, isobutyryloxy, valeryloxy, isovaleryloxy, 2-methylbutanoyloxy, pivaloyloxy, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkoxycarbonyloxy” means alkoxycarbonyl-O— groups wherein the alkyl has carbon atom number of a to b, and includes for example methoxycarbonyloxy, ethoxycarbonyloxy, n-propylcarbonyloxy, i-propylcarbonyloxy, n-butylcarbonyloxy, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkylsulfonyloxy” means alkylsulfonyl-O— groups wherein the alkyl has carbon atom number of a to b, and includes for example methylsulfonyloxy, ethylsulfonyloxy, n-propylsulfonyloxy, i-propylsulfonyloxy, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)haloalkylsulfonyloxy” means haloalkylsulfonyl-O— groups wherein the haloalkyl has carbon atom number of a to b, and includes for example difluoromethylsulfonyloxy, trifluoromethylsulfonyloxy, chlorodifluoromethylsulfonyloxy, bromodifluoromethanesulfonyloxy, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkylcarbonylthio” means alkylcarbonyl-S— groups wherein the alkyl has carbon atom number of a to b, and includes for example acetylthio, propionylthio, butyrylthio, isobutyrylthio, pivaloylthio, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)cycloalkyl C_(d)-C_(e)alkyl”, “hydroxy C_(d)-C_(e)alkyl”, “C_(a)-C_(b)alkoxy C_(d)-C_(e)alkyl”, “C_(a)-C_(b)haloalkoxy C_(d)-C_(e)alkyl”, “phenoxy C_(d)-C_(e)alky”, “C_(a)-C_(b)alkylthio C_(d)-C_(e)alkyl”, “C_(a)-C_(b)haloalkylthio C_(d)-C_(e)alkyl”, “phenylthio C_(d)-C_(e)alkyl”, “C_(a)-C_(b)alkylsulfinyl C_(d)-C_(e)alkyl”, “C_(a)-C_(b)haloalkylsulfinyl C_(d)-C_(e)alkyl”, “C_(a)-C_(b)alkylsulfonyl C_(d)-C_(e)alkyl”, “C_(a)-C_(b)haloalkylsulfonyl C_(d)-C_(e)alkyl”, “C_(a)-C_(b)alkoxycarbonyl C_(d)-C_(e)alkyl”, “C_(a)-C_(b)haloalkoxycarbonyl C_(d)-C_(e)alkyl”, “cyano C_(d)-C_(e)alkyl”, “phenyl C_(d)-C_(e)alkyl”, or “phenyl C_(d)-C_(e)alkyl substituted with (Z)_(p1)” means alkyl groups having carbon atom number of d to e, which a hydrogen atom (hydrogen atoms) bonded to carbon atom is (are) arbitrarily substituted with the C_(a)-C_(b)cycloalkyl, C_(a)-C_(b)alkoxy, C_(a)-C_(b)haloalkoxy, C_(a)-C_(b)alkylthio, C_(a)-C_(b)haloalkylthio, C_(a)-C_(b)alkylsulfinyl, C_(a)-C_(b)haloalkylsulfinyl, C_(a)-C_(b)alkylsulfonyl, C_(a)-C_(b)haloalkylsulfonyl, C_(a)-C_(b)alkoxycarbonyl, C_(a)-C_(b)haloalkoxycarbonyl, hydroxy, cyano, phenoxy, phenylthio, phenyl, or phenyl substituted with (Z)_(p1) that has the meaning mentioned above, respectively. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkyl arbitrarily substituted with R⁴”, “C_(a)-C_(b)alkyl arbitrarily substituted with R¹⁴”, “C_(a)-C_(b)alkyl arbitrarily substituted with R^(14a)”, “C_(a)-C_(b)alkyl arbitrarily substituted with R²⁴”, “C_(a)-C_(b)alkyl arbitrarily substituted with R³¹” or “C_(a)-C_(b)alkyl arbitrarily substituted with R³⁴” means straight-chain or branched-chain hydrocarbon groups having carbon atom number of a to b, which a hydrogen atom (hydrogen atoms) bonded to carbon atom is (are) arbitrarily substituted with R⁴, R¹⁴, R^(14a), R²⁴, R³¹ or R³⁴. It is selected from the scope of the indicated carbon atom number.

In this case, when two or more substituents R⁴, R¹⁴, R^(14a), R²⁴, R³¹ or R³⁴ are present on the C_(a)-C_(b)alkyl, respective R⁴, R¹⁴, R^(14a), R²⁴, R³¹ or R³⁴ may be identical with or different from each other.

In the specification, the indication of “hydroxy C_(d)-C_(e)haloalkyl”, “C_(a)-C_(b)alkoxy C_(d)-C_(e)haloalkyl”, “C_(a)-C_(b)haloalkoxy C_(d)-C_(e)haloalkyl”, “C_(a)-C_(b)alkylthio C_(d)-C_(e)haloalkyl”, “C_(a)-C_(b)haloalkylthio C_(d)-C_(e)haloalkyl” or “cyano C_(d)-C_(e)haloalkyl” means the haloalkyl having carbon atom number of d to e, which a hydrogen atom (hydrogen atoms) or a halogen atom (halogen atoms) bonded to carbon atom is (are) arbitrarily substituted with the C_(a)-C_(b)alkoxy, C_(a)-C_(b)haloalkoxy, C_(a)-C_(b)alkylthio, C_(a)-C_(b)haloalkylthio, hydroxy or cyano. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “hydroxy C_(d)-C_(e)cycloalkyl”, “C_(a)-C_(b)alkoxy C_(d)-C_(e)cycloalkyl”, “C_(a)-C_(b)alkenyl C_(d)-C_(e)cycloalkyl” or “C_(a)-C_(b)haloalkenyl C_(d)-C_(e)cycloalkyl” means the cycloalkyl having carbon atom number of d to e, which a hydrogen atom (hydrogen atoms) bonded to carbon atom is (are) arbitrarily substituted with C_(a)-C_(b)alkoxy, C_(a)-C_(b)alkenyl, C_(a)-C_(b)haloalkenyl or hydroxy. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)cycloalkyl arbitrarily substituted with R⁴”, “C_(a)-C_(b)cycloalkyl arbitrarily substituted with R¹⁴”, “C_(a)-C_(b)cycloalkyl arbitrarily substituted with R^(14a)”, “C_(a)-C_(b)cycloalkyl arbitrarily substituted with R²⁴” or “C_(a)-C_(b)cycloalkyl arbitrarily substituted with R³¹” means the cycloalkyl groups having carbon atom number of a to b, which a hydrogen atom (hydrogen atoms) bonded to carbon atom is (are) arbitrarily substituted with R⁴, R¹⁴, R^(14a), R²⁴ or R³¹. The substitution for R⁴, R¹⁴, R^(14a), R²⁴ or R³¹ may be in the ring structure moiety, the side chain moiety or both of them. In this case, when two or more substituents R⁴, R¹⁴, R^(14a), R²⁴ or R³¹ are present on the C_(a)-C_(b)cycloalkyl, respective R⁴, R¹⁴, R^(14a), R²⁴ or R³¹ may be identical with or different from each other.

In the specification, the indication of “C_(a)-C_(b)alkoxy C_(d)-C_(e)alkenyl” or “phenyl C_(d)-C_(e)alkenyl” means the alkenyl having carbon atom number of a to b, which a hydrogen atom (hydrogen atoms) bonded to carbon atom is (are) arbitrarily substituted with C_(a)-C_(b)alkoxy or phenyl. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkenyl arbitrarily substituted with R⁴”, “C_(a)-C_(b)alkenyl arbitrarily substituted with R¹⁴”, “C_(a)-C_(b)alkenyl arbitrarily substituted with R^(14a)”, “C_(a)-C_(b)alkenyl arbitrarily substituted with R²⁴” or “C_(a)-C_(b)alkenyl arbitrarily substituted with R³¹” means the alkenyl groups having carbon atom number of a to b, which a hydrogen atom (hydrogen atoms) bonded to carbon atom is (are) arbitrarily substituted with R⁴, R¹⁴, R^(14a), R²⁴ or R³¹. It is selected from the scope of the indicated carbon atom number. In this case, when two or more substituents R⁴, R¹⁴, R^(14a), R²⁴ or R³¹ are present on the C_(a)-C_(b)alkenyl, respective R⁴, R¹⁴, R^(14a), R²⁴ or R³¹ may be identical with or different from each other.

In the specification, the indication of “C_(a)-C_(b)alkynyl arbitrarily substituted with R⁴”, “C_(a)-C_(b)alkynyl arbitrarily substituted with R¹⁴”, “C_(a)-C_(b)alkynyl arbitrarily substituted with R^(14a)”, “C_(a)-C_(b)alkynyl arbitrarily substituted with R²⁴” or “C_(a)-C_(b)alkynyl arbitrarily substituted with R³¹” means the alkynyl groups having carbon atom number of a to b, which a hydrogen atom (hydrogen atoms) bonded to carbon atom is (are) arbitrarily substituted with R⁴, R¹⁴, R^(14a), R²⁴ or R³¹. It is selected from the scope of the indicated carbon atom number. In this case, when two or more substituents R⁴, R¹⁴, R^(14a), R²⁴ or R³¹ are present on the C_(a)-C_(b)alkenyl, respective R⁴, R¹⁴, R^(14a), R²⁴ or R³¹ may be identical with or different from each other.

In the specification, the indication of “C_(a)-C_(b)alkoxy C_(d)-C_(e)alkoxy” means the C_(d)-C_(e)alkoxy, which a hydrogen atom (hydrogen atoms) bonded to carbon atom is (are) arbitrarily substituted with C_(a)-C_(b)alkoxy. It is selected from the scope of the indicated carbon atom number.

In the specification, the indication of “C_(a)-C_(b)alkoxy C_(d)-C_(e)alkylthio”, “C_(a)-C_(b)haloalkoxy C_(d)-C_(e)alkylthio”, “C_(a)-C_(b)alkylthio C_(d)-C_(e)alkylthio” or “cyano C_(d)-C_(e)alkylthio” or the like means the C_(d)-C_(e)alkylthio, which a hydrogen atom (hydrogen atoms) bonded to carbon atom is (are) arbitrarily substituted with C_(a)-C_(b)alkoxy, C_(a)-C_(b)haloalkoxy, C_(a)-C_(b)alkylthio or cyano. It is selected from the scope of the indicated carbon atom number.

In the specification, concrete examples of the indication of

“R⁷ together with R⁶ may form 3- to 7-membered ring together with the nitrogen atom bonding them by forming C₂-C₆ alkylene chain, in this case, the alkylene chain may contain one oxygen atom, sulfur atom or nitrogen atom”, “R¹⁰ together with R⁹ may form 3- to 7-membered ring with the nitrogen atom bonding them by forming C₂-C₆alkylene chain, in this case, the alkylene chain may contain one oxygen atom, sulfur atom or nitrogen atom”, “R¹⁶ together with R¹⁵ may form 3- to 7-membered ring with the nitrogen atom bonding them by forming C₂-C₆alkylene chain, in this case, the alkylene chain may contain one oxygen atom, sulfur atom or nitrogen atom”, and “R²⁶ together with R²⁵ may form 3- to 6-membered ring with the nitrogen atom bonding them by forming C₂-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom”, are for example aziridine, azetidine, azetidine-2-one, pyrrolidine, pyrrolidine-2-one, oxazolidine, oxazolidine-2-one, oxazolidine-2-thione, thiazoridine, thiazoridine-2-one, thiazoridine-2-thione, imidazolidine, imidazolidine-2-one, imidazolidine-2-thione, piperidine, piperidine-2-one, piperidine-2-thione, 2H-3,4,5,6-tetrahydro-1,3-oxadine-2-one, 2H-3,4,5,6-tetrahydro-1,3-oxadine-2-thione, morpholine, 2H-3,4,5,6-tetrahydro-1,3-thiadine-2-one, 2H-3,4,5,6-tetrahydro-1,3-thiadine-2-thione, thiomorpholine, perhydropyrimidine-2-one, piperazine, homopiperidine, homopiperidine-2-one, heptamethyleneimine, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, concrete examples of the indication of

“R¹⁸ together with R¹⁷ may form 5- to 6-membered ring with the nitrogen atom bonding them by forming C₄-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom, sulfur atom or nitrogen atom”, “R²⁰ together with R¹⁹ may form 5- to 8-membered ring with the nitrogen atom bonding them by forming C₄-C₇alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom”, “R²⁹ together with R²⁸ may form 3- to 6-membered ring with the nitrogen atom bonding them by forming C₂-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom”, and “R³³ together with R³² may form 3- to 6-membered ring with the nitrogen atom bonding them by forming C₂-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom”, are for example aziridine, azetidine, pyrrolidine, oxazolidine, thiazoridine, imidazolidine, piperidine, morpholine, thiomorpholine, piperazine, homopiperidine, heptamethyleneimine, and the like. It is selected from the scope of the indicated carbon atom number.

In the specification, concrete examples of the indication of “R^(17b) together with R^(17a) may form 4- to 6-membered ring with the carbon atom bonding them by forming C₃-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom, sulfur atom or nitrogen atom” are for example cyclopentylidene, tetrahydrofuran-3-ylidene, tetrahydrothiphen-3-ylidene, cyclohexylidene, tetrahydropyran-3-ylidene, tetrahydropyran-4-ylidene, tetrahydrothiopyran-3-ylidene, tetrahydrothiopyran-4-ylidene, and the like. It is selected from the scope of the indicated carbon atom number.

In the compounds included in the present invention, the combination of the atoms of A¹, A² and A³ includes for example the following groups.

That is, A-I: A¹, A² and A³ are carbon atoms.

A-II: A¹ is nitrogen atom, A² and A³ are carbon atoms. A-III: A² is nitrogen atom, A¹ and A³ are carbon atoms. A-IV: A¹ and A³ are nitrogen atoms, A² is carbon atom. A-V: A¹ and A² are nitrogen atoms, A³ is carbon atom. A-V: A² and A³ are nitrogen atoms, A¹ is carbon atom.

In the compounds included in the present invention, the substituent shown in G includes aromatic 6-membered and 5-membered rings. Among them, aromatic 6-membered rings shown in G-1, G-3 and G-4 and aromatic 5-membered rings shown in any one of G-13, G-14, G-17, G-18, G-20, G-21 and G-22 are preferable, and aromatic 6-membered ring shown in G-1 is particularly preferable.

In the compounds included in the present invention, the substituent W includes for example oxygen atom or sulfur atom.

In the compounds included in the present invention, the substituent X includes for example the following groups. In each case mentioned below, when m is an integer of 2 or more, Xs may be identical with or different from each other.

That is, X-I: halogen atom and C₁-C₆haloalkyl.

X-II: halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, —OR⁵, and —S(O)_(r)R⁵ (wherein R⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl, and r is an integer of 0 to 2). X-III: halogen atom, cyano, nitro, —SF₅, C₁-C₆alkyl, C₁-C₆haloalkyl, hydroxy C₁-C₆haloalkyl, C₁-C₆alkoxy C₁-C₆haloalkyl, C₃-C₈halocycloalkyl, —OR⁵, —OSO₂R⁵, and —S(O)_(r)R⁵ (wherein R⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl or C₁-C₃haloalkoxy C₁-C₃haloalkyl, and r is an integer of 0 to 2). X-IV: halogen atom, C₁-C₆haloalkyl, C₁-C₆haloalkyl arbitrarily substituted with R⁴ (wherein R⁴ is —OH, C₁-C₆alkoxy or C₁-C₆haloalkoxy), C₃-C₈halocycloalkyl, C₂-C₆haloalkenyl, C₂-C₆haloalkynyl, —OR⁵, —OSO₂R⁵, and —S(O)_(r)R⁵ (wherein R⁵ is C₁-C₆haloalkyl, C₁-C₃haloalkoxy C₁-C₃haloalkyl, C₂-C₆haloalkenyl or C₃-C₆haloalkynyl, and r is an integer of 0 to 2). X-V: halogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkyl arbitrarily substituted with R⁴ (wherein R⁴ is C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylthio, C₁-C₆haloalkylthio, C₁-C₆alkylsulfinyl, C₁-C₆haloalkylsulfinyl, C₁-C₆alkylsulfonyl or C₁-C₆haloalkylsulfonyl), C₃-C₈cycloalkyl, C₂-C₆alkenyl, C₂-C₆alkynyl, —OH, —OR⁵, —OSO₂R⁵ and —S(O)_(r)R⁵ (wherein R⁵ is C₁-C₆alkyl, C₂-C₆alkenyl, C₃-C₆alkynyl, or C₁-C₆alkoxycarbonyl, and r is an integer of 0 to 2). X-VI: halogen atom, C₁-C₆haloalkyl, cyano, nitro, —SF₅ and tri(C₁-C₆alkyl)silyl. X-VII: m is 2, two adjacent Xs form 5- or 6-membered ring with the carbon atoms to which the two Xs are bonded by forming —CF₂OCF₂—, —OCF₂O—, —CF₂OCF₂O— or —OCF₂CF₂O—.

In the compounds included in the present invention, m indicating the number of substituent X is an integer of 0 to 5. Among them, m is preferably 1, 2 and 3.

In the compounds included in the present invention, the substituent Y includes for example the following groups. In each case mentioned below, when n is an integer of 2 or more, Ys may be identical with or different from each other.

That is, Y-I: halogen atom, C₁-C₆alkyl and C₁-C₆haloalkyl.

Y-II: halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, —OR⁵, —SR⁵ (wherein R⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl), —NH₂ and —N(R⁷)R⁶ (wherein R⁶ is C₁-C₆alkyl, —CHO, C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, and R⁷ is hydrogen atom or C₁-C₆alkyl). Y-III: halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R⁴ (wherein R⁴ is —OH, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylthio or C₁-C₆haloalkylthio), —OR⁵, —SR⁵ (wherein R⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl), —NH₂, —N(R⁷)R⁶ (wherein R⁶ is C₁-C₆alkyl, —CHO, C₁-C₆alkylcarbonyl, C₁-C₆haloalkylcarbonyl, C₁-C₆alkoxycarbonyl, C₁-C₆alkylthiocarbonyl, C₁-C₆alkoxythiocarbonyl, C₁-C₆alkyldithiocarbonyl, C₁-C₆alkylsulfonyl or C₁-C₆haloalkylsulfonyl, R⁷ is hydrogen atom or C₁-C₆alkyl) and —C(S)NH₂. Y-IV: halogen atom, cyano, C₁-C₆alkyl and C₁-C₆alkyl arbitrarily substituted with R⁴ (wherein R⁴ is halogen atom, —OH, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylthio, C₁-C₆haloalkylthio, C₁-C₆alkylsulfinyl, C₁-C₆haloalkylsulfinyl, C₁-C₆alkylsulfonyl or C₁-C₆haloalkylsulfonyl), C₂-C₆alkynyl, tri(C₁-C₆alkyl)silylethynyl, —C(O)NH₂ and —C(S)NH₂. Y-V: halogen atom, C₁-C₆alkyl, —OR⁵, —OSO₂R⁵ and —S(O)_(r)R⁵ (wherein R⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₂-C₆alkenyl, C₂-C₆haloalkenyl, C₃-C₆alkynyl or C₃-C₆haloalkynyl and r is an integer of 0 to 2). Y-VI: halogen atom, nitro, C₁-C₆alkyl, —NH₂, —N(R⁷)R⁶ (wherein R⁶ is C₁-C₆alkyl, C₁-C₆haloalkyl, —CHO, —C(O)R⁹, —C(O)OR⁹, —C(O)SR⁹, —C(S)OR⁹, —C(S)SR⁹ or —S(O)₂R⁹ (wherein R⁷ is hydrogen atom, C₁-C₆alkyl or C₁-C₆haloalkyl, and R⁹ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkyl or C₃-C₆halocycloalkyl), and —N═C(R⁹)OR⁸ (wherein R⁸ is C₁-C₆alkyl, and R⁹ is C₁-C₆alkyl or C₁-C₆haloalkyl).

In the compounds included in the present invention, n indicating the number of substituent Y is an integer of 0 to 4. Among them, n is preferably 0 and 1.

In the compounds included in the present invention, the substituent R¹ includes for example the following groups.

That is, R¹-I: —CH═NOR^(1a) (wherein R^(1a) is C₁-C₆alkyl).

R¹-II: —C(O)OR^(1c) (wherein R^(1c) is C₁-C₆alkyl or C₃-C₆cycloalkyl). R¹-III: —C(O)N(R^(1e))R^(1d) (wherein R^(1d) is hydrogen atom, —C(O)R¹⁵ or —C(O)OR¹⁵, R^(1e) is hydrogen atom or C₁-C₆alkyl, and R¹⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl). R¹—IV: phenyl substituted with (Z)_(p1), D-52, D-55, D-56, D-57 and D-58 (wherein Z is halogen atom or cyano, when p1, p2 or p3 is an integer of 2 or more, each Z may be identical with or different from each other, p1 is an integer of 1 to 3, p2 and p3 are an integer of 0 to 2 and t is 0). R¹-V: —C(R^(1b))═NOR^(1a) (wherein R^(1a) is hydrogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkyl C₁-C₄alkyl, C₃-C₆alkenyl or C₃-C₆alkynyl, and R^(1b) is hydrogen atom or C₁-C₆alkyl). R¹-VI: —C(O)OR^(1c), —C(O)SR^(1c) and —C(S)OR^(1c) (wherein R^(1c) is C₁-C₆alkyl, C₁-C₄alkyl arbitrarily substituted with R¹⁴ or C₃-C₆cycloalkyl, R¹⁴ is cyano, C₃-C₆cycloalkyl, C₁-C₆alkoxy, C₁-C₄alkoxy C₁-C₄alkoxy, C₁-C₆alkylthio, —S(D-52), —S(D-55), C₁-C₆alkylsulfonyl, —NHC(O)R³², —NHC(O)OR³², C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R³² is C₁-C₆alkyl or C₃-C₆cycloalkyl, Z is halogen atom or C₁-C₆alkyl, p2 and p3 are an integer of 0 or 1, and t is 0). R¹-VII: —C(O)N(R^(1e))R^(1d) or —C(S)N(R^(1e))R^(1d) (wherein R^(1d) is hydrogen atom, —C(O)R¹⁵, —C(O)OR¹⁵ or —C(O)SR¹⁵, R^(1e) is hydrogen atom or C₁-C₆alkyl, R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, phenyl or phenyl substituted with (Z)_(p1), Z is halogen atom, cyano, nitro or C₁-C₆alkoxy, when p1 is 2, each Z may be identical with or different from each other, p1 is an integer of 1 or 2). R¹-VIII: phenyl, phenyl substituted with (Z)_(p1), D-3, D-8, D-10, D-11, D-13 to D-15, D-17, D-22, D-35, D-52 to D-58 or D-59 (wherein R¹³ is C₁-C₆alkyl or C₁-C₆haloalkyl, Z is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylsulfonyloxy, C₁-C₆haloalkylsulfonyloxy, C₁-C₆alkylthio, C₁-C₆haloalkylthio, C₁-C₆alkylsulfinyl, C₁-C₆haloalkylsulfinyl, C₁-C₆alkylsulfonyl, C₁-C₆haloalkylsulfonyl, C₁-C₆alkoxycarbonyl, —C(O)NH₂ or —C(S)NH₂, when p1, p2 or p3 is an integer of 2 or more, each Z may be identical with or different from each other, further, when two Zs are adjacent, the adjacent two Zs may form 5-membered or 6-membered ring together with carbon atoms to which the two Zs are bonded by forming —OCH₂O— or —OCH₂CH₂O—, in this case, hydrogen atoms bonded to each carbon atom forming the ring may be arbitrarily substituted with halogen atom, p1 is an integer of 1 to 3, p2 and p3 are an integer of 0 to 2, p4 and p5 are an integer of 0 or 1 and t is an integer of 0 or 1). R¹-IX: —C(R^(1b))═NOR^(1a) (wherein R^(1a) is hydrogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R¹⁴, C₃-C₆cycloalkyl, E-4, E-6, E-8, E-10, E-25, E-26, E-28, E-29, E-31, E-32, E-35, C₃-C₆alkenyl, C₃-C₆haloalkenyl, C₃-C₆alkynyl, C₃-C₆haloalkynyl, phenylC₃-C₆alkynyl, phenyl or phenyl substituted with (Z)_(p1), R^(1b) is hydrogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxyC₁-C₄alkyl, C₁-C₄alkylthioC₁-C₄alkyl or C₃-C₆cycloalkyl, R¹⁴ is cyano, C₃-C₆cycloalkyl, C₃-C₆halocycloalkyl, E-5 to E-8, E-10 to E-12, E-19, E-24 to E-29, E-31 to E-33, E-44, —OR²⁵, —N(R²⁶)R²⁵, —S(O)_(r)R²⁷, C₅-C₆cycloalkenyl, C₅-C₈halocycloalkenyl, M-1, —C(O)OR²⁸, —C(O)SR²⁸, —C(O)NH₂, —C(O)N(R²⁹)R²⁸, M-11, M-28, —C(S)OR²⁸, —C(S)SR²⁸, —C(S)NH₂, —C(S)N(R²⁹)R²⁸, M-14, M-32, —CH═NOR³⁰, —C(R²⁸)═NOR³⁰, M-5, —SO₂N(R²⁹)R²⁸, phenyl, phenyl substituted with (Z)_(p1), D-1, D-2, D-52, D-53 or D-54, R²² is C₁-C₆alkyl or C₁-C₆haloalkyl, when q2 is 2, each R²² may be identical with or different from each other, R²³ is —CHO, C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R²⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³¹, —C(O)R³², —C(O)OR³², —C(O)N(R³³)R³², —C(S)N(R³³)R³², —SO₂R³², —S(O)₂N(R³³)R³², —P(O)(OR²¹)₂, —P(S)(OR²¹)₂ or phenyl, R²¹ is C₁-C₆alkyl, R²⁶ is hydrogen atom, C₁-C₆alkyl or C₁-C₆alkoxy, or R²⁶ together with R²⁵ may form 5- to 7-membered ring with the nitrogen atom bonding them by forming C₄-C₆alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom, R²⁷ is C₁-C₈alkyl, C₁-C₄alkyl arbitrarily substituted with R³¹, C₃-C₆alkenyl, C₃-C₆alkynyl, —C(O)R³², —C(O)N(R³³)R³², —C(S)N(R³³)R³², phenyl or D-55, R²⁸ is C₁-C₆alkyl, R²⁹ is hydrogen atom or C₁-C₆alkyl, or R²⁹ together with R²⁸ may form 5- to 6-membered ring with the nitrogen atom bonding them by forming C₄-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom, R³⁰ is C₁-C₆alkyl, R³¹ is C₁-C₄alkoxy, C₁-C₄alkoxy C₁-C₄alkoxy, C₁-C₄alkylthio or phenyl, R³² is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³⁴, C₂-C₆alkenyl or phenyl, R³³ is hydrogen atom or C₁-C₆alkyl, or R³³ together with R³² may form 5- to 6-membered ring with the nitrogen atom bonding them by forming C₄-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom, R³⁴ is C₁-C₄alkoxy, C₁-C₄alkylthio, phenyl, D-52, D-53 or D-54, Z is halogen atom, when p1 is 2, each Z may be identical with or different from each other, p1 is an integer of 1 or 2, p2 and p3 are an integer of 0 or 1, q2 is an integer of 0 to 2, q3, q4 and q5 are 0, q6 is an integer of 0 or 1, r is an integer of 0 to 2, and t is 0), M-5 and M-20 (wherein R²² is C₁-C₆alkyl, phenyl or phenyl substituted with (Z)_(p1), Z is halogen atom, when p1 is 2, each Z may be identical with or different from each other, p1 is an integer of 1 or 2, q5 is 0, and q6 is an integer of 0 to 1), and —C(R^(1b))═NN(R^(1e))R^(1f) (wherein R^(1b) is hydrogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxyC₁-C₄alkyl, C₁-C₄alkylthioC₁-C₄alkyl or C₃-C₆cycloalkyl, R^(1e) is hydrogen atom or C₁-C₆alkyl, and R^(1f) is C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl). R¹-X: —C(O)OR^(1c), —C(O)SR^(1c), —C(S)OR^(1c) and —C(S)SR^(1c) (wherein R^(1c) is C₁-C₆alkyl, C₁-C₄alkyl arbitrarily substituted with R¹⁴, C₃-C₆cycloalkyl, E-5, E-6, E-8, E-10, E-25, E-26, E-28, E-29, E-31, E-32, E-35, C₂-C₆alkenyl, C₃-C₆haloalkenyl, C₃-C₆alkynyl, C₃-C₆haloalkynyl, phenyl or phenyl substituted with (Z)_(p1), R¹⁴ is cyano, nitro, C₃-C₆cycloalkyl, C₃-C₆halocycloalkyl, E-5 to E-8, E-10 to E-12, E-19, E-24 to E-29, E-31 to E-33, E-44, —OR²⁵, —N(R²⁶)R²⁵, —S(O)_(r)R²⁷, C₅-C₆cycloalkenyl, M-1, —CHO, C₁-C₆alkylcarbonyl, —C(O)OR²⁸, —C(O)SR²⁸, —C(O)NH₂, —C(O)N(R²⁹)R²⁸, M-11, M-28, —C(S)OR²⁸, —C(S)SR²⁸, —C(S)NH₂, —C(S)N(R²⁹)R²⁸, M-14, M-32, —CH═NOR³⁰, —C(R²⁸)═NOR³⁰, M-5, —SO₂N(R²⁹)R²⁸, tri(C₁-C₆alkyl)silyl, phenyl, phenyl substituted with (Z)_(p1), D-1, D-52, D-53 or D-54, R²² is C₁-C₆alkyl or C₁-C₆haloalkyl, when q2 is 2, each R²² may be identical with or different from each other, R²³ is —CHO, C₁-C₆alkylcarbonyl, C₁-C₆haloalkylcarbonyl or C₁-C₆alkoxycarbonyl, R²⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³¹, —C(O)R³², —C(O)OR³², —C(O)N(R³³)R³², —C(S)N(R³³)R³², —SO₂R³², —S(O)₂N(R³³)R³², —P(O)(OR²¹)₂, —P(S)(OR²¹)₂ or phenyl, R²¹ is C₁-C₆alkyl, R²⁶ is hydrogen atom, C₁-C₆alkyl or C₁-C₆alkoxy, or R²⁶ together with R²⁵ may form 5- to 7-membered ring with the nitrogen atom bonding them by forming C₄-C₆alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom, R²⁷ is C₁-C₄alkyl, C₁-C₄alkyl arbitrarily substituted with R³¹, C₃-C₆alkenyl, C₃-C₆alkynyl, C₁-C₆alkylthio, C₁-C₈alkylcarbonyl, —C(O)N(R³³)R³², —C(S)N(R³³)R³², phenyl, D-21, D-52 or D-55, R²⁸ is C₁-C₆alkyl or C₁-C₆haloalkyl, R²⁹ is hydrogen atom or C₁-C₆alkyl, or R²⁹ together with R²⁸ may form 5- to 6-membered ring with the nitrogen atom bonding them by forming C₄-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom, R³⁰ is C₁-C₆alkyl, R³¹ is C₁-C₄alkoxy, C₁-C₄haloalkoxy, C₁-C₄alkoxy C₁-C₄alkoxy, C₁-C₄alkylthio or phenyl, R³² is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³⁴, C₃-C₆cycloalkyl, C₃-C₆alkenyl or phenyl, R³³ is hydrogen atom or C₁-C₆alkyl, or R³³ together with R³² may form 5- to 7-membered ring with the nitrogen atom bonding them by forming C₄-C₆alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom, R³⁴ is C₁-C₄alkoxy, C₁-C₄alkylthio, phenyl, D-52, D-53 or D-54, Z is halogen atom, cyano, nitro, C₁-C₆alkyl or C₁-C₆alkoxy, when p1 is 2, each Z may be identical with or different from each other, p1 is an integer of 1 or 2, p2, p3 and p4 are an integer of 0 or 1, q2 is an integer of 0 to 2, q3, q4 and q5 are 0, q6 is an integer of 0 or 1, r is an integer of 0 to 2, and t is 0). R¹-XI: —C(O)N(R^(1e))R^(1d) and —C(S)N(R^(1e))R^(1d) (wherein R^(1d) is hydrogen atom, —C(O)R¹⁵, —C(O)OR¹⁵, —C(O)SR¹⁵, —C(S)OR¹⁵, —C(S)SR¹⁵ or —S(O)₂R¹⁵, R^(1e) is hydrogen atom or C₁-C₆alkyl, R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³¹, C₃-C₆cycloalkyl, C₂-C₆alkenyl, C₂-C₆haloalkenyl, C₃-C₈halocycloalkenyl, C₂-C₆alkynyl, phenyl, phenyl substituted with (Z)_(p1), D-1 to D-4, D-28, D-52, D-53 or D-54, R³¹ is C₁-C₄alkoxy, phenoxy, C₁-C₄alkylthio, phenylthio, C₁-C₄alkoxycarbonyl or phenyl, Z is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylthio or C₁-C₆alkylsulfonyl, when p1 is 2, each Z may be identical with or different from each other, p1 is an integer of 1 or 2, p2, p3 and p5 are an integer of 0 or 1, and t is 0). R¹-XII: phenyl, phenyl substituted with (Z)_(p1), D-1 to D-5, D-7 to D-17, D-21 to D-45, D-47 to D-63 or D-65 (wherein R¹³ is C₁-C₆alkyl or C₁-C₆haloalkyl, Z is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylsulfonyloxy, C₁-C₆haloalkylsulfonyloxy, C₁-C₆alkylthio, C₁-C₆haloalkylthio, C₁-C₆alkylsulfinyl, C₁-C₆haloalkylsulfinyl, C₁-C₆alkylsulfonyl, C₁-C₆haloalkylsulfonyl, C₁-C₆alkoxycarbonyl, —C(O)NH₂ or —C(S)NH₂, when p1, p2, p3 or p4 is an integer of 2 or more, each Z may be identical with or different from each other, when two Zs are adjacent, the adjacent two Zs may form 5-membered or 6-membered ring together with carbon atoms to which the two Zs are bonded by forming —OCH₂O— or —OCH₂CH₂O—, in this case, hydrogen atoms bonded to each carbon atom forming the ring may be arbitrarily substituted with halogen atom, p1 is an integer of 1 to 5, p2 is an integer of 0 to 4, p3 is an integer of 0 to 3, p4 is an integer of 0 to 2, p5 is an integer of 0 or 1, and t is an integer of 0 or 1).

In the compounds included in the present invention, the substituent R² includes for example the following groups.

That is, R²-I: hydrogen atom. —CH₂R^(14a) (wherein R^(14a) is cyano or —OR²⁵, R²⁵ is C₁-C₄alkyl, C₁-C₄haloalkyl or —C(O)OR³², and R³² is C₁-C₆alkyl), C₃-C₆alkynyl and C₁-C₆alkoxycarbonyl.

R²-II: hydrogen atom, C₁-C₆alkyl, —CH₂R^(14a) (wherein R^(14a) is cyano, —OR²⁵ or —NHC(O)R³², R²⁵ is C₁-C₄alkyl, C₁-C₄haloalkyl or —C(O)OR³², and R³² is C₁-C₆alkyl), E-5 (wherein q3 is 0), —C(O)R¹⁵ (wherein R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxyC₁-C₄alkyl, C₁-C₄alkylthio C₁-C₄alkyl or C₃-C₆cycloalkyl), C₁-C₆alkoxycarbonyl, C₁-C₆haloalkoxycarbonyl or C₁-C₆haloalkylthio. R²-III: hydrogen atom and C₁-C₆alkyl. R²-IV: C₁-C₆alkyl, —CH₂R^(14a) (wherein R^(14a) is cyano or —OR²⁵, R²⁵ is C₁-C₄alkyl, C₁-C₄haloalkyl, —C(O)R³² or —C(O)OR³², and R³² is C₁-C₆alkyl or C₃-C₆cycloalkyl), C₃-C₆alkynyl, —C(O)R¹⁵, —C(O)OR¹⁵ and —C(O)C(O)OR¹⁵ (wherein R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxyC₁-C₄alkyl, C₁-C₄alkylthio C₁-C₄alkyl, C₁-C₄alkylsulfinyl C₁-C₄alkyl, C₁-C₄alkylsulfonyl C₁-C₄alkyl, C₃-C₆cycloalkyl, C₂-C₆alkenyl, C₂-C₆alkynyl, phenyl, phenyl substituted with (Z)_(p1), or D-52, Z is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆alkoxy, C₁-C₆alkylthio, C₁-C₆alkylsulfinyl or C₁-C₆alkylsulfonyl, when p1 is 2, each Z may be identical with or different from each other, p1 is an integer of 1 or 2, p2 is an integer of 0 or 1, and t is 0). R²-V: hydrogen atom. C₁-C₆alkyl, —CH₂R^(14a) (wherein R^(14a) is cyano, —OR²⁵ or —S(O)_(r)R²⁷, R²⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, —C(O)R³² or —C(O)OR³², R²⁷ is C₁-C₆alkyl or C₁-C₆haloalkyl, R³² is C₁-C₆alkyl or C₃-C₆cycloalkyl, and r is an integer of 0 to 2), C₃-C₆alkynyl, —C(O)OR¹⁵, —C(O)SR¹⁵, —C(S)OR¹⁵, —C(S)SR¹⁵ (wherein R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxyC₁-C₄alkyl, C₃-C₆cycloalkyl, C₂-C₆alkenyl, C₂-C₆alkynyl or phenyl), C₁-C₆haloalkylthio and —SN(R²⁰)R¹⁹ (wherein R¹⁹ is C₁-C₆alkyl, C₁-C₆alkoxycarbonyl C₁-C₄alky or C₁-C₆alkoxycarbonyl, and R²⁰ is C₁-C₆alkyl or benzyl). R²-VI: hydrogen atom. C₁-C₆alkyl, —CH₂R^(14a) (wherein R^(14a) is cyano, —OR²⁵, —NHC(O)OR³², —S(O)_(r)R²⁷, C₁-C₆alkylcarbonyl, C₁-C₆alkoxycarbonyl or phenyl, R²⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxy C₁-C₄alkyl, benzyl, C₃-C₆alkenyl, C₃-C₆alkynyl, —C(O)R³² or —C(O)OR³², R²⁷ is C₁-C₆alkyl, C₁-C₆haloalkyl, —C(O)R³² or —C(S)OR³², R³² is C₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkyl or phenyl, and r is an integer of 0 to 2), E-5, E-24 (wherein q3 and q4 are 0), C₃-C₆alkynyl, —C(O)R¹⁵, —C(O)C(O)OR¹⁵ (wherein R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³¹, C₃-C₆cycloalkyl, phenyl, phenyl substituted with (Z)_(p1), D-52, D-53 or D-54, R³¹ is C₁-C₄alkoxy, C₁-C₄alkylthio, C₁-C₄alkylsulfinyl or C₁-C₄alkylsulfonyl, Z is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆alkoxy, C₁-C₆alkylthio, C₁-C₆alkylsulfinyl or C₁-C₆alkylsulfonyl, when p1 is 2, each Z may be identical with or different from each other, p1 is an integer of 1 or 2, p2 is an integer of 0 or 1, and t is 0), C₁-C₆alkoxycarbonyl, C₁-C₆haloalkoxycarbonyl, C₁-C₆haloalkylthio and —SN(R²⁰)R¹⁹ (wherein R¹⁹ is C₁-C₆alkyl, C₁-C₆alkoxycarbonyl C₁-C₄alkyl or C₁-C₆alkoxycarbonyl, and R²⁰ is C₁-C₆alkyl or benzyl). R²-VII: hydrogen atom. C₁-C₆alkyl, —CH₂R^(14a) (wherein R^(14a) is cyano or —OR²⁵, R²⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl or —C(O)OR³², R³² is C₁-C₆alkyl or C₁-C₆cycloalkyl), C₃-C₆alkynyl, phenyl and phenyl substituted with (Z)_(p1) (wherein Z is halogen atom, and p1 is 1). R²-VIII: C₁-C₆alkyl, C₁-C₆haloalkyl, —CH₂R^(14a) (wherein R^(14a) is cyano, —OR²⁵, —S(O)_(r)R²⁷, C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R²⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxy C₁-C₄alkyl, benzyl, C₃-C₆alkenyl, C₃-C₆alkynyl, —C(O)R³² or —C(O)OR³², R²⁷ is C₁-C₆alkyl, C₁-C₆haloalkyl, —C(O)R³² or —C(S)OR³², R³² is C₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkyl or phenyl, and r is an integer of 0 to 2), C₃-C₆alkenyl, C₃-C₆alkynyl, —C(O)R¹⁵, —C(O)OR¹⁵, —C(O)SR¹⁵, —C(S)OR¹⁵, —C(S)SR¹⁵, —C(O)C(O)OR¹⁵ (wherein R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³¹, C₃-C₆cycloalkyl, C₂-C₆alkenyl, C₂-C₆alkynyl, phenyl, phenyl substituted with (Z)_(p1), D-52, D-53 or D-54, R³¹ is C₃-C₆cycloalkyl, C₁-C₄alkoxy, C₁-C₄haloalkoxy, C₁-C₄alkylthio, C₁-C₄alkylsulfinyl, C₁-C₄alkylsulfonyl or phenyl, Z is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylthio, C₁-C₆alkylsulfinyl or C₁-C₆alkylsulfonyl, when p1 is 2, each Z may be identical with or different from each other, p1 is an integer of 1 or 2, and p2 is an integer of 0 or 1, and t is 0), C₁-C₆haloalkylthio and —SN(R²⁰)R¹⁹ (wherein R¹⁹ is C₁-C₆alkyl, C₁-C₆alkoxycarbonyl C₁-C₄alky or C₁-C₆alkoxycarbonyl, and R²⁰ is C₁-C₆alkyl or benzyl). R²-IX: hydrogen atom. R²-X: C₁-C_(e)alkyl, C₃-C₆alkynyl, C₁-C₆alkylthio, C₁-C₆haloalkylthio, phenylthio and —SN(R²⁰)R¹⁹ (wherein R¹⁹ is C₁-C₆alkyl, C₁-C₄alkoxy C₁-C₄alkyl, C₁-C₆alkoxycarbonyl C₁-C₄alkyl, phenyl C₁-C₄alkyl, phenyl C₁-C₄alkyl substituted with (Z)_(p1) or C₁-C₆alkoxycarbonyl, and R²⁰ is C₁-C₆alkyl, phenyl C₁-C₄alkyl or phenyl C₁-C₄alkyl substituted with (Z)_(p1), or R²⁰ together with R¹⁹ may form 5- or 6-membered ring with the nitrogen atom bonding them by forming C₄-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom, and may be arbitrarily substituted with methyl or methoxy). R²-XI: C₁-C₆haloalkyl, —CH₂R^(14a) (wherein R^(14a) is cyano, —OR²⁵, —N(R²⁶)R²⁵, —S(O)_(r)R²⁷, C₁-C₆alkoxycarbonyl or phenyl, R²⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³¹, —C(O)R³², —C(O)OR³², —C(O)N(R³³)R³², —SO₂R³² or phenyl, R²⁶ is hydrogen atom or C₁-C₆alkyl, R²⁷ is C₁-C₈alkyl, C₁-C₈haloalkyl, —C(O)R³², —C(S)OR³² or —C(S)N(R³³)R³², R³¹ is C₁-C₄alkoxy or phenyl, R³² is C₁-C₆alkyl, phenyl C₁-C₄alkyl, C₃-C₆cycloalkyl or phenyl, R³³ is hydrogen atom or C₁-C₆alkyl, or R³³ together with R³² may form 5- to 6-membered ring with the nitrogen atom bonding them by forming C₄-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom, and r is an integer of 0 to 2) and C₃-C₆alkenyl. R²-XII: E-5, E-24 (wherein q3 and q4 are 0), C₁-C₆alkoxycarbonyl and C₁-C₆haloalkoxycarbonyl. R²-XII: C₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkyl C₁-C₄alkyl, —CH₂R^(14a) (wherein R^(14a) is cyano, —OR²⁵ or phenyl, R²⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl or —C(O)OR³², R³² is C₁-C₆alkyl or C₃-C₆cycloalkyl), C₃-C₆cycloalkyl, C₃-C₆alkenyl, C₃-C₆alkynyl, phenyl and phenyl substituted with (Z)_(p1) (wherein Z is halogen atom, cyano, nitro or C₁-C₆alkoxy, and p1 is 1). R²-XIV: C₃-C₆cycloalkyl, —C(O)NH₂, di(C₁-C₆alkyl)aminocarbonyl, —N(R¹⁸)R¹⁷ (wherein R¹⁷ is hydrogen atom, C₁-C₆alkyl, —CHO, —C(O)R²⁸, —C(O)OR²⁸, —C(O)NH₂, —C(O)N(R²⁹)R²⁸, —S(O)₂R²⁸, —S(O)₂NH₂, —S(O)₂N(R²⁹)R²⁸ or phenyl, R¹⁸ is hydrogen atom, C₁-C₆alkyl or C₁-C₆alkylcarbonyl, R²⁸ is C₁-C₆alkyl, C₁-C₆haloalkyl or phenyl, R²⁹ is hydrogen atom or C₁-C₆alkyl), —N═C(R^(17b))R^(17a) (wherein R^(17a) is C₁-C₆alkyl or phenyl, R^(17b) is hydrogen atom or C₁-C₆alkyl), phenyl and phenyl substituted with (Z)_(p1) (wherein Z is halogen atom, cyano, nitro or C₁-C₆alkoxy, and p1 is 1). R²-XV: —CH₂R^(14a) (wherein R^(14a) is cyano, —OR²⁵, —N(R²⁶)R²⁵, —S(O)_(r)R²⁷, tri(C₁-C₆alkyl)silyl, —CHO, C₁-C₆alkylcarbonyl, phenylcarbonyl, C₁-C₆alkoxycarbonyl or phenyl, R²⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³¹, C₃-C₆cycloalkyl, E-6, E-8, E-25, E-26, E-28, E-29, C₃-C₆alkenyl, C₃-C₆alkynyl, —C(O)R³², —C(O)OR³², —C(O)NH₂, —C(O)N(R³³)R³², C₁-C₆alkylsulfonyl or phenyl, R²⁶ is hydrogen atom, C₁-C₆alkyl or phenyl, or R²⁶ together with R²⁵ may form 5- to 6-membered ring with the nitrogen atom bonding them by forming C₄-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom, R²⁷ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³¹, —C(O)R³², —C(S)R³², —C(S)OR³², —C(S)N(R³³)R³², phenyl, D-34, D-35 or D-50, R¹³ is C₁-C₆alkyl or phenyl, R³¹ is cyano, C₃-C₆cycloalkyl, C₃-C₆halocycloalkyl, E-5 to E-8, E-11, E-19, —OR³², —OC(O)R³², —OC(O)OR³², C₁-C₄alkylthio, C₁-C₄alkylsulfinyl, C₁-C₄alkylsulfonyl, C₁-C₄alkoxycarbonyl or phenyl, R³² is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³⁴, C₃-C₆cycloalkyl, phenyl, D-1 to D-4, D-14, D-52, D-53 or D-54, R³³ is hydrogen atom or C₁-C₆alkyl, or R³³ together with R³² may form 5- to 6-membered ring with the nitrogen atom bonding them by forming C₄-C₅alkylene chain, in this case, the alkylene chain may contain one oxygen atom or sulfur atom, R³⁴ is E-5, C₁-C₄alkoxy, phenoxy, phenylthio, —N(R³⁶)R³⁵, phenyl, D-1, D-3 or D-53, R³⁵ is hydrogen atom, C₁-C₆alkyl, C₁-C₆alkoxycarbonyl or phenylcarbonyl, R³⁶ is hydrogen atom or C₁-C₆alkyl, Z is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy, C₁-C₆alkylthio or phenyl, when p1, p2 or p3 is an integer of 2 or more, each Z may be identical with or different from each other, p1 is an integer of 1 to 3, p2 and p3 are an integer of 0 to 2, p5 is an integer of 0 or 1, q2, q3 and q4 are 0, r is an integer of 0 to 2, and t is 0), and C₁-C₆alkylsulfonyl. R²-XVI: —C(O)R¹⁵ and —C(O)C(O)OR¹⁵ (wherein R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³¹, C₃-C₆cycloalkyl, C₂-C₆alkenyl, C₂-C₆alkynyl, phenyl, phenyl substituted with (Z)_(p1), naphthyl, D-1 to D-4, D-52, D-53 or D-54, R³¹ is C₃-C₆cycloalkyl, C₁-C₄alkoxy, C₁-C₄alkylthio, C₁-C₄alkylsulfinyl or C₁-C₄alkylsulfonyl, Z is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylthio, C₁-C₆alkylsulfinyl or C₁-C₆alkylsulfonyl, when p1, p2 or p3 is an integer of 2 or more, each Z may be identical with or different from each other, p1 is an integer of 1 to 3, p2 is an integer of 0 to 2, and t is 0). R²-XVII: —C(O)OR¹⁵, —C(O)SR¹⁵, —C(S)OR¹⁵ and —C(S)SR¹⁵ (wherein R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³¹, C₃-C₆cycloalkyl, C₂-C₆alkenyl, C₂-C₆alkynyl, phenyl, phenyl substituted with (Z)_(p1), naphthyl, D-1 to D-4, D-52, D-53 or D-54, R³¹ is C₃-C₆cycloalkyl, —OR³², C₁-C₄alkylthio, C₁-C₄alkylsulfinyl, C₁-C₄alkylsulfonyl, phenyl or phenyl substituted with (Z)_(p1), R³² is C₁-C₆alkyl, C₁-C₄alkoxy C₁-C₄alkyl, benzyl or phenyl, Z is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylthio, C₁-C₆alkylsulfinyl or C₁-C₆alkylsulfonyl, when p1, p2 or p3 is an integer of 2 or more, each Z may be identical with or different from each other, p1 is an integer of 1 to 3, p2 and p3 are an integer of 0 to 2, and t is 0). R²-XVIII: R² together with R¹ forms ═C(R^(2b))R^(2a) (wherein R^(2a) is —OR^(1c), —SRo or di(C₁-C₆alkyl)amino, R^(1c) is C₁-C₆alkyl or C₃-C₆cycloalkyl, R^(2b) is R^(1b), C₁-C₆alkylthio, C₁-C₆haloalkylthio, —SCH₂R^(14a), C₃-C₆alkenylthio, C₃-C₆haloalkenylthio, C₃-C₆alkynylthio, C₃-C₆haloalkynylthio or —SC(O)R¹⁵, R^(1b) is hydrogen atom, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxy C₁-C₄alkyl, C₁-C₄alkylthio C₁-C₄alkyl or C₃-C₆cycloalkyl, R^(14a) is cyano, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylthio, C₁-C₆haloalkylthio, C₁-C₆alkoxycarbonyl or phenyl, R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkyl or phenyl).

In the compounds included in the present invention, the substituent R³ includes for example the following groups.

That is, R³-I: —CF₃ and —CF₂Cl.

R³-II: —CHF₂, —CF₃, —CF₂Cl, —CF₂Br, —CF₂CHF₂ and —CF₂CF₃.

R³-III: C₁-C₆alkyl substituted with 2 or more of arbitrary halogen atoms. R³-IV: C₁-C₆haloalkyl. R³-V: C₁-C₆haloalkyl and C₃-C₈halocycloalkyl. R³-VI: C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxy C₁-C₄haloalkyl, C₁-C₄haloalkoxy C₁-C₄haloalkyl, C₁-C₄alkylthio C₁-C₄haloalkyl, C₁-C₄haloalkylthio C₁-C₄haloalkyl, cyano C₁-C₆haloalkyl, C₃-C₆cycloalkyl and C₃-C₈halocycloalkyl.

Each group showing the scope of each substituent in the compounds included in the present invention can be arbitrarily combined one another, and all combination thereof falls within the scope of the present invention. Examples of the combination of the scope of X, Y, R¹ and R² include for example the combination showing in Table 1. In the meantime, the combination of Table 1 is for illustrative purposes, and the present invention is not limited thereto.

TABLE 1 X Y R¹ R² X-I Y-I R¹-I R²-I X-I Y-I R¹-I R²-V X-I Y-I R¹-I R²-IX X-I Y-I R¹-I R²-X X-I Y-I R¹-I R²-XI X-I Y-I R¹-I R²-XVII X-I Y-I R¹-II R²-II X-I Y-I R¹-II R²-VI X-I Y-I R¹-II R²-IX X-I Y-I R¹-II R²-X X-I Y-I R¹-II R²-XII X-I Y-I R¹-II R²-XV X-I Y-I R¹-II R²-XVI X-I Y-I R¹-III R²-III X-I Y-I R¹-III R²-VII X-I Y-I R¹-III R²-IX X-I Y-I R¹-III R²-XIII X-I Y-I R¹-IV R²-IV X-I Y-I R¹-IV R²-VIII X-I Y-I R¹-IV R²-X X-I Y-I R¹-IV R²-XIV X-I Y-I R¹-IV R²-XV X-I Y-I R¹-IV R²-XVI X-I Y-I R¹-IV R²-XVII X-I Y-I R¹-V R²-I X-I Y-I R¹-V R²-V X-I Y-I R¹-V R²-IX X-I Y-I R¹-V R²-X X-I Y-I R¹-V R²-XI X-I Y-I R¹-V R²-XVII X-I Y-I R¹-VI R²-II X-I Y-I R¹-VI R²-VI X-I Y-I R¹-VI R²-IX X-I Y-I R¹-VI R²-X X-I Y-I R¹-VI R²-XII X-I Y-I R¹-VI R²-XV X-I Y-I R¹-VI R²-XVI X-I Y-I R¹-VII R²-III X-I Y-I R¹-VII R²-VII X-I Y-I R¹-VII R²-IX X-I Y-I R¹-VII R²-XIII X-I Y-I R¹-VIII R²-IV X-I Y-I R¹-VIII R²-VIII X-I Y-I R¹-VIII R²-X X-I Y-I R¹-VIII R²-IX X-I Y-I R¹-VIII R²-XV X-I Y-I R¹-VIII R²-XVI X-I Y-I R¹-VIII R²-XVII X-I Y-I R¹-IX R²-I X-I Y-I R¹-IX R²-V X-I Y-I R¹-IX R²-IX X-I Y-I R¹-X R²-II X-I Y-I R¹-X R²-VI X-I Y-I R¹-X R²-IX X-I Y-I R¹-XI R²-III X-I Y-I R¹-XI R²-VII X-I Y-I R¹-XI R²-IX X-I Y-I R¹-XII R²-IV X-I Y-I R¹-XII R²-VIII X-I Y-I R¹-XII R²-X X-I Y-I R¹-XII R²-XV X-I Y-I — R²-XVIII X-I Y-II R¹-I R²-I X-I Y-II R¹-I R²-V X-I Y-II R¹-I R²-IX X-I Y-II R¹-I R²-X X-I Y-II R¹-I R²-XI X-I Y-II R¹-I R²-XVII X-I Y-II R¹-II R²-II X-I Y-II R¹-II R²-VI X-I Y-II R¹-II R²-IX X-I Y-II R¹-II R²-X X-I Y-II R¹-II R²-XII X-I Y-II R¹-II R²-XV X-I Y-II R¹-II R²-XVI X-I Y-II R¹-III R²-III X-I Y-II R¹-III R²-VII X-I Y-II R¹-III R²-IX X-I Y-II R¹-III R²-XIII X-I Y-II R¹-IV R²-IV X-I Y-II R¹-IV R²-VIII X-I Y-II R¹-IV R²-X X-I Y-II R¹-IV R²-XIV X-I Y-II R¹-IV R²-XV X-I Y-II R¹-IV R²-XVI X-I Y-II R¹-IV R²-XVII X-I Y-II R¹-V R²-I X-I Y-II R¹-V R²-V X-I Y-II R¹-V R²-IX X-I Y-II R¹-VI R²-II X-I Y-II R¹-VI R²-VI X-I Y-II R¹-VI R²-IX X-I Y-II R¹-VII R²-III X-I Y-II R¹-VII R²-VII X-I Y-II R¹-VII R²-IX X-I Y-II R¹-VIII R²-IV X-I Y-II R¹-VIII R²-VIII X-I Y-II R¹-IX R²-I X-I Y-II R¹-IX R²-IX X-I Y-II R¹-X R²-II X-I Y-II R¹-X R²-IX X-I Y-II R¹-XI R²-III X-I Y-II R¹-XI R²-IX X-I Y-II R¹-XII R²-IV X-I Y-II — R²-XVIII X-I Y-III R¹-I R²-I X-I Y-III R¹-I R²-V X-I Y-III R¹-I R²-IX X-I Y-III R¹-II R²-II X-I Y-III R¹-II R²-VI X-I Y-III R¹-II R²-IX X-I Y-III R¹-III R²-III X-I Y-III R¹-III R²-VII X-I Y-III R¹-III R²-IX X-I Y-III R¹-IV R²-IV X-I Y-III R¹-IV R²-VIII X-I Y-III R¹-V R²-I X-I Y-III R¹-V R²-IX X-I Y-III R¹-VI R²-II X-I Y-III R¹-VI R²-IX X-I Y-III R¹-VII R²-III X-I Y-III R¹-VII R²-IX X-I Y-III R¹-VIII R²-IV X-I Y-III — R²-XVIII X-I Y-IV R¹-I R²-I X-I Y-IV R¹-I R²-IX X-I Y-IV R¹-II R²-II X-I Y-IV R¹-II R²-IX X-I Y-IV R¹-III R²-III X-I Y-IV R¹-III R²-IX X-I Y-IV R¹-IV R²-IV X-I Y-V R¹-I R²-I X-I Y-V R¹-I R²-IX X-I Y-V R¹-II R²-II X-I Y-V R¹-II R²-IX X-I Y-V R¹-III R²-III X-I Y-V R¹-III R²-IX X-I Y-V R¹-IV R²-IV X-I Y-VI R¹-I R²-I X-I Y-VI R¹-I R²-IX X-I Y-VI R¹-II R²-II X-I Y-VI R¹-II R²-IX X-I Y-VI R¹-III R²-III X-I Y-VI R¹-III R²-IX X-I Y-VI R¹-IV R²-IV X-II Y-I R¹-I R²-I X-II Y-I R¹-I R²-V X-II Y-I R¹-I R²-IX X-II Y-I R¹-I R²-X X-II Y-I R¹-I R²-XI X-II Y-I R¹-I R²-XVII X-II Y-I R¹-II R²-II X-II Y-I R¹-II R²-VI X-II Y-I R¹-II R²-IX X-II Y-I R¹-II R²-X X-II Y-I R¹-II R²-XII X-II Y-I R¹-II R²-XV X-II Y-I R¹-II R²-XVI X-II Y-I R¹-III R²-III X-II Y-I R¹-III R²-VII X-II Y-I R¹-III R²-IX X-II Y-I R¹-III R²-XIII X-II Y-I R¹-IV R²-IV X-II Y-I R¹-IV R²-VIII X-II Y-I R¹-IV R²-X X-II Y-I R¹-IV R²-XIV X-II Y-I R¹-IV R²-XV X-II Y-I R¹-IV R²-XVI X-II Y-I R¹-IV R²-XVII X-II Y-I R¹-V R²-I X-II Y-I R¹-V R²-V X-II Y-I R¹-V R²-IX X-II Y-I R¹-VI R²-II X-II Y-I R¹-VI R²-VI X-II Y-I R¹-VI R²-IX X-II Y-I R¹-VII R²-III X-II Y-I R¹-VII R²-VII X-II Y-I R¹-VII R²-IX X-II Y-I R¹-VIII R²-IV X-II Y-I R¹-VIII R²-VIII X-II Y-I R¹-IX R²-I X-II Y-I R¹-IX R²-IX X-II Y-I R¹-X R²-II X-II Y-I R¹-X R²-IX X-II Y-I R¹-XI R²-III X-II Y-I R¹-XI R²-IX X-II Y-I R¹-XII R²-IV X-II Y-I — R²-XVIII X-II Y-II R¹-I R²-I X-II Y-II R¹-I R²-V X-II Y-II R¹-I R²-IX X-II Y-II R¹-I R²-X X-II Y-II R¹-I R²-XI X-II Y-II R¹-I R²-XVII X-II Y-II R¹-II R²-II X-II Y-II R¹-II R²-VI X-II Y-II R¹-II R²-IX X-II Y-II R¹-II R²-X X-II Y-II R¹-II R²-XII X-II Y-II R¹-II R²-XV X-II Y-II R¹-II R²-XVI X-II Y-II R¹-III R²-III X-II Y-II R¹-III R²-VII X-II Y-II R¹-III R²-IX X-II Y-II R¹-III R²-XIII X-II Y-II R¹-IV R²-IV X-II Y-II R¹-IV R²-VIII X-II Y-II R¹-IV R²-X X-II Y-II R¹-IV R²-XIV X-II Y-II R¹-IV R²-XV X-II Y-II R¹-IV R²-XVI X-II Y-II R¹-IV R²-XVII X-II Y-II R¹-V R²-I X-II Y-II R¹-V R²-V X-II Y-II R¹-V R²-IX X-II Y-II R¹-VI R²-II X-II Y-II R¹-VI R²-VI X-II Y-II R¹-VI R²-IX X-II Y-II R¹-VII R²-III X-II Y-II R¹-VII R²-VII X-II Y-II R¹-VII R²-IX X-II Y-II R¹-VIII R²-IV X-II Y-II R¹-VIII R²-VIII X-II Y-II R¹-IX R²-I X-II Y-II R¹-IX R²-IX X-II Y-II R¹-X R²-II X-II Y-II R¹-X R²-IX X-II Y-II R¹-XI R²-III X-II Y-II R¹-XI R²-IX X-II Y-II R¹-XII R²-IV X-II Y-II — R²-XVIII X-II Y-III R¹-I R²-I X-II Y-III R¹-I R²-V X-II Y-III R¹-I R²-IX X-II Y-III R¹-II R²-II X-II Y-III R¹-II R²-VI X-II Y-III R¹-II R²-IX X-II Y-III R¹-III R²-III X-II Y-III R¹-III R²-VII X-II Y-III R¹-III R²-IX X-II Y-III R¹-IV R²-IV X-II Y-III R¹-IV R²-VIII X-II Y-III R¹-VIII R²-IV X-II Y-IV R¹-I R²-I X-II Y-IV R¹-I R²-IX X-II Y-IV R¹-II R²-II X-II Y-IV R¹-II R²-IX X-II Y-IV R¹-III R²-III X-II Y-IV R¹-III R²-IX X-II Y-IV R¹-IV R²-IV X-II Y-V R¹-I R²-I X-II Y-V R¹-I R²-IX X-II Y-V R¹-II R²-II X-II Y-V R¹-II R²-IX X-II Y-V R¹-III R²-III X-II Y-V R¹-III R²-IX X-II Y-V R¹-IV R²-IV X-II Y-VI R¹-I R²-I X-II Y-VI R¹-I R²-IX X-II Y-VI R¹-II R²-II X-II Y-VI R¹-II R²-IX X-II Y-VI R¹-III R²-III X-II Y-VI R¹-III R²-IX X-II Y-VI R¹-IV R²-IV X-III Y-I R¹-I R²-I X-III Y-I R¹-I R²-V X-III Y-I R¹-I R²-IX X-III Y-I R¹-II R²-II X-III Y-I R¹-II R²-VI X-III Y-I R¹-II R²-IX X-III Y-I R¹-III R²-III X-III Y-I R¹-III R²-VII X-III Y-I R¹-III R²-IX X-III Y-I R¹-IV R²-IV X-III Y-I R¹-IV R²-VIII X-III Y-I R¹-V R²-I X-III Y-I R¹-V R²-IX X-III Y-I R¹-VI R²-II X-III Y-I R¹-VI R²-IX X-III Y-I R¹-VII R²-III X-III Y-I R¹-VII R²-IX X-III Y-I R¹-VIII R²-IV X-III Y-I — R²-XVIII X-III Y-II R¹-I R²-I X-III Y-II R¹-I R²-V X-III Y-II R¹-I R²-IX X-III Y-II R¹-II R²-II X-III Y-II R¹-II R²-VI X-III Y-II R¹-II R²-IX X-III Y-II R¹-III R²-III X-III Y-II R¹-III R²-VII X-III Y-II R¹-III R²-IX X-III Y-II R¹-IV R²-IV X-III Y-II R¹-IV R²-VIII X-III Y-II R¹-VIII R²-IV X-III Y-III R¹-I R²-I X-III Y-III R¹-I R²-V X-III Y-III R¹-I R²-IX X-III Y-III R¹-II R²-II X-III Y-III R¹-II R²-VI X-III Y-III R¹-II R²-IX X-III Y-III R¹-III R²-III X-III Y-III R¹-III R²-VII X-III Y-III R¹-III R²-IX X-III Y-III R¹-IV R²-IV X-III Y-III R¹-IV R²-VIII X-III Y-III R¹-VIII R²-IV X-III Y-IV R¹-I R²-I X-III Y-IV R¹-I R²-IX X-III Y-IV R¹-II R²-II X-III Y-IV R¹-II R²-IX X-III Y-IV R¹-III R²-III X-III Y-IV R¹-III R²-IX X-III Y-IV R¹-IV R²-IV X-III Y-V R¹-I R²-I X-III Y-V R¹-I R²-IX X-III Y-V R¹-II R²-II X-III Y-V R¹-II R²-IX X-III Y-V R¹-III R²-III X-III Y-V R¹-III R²-IX X-III Y-V R¹-IV R²-IV X-III Y-VI R¹-I R²-I X-III Y-VI R¹-I R²-IX X-III Y-VI R¹-II R²-II X-III Y-VI R¹-II R²-IX X-III Y-VI R¹-III R²-III X-III Y-VI R¹-III R²-IX X-III Y-VI R¹-IV R²-IV X-IV Y-I R¹-I R²-I X-IV Y-I R¹-I R²-IX X-IV Y-I R¹-II R²-II X-IV Y-I R¹-II R²-IX X-IV Y-I R¹-III R²-III X-IV Y-I R¹-III R²-IX X-IV Y-I R¹-IV R²-IV X-IV Y-II R¹-I R²-I X-IV Y-II R¹-I R²-IX X-IV Y-II R¹-II R²-II X-IV Y-II R¹-II R²-IX X-IV Y-II R¹-III R²-III X-IV Y-II R¹-III R²-IX X-IV Y-II R¹-IV R²-IV X-IV Y-III R¹-I R²-I X-IV Y-III R¹-I R²-IX X-IV Y-III R¹-II R²-II X-IV Y-III R¹-II R²-IX X-IV Y-III R¹-III R²-III X-IV Y-III R¹-III R²-IX X-IV Y-III R¹-IV R²-IV X-IV Y-IV R¹-I R²-I X-IV Y-IV R¹-I R²-IX X-IV Y-IV R¹-II R²-II X-IV Y-IV R¹-II R²-IX X-IV Y-IV R¹-III R²-III X-IV Y-IV R¹-III R²-IX X-IV Y-IV R¹-IV R²-IV X-IV Y-V R¹-I R²-I X-IV Y-V R¹-I R²-IX X-IV Y-V R¹-II R²-II X-IV Y-V R¹-II R²-IX X-IV Y-V R¹-III R²-III X-IV Y-V R¹-III R²-IX X-IV Y-V R¹-IV R²-IV X-IV Y-VI R¹-I R²-I X-IV Y-VI R¹-I R²-IX X-IV Y-VI R¹-II R²-II X-IV Y-VI R¹-II R²-IX X-IV Y-VI R¹-III R²-III X-IV Y-VI R¹-III R²-IX X-IV Y-VI R¹-IV R²-IV X-V Y-I R¹-I R²-I X-V Y-I R¹-I R²-IX X-V Y-I R¹-II R²-II X-V Y-I R¹-II R²-IX X-V Y-I R¹-III R²-III X-V Y-I R¹-III R²-IX X-V Y-I R¹-IV R²-IV X-V Y-II R¹-I R²-I X-V Y-II R¹-I R²-IX X-V Y-II R¹-II R²-II X-V Y-II R¹-II R²-IX X-V Y-II R¹-III R²-III X-V Y-II R¹-III R²-IX X-V Y-II R¹-IV R²-IV X-V Y-III R¹-I R²-I X-V Y-III R¹-I R²-IX X-V Y-III R¹-II R²-II X-V Y-III R¹-II R²-IX X-V Y-III R¹-III R²-III X-V Y-III R¹-III R²-IX X-V Y-III R¹-IV R²-IV X-V Y-IV R¹-I R²-I X-V Y-IV R¹-I R²-IX X-V Y-IV R¹-II R²-II X-V Y-IV R¹-II R²-IX X-V Y-IV R¹-III R²-III X-V Y-IV R¹-III R²-IX X-V Y-IV R¹-IV R²-IV X-V Y-V R¹-I R²-I X-V Y-V R¹-I R²-IX X-V Y-V R¹-II R²-II X-V Y-V R¹-II R²-IX X-V Y-V R¹-III R²-III X-V Y-V R¹-III R²-IX X-V Y-V R¹-IV R²-IV X-V Y-VI R¹-I R²-I X-V Y-VI R¹-I R²-IX X-V Y-VI R¹-II R²-II X-V Y-VI R¹-II R²-IX X-V Y-VI R¹-III R²-III X-V Y-VI R¹-III R²-IX X-V Y-VI R¹-IV R²-IV X-VI Y-I R¹-I R²-I X-VI Y-I R¹-I R²-IX X-VI Y-I R¹-II R²-II X-VI Y-I R¹-II R²-IX X-VI Y-I R¹-III R²-III X-VI Y-I R¹-III R²-IX X-VI Y-I R¹-IV R²-IV X-VI Y-II R¹-I R²-I X-VI Y-II R¹-I R²-IX X-VI Y-II R¹-II R²-II X-VI Y-II R¹-II R²-IX X-VI Y-II R¹-III R²-III X-VI Y-II R¹-III R²-IX X-VI Y-II R¹-IV R²-IV X-VI Y-III R¹-I R²-I X-VI Y-III R¹-I R²-IX X-VI Y-III R¹-II R²-II X-VI Y-III R¹-II R²-IX X-VI Y-III R¹-III R²-III X-VI Y-III R¹-III R²-IX X-VI Y-III R¹-IV R²-IV X-VI Y-IV R¹-I R²-I X-VI Y-IV R¹-I R²-IX X-VI Y-IV R¹-II R²-II X-VI Y-IV R¹-II R²-IX X-VI Y-IV R¹-III R²-III X-VI Y-IV R¹-III R²-IX X-VI Y-IV R¹-IV R²-IV X-VI Y-V R¹-I R²-I X-VI Y-V R¹-I R²-IX X-VI Y-V R¹-II R²-II X-VI Y-V R¹-II R²-IX X-VI Y-V R¹-III R²-III X-VI Y-V R¹-III R²-IX X-VI Y-V R¹-IV R²-IV X-VI Y-VI R¹-I R²-I X-VI Y-VI R¹-I R²-IX X-VI Y-VI R¹-II R²-II X-VI Y-VI R¹-II R²-IX X-VI Y-VI R¹-III R²-III X-VI Y-VI R¹-III R²-IX X-VI Y-VI R¹-IV R²-IV X-VII Y-I R¹-I R²-I X-VII Y-I R¹-I R²-IX X-VII Y-I R¹-II R²-II X-VII Y-I R¹-II R²-IX X-VII Y-I R¹-III R²-III X-VII Y-I R¹-III R²-IX X-VII Y-I R¹-IV R²-IV X-VII Y-II R¹-I R²-I X-VII Y-II R¹-I R²-IX X-VII Y-II R¹-II R²-II X-VII Y-II R¹-II R²-IX X-VII Y-II R¹-III R²-III X-VII Y-II R¹-III R²-IX X-VII Y-II R¹-IV R²-IV X-VII Y-III R¹-I R²-I X-VII Y-III R¹-I R²-IX X-VII Y-III R¹-II R²-II X-VII Y-III R¹-II R²-IX X-VII Y-III R¹-III R²-III X-VII Y-III R¹-III R²-IX X-VII Y-III R¹-IV R²-IV X-VII Y-IV R¹-I R²-I X-VII Y-IV R¹-I R²-IX X-VII Y-IV R¹-II R²-II X-VII Y-IV R¹-II R²-IX X-VII Y-IV R¹-III R²-III X-VII Y-IV R¹-III R²-IX X-VII Y-IV R¹-IV R²-IV X-VII Y-V R¹-I R²-I X-VII Y-V R¹-I R²-IX X-VII Y-V R¹-II R²-II X-VII Y-V R¹-II R²-IX X-VII Y-V R¹-III R²-III X-VII Y-V R¹-III R²-IX X-VII Y-V R¹-IV R²-IV X-VII Y-VI R¹-I R²-I X-VII Y-VI R¹-I R²-IX X-VII Y-VI R¹-II R²-II X-VII Y-VI R¹-II R²-IX X-VII Y-VI R¹-III R²-III X-VII Y-VI R¹-III R²-IX X-VII Y-VI R¹-IV R²-IV

The compounds of the present invention can be produced for example according to the methods mentioned below.

The compound of formula (1-1) (wherein A¹, A², A³, G, X, Y, R¹, R², R³, m and n are as defined above) that W in the formula (1) is oxygen atom according to the present invention can be obtained by reacting the compound of formula (3) (wherein A¹, A², A³, G, X, Y, R³, m and n are as defined above) with a halogenating agent such as thionyl chloride, phosphorus pentaoxide or oxalyl chloride or the like according to any methods known from documents such as a method stated in J. Med. Chem., 1991, vol. 34, p. 1630, or the like, with an organic acid halide such as pivaloyl chloride or isobutyl chloroformate or the like optionally in the presence of a base aqccording to a method stated in Tetrahedron Lett., 2003, vol. 44, p. 4819, or J. Med. Chem., 1991, vol. 34, p. 222, or the like, or with carbonyldiimidazole or sulfonyldiimidazole, etc. according to a method stated in J. Org. Chem., 1989, vol. 54, p. 5620 or the like, to synthesize the compound of formula (4) (wherein A¹, A², A³, G, X, Y, R³, m and n are as defined above, J¹ is chlorine atom, bromine atom, C₁-C₄alkylcarbonyloxy (for example pivaloyloxy), C₁-C₄alkoxycarbonyloxy (for example isobutyloxycarbonyloxy) or azolyl (for example imidazole-1-yl)), and reacting the compound of formula (4) with the compound of formula (5) (wherein R¹ and R² are as defined above) optionally by use of a solvent inactive for the reaction, optionally in the presence of a base.

The reaction substrates can be used in an amount of 1 to 50 equivalents of the compound of formula (5) based on 1 equivalent of the compound of formula (4).

In case where a solvent is used, the solvent is not specifically limited if it dose not inhibit the progress of the reaction, but it includes for example aromatic hydrocarbons such as benzene, toluene, xylene or the like, aliphatic hydrocarbons such as hexane, heptane or the like, alicyclic hydrocarbons such as cyclohexane or the like, aromatic halogenated hydrocarbons such as chlorobenzene, dichlorobenzene or the like, aliphatic halogenated hydrocarbons such as dichloro methane, chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,1,1-trichloroethane, trichloroethylene, tetrachloroethylene or the like, ethers such as diethyl ether, t-butyl methyl ether, 1,2-dimethoxyethane, tetrahydrofuran, 1,4-dioxane or the like, esters such as ethyl acetate, ethyl propionate or the like, amides such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrolidone or the like, amines such as triethyl amine, tributyl amine, N,N-dimethyl aniline or the like, pyridines such as pyridine, picoline or the like, acetonitrile and water, and the like. These solvents may be used alone or in a mixture of two or more.

The addition of a base is not necessarily required. However, when the base is used, alkali metal hydroxides such as sodium hydroxide, potassium hydroxide or the like, alkali metal carbonates such as sodium carbonate, potassium carbonate or the like, alkali metal bicarbonates such as sodium hydrogen carbonate, potassium hydrogen carbonate or the like, organic bases such as triethyamine, tributylamine, N,N-dimethylaniline, pyridine, 4-(dimethylamino)pyridine, imidazole, 1,8-diazabicyclo[5.4.0]-7-undecene, and the like can be used in an amount of 1 to 4 equivalents based on the compound of formula (4).

The reaction temperature may be an arbitrary temperature ranging from −60° C. to the reflux temperature of a reaction mixture, and the reaction time may be an arbitrary time ranging from 5 minutes to 100 hours although it varies depending on the concentration of the reaction substrates or the reaction temperature.

Generally, it is preferable to carry out the reaction by using 1 to 10 equivalents of the compound of formula (5) based on 1 equivalent of the compound of formula (4), optionally in the presence of 1 to 2 equivalents of a base such as potassium carbonate, triethylamine, pyridine, 4-(dimethylamino)pyridine or the like, without solvent or in a solvent such as dichloromethane, chloroform, diethyl ether, tetrahydrofurane, 1,4-dioxane, ethyl acetate, acetonitrile or the like, at a temperature ranging from 0° C. to the reflux temperature of these solvents for 10 minutes to 24 hours.

In addition, the compound of formula (1-1) according to the present invention can be also obtained by directly reacting the compound of formula (3) with the compoud of formula (5) (wherein R¹ and R² are as defined above) by use of a condensation agent optionally by use of a solvent inactive for the reaction, optionally in the presence of a base.

The reaction substrates can be used in an amount of 1 to 100 equivalents of the compound of formula (5) based on 1 equivalent of the compound of formula (3).

The condensation agent is not specifically limited if it is a compound used for ordinary amide synthesis, but it is for example Mukaiyama agent (2-chloro-N-methylpyridinium iodide), DCC (1,3-dicyclohexyl carbodiimide), WSC (1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride), CDI (carbonyl diimidazole), dimethylpropynyl sulfonium bromide, propargyl triphenyl phosphonium bromide, DEPC (diethyl phosphorocyanidate) or the like, and can be used in an amount of 1 to 4 equivalents based on the compound of formula (3).

In case where a solvent is used, the solvent is not specifically limited if it dose not inhibit the progress of the reaction, but it includes for example aromatic hydrocarbons such as benzene, toluene, xylene or the like, aliphatic hydrocarbons such as hexane, heptane or the like, alicyclic hydrocarbons such as cyclohexane or the like, aromatic halogenated hydrocarbons such as chlorobenzene, dichlorobenzene or the like, aliphatic halogenated hydrocarbons such as dichloro methane, chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,1,1-trichloroethane, trichloroethylene, tetrachloroethylene or the like, ethers such as diethyl ether, t-butyl methyl ether, 1,2-dimethoxyethane, tetrahydrofuran, 1,4-dioxane or the like, esters such as ethyl acetate, ethyl propionate or the like, amides such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrolidone or the like, amines such as triethyl amine, tributyl amine, N,N-dimethyl aniline or the like, pyridines such as pyridine, picoline or the like, acetonitrile and dimethylsulfoxide, and the like. These solvents may be used alone or in a mixture of two or more.

The addition of a base is not necessarily required. However, when the base is used, alkali metal hydroxides such as sodium hydroxide, potassium hydroxide or the like, alkali metal carbonates such as sodium carbonate, potassium carbonate or the like, alkali metal bicarbonates such as sodium hydrogen carbonate, potassium hydrogen carbonate or the like, organic bases such as triethyamine, tributylamine, N,N-dimethylaniline, pyridine, 4-(dimethylamino)pyridine, imidazole, 1,8-diazabicyclo[5.4.0]-7-undecene, and the like can be used in an amount of 1 to 4 equivalents based on the compound of formula (3).

The reaction temperature may be an arbitrary temperature ranging from −60° C. to the reflux temperature of a reaction mixture, and the reaction time may be an arbitrary time ranging from 5 minutes to 100 hours although it varies depending on the concentration of the reaction substrates or the reaction temperature.

Generally, it is preferable to carry out the reaction by using 1 to 20 equivalents of the compound of formula (5) and 1 to 4 equivalents of a condensation agent such as WSC (1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride), CDI (carbonyl diimidazole) or the like based on 1 equivalent of the compound of formula (3), optionally in the presence of 1 to 4 equivalents of a base such as potassium carbonate, triethylamine, pyridine, 4-(dimethylamino)pyridine or the like, without solvent or in a solvent such as dichloromethane, chloroform, diethyl ether, tetrahydrofurane, 1,4-dioxane or the like, at a temperature ranging from 0° C. to the reflux temperature of these solvents for 10 minutes to 24 hours.

Hydroxamic chloride of formula (7) (wherein A¹, A², A³, W, Y, R¹, R² and n are as defined above, J² means halogen atom such as chlorine atom and bromine atom or the like) can be obtained by halogenating the compound of formula (6) (wherein A¹, A², A³, W, Y, R¹, R² and n are as defined above) using a halogenating reagent optionally by using a solvent inactive for the reaction, optionally in the presence of a base.

Halogenating agents include for example N-halosuccinimides such as N-chlorosuccinimide, N-bromosuccinimide or the like, hypohalogenous acid alkali metal salts such as sodium hypochlorite or the like, hypohalogenous acid esters such as hypochlorous acid-t-butyl ester or the like, simple substance halogens such as chlorine gas or the like, and it can be used in an amount of 1 to 10 equivalents based on the compound of formula (6).

In case where a solvent is used, the solvent is not specifically limited if it dose not inhibit the progress of the reaction, but it includes for example aromatic hydrocarbons such as benzene, toluene, xylene or the like, aliphatic hydrocarbons such as hexane, heptane or the like, alicyclic hydrocarbons such as cyclohexane or the like, aromatic halogenated hydrocarbons such as chlorobenzene, dichlorobenzene or the like, aliphatic halogenated hydrocarbons such as dichloro methane, chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,1,1-trichloroethane, trichloroethylene, tetrachloroethylene or the like, ethers such as diethyl ether, t-butyl methyl ether, 1,2-dimethoxyethane, tetrahydrofuran, 1,4-dioxane or the like, esters such as ethyl acetate, ethyl propionate or the like, amides such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrolidone or the like, alcohols such as methanol, ethanol, ethylene glycol or the like, carboxylic acids such as acetic acid, propionic acid or the like, acetonitrile and water, and the like. These solvents may be used alone or in a mixture of two or more.

The reaction temperature may be an arbitrary temperature ranging from −60° C. to the reflux temperature of a reaction mixture, and the reaction time may be an arbitrary time ranging from 5 minutes to 24 hours although it varies depending on the concentration of the reaction substrates or the reaction temperature.

The compounds of formula (1) (wherein A¹, A², A³, G, W, X, Y, R¹, R², R³, m and n are as defined above) according to the present invention can be obtained by reacting the compound of formula (7) obtained as above with the compound of formula (8) (wherein G, X, R³ and m are as defined above) in the presence of a base optionally by use of a solvent inactive for the reaction.

The reaction substrates can be used in an amount of 1 to 5 equivalents of the compound of formula (8) based on 1 equivalent of the compound of formula (7).

The used base includes for example alkali metal hydroxides such as sodium hydroxide, potassium hydroxide or the like, alkali metal carbonates such as sodium carbonate, potassium carbonate or the like, alkali metal bicarbonates such as sodium hydrogen carbonate, potassium hydrogen carbonate or the like, organic bases such as triethyamine, tributylamine, N,N-dimethylaniline, pyridine, 4-(dimethylamino)pyridine, imidazole, 1,8-diazabicyclo[5.4.0]-7-undecene, and the like can be used in an amount of 1 to 5 equivalents based on the compound of formula (7).

In case where a solvent is used, the solvent is not specifically limited if it dose not inhibit the progress of the reaction, but it includes for example aromatic hydrocarbons such as benzene, toluene, xylene or the like, aliphatic hydrocarbons such as hexane, heptane or the like, alicyclic hydrocarbons such as cyclohexane or the like, aromatic halogenated hydrocarbons such as chlorobenzene, dichlorobenzene or the like, aliphatic halogenated hydrocarbons such as dichloro methane, chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,1,1-trichloroethane, trichloroethylene, tetrachloroethylene or the like, ethers such as diethyl ether, 1,2-dimethoxyethane, tetrahydrofuran, 1,4-dioxane or the like, esters such as ethyl acetate, ethyl propionate or the like, amides such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrolidone or the like, and acetonitrile, and the like. These solvents may be used alone or in a mixture of two or more.

The reaction temperature may be an arbitrary temperature ranging from −60° C. to the reflux temperature of a reaction mixture, and the reaction time may be an arbitrary time ranging from 5 minutes to 100 hours although it varies depending on the concentration of the reaction substrates or the reaction temperature.

Generally, the compound of formula (7) can be obtained for example by carrying out the reaction by using 1 to 2 equivalents of a halogenating agent such as N-chlorosuccinimide, sodium hypochlorite aqueous solution, hypochlorous acid-t-butyl ester, chlorine gas or the like based on 1 equivalent of the compound of formula (6) in a solvent such as dichloromethane, chloroform, 1,2-dimethoxyethane, tetrahydrofurane, 1,4-dioxane, N,N-dimethylformamide or the like, at a temperature ranging from 00° C. to the reflux temperature of these solvents for 10 minutes to 2 hours. Then, preferably without the isolation of the compound of formula (7), 1 to 2 equivalents of the compound of formula (8) and 1 to 2 equivalents of a base such as sodium carbonate, sodium hydrogen carbonate, triethyl amine or the like are added, and the reaction is carried out at a temperature ranging from 0° C. to the reflux temperature of these solvents for 10 minutes to 24 hours.

The substituted acylisocyanate of formula (10) (wherein A¹, A², A³, G, X, Y, R³, m and n are as defined above) can be obtained by reacting the compound of formula (4) (wherein A¹, A², A³, G, X, Y, R³, m, n and J¹ are as defined above) used in Production Method A with ammonia water or the like according to any methods known from documents such as a method stated in J. Med. Chem., 1991, vol. 34, p. 1630, or the like to synthesize the compound of formula (9) (wherein A¹, A², A³, G, X, Y, R³, m and n are as defined above), and reacting the compound of formula (9) with oxalyl chloride under an inert gas atmosphere such as nitrogen or argon, etc., optionally by use of a solvent inactive for the reaction.

The reaction substrates can be used in an amount of 1 to 2 equivalents of oxaly chloride based on 1 equivalent of the compound of formula (9).

In case where a solvent is used, the solvent is not specifically limited if it dose not inhibit the progress of the reaction, but it includes for example aromatic hydrocarbons such as benzene, toluene, xylene or the like, aliphatic hydrocarbons such as hexane, heptane or the like, alicyclic hydrocarbons such as cyclohexane or the like, aromatic halogenated hydrocarbons such as chlorobenzene, dichlorobenzene or the like, aliphatic halogenated hydrocarbons such as dichloro methane, chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,1,1-trichloroethane, trichloroethylene, tetrachloroethylene or the like, and the like. These solvents may be used alone or in a mixture of two or more.

The reaction temperature may be an arbitrary temperature ranging from −60° C. to the reflux temperature of a reaction mixture, and the reaction time may be an arbitrary time ranging from 5 minutes to 100 hours although it varies depending on the concentration of the reaction substrates or the reaction temperature.

Generally, it is preferable to carry out the reaction by adding 1 to 1.5 equivalent of oxalyl chloride based on 1 equivalent of the compound of formula (9), for example under nitrogen atmosphere, by use of a solvent such as toluene, dichloromethane, 1,2-dichloroethane or the like, at a temperature ranging from 0° C. to room temperature, and then reacting at a temperature ranging from room temperature to the reflux temperature of these solvents for 10 minutes to 24 hours.

The compound of formula (1-2) (wherein A¹, A², A³, G, X, Y, R^(1c), R³, m and n are as defined above, W^(a) is oxygen atom or sulfur atom) that in the formula (1) W is oxygen atom, R¹ is —C(O)—W^(a)—R^(1c) and R² is hydrogen atom according to the present invention can be obtained by reacting the substituted acylisocyanate of formula (10) obtained as above with the alcohol or thiol of formula (11) (wherein W^(a) is oxygen atom or sulfur atom, R^(1c) is as defined above), optionally in the presence of a base, optionally by use of a solvent inactive for the reaction.

The reaction substrates can be used in an amount of 1 to 100 equivalents of the compound of formula (11) based on 1 equivalent of the compound of formula (10).

In case where a solvent is used, the solvent is not specifically limited if it dose not inhibit the progress of the reaction, but it includes for example aromatic hydrocarbons such as benzene, toluene, xylene or the like, aliphatic hydrocarbons such as hexane, heptane or the like, alicyclic hydrocarbons such as cyclohexane or the like, aromatic halogenated hydrocarbons such as chlorobenzene, dichlorobenzene or the like, aliphatic halogenated hydrocarbons such as dichloro methane, chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,1,1-trichloroethane, trichloroethylene, tetrachloroethylene or the like, ethers such as diethyl ether, t-butyl methyl ether, 1,2-dimethoxyethane, tetrahydrofuran, 1,4-dioxane or the like, ketones such as acetone, methyl ethyl ketone or the like, esters such as ethyl acetate, ethyl propionate or the like, amides such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrolidone or the like, amines such as triethyl amine, tributyl amine, N,N-dimethyl aniline or the like, pyridines such as pyridine, picoline or the like, acetonitrile and dimethylsulfoxide, and the like. These solvents may be used alone or in a mixture of two or more.

The addition of a base is not necessarily required. However, when the base is used, alkali metal carbonates such as sodium carbonate, potassium carbonate or the like, alkali metal bicarbonates such as sodium hydrogen carbonate, potassium hydrogen carbonate or the like, organic bases such as triethyamine, tributylamine, N,N-dimethylaniline, pyridine, 4-(dimethylamino)pyridine, imidazole, 1,8-diazabicyclo[5.4.0]-7-undecene, and the like can be used in an amount of 1 to 4 equivalents based on the compound of formula (10).

The reaction temperature may be an arbitrary temperature ranging from −60° C. to the reflux temperature of a reaction mixture, and the reaction time may be an arbitrary time ranging from 5 minutes to 100 hours although it varies depending on the concentration of the reaction substrates or the reaction temperature.

Generally, it is preferable to carry out the reaction by using 1 to 20 equivalents of the compound of formula (11) based on 1 equivalent of the compound of formula (10), optionally in the presence of 1 to 4 equivalents of a base such as potassium carbonate, triethylamine, pyridine, 4-(dimethylamino)pyridine or the like, without solvent or in a solvent such as benzene, toluene, dichloromethane, chloroform, diethyl ether, tetrahydrofurane, 1,4-dioxane or the like, at a temperature ranging from 0° C. to the reflux temperature of these solvents for 10 minutes to 24 hours.

The compound of formula (1-3) (wherein A¹, A², A³, G, X, Y, R³, m and n are as defined) that in formula (1) W is oxygen atom, R¹ is —C(O)NH₂, and R² is hydrogen atom, according to the present invention can be obtained by reacting the substituted acylisocyanate of formula (10) (wherein A¹, A², A³, G, X, Y, R³, m and n are as defined above) used in Production Method C with ammonia, optionally by using a solvent inactive for the reaction.

The reaction substrates can be used in an amount of 1 to 100 equivalents of ammonia based on 1 equivalent of the compound of formula (10).

In case where a solvent is used, the solvent is not specifically limited if it dose not inhibit the progress of the reaction, but it includes for example aromatic hydrocarbons such as benzene, toluene, xylene or the like, aliphatic hydrocarbons such as hexane, heptane or the like, alicyclic hydrocarbons such as cyclohexane or the like, aromatic halogenated hydrocarbons such as chlorobenzene, dichlorobenzene or the like, aliphatic halogenated hydrocarbons such as dichloro methane, chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,1,1-trichloroethane, trichloroethylene, tetrachloroethylene or the like, ethers such as diethyl ether, t-butyl methyl ether, 1,2-dimethoxyethane, tetrahydrofuran, 1,4-dioxane or the like, ketones such as acetone, methyl ethyl ketone or the like, esters such as ethyl acetate, ethyl propionate or the like, amides such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrolidone or the like, amines such as triethyl amine, tributyl amine, N,N-dimethyl aniline or the like, pyridines such as pyridine, picoline or the like, acetonitrile and dimethylsulfoxide, and the like. These solvents may be used alone or in a mixture of two or more.

The reaction temperature may be an arbitrary temperature ranging from −60° C. to the reflux temperature of a reaction mixture, and the reaction time may be an arbitrary time ranging from 5 minutes to 100 hours although it varies depending on the concentration of the reaction substrates or the reaction temperature.

Generally, it is preferable to carry out the reaction by using 1 to 20 equivalents of ammonia water or ammonia gas based on 1 equivalent of the compound of formula (10), by use of a solvent such as benzene, toluene, dichloromethane, chloroform, diethyl ether, tetrahydrofurane, 1,4-dioxane or the like, at a temperature ranging from 0° C. to to the reflux temperature of these solvents for 10 minutes to 24 hours.

The substituted acylisothiocyanate of formula (12) (wherein A¹, A², A³, G, X, Y, R³, m and n are as defined above) can be obtained by reacting the compound of formula (4) (wherein A¹, A², A³, G, X, Y, R³, m, n and J¹ are as defined above) used in Production Method A with a thiocyanate such as potassium thiocyanate, sodium thiocyanate, ammonium thiocyanate or lead thiocyanate or the like, under an inert gas atmosphere such as nitrogen or argon, etc., optionally by use of a solvent inactive for the reaction.

The reaction substrates can be used in an amount of 1 to 10 equivalents of thiocyanate based on 1 equivalent of the compound of formula (4).

In case where a solvent is used, the solvent is not specifically limited if it dose not inhibit the progress of the reaction, but it includes for example aromatic hydrocarbons such as benzene, toluene, xylene or the like, aliphatic hydrocarbons such as hexane, heptane or the like, alicyclic hydrocarbons such as cyclohexane or the like, aromatic halogenated hydrocarbons such as chlorobenzene, dichlorobenzene or the like, aliphatic halogenated hydrocarbons such as dichloro methane, chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,1,1-trichloroethane, trichloroethylene, tetrachloroethylene or the like, ethers such as diethyl ether, t-butyl methyl ether, 1,2-dimethoxyethane, tetrahydrofuran, 1,4-dioxane or the like, ketones such as acetone, methyl ethyl ketone or the like, esters such as ethyl acetate, ethyl propionate or the like, amides such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrolidone or the like, and acetonitrile, and the like. These solvents may be used alone or in a mixture of two or more.

The reaction temperature may be an arbitrary temperature ranging from −60° C. to the reflux temperature of a reaction mixture, and the reaction time may be an arbitrary time ranging from 5 minutes to 100 hours although it varies depending on the concentration of the reaction substrates or the reaction temperature.

Generally, it is preferable to carry out the reaction by adding 1 to 1.5 equivalent of potassium thiocyanate, sodium thiocyanate or ammonium thiocyanate based on 1 equivalent of the compound of formula (4), for example under nitrogen atmosphere, by use of a solvent such as benzene, toluene, dichloromethane, acetone, acetonitrile or the like, at a temperature ranging from 0° C. to room temperature, and then reacting at a temperature ranging from room temperature to the reflux temperature of these solvents for 10 minutes to 24 hours.

The compound of formula (1-4) (wherein A¹, A², A³, G, X, Y, R^(1c), R³, m and n are as defined above, W^(a) is oxygen atom or sulfur atom) that in the formula (1) W is oxygen atom, R¹ is —C(S)—W^(a)—R^(1c) and R² is hydrogen atom according to the present invention can be obtained by reacting the substituted acylisothiocyanate of formula (12) obtained as above with the alcohol or thiol of formula (11) (wherein W^(a) and R^(1c) are as defined above) under a condition similar to that of Production Method C.

The substituted acylisothiocyanate of formula (1-5) (wherein A¹, A², A³, G, X, Y, R³, m and n are as defined above) that in the formula (1) W is oxygen atom, R¹ is —C(S)NH₂ and R² is hydrogen atom according to the present invention can be obtained by reacting the compound of formula (12) (wherein A¹, A², A³, G, X, Y, R³, m and n are as defined above) used in Production Method E with ammonia under a condition similar to that of Production Method D.

The substituted acylisothiocyanate of formula (1-6) (wherein A¹, A², A³, G, X, Y, R^(1b), R³, m and n are as defined above, R^(b) and R^(c) independently of each other are C₁-C₆alkyl) that in the formula (1) W is oxygen atom, R² together with R¹ forms ═C(R^(1b))N(R)R^(b) according to the present invention can be obtained by reacting the compound of formula (9) (wherein A¹, A², A³, G, X, Y, R³, m and n are as defined above) used in Production Method C with the compound of formula (13) (wherein R^(1b) is as defined above, R^(a), R^(b) and R^(c) independently of one another are C₁-C₆alkyl), optionally under an inert gas atmosphere such as nitrogen or argon, etc., optionally in the presence of an acid catalyst, optionally by use of a solvent inactive for the reaction.

The reaction substrates can be used in an amount of 1 to 100 equivalents of the compound of formula (13) based on 1 equivalent of the compound of formula (9).

In case where a solvent is used, the solvent is not specifically limited if it dose not inhibit the progress of the reaction, but it includes for example aromatic hydrocarbons such as benzene, toluene, xylene or the like, aliphatic hydrocarbons such as hexane, heptane or the like, alicyclic hydrocarbons such as cyclohexane or the like, aromatic halogenated hydrocarbons such as chlorobenzene, dichlorobenzene or the like, aliphatic halogenated hydrocarbons such as dichloro methane, chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,1,1-trichloroethane, trichloroethylene, tetrachloroethylene or the like, alcohols such as methanol, ethanol, 2-propanol, 2-methoxyethanol or the like, ethers such as diethyl ether, t-butyl methyl ether, 1,2-dimethoxyethane, tetrahydrofuran, 1,4-dioxane or the like, amides such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrolidone or the like, and the like. These solvents may be used alone or in a mixture of two or more.

The addition of a catalyst is not necessarily required. However, when the catalyst is used, mineral acids such as hydrochloric acid, sulfuric acid, nitric acid or the like, organic acids such as formic acid, acetic acid, propionic acid, trifluoroacetic acid, methane sulfonic acid, benzene sulfonic acid, p-toluene sulfonic acid or the like, Lewis acid such as zinc chloride, zinc iodide, titanium tetrachloride, cerium chloride, ytterbium trifluorate, boron trifluoride-ether complex or the like, and the like can be used in an amount of 0.001 to 1 equivalent based on the compound of formula (4).

The reaction temperature may be an arbitrary temperature ranging from −60° C. to the reflux temperature of a reaction mixture, and the reaction time may be an arbitrary time ranging from 5 minutes to 100 hours although it varies depending on the concentration of the reaction substrates or the reaction temperature.

Generally, it is preferable to carry out the reaction by using 2 to 10 equivalents of the compound of formula (13) based on 1 equivalent of the compound of formula (9), for example under nitrogen atmosphere, without solvent or in a solvent such as benzene, toluene or the like, at a temperature ranging from room temperature to the reflux temperature of these solvents for 1 to 24 hours.

The compound of formula (1-7) (wherein A¹, A², A³, G, X, Y, R^(1a), R^(1b), R³, m and n are as defined above) that in the formula (1) W is oxygen atom, R¹ is —C(R^(1b))═NOR^(1a) and R² is hydrogen atom according to the present invention can be obtained by reacting the compound of formula (1-6) obtained as above according to the present invention with the alkoxyamines or the salts thereof of formula (14) (wherein R^(1a) is as defined above), optionally in the presence of a base, optionally by use of a solvent inactive for the reaction.

The reaction substrates can be used in an amount of 1 to 20 equivalents of the compound of formula (14) based on 1 equivalent of the compound of formula (1-6).

In case where a solvent is used, the solvent is not specifically limited if it dose not inhibit the progress of the reaction, but it includes for example alcohols such as methanol, ethanol, 2-propanol, 2-methoxyethanol or the like, ethers such as diethyl ether, t-butyl methyl ether, 1,2-dimethoxyethane, tetrahydrofuran, 1,4-dioxane or the like, amides such as N,N-dimethylformamide, N,N-dimethylacetoamide, N-methyl-2-pyrolidone or the like, amines such as triethyl amine, tributyl amine, N,N-dimethyl aniline or the like, pyridines such as pyridine, picoline or the like, and the like. These solvents may be used alone or in a mixture of two or more.

The addition of a base is not necessarily required. However, when the compound of formula (14) is a salt with hydrochloric acid, sulfonic acid or the like, for example alkali metal carbonates such as sodium carbonate, potassium carbonate or the like, alkali metal bicarbonates such as sodium hydrogen carbonate, potassium hydrogen carbonate or the like, organic bases such as triethyamine, tributylamine, N,N-dimethylaniline, pyridine, 4-(dimethylamino)pyridine, imidazole, 1,8-diazabicyclo[5.4.0]-7-undecene, and the like can be used in an amount of 1 to 4 equivalents based on the compound of formula (14).

The reaction temperature may be an arbitrary temperature ranging from −60° C. to the reflux temperature of a reaction mixture, and the reaction time may be an arbitrary time ranging from 5 minutes to 100 hours although it varies depending on the concentration of the reaction substrates or the reaction temperature.

Generally, it is preferable to carry out the reaction by using 1 to 5 equivalents of the compound of formula (14) based on 1 equivalent of the compound of formula (1-6), in case where the compound of formula (14) is a salt, by adding 1 to 4 equivalents of a base such as triethylamine, 1,8-diazabicyclo[5.4.0]-7-undecene or the like, without solvent or in a solvent such as methanol, ethanol, diethyl ether, tetrahydrofurane, 1,4-dioxane or the like, at a temperature ranging from room temperature to the reflux temperature of these solvents for 10 minutes to 24 hours.

The substituted acylisothiocyanate of formula (1-1) (wherein A¹, A², A³, G, X, Y, R³, m and n are as defined above, R¹ is —C(R^(1b))═NOR^(1a), M-5, M-20, M-48, —C(O)OR^(1c), —C(O)SR^(1c), phenyl, phenyl substituted with (Z)_(p1) or D-1 to D-65, R² has the meaning mentioned above other than hydrogen atom) that W in the formula (1) is oxygen atom according to the present invention can be obtained by reacting the compound of formula (15) (wherein A¹, A², A³, G, X, Y, R³, m and n are as defined above, R¹ is —C(R^(1b))═NOR^(1a), M-5, M-20, M-48, —C(O)OR^(1c), —C(O)SR^(1c), phenyl, phenyl substituted with (Z)_(p1) or D-1 to D-65 or the like) with the compound of formula (16) (wherein R² has the meaning mentioned above other than hydrogen atom, J³ is a good leaving group such as chlorine atom, bromine atom, iodine atom, C₁-C₄alkylcarbonyloxy (for example pivaloyloxy), C₁-C₄alkylsulfonate (for example methane sulfonyloxy), C₁-C₄haloalkylsulfonate (for example trifluoromethane sulfonyloxy), arylsulfonate (for example benzene sulfonyloxy or p-toluenesulfonyloxy) or azolyl (for example imidazole-1-yl)), optioanally in the presence of a base, optionally by use of a solvent inactive for the reaction.

The reaction substrates can be used in an amount of 1 to 50 equivalents of the compound of formula (16) based on 1 equivalent of the compound of formula (15).

In case where a solvent is used, the solvent is not specifically limited if it dose not inhibit the progress of the reaction, but it includes for example aromatic hydrocarbons such as benzene, toluene, xylene or the like, aliphatic hydrocarbons such as hexane, heptane or the like, alicyclic hydrocarbons such as cyclohexane or the like, aromatic halogenated hydrocarbons such as chlorobenzene, dichlorobenzene or the like, aliphatic halogenated hydrocarbons such as dichloro methane, chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,1,1-trichloroethane, trichloroethylene, tetrachloroethylene or the like, ethers such as diethyl ether, t-butyl methyl ether, 1,2-dimethoxyethane, tetrahydrofuran, 1,4-dioxane or the like, esters such as ethyl acetate, ethyl propionate or the like, amides such as dimethylformamide, dimethylacetamide, N-methyl-2-pyrolidone or the like, amines such as triethyl amine, tributyl amine, N,N-dimethyl aniline or the like, pyridines such as pyridine, picoline or the like, alcohols such as methanol, ethanol, ethylene glycol or the like, acetonitrile, dimethylsulfoxide, sulfolane, 1,3-dimethyl-2-imidazolidinone and water, and the like. These solvents may be used alone or in a mixture of two or more.

In case where a base is used, for example alkali metal hydrides such as sodium hydride, potassium hydride or the like, alkali metal hydroxides such as sodium hydroxide, potassium hydroxide or the like, alkali metal alkoxides such as sodium ethoxide, potassium t-butoxide or the like, alkali metal amides such as lithium diisopropylamide, lithium hexamethyldisilazane, sodium amide or the like, organic metal compounds such as t-butyl lithium or the like, alkali metal carbonates such as sodium carbonate, potassium carbonate, sodium hydrogen carbonate or the like, organic bases such as triethyamine, tributylamine, N,N-dimethylaniline, pyridine, 4-(dimethylamino)pyridine, imidazole, 1,8-diazabicyclo[5.4.0]-7-undecene, and the like can be used in an amount of 1 to 4 equivalents based on the compound of formula (15).

The reaction temperature may be an arbitrary temperature ranging from −60° C. to the reflux temperature of a reaction mixture, and the reaction time may be an arbitrary time ranging from 5 minutes to 100 hours although it varies depending on the concentration of the reaction substrates or the reaction temperature.

Generally, it is preferable to carry out the reaction by using 1 to 10 equivalents of the compound of formula (16) based on 1 equivalent of the compound of formula (15), in a polar solvent such as tetrahydrofurane, 1,4-dioxane, acetonitrile, N,N-dimethylformamide or the like, optionally by use of a base such as sodium hydride, potassium t-butoxide, potassium hydroxide, potassium carbonate, triethylamine, pyridine or the like in an amount of 1 to 3 equivalents based on 1 equivalent of the compound of formula (15), at a temperature ranging from 000° C. to 90° C. for 10 minutes to 24 hours.

The substituted acylisothiocyanate of formula (1-8) (wherein A¹, A², A³, G, Wa, X, Y, R^(1c), R³, m and n are as defined above, R^(d) is C₁-C₆alkyl, C₁-C₆haloalkyl, —CH₂R^(14a), C₃-C₆alkenyl, C₃-C₆haloalkenyl, C₃-C₆alkynyl, C₃-C₆haloalkynyl, —C(O)R¹⁵, —C(O)OR¹⁵ or the like, R^(14a), R¹⁵ and J³ have the meaning mentioned above) that in the formula (1) W is oxygen atom and R² together with R¹ forms ═C(SR^(d))—W^(a)—R^(1c) according to the present invention can be obtained by reacting the compound of formula (1-4) (wherein A¹, A², A³, G, Wa, X, Y, R^(1c), R³, m and n are as defined above) that can be synthesized by use of Production Method E according to the present invention with the compound of formula (17) (wherein R^(d) is C₁-C₆alkyl, C₁-C₆haloalkyl, —CH₂R^(14a), C₃-C₆alkenyl, C₃-C₆haloalkenyl, C₃-C₆alkynyl, C₃-C₆haloalkynyl, —C(O)R¹⁵ —C(O)OR¹⁵ or the like, R^(14a), R¹⁵ and J³ have the meaning mentioned above), by use of a condition similar to that of Produciton Method H.

The compound of formula (1-9) (wherein A¹, A², A³, G, X, Y, R^(1d), R², R³, m and n are as defined above, W^(b) is oxygen atom or sulfur atom) that in the formula (1) W is oxygen atom and R¹ is —C(W^(b))NHR^(d) according to the present invention can be obtained by reacting the compound of formula (18) (wherein A¹, A², A³, G, X, Y, R², R³, m and n are as defined above) with the compound of formula (19) (wherein W^(b) is oxygen atom or sulfur atom, R^(1d) has the meaning mentioned above), optioanally in the presence of a base, optionally by use of a solvent inactive for the reaction.

The reaction substrates can be used in an amount of 1 to 10 equivalents of the compound of formula (19) based on 1 equivalent of the compound of formula (18).

In case where a solvent is used, the solvent is not specifically limited if it dose not inhibit the progress of the reaction, but it includes for example aromatic hydrocarbons such as benzene, toluene, xylene or the like, aliphatic hydrocarbons such as hexane, heptane or the like, alicyclic hydrocarbons such as cyclohexane or the like, aromatic halogenated hydrocarbons such as chlorobenzene, dichlorobenzene or the like, aliphatic halogenated hydrocarbons such as dichloro methane, chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,1,1-trichloroethane, trichloroethylene, tetrachloroethylene or the like, ethers such as diethyl ether, t-butyl methyl ether, 1,2-dimethoxyethane, tetrahydrofuran, 1,4-dioxane or the like, ketones such as acetone, methyl ethyl ketone or the like, alcohols such as methanol, ethanol, ethylene glycol or the like, and acetonitrile, and the like. These solvents may be used alone or in a mixture of two or more.

In case where a base is used, for example alkali metal hydrides such as sodium hydride, potassium hydride or the like, alkali metal carbonates such as sodium carbonate, potassium carbonate, sodium hydrogen carbonate or the like, organic bases such as triethyamine, tributylamine, N,N-dimethylaniline, pyridine, 4-(dimethylamino)pyridine, imidazole, 1,8-diazabicyclo[5.4.0]-7-undecene, and the like can be used in an amount of 1 to 5 equivalents based on the compound of formula (18).

The reaction temperature may be an arbitrary temperature ranging from −20° C. to the reflux temperature of a reaction mixture, and the reaction time may be an arbitrary time ranging from 5 minutes to 100 hours although it varies depending on the concentration of the reaction substrates or the reaction temperature.

Generally, it is preferable to carry out the reaction by using 1 to 2 equivalents of the compound of formula (19) based on 1 equivalent of the compound of formula (18), in a solvent such as benzene, toluene, 1,2-dichloroethane, tetrahydrofuran, ethanol, acetonitrile or the like, optionally by use of a base such as sodium hydride, pyridine or the like in an amount of 1 to 2 equivalents based on 1 equivalent of the compound of formula (18), at a temperature ranging from room temperature to the reflux temperature of a reaction mixture for 1 to 24 hours.

The compound of formula (1-11) (wherein A¹, A², A³, G, X, Y, R², R³, m and n are as defined above, W^(b) is oxygen atom or sulfur atom) that in the formula (1) W is oxygen atom and R¹ is —C(W^(b))NH₂ according to the present invention can be obtained by reacting the compound of formula (1-10) (wherein A¹, A², A³, G, X, Y, R², R³, m and n are as defined above, W^(b) is oxygen atom or sulfur atom, R¹⁵ is C₁-C₄haloalkyl (for example trichloromethyl or the like)) that is the compound of formula (1-9) of the present invention wherein R^(1d) is —C(O)R¹⁵ and can be synthesized according to Production method I with water or the alcohol of formula (20) (wherein R^(a) is C₁-C₄alkyl), optioanally in the presence of an acid or base catalyst, optionally by use of a solvent inactive for the reaction.

The reaction substrates can be used in an amount of 1 to 100 equivalents of water or the alcohol of formula (20) based on 1 equivalent of the compound of formula (1-10) according to the present invention.

In case where a solvent is used, the solvent is not specifically limited if it dose not inhibit the progress of the reaction, but it includes for example aromatic hydrocarbons such as benzene, toluene, xylene or the like, aliphatic halogenated hydrocarbons such as dichloro methane, chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,1,1-trichloroethane, trichloroethylene, tetrachloroethylene or the like, ethers such as diethyl ether, t-butyl methyl ether, 1,2-dimethoxyethane, tetrahydrofuran, 1,4-dioxane or the like, esters such as ethyl acetate, ethyl propionate or the like, amides such as dimethylformamide, dimethylacetamide, N-methyl-2-pyrolidone or the like, alcohols such as methanol, ethanol, ethylene glycol or the like, acetonitrile, dimethylsulfoxide, sulfolane, 1,3-dimethyl-2-imidazolidinone and water, and the like. These solvents may be used alone or in a mixture of two or more.

In case where an acid catalyst is used, as the catalyst for reaction, for example mineral acids such as hydrochloric acid, sulfuric acid, nitric acid or the like, organic acids such as formic acid, acetic acid, propionic acid, trifluoroacetic acid, methane sulfonic acid, benzene sulfonic acid, p-toluene sulfonic acid or the like, or silica gel, and the like can be used in an amount of 0.001 to 1 equivalent based on the compound of formula (1-10) according to the present invention or in an amount of 10 to 1000 g/mol.

In case where a base catalyst is used, for example alkali metal hydroxides such as sodium hydroxide, potassium hydroxide or the like, alkali metal carbonates such as sodium carbonate, potassium carbonate, sodium hydrogen carbonate or the like, organic bases such as triethyamine, tributylamine, N,N-dimethylaniline, pyridine, 4-(dimethylamino)pyridine, imidazole, 1,8-diazabicyclo[5.4.0]-7-undecene, and the like can be used in an amount of 0.001 to 1 equivalent based on the compound of formula (1-10) according to the present invention.

The reaction temperature may be an arbitrary temperature ranging from 0° C. to the reflux temperature of a reaction mixture, and the reaction time may be an arbitrary time ranging from 5 minutes to 100 hours although it varies depending on the concentration of the reaction substrates or the reaction temperature.

Generally, it is preferable to carry out the reaction by using 0.01 to 0.1 equivalent of an acid catalyst such as hydrochloric acid or sulfuric acid, etc. based on 1 equivalent of the compound of formula (1-10) according to the present invention, in a solvent such as methanol or the like, at a temperature ranging from room temperature to the reflux temperature of a reaction mixture for 10 minutes to 24 hours.

The compound of formula (1-12) (wherein A¹, A², A³, G, X, Y, R¹, R², R³, m and n are as defined above) according to the present invention that is the compound of formula (1) wherein W is sulfur atom can be obtained by reacting the compound of formula (1-1) (wherein A¹, A², A³, G, X, Y, R¹, R², R³, m and n are as defined above) according to the present invention that is the compound of formula (1) wherein W is oxygen atom with a sulfurizing agent such as diphosphorus pentasulfide, diphosphorus pentasulfide-HMDO (hexamethyldisiloxane), Lawesson's Reagent (2,4-bis(4-methoxyphenyl)-1,3,2,4-dithiadiphosphetane-2,4-disulfide), optionally by using a solvent inactive for the reaction, optionally in the presence of a base.

The reaction substrates can be used in an amount of 1 to 50 equivalents of the sulfurizing agent based on 1 equivalent of the compound of formula (1-1).

In case where a solvent is used, the solvent is not specifically limited if it dose not inhibit the progress of the reaction, but it includes for example aromatic hydrocarbons such as benzene, toluene, xylene or the like, aliphatic hydrocarbons such as hexane, heptane or the like, alicyclic hydrocarbons such as cyclohexane or the like, aromatic halogenated hydrocarbons such as chlorobenzene, dichlorobenzene or the like, aliphatic halogenated hydrocarbons such as dichloro methane, chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,1,1-trichloroethane, trichloroethylene, tetrachloroethylene or the like, ethers such as diethyl ether, t-butyl methyl ether, 1,2-dimethoxyethane, tetrahydrofuran, 1,4-dioxane or the like, amines such as triethyl amine, tributyl amine, N,N-dimethyl aniline or the like, pyridines such as pyridine, picoline or the like, and HMPA (hexamethylphosphoric triamide), and the like. These solvents may be used alone or in a mixture of two or more.

The addition of a base is not necessarily required. However, when the base is used, alkali metal carbonates such as sodium carbonate, potassium carbonate, sodium hydrogen carbonate or the like, organic bases such as triethyamine, tributylamine, N,N-dimethylaniline, pyridine, 4-(dimethylamino)pyridine, imidazole, 1,8-diazabicyclo[5.4.0]-7-undecene, and the like can be used in an amount of 1 to 10 equivalents based on the compound of formula (1-1).

The reaction temperature may be an arbitrary temperature ranging from 0° C. to the reflux temperature of a reaction mixture, and the reaction time may be an arbitrary time ranging from 5 minutes to 100 hours although it varies depending on the concentration of the reaction substrates or the reaction temperature.

Generally, it is preferable to carry out the reaction by using 1 to 10 equivalents of a sulfurizing agent such as diphosphorus pentasulfide, diphosphorus pentasulfide-HMDO, Lawesson's Reagent or the like, based on 1 equivalent of the compound of formula (1-1), optionally in the presence of 1 to 4 equivalents of a base such as sodium hydrogen carbonate, triethyamine, pyridine or the like, in a solvent such as benzene, toluene, chlorobenzene, dichloromethane, chloroform, 1,2-dimethoxyethane, tetrahydrofurane, 1,4-dioxane, HMPA or the like, at a temperature ranging from room temperature to the reflux temperature of the reaction mixture for 10 minutes to 50 hours, or in a solvent amount of pyridine at a temperature of 80° C. to the reflux temperature of the reaction mixture for 1 to 3 hours.

In Production Method A to Production Method L, the aimed compound of the present invention can be obtained by subjecting the reaction mixture after the completion of the reaction to ordinary post-treatment such as a direct concentration, or a concentration after dissolving in an organic solvent and washing with water or a concentration after placing in ice water and extracting with an organic solvent. In addition, when a purification is required, it can be separated and purified by an arbitrary purification process such as recrystallization, column chromatograph, thin layer chromatograph, liquid chromatograph collection or the like.

The compound of formula (3) used in Production Method A can be synthesized as follows, for example.

That is, the compound of formula (3) (wherein A¹, A², A³, G, X, Y, R³, m and n are as defined above) can be obtained by reacting the compound of formula (21) wherein A¹, A², A³, G, X, Y, R³, m and n are as defined above, J⁴ is bromine atom, iodine atom, halosulfonyloxy (for example fluorosulfonyloxy), C₁-C₄haloalkylsulfonyloxy (for example trifluoromethane sulfonyloxy) or arylsulfonyloxy (for example benzenesulfonyloxy) according to a known method disclosed in documents, for example by CO insertion reaction by use of a transition metal catalyst such as palladium or the like stated in J. Org. Chem., 1999, vol. 64, p. 6921 or the like, or by a process by lithiation and then reaction with carbonic acid gas stated in Chem. Rev., 1990, vol. 90, p. 879.

In addition, the compound of formula (3) can be obtained by subjecting the compound of formula (21) to a reaction according to a reaction condition for CO insertion reaction by use of a transition metal catalyst such as palladium or the like stated in J. Org. Chem., 1974, vol. 39, p. 3318 or the like to convert the compound of formula (22) (wherein A¹, A², A³, G, X, Y, R³, m and n are as defined above, R^(a) is C₁-C₆alkyl), and then hydrolizing according to an ordinary ester hydrolysis disclosed in documents, for example a reaction condition stated in Angew. Chem., 1951, vol. 63, p. 329, J. Am. Chem. Soc., 1929, vol. 51, p. 1865 or the like.

Some of the compounds of formula (5) used in Production Method A are known compounds, and a part thereof is commercially available. Also, the compounds other than the above-mentioned compounds can be synthesized according to methods stated in for example Can. J. Chem., 1979, vol. 57, p. 1253, J. Chem. Soc., Chem. Commun., 1987, p. 114, J. Org. Chem., 1985, vol. 50, p. 3243 and 1995, vol. 60, p. 8124, Synlett, 2005, p. 2214, WO 2002/062805, JP 10-130221 or the like.

The compounds of formula (6) used in Production Method B can be synthesized as follows, for example.

That is, the compound of formula (6) (wherein A¹, A², A³, W, Y, R¹, R² and n are as defined above) can be easily synthesized by reacting the compound of formula (23) (wherein A¹, A², A³, W, Y, R¹, R² and n are as defined above) with hydroxyamine or the salt thereof according to known methods disclosed in documents, for example the method stated in J. Med. Chem., 2001, vol. 44, p. 2308 or the like.

The compounds of formula (8) used in Production Method B can be

That is, the compound of formula (8) (wherein G, X, R³ and m are as defined above) can be obtained by reacting the known compound of formula (24) (wherein G, X and m are as defined above, J⁵ is bromine atom, iodine atom, C₁-C₄haloalkylsulfonyloxy (for example trifluoromethanesulfonyloxy), —B(OH)₂, 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl, —Si(OEt)₃, —ZnCl, —ZnBr or —ZnI, etc.) with the compound of formula (25) (wherein R³ is as defined above, J⁶ is halogen atom such as bromine atom, iodine atom or the like, or —B(OH)₂) according to an ordinary crosscoupling reaction by use of a transition metal catalyst such as palladium or the like disclosed in documents, for example a reaction condtioin stated in J. Org. Chem., 1991, vol. 56, p. 7336, Tetrahedron Lett., 2001, vol. 42, p. 4083, or the like.

Some of the compounds of formula (25) used in the above-mentioned process are known compounds, and a part thereof is commercially available. Also, the compounds other than the above-mentioned compounds can be synthesized according to methods disclosed in documents, for example a method stated in J. Am. Chem. Soc., 1971, vol. 93, p. 1925, Tetrahedron Lett., 1990, vol. 31, p. 1919 and 2001, vol. 42, p. 4083 or the like.

In addition, the compounds of formula (8) can be obtained by reacting the compound of formula (26) (wherein G, X, R³ and m are as defined above) according to a reaction of converting carbonyl to olefine disclosed in documents, for example a reaction condition stated in J. Org. Chem., 1986, vol. 51, p. 5252 and 1994, vol. 59, p. 2898, Synthesis, 1991, p. 29, Tetrahedron Lett., 1985, vol. 26, p. 5579 or the like.

The compounds of formula (11) used in Production method C and Production method E are known compounds, and a part thereof is commercially available. Also, the compounds other than the above-mentioned compounds can be easily synthesized according to general synthesis methods of alcohols and thiols that are disclosed in documents.

The compounds of formula (13) used in Production Method G are known compounds and a part thereof is commercially available. Also, the compounds other than the above-mentioned compounds can be easily synthesized according to any methods disclosed in documents, for example a method stated in J. Org. Chem., 1984, vol. 49, p. 3659 or the like

The compounds of formula (14) used in Production Method G are known compounds and a part thereof is commercially available. Also, the compounds other than the above-mentioned compounds can be easily synthesized according to any methods disclosed in documents, for example a method stated in J. Org. Chem., 2005, vol. 70, p. 6991 or the like

The compounds of formula (15) used in Production Method H can be synthesized as follows, for example.

Reaction Scheme 4

The compounds of formula (15) used in Production Method H can be synthesized as follows, for example.

That is, the compound of formula (16) (wherein A¹, A², A³, G, X, Y, R¹, R³, m and n are as defined above) can be obtained by reacting the compopund of formula (3) (wherein A¹, A², A³, G, X, Y, R³, m and n are as defined above) with the known compound of formula (27) (wherein R¹ is as defined above) under a condition similar to that of Production Method A.

Some of the compounds of formula (16) used in Production Method H and of the compounds of formula (17) used in Production Method I are known compounds, and a part thereof is commercially available. Also, the compounds other than the above-mentioned compounds can be synthesized according to methods disclosed in documents, for example a method stated in Chem. Pharm, Bull., 1986, vol. 34, p. 540 and 2001, vol. 49, p. 1102, J. Am. Chem. Soc., 1964, vol. 86, p. 4383, J. Org. Chem., 1983, vol. 48, p. 5280, Org. Synth., 1988, Collective Volume 6, p. 101, Synlett, 2005, p. 2847, Synthesis, 1990, p. 1159, JP 05-125017, EP 0,051,273, GB 2,161,802 or the like.

The compounds of formula (18) used in Production Method J can be synthesized as follows, for example.

That is, the compound of formula (18) (wherein A¹, A², A³, G, X, Y, R², R³, m and n are as defined above) can be obtained by reacting the compopund of formula (3) (wherein A¹, A², A³, G, X, Y, R³, m and n are as defined above) with the known compound of formula (28) (wherein R² is as defined above) under a condition similar to that of Production Method A.

The compounds of formula (19) used in Production Method J are known compounds, and a part thereof is commercially available. Also, the compounds other than the above-mentioned compounds can be synthesized according to for example a general synthesis method of acylisocyanates stated in Angew. Chem., 1977, vol. 89, p. 789, Chem. Ber, 1982, vol. 115, p. 1252, J. Med. Chem., 1991, vol. 34, p. 1630, EP 0,585,165 or the like, a general synthesis method of sulfonylisocyanates stated in J. Org. Chem., 1985, vol. 50, p. 169 or the like, a general synthesis method of acylisothiocyanates stated in Chem. Ber, 1982, vol. 115, p. 1252 and 1983, vol. 116, p. 1297, J. Org. Chem., 1990, vol. 55, p. 5230.

The compounds of formula (21) can be synthesized as follows, for example.

That is, the compounds of formula (21) (wherein A¹, A², A³, G, X, Y, R³, m, n and J⁴ are as defined above) can be obtained by halogenating the compound of formula (29) (wherein A¹, A², A³, Y, n and J⁴ are as defined above) under a condition similar to that of Production Method B to obtain the compound of formula (30) (wherein A¹, A², A³, Y, n, J³ and J⁴ are as defied above), and then reacting it with the compound of formula (8) (wherein G, X, R³ and m are as defined above).

The compound of formula (29) used above can be easily synthesized by use of the corresponding known substituted aromatic aldehyde similarly to the process described in Reaction Scheme 2.

The compound of formula (23) can be synthesized for example acccording to Reaction Scheme 7 or Reaction Scheme 8.

The compounds of formula (23) (wherein A¹, A², A³, W, Y, R¹, R² and n are as defined above) can be obtained by subjecting the compound of formula (31) (wherein A¹, A², A³, W, Y, R¹, R², n and J⁴ are as defined above) to CO insertion reaction according to known methods disclosed in documents, for example the reaction by use of a transition metal catalyst such as palladium or the like in the presence of hydride source such as formic acid or the like stated in Bull. Chem. Soc. Jpn., 1994, vol. 67, p. 2329, J. Am. Chem. Soc., 1986, vol. 108, p. 452, or the like.

The compounds of formula (23-1) (wherein A¹, A², A³, Y, R¹, R² and n are as defined above) that are the compounds of formula (23) wherein W is oxygen atom can be synthesized by reacting the compound of formula (32) (wherein A¹, A², A³, Y and n are as defined above) with the compound of formula (5) (wherein R¹ and R² are as defined above) by use of the method similar to that of Production Method A.

The compound of formula (32) used above can be easily synthesized by use of the corresponding known benzoate under a reaction condition of a general hydrolysis of esters that are stated in documents.

The compounds of formula (26) can be synthesized as follows, for example.

That is, the compounds of formula (26) (wherein X, R³ and m are as defined above, G is benzene ring) can be obtained by reacting the known compound of formula (34) (wherein X and m are as defined above, G is benzene ring) with the known compound of formula (35) (wherein R³ is as defined above, J⁷ is a leaving group such as halogen atom, trifluoromethanesulfonyloxy, 2-pyridyloxy or the like), or the known compound of formula (36) (wherein R³ is as defined above) according to a genaral acylating reaction of aromatic ring disclosed in documents, for example a method stated in Chem. Lett., 1990, p. 783, J. Org. Chem., 1991, vol. 56, p. 1963 or the like.

In addition, the compound of formula (26) (wherein G, X, R³ and m are as defined above) can be obtained according to general methods disclosed in documents for example by a method stated in J. Am. Chem. Soc., 1955, vol. 77, p. 3657, Tetrahedron Lett., 1980, vol. 21, p. 2129 and 1991, vol. 32, p. 2003, U.S. Pat. No. 5,514,816 in which the compound of formula (37) (wherein G, X and m are as defined above, J⁸ is bromine atom or iodine atom) is lithiated and the resulting compound is reacted with the known compound of formula (38) (wherein R³ is as defined above, J⁹ is halogen atom, hydroxy, metal salt (for example, —OLi, —ONa), C₁-C₄alkoxy (for example, methoxy, ethoxy), di(C₁-C₄alkyl)amino (for example, diethylamino), C₁-C₄alkoxy C₁-C₄alkyl amino (for example O,N-dimethylhydroxyamino) or cyclic amino (for example, piperidin-1-yl, morpholin-4-yl, 4-methylpiperadin-1-yl)), or the known compound of formula (36), or by a method stated in Heterocycles, 1987, vol. 25, p. 221, Synth. Commun., 1985, vol. 15, p. 1291 and 1990, vol. 20, p. 1469, DE 19727042, or the like in which a Grignard reagent is formed and then it is reacted with the compound of formula (38) or the compound of formula (36).

The compounds of formula (31) can be synthesized according to for example Reaction Scheme 10 to Reaction Scheme 18.

The compounds of formula (31-1) (wherein A¹, A², A³, Y, R¹, R², n and J⁴ are as defined above) that are the compounds of formula (31) wherein W is oxygen atom can be obtained by reacting the known compound of formula (39) (wherein A¹, A², A³, Y, n and J⁴ are as defined above) with the compound of formula (5) (wherein R¹ and R² are as defined above) by use of the method similar to Production Method A.

The compounds of formula (31-2) (wherein A¹, A², A³, Y, R^(lc), n and J⁴ are as defined above, W^(a) is oxygen atom or sulfur atom) that are the compounds of formula (31) wherein W is oxygen atom, R¹ is —C(O)—W^(a)—R^(1c) and R² is hydrogen atom can be obtained by reacting the compound of formula (40) (wherein A¹, A², A³, Y, n, J¹ and J⁴ are as defined above) as a starting material according to a method similar to that of Production Method C.

The compounds of formula (31-3) (wherein A¹, A², A³, Y, n and J⁴ are as defined above) that are the compounds of formula (31) wherein W is oxygen atom, R¹ is —C(O)NH₂ and R² is hydrogen atom can be obtained by reacting the substituted acylisocyanate of formula (42) (wherein A¹, A², A³, Y, n and J⁴ are as defined above) with ammonia according to a method similar to that of Production Method D.

The compounds of formula (31-4) (wherein A¹, A², A³, Y, R^(1c), n and J⁴ are as defined above, W^(a) is oxygen atom or sulfur atom) that are the compounds of formula (31) wherein W is oxygen atom, R¹ is —C(S)—W^(a)—R^(1c) and R² is hydrogen atom can be obtained by reacting the compound of formula (40) (wherein A¹, A², A³, Y, n, J¹ and J⁴ are as defined above) as a starting material according to a method similar to that of Production Method E.

The compounds of formula (31-5) (wherein A¹, A², A³, Y, n and J⁴ are as defined above) that are the compounds of formula (31) wherein W is oxygen atom, R¹ is —C(S)NH₂ and R² is hydrogen atom can be obtained by reacting the substituted acylisothiocyanate of formula (43) (wherein A¹, A², A³, Y, n and J⁴ are as defined above) with ammonia according to a method similar to that of Production Method D.

The compounds of formula (31-1) (wherein A¹, A², A³, Y, R¹, n and J⁴ are as defined above, and R² has the meaning other than hydrogen atom) that are the compounds of formula (31) wherein W is oxygen atom can be obtained by reacting the compound of formula (44) (wherein A¹, A², A³, Y, R¹, n and J⁴ are as defined above) with the compound of formula (16) (wherein R² and J³ are as defined above) under a condition similar to that of Production Method H.

The compounds of formula (44) used above can be produced from the above-mentioned known compound of formula (39) according to a method similar to that of Production Methods A, C and E.

The compounds of formula (31-6) (wherein A¹, A², A³, Y, R^(1d), R², n and J⁴ are as defined above, and W^(b) is oxygen atom or sulfur atom) that are the compounds of formula (31) wherein W is oxygen atom and R¹ is —C(W^(b))NHR^(1d) can be obtained by reacting the compound of formula (45) (wherein A¹, A², A³, Y, R², n and J⁴ are as defined above) with the compound of formula (19) (wherein W^(b) and R^(1d) are as defined above) under a condition similar to that of Production Method J.

The compounds of formula (45) used above can be produced from the above-mentioned known compound of formula (39) according to a method similar to that of Production Method A.

The compound of formula (31-8) (wherein A¹, A², A³, Y, R², n and J⁴ are as defined above, W^(b) is oxygen atom or sulfur atom) that in the formula (31) W is oxygen atom and R¹ is —C(W^(b))NH₂ can be obtained by reacting the compound of formula (31-7) (wherein A¹, A², A³, Y, R², n and J⁴ are as defined above, W^(b) is oxygen atom or sulfur atom, R¹⁵ is C₁-C₄haloalkyl (for example trichloromethyl or the like)) that is the compound of formula (31-6) wherein R^(1d) is —C(O)R¹⁵ and can be synthesized by use of Reaction Scheme 16 with water or the alcohol of formula (20) (wherein R^(a) is as defined above), under a condition similar to that of Production Method K.

The compounds of formula (31-9) (wherein A¹, A², A³, Y, R¹, R², n and J⁴ are as defined above) that are the compounds of formula (31) wherein W is sulfur atom can be obtained by reacting the compound of formula (31-1) (wherein A¹, A², A³, Y, R¹, R², n and J⁴ are as defined above) that are the compounds of formula (31) wherein W is oxygen atom with a sulfurizing agent under a condition similar to that of Production Method L.

In each reaction, after the completion of the reaction, each production intermediate that is a starting compound in Production Method A to Production Method L can be obtained by carrying out normal post-treatments.

In addition, each production intermediate produced by the above-mentioned methods can be used for the following reaction step as such without isolation or purification.

The active compounds included in the present invention concretely include for example the compounds shown in Tables 2 and 3. The compounds that can be used as novel production intermediates for producing the active compounds included in the present invention concretely include for example the compounds shown in Table 4. In the interim, the compounds shown in Tables 2 to 4 are for purposes of illustration and the present invention is not limited thereto.

In the meantime, in Tables, the indication “Et” means ethyl, hereinafter similarly thereto, “n-Pr” and “Pr-n” mean normal propyl, “i-Pr” and “Pr-i” mean isopropyl, “c-Pr” and “Pr-c” mean cyclopropyl, “n-Bu” and “Bu-n” mean normal butyl, “i-Bu” and “Bu-i” mean isobutyl, “s-Bu” and “Bu-s” mean secondary butyl, “c-Bu” and “Bu-c” mean cyclobutyl, “t-Bu” and “Bu-t” mean tertiary butyl, “n-Pen” and “Pen-n” mean normal pentyl, “c-Pen” and “Pen-c” mean cyclopentyl, “n-Hex” and “Hex-n” mean normal hexyl, “c-Hex” and “Hex-c” mean cyclohexyl, “Hept” means heptyl, “Oct” means octyl, “Ph” means phenyl, “1-Naph” means 1-naphthyl, “2-Naph” means 2-naphthyl, TMS means trimethylsilyl, and in Tables, aromatic heterocyclic rings of D-1a to D-65b are the following structures, respectively

For example, the indication “[(D-17b)Cl]” means 3-chloro-1-methylpyrazol-5-yl, the indication “[(D-52f)-3-F-5-Cl] means 5-chloro-3-fluoropyridine-2-yl. In addition, in Tables, aliphatic heterocyclic rings of E-4-a to E-44a are the following structures, respectively

For example, the indication “[C(O)OCH₂(E-9a)C(O)CH₃]” means N-acetylpyrrolidine-3-ylmethoxycarbonyl, the indication “[C(O)O(E-9a)C(O)OCH₃]” means N-methoxycarbonylpyrrolidine-3-yloxycarbonyl.

Further, in Tables, partially saturated heterocyclic rings of M-1a to M-32a are the following structures, respectively

For example, the indication “[(M-5c)CH₃]” means 5-methyl-4,5-dihydroisoxazole-3-yl, the indication “[(M-5c)Ph-4-F]” means 5-(4-fluorophenyl)-4,5-dihydroisoxazole-3-yl. Further, in Tables, T-1 to T-21 are the following structures, respectively

Lengthy table referenced here US20140135496A1-20140515-T00001 Please refer to the end of the specification for access instructions.

Lengthy table referenced here US20140135496A1-20140515-T00002 Please refer to the end of the specification for access instructions.

Lengthy table referenced here US20140135496A1-20140515-T00003 Please refer to the end of the specification for access instructions.

The compounds of the present invention can effectively control in a low concentration so-called agricultural insects injuring agricultural and horticultural crops and trees, so-called domestic animal pests parasitizing domestic animals and domestic fowls, so-called hygienic pests having an adverse affect on human being's environment such as houses, insects as so-called stored grain insects injuring grains and the like stored in storehouses, and any pests of acarids, crustaceans, mollusks and nematodes generating in the similar scenes.

The insects, acarids, crustaceans, mollusks and nematodos that the compounds of the present invention can control concretely include for example the followings:

Lepidoptera insects, such as Adoxophyes honmai, Adoxophyes orana faciata, Archips breviplicanus, Archips fuscocupreanus, Grapholita molesta, Homona magnanima, Leguminivora glycinivorella, Matsumuraeses phaseoli, Pandemis heparana, Bucculatrix pyrivorella, Lyonetia clerkella, Lyonetia prunifoliella malinella, Caloptilia theivora, Phyllonorycter ringoniella, Phyllocnistis citrella, Acrolepiopsis sapporensis, Acrolepiopsis suzukiella, Plutella xylostella, Stathmopoda masinissa, Helcystogramma triannulella, Pectinophora gossypiella, Carposina sasakii, Cydla pomonella, Chilo suppressalis, Cnaphalocrocis medinalis, Conogethes punctiferalis, Diaphania indica, Etiella zinckenella, Glyphodes pyloalis, Hellula undalis, Ostrinia furnacalis, Ostrinia scapulalis, Ostrinia nubilalis, Parapediasia teterrella, Parnara guttata, Pieris brassicae, Pieris rapae crucivora, Ascotis selenaria, Pseudoplusia includens, Euproctis pseudoconspersa, Lymantria dispar, Orgyia thyellina, Hyphantria cunea, Lemyra imparilis, Adris tyrannus, Aedia leucomelas, Agrotis ipsilon, Agrotis segetum, Autographa nigrisigna, Ctenoplusia agnata, Helicoverpa armigera, Helicoverpa assulta, Helicoverpa zea, Heliothis virescens, Mamestra brassicae, Mythimna separata, Naranga aenescens, Spodoptera eridania, Spodoptera exigua, Spodoptera frugiperda, Spodoptera littoralis, Spodoptera litura, Spodoptera depravata, Trichoplusia ni, Endopiza viteana, Manduca quinquemaculata, Manduca sexta, or the like;

Thysanoptera insects, such as Frankliniella intonsa, Frankliniella occidentalis, Heliothrips haemorrhoidalis, Scirtothrips dorsalis, Thrips palmi, Thrips tabaci, Ponticulothrips diospyrosi, or the like;

Hemiptera insects, such as Dolycoris baccarum, Eurydema rugosum, Eysarcoris aeneus, Eysarcoris lewisi, Eysarcoris ventralis, Glaucias subpunctatus, Halyomorpha halys, Nezara antennata, Nezara viridula, Piezodorus hybneri, Plautia crossota, Scotinophora lurida, Cletus punctiger, Leptocorisa chinensis, Riptortus clavatus, Rhopalus msculatus, Cavelerius saccharivorus, Togo hemipterus, Dysdercus cingulatus, Stephanitis pyrioides, Halticus insularis, Lygus lineolaris, Stenodema sibiricum, Stenotus rubrovittatus, Trigonotylus caelestialium, Arboridia apicalis, Balclutha saltuella, Epiacanthus stramineus, Empoasca fabae, Empoasca nipponica, Empoasca onukii, Empoasca sakaii, Macrosteles striifrons, Nephotettix cinctinceps, Psuedatomoscelis seriatus, Laodelphax striatella, Nilaparvata lugens, Sogatella furcifera, Diaphorina citri, Psylla pyrisuga, Aleurocanthus spiniferus, Bemisia argentifolii, Bemisia tabaci, Dialeurodes citri, Trialeurodes vaporariorum, Viteus vitifolii, Aphis gossypii, Aphis spiraecola, Myzus persicae, Toxoptera aurantii, Drosicha corpulenta, Icerya purchasi, Phenacoccus solani, Planococcus citri, Planococcus kuraunhiae, Pseudococcus comstocki, Ceroplastes ceriferus, Ceroplastes rubens, Aonidiella aurantii, Comstockaspis perniciosa, Fiorinia theae, Pseudaonidia paeoniae, Pseudaulacaspis pentagona, Pseudaulacaspis prunicola, Unaspis euonymi, Unaspis yanonensis, Cimex lectularius, or the like;

Coleoptera insects, such as Anomala cuprea, Anomala rufocuprea, Gametis jucunda, Heptophylla picea, Popillia japonica, Lepinotarsa decemlineata, Melanotus fortnumi, Melanotus tamsuyensis, Lasioderma serricorne, Epuraea domina, Epilachna varivestis, Epilachna vigintioctopunctata, Tenebrio molitor, Tribolium castaneum, Anoplophora malasiaca, Monochamus alternatus, Psacothea hilaris, Xylotrechus pyrrhoderus, Callosobruchus chinensis, Aulacophora femoralis, Chaetocnema concinna, Diabrotica undecimpunctata, Diabrotica virgifera, Diabrotica barberi, Oulema oryzae, Phyllotreta striolata, Psylliodes angusticollis, Rhynchites heros, Cylas formicarius, Anthonomus grandis, Echinocnemus squameus, Euscepes postfasciatus, Hypera postica, Lissohoptrus oryzophilus, Otiorhynchus sulcatus, Sitophilus granarius, Sitophilus zeamais, Sphenophorus venatus vestitus, Paederus fuscipes, or the like;

Diptera insects, such as Asphondylia yushimai, Sitodiplosis mosellana, Bactrocera cucurbitae, Bactrocera dorsalis, Ceratitis capitata, Hydrellia griseola, Drosophila suzukii, Agromyza oryzae, Chromatomyia horticola, Liriomyza bryoniae, Liriomyza chinensis, Liriomyza sativae, Liriomyza trifolii, Delia platura, Pegomya cunicularia, Rhagoletis pomonella, Mayetiola destructor, Musca domestica, Stomoxys calcitrans, Melophagus ovinus, Hypoderma bovis, Hypoderma lineatum, Oestrus ovis, Glossina palpalis, Glossina morsitans, Prosimulium yezoensis, Tabanus trigonus, Telmatoscopus albipunctatus, Leptoconops nipponensis, Culex pipiens pallens, Aedes aegypti, Aedes albopicutus, Anopheles hyracanus sinesis, or the like;

Hymenoptera insects, such as Apethymus kuri, Athalia rosae, Arge pagana, Neodiprion sertifer, Dryocosmus kuriphilus, Eciton burchelli, Eciton schmitti, Camponotus japonicus, Vespa mandarina, Myrmecia spp., Solenopsis spp., Monomorium pharaonis, or the like;

Orthoptera insects, such as Teleogryllus emma, Gryllotalpa orientalis, Locusta migratoria, Oxya yezoensis, Schistocerca gregaria, or the like;

Collembola insects, such as Onychiurus folsomi, Onychiurus sibiricus, Bourletiella hortensis, or the like;

Dictyoptera insect, such as Periplaneta fuliginosa, Periplaneta japonica, Blattella germanica, or the like;

Isoptera insects, such as Coptotermes formosanus, Reticulitermes speratus, Odontotermes formosanus, or the like;

Siphonaptera insects, such as Ctenocephalidae felis, Ctenocephalides canis, Echidnophaga gallinacea, Pulex irritans, Xenopsylla cheopis, or the like;

Mallophaga insects, such as Menacanthus stramineus, Bovicola bovis, or the like;

Anoplura insects, such as Haematopinus eurysternus, Haematopinus suis, Linognathus vituli, Solenopotes capillatus, or the like;

Tarsonemid mites, such as Phytonemus pallidus, Polyphagotarsonemus latus, Tarsonemus bilobatus, or the like;

Eupodid mites, such as Penthaleus erythrocephalus, Penthaleus major, or the like;

Spider mites, such as Oligonychus shinkajii, Panonychus citri, Panonychus mori, Panonychus ulmi, Tetranychus kanzawai, Tetranychus urticae, or the like;

Eriophyid mites, such as Acaphylla theavagrans, Aceria tulipae, Aculops lycopersici, Aculops pelekassi, Aculus schlechtendali, Eriophyes chibaensis, Phyllocoptruta oleivora, or the like;

Acarid mites, such as Rhizoglyphus robini, Tyrophagus putrescentiae, Tyrophagus similis, or the like;

Bee brood mites, such as Varroa jacobsoni, or the like;

Ixodides, such as Boophilus microplus, Rhipicephalus sanguineus, Haemaphysalis longicornis, Haemophysalis flava, Haemophysalis campanulata, Ixodes ovatus, Ixodes persulcatus, Amblyomma spp., Dermacentor spp., or the like;

Cheyletidae, such as Cheyletiella yasguri, Cheyletiella blakei, or the like;

Demodicidae, such as Demodex canis, Demodex cati, or the like;

Psoroptidae, such as Psoroptes ovis, or the like;

Scarcoptidae, such as Sarcoptes scabiei, Notoedres cati, Knemidocoptes spp., or the like;

Crustacea, such as Armadillidium vulgare, or the like;

Gastropoda, such as Pomacea canaliculata, Achatina fulica, Meghimatium bilineatum, Limax Valentiana, Acusta despecta sieboldiana, Euhadra peliomphala, or the like;

Nematodes, such as Prathylenchus coffeae, Prathylenchus penetrans, Prathylenchus vulnus, Globodera rostochiensis, Heterodera glycines, Meloidogyne hapla, Meloidogyne incognita, Aphelenchoides besseyi, Bursaphelenchus xylophilus, or the like. But the present invention is not limited thereto.

The endo-parasites of domestic animals, domestic fowls, pets and the like that the compounds of the present invention can control concretely include for example the followings:

Nematodes, such as Haemonchus, Trichostrongylus, Ostertagia, Nematodirus, Cooperia, Ascaris, Bunostomum, Oesophagostomum, Chabertia, Trichuris, Storongylus, Trichonema, Dictyocaulus, Capillaria, Heterakis, Toxocara, Ascaridia, Oxyuris, Ancylostoma, Uncinaria, Toxascaris, Parascaris, or the like; Filariidae in nematodes, such as Wuchereria, Brugia, Onchoceca, Dirofilaria, Loa, or the like;

Dracunculidae in nematodes, such as Deacunculus, or the like;

Cestoda, such as Dipylidium caninum, Taenia taeniaeformis, Taenia solium, Taenia saginata, Hymenolepis diminuta, Moniezia benedeni, Diphyllobothrium latum, Diphyllobothrium erinacei, Echinococcus granulosus, Echinococcus multilocularis, or the like;

Trematoda, such as Fasciola hepatica, F. gigantica, Paragonimus westermanii, Fasciolopsic bruski, Eurytrema pancreaticum, E. coelomaticum, Clonorchis sinensis, Schistosoma japonicum, Schistosoma haematobium, Schistosoma mansoni, or the like;

Eimeria spp., such as Eimeria tenella, Eimeria acervulina, Eimeria brunetti, Eimeria maxima, Eimeria necatrix, Eimeria bovis, Eimeria ovinoidalis, or the like;

Trypanosomsa cruzi, Leishmania spp., Plasmodium spp., Babesis spp., Trichomonadidae spp., Histomanas spp., Giardia spp., Toxoplasma spp., Entamoeba histolytica, Theileria spp., or the like. But the present invention is not limited thereto.

Further, the compounds of the present invention are effective for pests acquiring high resistance against existing insecticides such as organic phosphorus compounds, carbamate compounds or pyrethroid compounds, etc.

That is, the compounds of the present invention can effectively control pests that belong to insects such as Collembola, Dictyoptera, Orthoptera, Isoptera, Thysanoptera, Hemiptera, Lepidoptera, Coleoptera, Hymenoptera, Diptera, Isoptera and Anoplura, Acarina, Gastropoda and Nematoda, in a low concentration. On the other hand, the compounds of the present invention have an extremely useful charactristic that they have little adverse affect on mammals, fishes, crustaceans and useful insects (beneficial insect such as honeybee, bumblebee or the like, or, natural enemies such as Aphytis lingnanensis, Aphidius colemani, Orius strigicollis, Amblyseius californicus, or the like).

When the compounds of the present invention are used, they can be generally mixed with a suitable solid carrier or liquid carrier, optionally along with surfactant, penetrating agent, spreading agent, thickener, anti-freezing agent, binder, anti-caking agent, disintegrating agent, anti-foaming agent, preservative, stabilizer, and the like, and can be formulated into any desired forms for practical use, such as soluble concentrates, emulsifiable concentrates, wettable powders, water soluble powders, water dispersible granules, water soluble granules, suspension concentrates, concentrated emulsions, suspoemulsions, microemulsions, dustable powders, granules, tablets and emulsifiable gels. From the viewpoint of an elimination or reduction of labor and an improvement of safety, the formulations in any desired forms described above may be included into a water-soluble bag made of water-soluble capsule or water-soluble film.

The solid carrier includes, for example, natural minerals such as quartz, calcite, sepiolite, dolomaite, chalk, kaolinite, pyrofilite, celicite, halocite, methahalocite, kibushi clay, gairome clay, pottery stone, zeaklite, allophane, white sand, mica, talc, bentonite, activeted earth, acid china clay, pumice, attapulgite, zeolite and diatomaceous earth, etc., calcined products of natural minerals such as calcined clay, perlite, white sand balloon (loam balloon), vermiculite, attapulgus clay and calcined diatomaceous earth, etc., inorganic salts such as magnesium carbonate, calcium carbonate, sodium carbonate, sodium hydrogen carbonate, ammonium sulfate, sodium sulfate, magnesium sulfate, diammonium hydrogen phosphate, ammonium dihydrogen phosphate and potassium chloride, etc., saccharides such as glucose, fructose, sucrose and lactose, etc., polysaccharides such as starch, powder cellulose and dextrin, etc., organic materials such as urea, urea derivatives, benzoic acid and a salt of benzoic acid, etc., plants such as wood powder, cork powder, corn head stem, walnut shell and tobacco stem, etc., fly ash, white carbon (e.g., hydrated synthetic silica, anhydrous synthetic silica and hydrated synthetic silicate, etc.) and feritilizers, etc.

As the liquid carrier, there may be mentioned, for example, aromatic hydrocarbons such as xylene, alkyl(C₉ or C₁₀, etc.)benzene, phenylxylylethane and alkyl(C₁ or C₃, etc.)naphthalene, etc., aliphatic hydrocarbons such as machine oil, normal paraffin, isoparaffin and naphthene, etc., a mixture of aromatic hydrocarbons and aliphatic hydrocarbons such as kerosene, etc., alcohols such as ethanol, isopropanol, cyclohexanol, phenoxyethanol and benzylalcohol, etc., polyvalent alcohols such as ethylene glycol, propyleneglycol, diethylene glycol, hexylene glycol, polyethylene glycol and polypropyleneglycol, etc., ethers such as propyl cellosolve, butyl cellosolve, phenyl cellosolve, propyleneglycol monomethyl ether, propyleneglycol monoethyl ether, propyleneglycol monopropyl ether, propyleneglycol monobutyl ether and propyleneglycol monophenyl ether, etc., ketones such as acetophenone, cyclohexanone and γ-butyrolactone, etc., esters such as aliphatic acid methyl ester, dialkyl succinate, dialkyl glutamate, dialkyl adipate and dialkyl phthalate, etc., acid amides such as N-alkyl(C₁, C₈ or C₁₂, etc.)pyrrolidone, etc., oil and fats such as soybean oil, linseed oil, rapeseed oil, coconut oil, cottonseed oil and caster oil, etc., dimethylsulfoxide and water.

These solid and liquid carriers may be used alone or in combination of two or more kinds in combination.

As the surfactant, there may be mentioned, for example, nonionic surfactants such as polyoxyethylene alkyl ether, polyoxyethylene alkyl (mono- or di-)phenyl ether, polyoxyethylene (mono-, di- or tri-)styrylphenyl ether, polyoxyethylene polyoxypropylene block copolymer, polyoxyethylene fatty acid (mono- or di-)ester, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, caster oil-ethylene oxide adducts, acetylene glycol, acetylene alcohol, ethylene oxide adducts of acetylene glycol, ethylene oxide adducts of acetylene alcohol and alkyl glycoside, etc., anionic surfactants such as alkyl sulfate, alkylbenzenesulfonate, lignine sulfonate, alkylsulfosuccinate, naphthalene sulfonate, alkylnaphthalene sulfonate, formalin condensate salt of naphthalene sulfonic acid, formalin condensate salt of alkylnaphthalene sulfonic acid, polyoxyethylene alkyl ether sulfate or phosphate, polyoxyethylene (mono- or di-)alkylphenyl ether sulfate or phosphate, polyoxyethylene (mono-, di- or tri-)styrylphenyl ether sulfate or phosphate, polycarboxylate (e.g., polyacryaltes, polymaleates and copolymer materials of maleic acid and olefin, etc.) and polystyrenesulfonate, etc., cationic surfactants such as alkylamine salt and alkyl quaternary ammonium salt, etc., amphoteric surfactants such as amino acid type and betaine type, etc., silicone type surfactants and fluorine type surfactants.

A content of these surfactants is not specifically limited, and it is desirably in the range of 0.05 to 20 parts by weight in general based on 100 parts by weight of the preparation according to the present invention. Also, these surfactants may be used alone or in combination of two or more kinds in combination.

A dose of the compound of the present invention to be applied may vary depending on the place to be applied, time to be applied, method to be applied, crops to cultivate, etc., and in general, it is suitable in an amount of about 0.005 to 50 kg or so per a hectare (ha) as an amount of the effective ingredient.

On the other hand, when the compound of the present invention is used for controlling ecto- or endo-parasites of mammals and birds as domestic animals and pets, the effective amount of the compound of the present invention together with additives for formulations can be administered through oral administration, parenteral administration such as injection (intramuscular, subcutaneous, intravenous, intraperitoneal) or the like; transdermal administration such as dipping, spray, bathing, washing, pouring-on and spotting-on, and dusting, or the like; transversal administration. The compound of the present invention can be also administered through a formed product by use of a strip, a plate, a band, a collar, an ear mark, a limb band, a labe apparatus, or the like. In administration, the compound of the present invention can be formed in an arbitrary dosage form that is suited for the administration route.

The arbitrary dosage form includes solid preparations such as a dustable powder, a granule, wettable powder, a pellete, a tablet, a bolus, a capsule, a formed product containing an active compound; liquid formulations such as an injectable liquid formulation, an oral liquid formulation, a liquid formulation used on skin or in body cavity; solution preparations such as a pour-on agent, a spot-on agent, a flowable agent, an emulsifiable concentrate; semi-solid preparations such as an ointment, gel or the like.

The solid preparations can be mainly used through oral administration or transdermal administration by diluting with water or the like, or by environmental treatment. The solid preparations can be prepared by mixing the active compound with suitable excipients and optionally auxiliary substances and converting to a desired form. The suitable excipients include for example inorganic substances such as carbonates, hydrogen carbonates, phosphates, aluminum oxide, silica, clay or the like, organic substances such as sugar, cellulose, milled cereal, starch or the like.

The injectable liquid formulation can be administered intravenously, intramuscularly and subcutaneously. The injectable liquid formulation can be prepared by dissolving an active compound in a suitable solvent and optionally by adding an additive such as a solubilizing agent, an acid, a base, a buffering salt, an antioxidant, and a protective agent or the like. Suitable solvent is for example water, ethanol, butanol, benzyl alcohol, glycerin, propylene glycol, poethylene glycol, N-methylpyrrolidone, and a mixture thereof, a physiologically permissible vegetable oil, a synthetic oil suitable for injection, or the like. The solubilizing agent includes polyvinyl pyrrolidone, polyoxyethylated castor oil and polyoxyethylated sorbitan ester, or the like. The protective agent includes benzyl alcohol, trichlorobutanol, p-hydroxybenzoic acid ester and n-butanol or the like.

The oral liquid formulation can be administered directly or after dilution. It can be prepared similarly to the injectable liquid formulation.

The flowable agent and the emulsifiable concentrate can be administered directly or after dilution through transdermal administration or environmental treatment.

The liquid formulation used on skin can be administered by pouring on, spreading, rubbing, atomizing, spraying, or dipping (dipping, bathing or washing). These liquid can be prepared similarly to the injectable liquid formulation.

The pour-on agent and the spot-on agent are poured or atomized on the limited spot on the skin, thereby the active compound can be penetrated into the skin and act in the whole body. The pour-on agent and the spot-on agent can be prepared by dissolving, suspending or emulsifying an active ingredient in a suitable skin-fitted solvent or solvent mixture. If required, an auxiliary substance such as a surfactant, a colorant, an absorption promoting agent, an antioxidant, a light stabilizer and an adhesive, etc. may be added.

Suitable solvent includes water, alkanol, glycol, polyethylene glycol, polypropylene glycol, glycerin, benzyl alcohol, phenylethanol, phenoxyethanol, ethyl acetate, butyl acetate, benzyl benzoate, dipropylene glycol monomethyl ether, diethylene glycol monobutyl ether, acetone, methyl ethyl ketone, aromatic and/or aliphatic hydrocarbon, vegetable or synthetic oil, DMF, liquid paraffin, light-duty liquid paraffin, silicone, dimethylacetamide, N-methylpyrrolidone or 2,2-dimethyl-4-oxy-methylene-1,3-dioxolane. The absorption promoting agent includes DMSO, isopropyl myristate, dipropylene glycol pelargonate, silicone oil, aliphatic ester, triglyceride and fatty alcohol. The antioxidant includes sulfite, metabisulfite, ascorbic acid, butylhydroxytoluene, butylhydroxyanisole and tocopherol.

The emulsifiable concentrate can be administrated orally, subcutaneously or injectably. The emulsifiable concentrate can be prepared by dissolving an active ingredient in a hydrophobic phase or a hydrophilic phase, and then homogenating the resulting solution with a suitable emulsifying agent optionally with further an auxiliary substance such as a colorant, an absorption promoting agent, a protective agent, an antioxidant, a light screen and a thickening agent.

The hydrophobic phase (oil) includes paraffin oil, silicone oil, sesame-seed oil, oil of almonds, castor oil, synthetic triglyceride, ethyl stearate, di-n-butyryl adipate, hexyl laurate, dipropylene glycol pelargonate, ester of branched short chain length aliphatic acid with saturated aliphatic acid of chain length C16 to C18, isopropyl myristate, isopropyl palmitate, capryl/caprylic acid ester of saturated fatty alcohol of chain length C12 to C18, isopropyl stearate, oleyl oleate, decyl oleate, ethyl oleate, ethyl lactate, wax-like fatty acid ester, dibutyl phthalate, diisopropyl adipate, isotridecyl alcohol, 2-octyldodecanol, cetylstearyl alcohol, oleyl alcohol.

The hydrophilic phase includes water, propylene glycol, glycerin, sorbitol.

The emulsifying agent includes non-ionic surfactants such as polyoxyethylated castor oil, polyoxyethylated sorbitan mono-olefinate, sorbitan monostearate, glycerin monostearate, polyoxyethyl stearate, alkylphenol polyglycol ether; amphoteric surfactants such as di-sodium N-lauryl (3-iminodipropionate, lecithin or the like; anionic surfactants such as sodium lauryl sulfate, fatty alcohol sulfuric acid ether, monoethanol amine salt of mono/dialkylpolyglycol orthophosphate or the like; cationic surfactants such as cetyl chloride trimethylammonium or the like.

The other auxiliary substance includes carboxymethylcellulose, methylcellulose, polyacrylate, arginate, gelatin, gum arabic, polyvinyl pyrrolidone, polyvinyl alcohol, methylvinyl ether, copolymer of maleic anhydride, polyethylene glycol, wax, colloidal silica.

The semi-solid preparation can be administered by coating or spreading on the skin, or by introducing in body cavity. The gel can be prepared by adding a thickener in an amount enough to provide a clear substance having a viscosity of ointment in a solution prepared for the injectable liquid formulation as mentioned above.

Next, formulation examples of the preparation in case where the compound of the present invention is used are shown below. Provided that formulation examples of the present invention are not limited only thereto. In the interim, in the following Formulation Examples, “part(s)” mean part(s) by weight.

(Wettable powder) Compound of the present invention 0.1 to 80 parts Solid carrier 5 to 98.9 parts Surfactant   1 to 10 parts Others   0 to 5 parts

As other components, there may be mentioned, for example, a non-caking agent, a decomposition preventing agent, and the like.

(Emulsifiable concentrate) Compound of the present invention 0.1 to 30 parts Liquid carrier  45 to 95 parts Surfactant 4.9 to 15 parts Others   0 to 10 parts

As other components, there may be mentioned, for example, a spreading agent, a decomposition preventing agent, and the like.

(Suspension concentrate) Compound of the present invention  0.1 to 70 parts Liquid carrier 15 to 98.89 parts Surfactant    1 to 12 parts Others  0.01 to 30 parts

As other components, there may be mentioned, for example, an antifreezing agent, a thicknening agent, and the like.

(Water dispersible granule) Compound of the present invention 0.1 to 90 parts Solid carrier 0 to 98.9 parts Surfactant   1 to 20 parts Others   0 to 10 parts

As other components, there may be mentioned, for example, a binder, a decomposition preventing agent, and the like.

(Soluble concentrate) Compound of the present invention  0.01 to 70 parts Liquid carrier 20 to 99.99 parts Others    0 to 10 parts

As other components, there may be mentioned, for example, an antifreezing agent, a spreading agent, and the like.

(Granule) Compound of the present invention  0.01 to 80 parts Solid carrier 10 to 99.99 parts Others    0 to 10 parts

As other components, there may be mentioned, for example, a binder, a decomposition preventing agent, and the like.

(Dustable powder) Compound of the present invention 0.01 to 30 parts Solid carrier 65 to 99.99 parts Others 0 to 5 parts

As other components, there may be mentioned, for example, a drift preventing agent, a decomposition preventing agent, and the like.

Next, formulation examples using the compound of the present invention as an effective ingredient are described in more detail, but the present invention is not limited thereto. In the interim, in the following Formulation Examples, “part(s)” mean part(s) by weight.

(Formulation Example 1) Wettable powder Compound of the present invention No. 5-108 20 parts Pyrophylite 74 parts Solpol 5039 4 parts (A mixture of a nonionic surfactant and an anionic surfactant: available from TOHO Chemical Industry Co., LTD, Tradename) CARPREX #80D 2 parts (Synthetic hydrated silicic acid: available from Shionogi & Co., Ltd., Tradename)

The above materials are uniformly mixed and pulverized to make wettable powder.

(Formulation Example 2) Emulsion Compound of the present invention No. 5-108 5 parts Xylene 75 parts N-methylpyrrolidone 15 parts Solpol 2680 5 parts (A mixture of a nonionic surfactant and an anionic surfactant: available from TOHO Chemical Industry Co., LTD, Tradename)

The above materials are uniformly mixed to make emulsifiable concentrate.

(Formulation Example 3) Suspension concentrate Compound of the present invention No. 5-108 25 parts Agrisol S-710 10 parts (a nonionic surfactant: available from KAO CORPORATION, Tradename) Lunox 1000C 0.5 part (an anionic surfactant: available from TOHO Chemical Industry Co., LTD, Tradename) Xanthan gum 0.2 part Water 64.3 parts

The above materials are uniformly mixed, and then, wet pulverized to make suspension concentrate.

(Formulation Example 4) Water dispersible granule Compound of the present invention No. 5-108 75 parts HITENOL NE-15 5 parts (an anionic surfactant: available from DAI-ICHI KOGYO SEIYAKU CO., LTD., Tradename) VANILLEX N 10 parts (an anionic surfactant: available from Nippon Paper Chemicals Co., Ltd., Tradename) CARPREX #80D 10 parts (Synthetic hydrated silicic acid: available from Shionogi & Co., Ltd., Tradename)

The above materials are uniformly mixed and pulverized, and then, a small amount of water is added to the mixture and the resulting mixture is mixed under stirring, granulated by an extrusion granulator, and dried to make water dispersible granule.

(Formulation Example 5) Granule Compound of the present invention No. 5-108  5 parts Bentonite 50 parts Talc 45 parts

The above materials are uniformly mixed and pulverized, and then, a small amount of water is added to the mixture and the resulting mixture is mixed under stirring, granulated by an extrusion granulator, and dried to make granule.

(Formulation Example 6) Dustable powder Compound of the present invention No. 5-10   3 parts CARPREX #80D 0.5 parts (Synthetic hydrated silicic acid: available from Shionogi & Co., Ltd., Tradename) Kaolinite  95 parts Diisopropyl phosphate 1.5 parts

The above materials are uniformly mixed and pulverized to make dustable powder. When the formulation is used, it is sprayed by diluting with water in 1- to 10000-fold concentration, or directly without dilution.

(Formulation Example 7) Wettable powder preparation Compound of the present invention No. 5-108 25 parts Sodium diisobutylnaphthalenesulfonate 1 part Calcium n-dodecylbenzenesulfonate 10 parts Alkylaryl polyglycol ether 12 parts Sodium salt of naphthalenesulfonic acid formalin condensate 3 parts Emulsion type silicone 1 part Silicon dioxide 3 parts Kaoline 45 parts

(Formulation Example 8) Water-soluble concentrate preparation Compound of the present invention No. 5-108 20 parts Polyoxyethylene lauryl ether 3 parts Sodium dioctylsulfosuccinate 3.5 parts Dimethylsulfoxide 37 parts 2-Propanol 36.5 parts

(Formulation Example 9) Liquid formulation for atomization Compound of the present invention No. 5-108  2 parts Dimethylsulfoxide 10 parts 2-Propanol 35 parts Acetone 53 parts

(Formulation Example 10) Liquid formulation for transdermal administration Compound of the present invention No. 5-108  5 parts Hexylene glycol 50 parts Isopropanol 45 parts

(Formulation Example 11) Liquid formulation for transdermal administration Compound of the present invention No. 5-108  5 parts Propylene glycol monomethyl ether 50 parts Dipropylene glycol 45 parts

(Formulation Example 12) Liquid formulation for transdermal administration (pouring-on) Compound of the present invention No. 5-108  2 parts Light-duty liquid paraffin 98 parts

(Formulation Example 13) Liquid formulation for transdermal administration (pouring-on) Compound of the present invention No. 5-108 2 parts Light-duty liquid paraffin 58 parts Olive oil 30 parts ODO-H 9 parts Shinetsu silicone 1 part

Also, when the compound of the present invention is used as an agricultural chemicals, it may be mixed with other kinds of herbicides, various kinds of insecticides, acaricides, nematocides, fungicides, vegetable growth regulators, synergists, fertilizers, soil improvers, etc., and applied, at the time of preparing the formulation or at the time of spreading, if necessary.

In particular, by mixing with the other agricultural chemicals or plant hormones and applying the mixture, it can be expected that a cost is reduced due to reduction in a dose to be applied, enlargement in insecticidal spectrum or higher prevention and extinction effect of noxious organisms due to synergistic effect by mixing agricultural chemicals. At this time, it is possible to use the compound with a plural number of the conventionally known agricultural chemicals in combination simultaneously. As the kinds of the agricultural chemicals to be used in admixture with the compound of the present invention, there may be mentioned, for example, the compounds described in Farm Chemicals Handbook, 2005 ed. and the like. Specific examples of the general names can be enumerated below, but the invention is not necessarily limited only thereto.

Fungicide: acibenzolar-5-methyl, acylaminobenzamide, acypetacs, aldimorph, amisulbrom, amobam, ampropylos, anilazine, azaconazole, azithiram, azoxystrobin, barium polysulfide, benalaxy, benodanil, benomyl, benquinox, bentaluron, benthiavalicarb, benthiazole, benzamacril, benzamorf, bethoxazine, binapacryl, biphenyl, bitertanol, blasticidin-S, bordeaux mixture, boscalid, bromoconazole, bupirimate, buthiobate, calcium polysulfide, captafol, captan, carpropamid, carbamorph, carbendazim, carboxin, carvone, cheshunt mixture, chinomethionat, chlobenthiazone, chloraniformethane, chloranil, chlorfenazol, chloroneb, chloropicrin, chlorothalonil, chlorquinox, chlozolinate, climbazole, clotrimazole, copper acetate, copper carbonate, basic, copper hydroxide, copper naphthenate, copper oleate, copper oxychloride, copper sulfate, copper sulfate, basic, copper zinc chromate, cufraneb, cuprobam, cyazofamid, cyclafuramid, cycloheximide, cyflufenamid, cymoxanil, cypendazole, cyproconazol, cyprodinil, cyprofuram, dazomet, debacarb, decafentin, dehydroacetic acid, dichlofluanid, dichlone, dichlorophen, dichlozoline, diclobutrazol, diclocymet, diclomedine, dicloran, diethofencarb, difenoconazole, diflumetorim, dimethirimol, dimethomorph, dimoxystrobin, diniconazole, diniconazole-M, dinobuton, dinocap, dinocap-4, dinocap-6, dinocton, dinosulfon, dinoterbon, diphenylamine, dipyrithione, ditalimfos, dithianon, dodemorph, dodine, drazoxolon, edifenphos, epoxiconazole, etaconazole, etem, ethirimol, ethoxyquin, etridiazole, famoxadone, fenarimol, febuconazole, fenamidone, fenaminosulf, fenapanil, fendazosulam, fenfuram, fenhexamid, fenitropan, fenoxanil, fenpiclonil, fenpropidin, fenpropimorph, fentin, ferbam, ferimzone, fluazinam, fludioxonil, flumetover, flumorph, fluoroimide, fluotrimazole, fluoxastrobin, fluquinconazole, flusilazole, flusulfamide, flutolanil, flutriafol, folpet, fosetyl-aluminium, fuberidazole, furalaxyl, furametpyr, furcarbanil, furconazole, furconazole-cis, furmecyclox, furphanate, glyodin, griseofulvin, guazatine, halacrinate, hexachlorobenzene, hexaconazole, hexylthiofos, 8-hydroxyquinoline sulfate, hymexazol, imazalil, imibenconazole, iminoctadine, ipconazole, iprobenfos, iprodione, iprovalicarb, isoprothiolane, isovaledione, kasugamycin, kresoxim-methyl, mancopper, mancozeb, maneb, mebenil, mecarbinzid, mepanipyrim, mepronil, metalaxyl, metalaxyl-M, metam, metazoxolon, metconazole, methasulfocarb, methfuroxam, methyl isothiocyanate, metiram, metominostrobin, metrafenone, metsulfovax, milneb, myclobutanil, myclozolin, nabam, natamycin, nickel bis(dimethyldithiocarbamate), nitrostyrene, nitrothal-isopropyl, nuarimol, OCH, octhilinone, ofurace, orysastrobin, oxadixyl, oxine copper, oxycarboxin, oxpoconazole fumarate, pefurzoate, penconazole, pencycuron, penthiopyrad, o-phenylphenol, phosdiphen, phthalide, picoxystrobin, piperalin, polycarbamate, polyoxins, polyoxorim, potassium azide, potassium hydrogen carbonate, proquinazid, probenazole, prochloraz, procymidone, propamocarb hydrochloride, propiconazole, propineb, prothiocarb, prothioconazole, pyracarbolid, pyraclostrobin, pyrazophos, pyridinitril, pyrifenox, pyrimethanil, pyroquilon, pyroxychlor, pyroxyfur, quinomethionate, quinoxyfen, quintozene, quinacetol-sulfate, quinazamid, quinconazole, rabenzazole, sodium azide, sodium hydrogen carbonate, sodium hypochlorite, sulfur, spiroxamine, salycylanilide, silthiofam, simeconazole, tebuconazole, tecnazene, tecoram, tetraconazole, thiabendazole, thiadifluor, thicyofen, thifluzamide, thiochlorfenphim, thiophanate, thiophanate-methyl, thioquinox, thiram, tiadinil, tioxymid, tolclofos-methyl, tolylfluanid, triadimefon, toriadimenol, triamiphos, triarimol, triazoxide, triazbutil, tributyltin oxide, trichlamide, tricyclazole, tridemorph, trifloxystrobin, triflumizole, triforine, triticonazole, validamycin, vinclozolin, zarilamide, zinc sulfate, zineb, ziram, zoxamide, and shiitake mushroom hyphae extract, etc.; Bactericides: benzalkonium chloride, bithionol, bronopol, cresol, formaldehyde, nitrapyrin, oxolinic acid, oxyterracycline, streptomycin and tecloftalam, etc.; Nematocides: aldoxycarb, cadusafos, DBCP, dichlofenthion, DSP, ethoprophos, fenamiphos, fensulfothion, fosthiazate, fosthietan, imicyafos, isamidofos, isazofos, oxamyl and thionazin, etc.;

Acaricides: acequinocyl, acrinathrin, amitraz, BCI-033(test name), bifenazate, bromopropylate, chinomethionat, chlorobezilate, clofentezine, cyenopyrafen, cyflumetofen, cyhexatine, dicofol, dienochlor, DNOC, etoxazole, fenazaquin, fenbutatin oxide, fenothiocarb, fenpropathrin, fenpyroximate, fluacrypyrim, halfenprox, hexythiazox, milbemectin, propargite, pyridaben, pyrimidifen), S-1870(test name), spirodiclofen, spyromesifen and ebufenpyrad, etc.;

Insecticides: abamectin, acephate, acetamipirid, alanycarb, aldicarb, allethrin, azinphos-methyl, bacillus thuringiensis, bendiocarb, benfuracarb, bensultap, bifenthrin, buprofezin, butocarboxim, carbaryl, carbofuran, carbosulfan, cartap, chlorfenapyr, chlorfenvinphos, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clothianidin, cycloprothrin, cyflumetofen, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, cypermethrin, cyromazine, deltamethrin, diacloden, diafenthiuron, diazinon, dichlorvos, diflubenzuron, dimethylvinphos, dinotefuran, diofenolan, disulfoton, dimethoate, emamectin-benzoate, EPN, esfenvalerate, ethiofencarb, ethiprole, etofenprox, etrimfos, fenitrothion, fenobucarb, fenoxycarb, fenpropathrin, fenthion, fenvalerate, fipronil, flonicamid, flubendiamide, flucythrinate, flufenerim, flufenoxuron, flufenprox, fluvalinate, tau-fluvalinate, fonophos, formetanate, formothion, furathiocarb, halofenozide, hexaflumuron, hydramethylnon, imidacloprid, isofenphos, indoxacarb, isoprocarb, isoxathion, lepimectin, lufenuron, malathion, metaldehyde, methamidophos, methidathion, methacrifos, metaflumizone, metalcarb, methomyl, methoprene, methoxychlor, methoxyfenozide, methyl bromide, monocrotophos, muscalure, nitenpyram, NNH-0101(test name), omethoate, oxamyl, oxydemeton-methyl, oxydeprofos, parathion, parathion-methyl, pentachlorophenol (PCP), permethrin, phenthoate, phoxim, phorate, phosalone, phosmet, phosphamidon, pirimicarb, pirimiphos-methyl, profenofos, prothiofos, propaphos, protrifenbute, pymetrozine, pyraclofos, pyridalyl, pyriproxyfen, rotenone, rynaxypyr, SI-0405 (test name), sulprofos, silafluofen, spinosad, sulfotep, SYJ-0159 (test name), tebfenozide, teflubenzuron, tefluthorin, terbufos, tetrachlorvinphos, thiacloprid, thiocyclam, thiodicarb, thiamethoxam, thiofanox, thiometon, tolfenpyrad, tralomethrin, trichlorfon, triazuron, triflumuron and vamidothion, etc.

EXAMPLES

Hereinafter, the present invention will be explained in more detail by specifically referring to Synthetic Examples and Test Examples of the compound of the present invention as working examples to which the present invention is not limited.

SYNTHETIC EXAMPLES Synthetic Example 1 4-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-N-ethyl-4′-fluoro-2-methyl benzoic acid anilide (Compound of the present invention No. 5-005) Step 1: Production of 3,5-dichloro-1-(1-trifluoromethylethenyl)benzene

In a solution of 25.0 g of 3,5-dichlorophenyl boric acid in 200 mL of tetrahydrofuran and 100 mL of water, 27.5 g of 2-bromo-3,3,3-trifluoropropene, 38.0 g of potassium carbonate and 1.84 g of dichlorobis(triphenylphosphine) palladium (II) were added, and stirred under reflux with heat for 3 hours. After the completion of the reaction, the reaction mixture was left and cooled to room temperature, 500 mL of ice water was added, and extracted with ethyl acetate (500 mL×1). The organic phase was washed with water, dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with hexane to obtain 25.7 g of the aimed product as colorless oily substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.41 (t, J=2.0 Hz, 1H), 7.3-7.35 (m, 2H), 6.05 (q, J=3.2 Hz, 1H), 5.82 (q, J=3.2 Hz, 1H).

Step 2: Production of 4-bromo-α-chloro-3-methylbenzaldoxime

In a solution of 82.0 g of 4-bromo-3-methylbenzaldoxime in 450 mL of tetrahydrofuran, 120.0 g of concentrated hydrochloric acid was added dropwise under cooling with ice and with stirring over 45 minutes. Then, 220 mL of 8% sodium hypochlorite aqueous solution was added dropwise over 75 minutes carefully so that the temperature of the reaction mixture would not exceed 5° C. After the completion of the addition dropwise, it was continued to stir at a temperature of 10° C. or less for further 90 minutes. After the completion of the reaction, the reaction mixture was blown with nitrogen gas for 45 minutes, then precipitated insoluble material was filtered off, tetrahydrofuran was distilled off under reduced pressure. The residual aqueous solution was extracted with 240.0 g of ethyl acetate, and the organic phase was washed with water (240 mL×2). The insoluble material was filtered off, the solvent was distilled off under reduced pressure to obtain 93.5 g of the aimed product as pale yellow crystal.

Melting point 77.0 to 78.0° C.

¹H NMR (CDCl₃, Me₄Si, 400 MHz) δ8.00 (bs, 1H), 7.71 (d, J=2.2 Hz, 2H), 7.57 (d, J=8.4 Hz, 1H), 7.51 (dd, J=8.4 Hz, 2.2 Hz, 1H), 2.44 (s, 3H).

Step 3: Production of 3-(4-bromo-3-methylphenyl)-5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole

In a solution of 22.7 g of 3,5-dichloro-1-(1-trifluoromethylethenyl)benzene produced in Step 1 and 26.0 g of 4-bromo-α-chloro-3-methylbenzaldoxime produced in Step 2 in 120 mL of tetrahydrofuran, 15.7 g of potassium hydrogen carbonate was added, and stirred under reflux with heat for 5 hours. After the completion of the reaction, the reaction mixture was left and cooled to room temperature, insoluble material was filtered off, and then the solvent was distilled off under reduced pressure. 150 mL of water was added in the residue, stirred at room temperature for 18 hours, and then precipitated crystal was filtered off, and dried to obtain 38.6 g of the aimed product as white crystal.

Melting point 105.0 to 108.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.59 (d, J=8.4 Hz, 1H), 7.45-7.55 (m, 3H), 7.42 (t, J=1.8 Hz, 1H), 7.33 (dd, J=8.4, 2.1 Hz, 1H), 4.07 (d, J=17.1 Hz, 1H), 3.68 (d, J=17.1 Hz, 1H), 2.43 (s, 3H).

Step 4: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methylbenzoyl-chloride

In a solution of 18.1 g of 3-(4-bromo-3-methylphenyl)-5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole and 3.94 g of sodium acetate in 42 mL of 1,2-dimethoxyethane and 42 mL of water in an autoclave, 0.42 g of triphenyl phosphine and 0.09 of palladium (II) acetate were added, and stirred under atomosphere of 1.5 MPa of carbon monoxide at 110° C. for 7 hours. After the completion of the reaction, the reaction mixture was left and cooled to room temperature, the solid was filtered off, and poured in 100 mL of ethyl acetate. The organic phase was washed with 1% sodium hydrogen carbonate aqueous solution (70 mL×2) and then with 1N hydrochloric acid (55 mL×1), dried over saturated sodium chloride aqueous solution, the solvent was substituted with toluene. In the resulting toluene solution, 2 drops of N,N-dimethylformamide was added, 6.0 g of thionyl chloride was added dropwise at 80° C. with stirring, and continued to stir further for 1.5 hour at the same temperature. After the completion of the reaction, insoluble material was filtered off, and the solvent was distilled off under reduced pressure until the whole amount was reduced by about one-third. Then, 50 mL of hexane was added slowly at 60° C. with stirring. After the completion of the addition dropwise, the reaction mixture was left and cooled to room temperature, and continued to stir at room temperature further for 1 hour. The precipitated crystal was filtered off, and dried to obtain 13.4 g of the aimed product as white crystal.

Melting point 140.5 to 143.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.25 (d, J=8.7 Hz, 1H), 7.64 (d, J=8.7 Hz, 1H), 7.59 (s, 1H), 7.51 (s, 2H), 7.43 (s, 1H), 4.11 (d, J=17.4 Hz, 1H), 3.73 (d, J=17.4 Hz, 1H), 2.60 (s, 3H).

Step 5: Production of 4-[5-(3,5-dichloro phenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-4′-fluoro-2-methyl benzoic acid anilide

In a solution of 0.40 g of 4-fluoroaniline and 0.35 g of pyridine in 30 mL of dichloromethane, a solution of 1.30 g of 4-[5-(3,5-dichloro phenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methylbenzoyl-chloride in 10 mL of dichloromethane was added dropwise. After the completion of the addition dropwise, it was continued to stir at the same temperature further for 1 hour. After the completion of the reaction, the solvent was distilled under reduced pressure, and the residue was dissolved in 50 mL of ethyl acetate, washed with 20 mL of 2N hydrochloric acid and then with 20 mL of sodium hydrogen carbonate aqueous solution, and dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:4) to obtain 1.35 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.5-7.65 (m, 7H), 7.4-7.45 (m, 2H), 7.08 (t, J=8.4 Hz, 2H), 4.10 (d, J=17.3 Hz, 1H), 3.72 (d, J=17.3 Hz, 1H), 2.53 (s, 3H).

Step 6: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-N-ethyl-4′-fluoro-2-methyl benzoic acid anilide

In a solution of 0.26 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-4′-fluoro-2-methyl benzoic acid anilide in 2 mL of N,N-dimethylformamide, 0.35 g of potassium carbonate and 0.27 g of ethyl bromide was added at room temperature with stirring, and stirred at 80° C. for 5 hours. After the completion of the reaction, the reaction mixture was poured in 10 mL of water, extracted with ethyl acetate (10 mL×1), the organic phase was washed with 10 mL of 2N hydrochloric acid and then dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (3:7) to obtain 0.23 g of the aimed product as white crystal.

Melting point 160.0 to 163.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.15-7.5 (m, 5H), 6.8-7.1 (m, 5H), 3.99 (d, J=17.1 Hz, 1H), 3.96 (q, J=6.9 Hz, 2H), 3.59 (d, J=17.1 Hz, 1H), 2.36 (s, 3H), 1.24 (t, J=6.9 Hz, 3H).

Synthetic Example 2 4-[5-(3,5-Dichloro phenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-4′-fluoro-N-methoxymethyl-2-methyl benzoic acid anilide (Compound of the present invention No. 5-007)

In a solution of 0.20 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-4′-fluoro-2-methyl benzoic acid anilide produced in Step 5 of Synthetic Example 1 in 2 mL of tetrahydrofuran, 0.39 mL of tetrahydrofuran solution (1.0 mol/1 L) of lithium bis(trimethylsilyl)amide and then 0.03 g of chloromethyl methyl ether were added dropwise at room temperature with stirring. After the completion of the addition dropwise, it was continued to stir at room temperature further for 20 minutes. After the completion of the reaction, the reaction mixture was poured in 5 m of water, extracted with ethyl acetate (10 mL×1), the organic phase was washed with water and then dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:1) to obtain 0.07 g of the aimed product as white crystal.

Melting point 140.0 to 143.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ6.75-7.7 (m, 10H), 5.24 (s, 2H), 4.01 (d, J=17.7 Hz, 1H), 3.61 (d, J=17.7 Hz, 1H), 3.55 (s, 3H), 2.40 (s, 3H).

J=17.1 Hz, 1H), 2.43 (s, 3H).

Synthetic Example 3 N-Cyanomethyl-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-4′-fluoro-2-methyl benzoic acid anilide (Compound of the present invention No. 5-008)

In a solution of 0.30 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-4′-fluoro-2-methyl benzoic acid anilide produced in Step 5 of Synthetic Example 1 in 2 mL of tetrahydrofuran, 0.14 g bromoacetonitrile and 0.14 g of potassium tert-butoxide were added at room temperature with stirring, and stirred at room temperature for 5 hours. After the completion of the reaction, the reaction mixture was poured in 5 m of water, extracted with ethyl acetate (10 mL×1), the organic phase was washed with 5 mL of 2N hydrochloric acid and then dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (3:7) to obtain 0.19 g of the aimed product as pale brown crystal.

Melting point 60.0 to 66.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.46 (s, 2H), 7.35 (m, 2H), 7.25-7.35 (m, 1H), 7.0-7.2 (m, 3H), 6.9-7.0 (m, 2H), 4.77 (s, 2H), 4.01 (d, J=17.4 Hz, 1H), 3.62 (d, J=17.4 Hz, 1H), 2.38 (s, 3H).

Synthetic Example 4

Methyl N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl benzoyl]-N-(2-pyrimidinyl) carbamate (Compound of the present invention No. 5-014)

In 0.02 g of 55% oily sodium hydride suspended in 3 mL of tetrahydrofuran, a solution of 0.17 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methyl-N-(2-pyrimidinyl)benzoic acid amide synthesized similarly to Step 5 of Synthetic Example 1 in 3 mL of tetrahydrofuran was added dropwise. After the completion of the addition dropwise, it was continued to stir at the same temperature for 10 minutes, then 0.05 g of methyl chloroformate was added, and continued to stir at the same temperature for 1 hour. After the completion of the reaction, the reaction mixture was poured in 10 mL of ice water, extracted with ethyl acetate (10 mL×2), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate to obtain 0.11 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.79 (d, J=5.1 Hz, 2H), 7.55 (s, 1H), 7.50 (s, 4H), 7.43 (s, 1H), 7.30 (t, J=4.8 Hz, 1H), 4.08 (d, J=17.4 Hz, 1H), 3.72 (s, 3H), 3.69 (d, J=17.4 Hz, 1H), 2.54 (s, 3H).

Synthetic Example 5 N-Acetyl-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2′,4′-difluoro-2-methyl benzoic acid anilide (Compound of the present invention No. 5-033) Step 1: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2′,4′-difluoro-2-methyl benzoic acid anilide

In a solution of 0.85 g of 2,4-difluoroaniline and 1.42 g of pyridine in 30 mL of dichloromethane, a solution of 2.62 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methylbenzoyl-chloride synthesized in Step 4 of Synthetic Example 1 in 20 mL of dichloromethane was added dropwise. After the completion of the addition dropwise, it was continued to stir at the same temperature further for 30 minutes. After the completion of the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in 30 mL of ethyl acetate, washed with 15 mL of 2N hydrochloric acid and then with 15 mL of saturated sodium hydrogen carbonate aqueous solution. The organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with neutral alumina column chromatography and silica gel chromatography that were eluated with ethyl acetate to obtain 2.92 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.4-7.6 (m, 7H), 6.85-7.0 (m, 2H), 6.65-6.85 (m, 1H), 4.11 (d, J=17.1 Hz, 1H), 3.72 (d, J=17.1 Hz, 1H), 2.55 (s, 3H).

Step 2: Production of N-acetyl-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2′,4′-difluoro-2-methyl benzoic acid anilide

In 0.04 g of 55% oily sodium hydride suspended in 3 mL of tetrahydrofuran, a solution of 0.30 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2′,4′-difluoro-2-methyl benzoic acid anilide in 3 mL of tetrahydrofuran was added and continued to stir at the same temperature for 10 minutes. After ceasing the generation of hydrogen gas, 0.07 g of acetyl chloride was added, ice bath was removed and continued to stir for 2 hours, and then 1.2 mL of tetrahydrofuran solution (1.0 mol/1 L) of lithium bis(trimethylsilyl)amide was added and continued to stir at the same temperature further for 16 hours. After the completion of the reaction, the reaction mixture was poured in 10 mL of ice water, extracted with ethyl acetate (10 mL×2), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:2) to obtain 0.28 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.3-8.45 (m, 1H), 7.35-7.65 (m, 5H), 6.8-7.0 (m, 3H), 4.11 (d, J=17.1 Hz, 1H), 3.73 (d, J=17.1 Hz, 1H), 2.54 (s, 3H), 2.04 (s, 3H).

Synthetic Example 6 N-Acetyl-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl-N-(1-pyrazolyl)benzoic acid amide (Compound of the present invention No. 5-044) Step 1: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl-N-(1-pyrazolyl)benzoic acid amide

In 4 mL of N,N-dimethylacetamide, 0.23 g of 50% N,N-dimethylformamide solution of 1-aminopyrazole was added, and 0.30 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methylbenzoyl-chloride synthesized in Step 4 of Synthetic Example 1 was added at room temperature with stirring, and stirred at the same temperature for 2 hours. After the completion of the reaction, 20 mL of ethyl acetate was added in the reaction mixture, washed with water (20 mL×1), and then the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with neutral alumina column chromatography that was eluated with chloroform to obtain 0.22 g of the aimed product as yellow resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.4-7.75 (m, 9H), 6.38 (bs, 1H), 4.08 (d, J=17.3 Hz, 1H), 3.70 (d, J=17.3 Hz, 1H), 2.53 (s, 3H).

Step 2: Production of N-acetyl-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl-N-(1-pyrazolyl)benzoic acid amide

In a solution of 0.20 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methyl-N-(1-pyrazolyl)benzoic acid amide in 3 mL of tetrahydrofuran, 0.027 g of 60% oily sodium hydride was added and stirred at room temperature for 10 minutes. After ceasing the generation of hydrogen gas, 0.049 g of acetyl chloride was added under cooling with ice and with stirring, and continued to stir at the same temperature further for 10 minutes. After the completion of the reaction, the reaction mixture was poured in 10 mL of ice water, extracted with ethyl acetate (10 mL×1), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (2:3) to obtain 0.058 g of the aimed product as yellow resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.35-7.7 (m, 8H), 6.33 (t, J=2.4 Hz, 1H), 4.05 (d, J=17.3 Hz, 1H), 3.66 (d, J=17.3 Hz, 1H), 2.48 (s, 3H), 2.38 (s, 3H).

Synthetic Example 7

Methyl N-(5-chloro-2-pyridyl)-N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methylbenzoyl]carbamate (Compound of the present invention No. 5-060)

Step 1: Production of N-(5-chloro-2-pyridyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl benzoic acid amide

In a solution of 0.59 g of 2-amino-5-chloropyridine in 10 mL of pyridine, 2.0 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methylbenzoyl-chloride synthesized in Step 4 of Synthetic Example 1 was added at room temperature with stirring, and stirred at the same temperature for 15 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in 50 mL of ethyl acetate, then washed with 3N hydrochloric acid (50 mL×1), and then the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with neutral alumina column chromatography that was eluated with chloroform to obtain 1.80 g of the aimed product as white crystal.

Melting point 129.0 to 132.5° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.45 (s, 1H), 8.35 (d, J=8.7 Hz, 1H), 8.09 (d, J=2.4 Hz, 1H), 7.73 (dd, J=8.7, 2.4 Hz, 1H), 7.4-7.65 (m, 6H), 4.11 (d, J=17.4 Hz, 1H), 3.72 (d, J=17.4 Hz, 1H), 2.54 (s, 3H).

Step 2: Production of methyl N-(5-chloro-2-pyridyl)-N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methylbenzoyl]carbamate

In a solution of 0.30 g of N-(5-chloro-2-pyridyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methyl benzoic acid amide in 3 mL of tetrahydrofuran, 0.037 g of 60% oily sodium hydride was added and stirred at room temperature for 10 minutes. After ceasing the generation of hydrogen gas, 0.080 g of methyl chloroformate was added under cooling with ice and with stirring, and continued to stir at the same temperature further for 10 minutes. After the completion of the reaction, the reaction mixture was poured in 10 mL of ice water, extracted with ethyl acetate (10 mL×1), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (2:3) to obtain 0.29 g of the aimed product as yellow resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.49 (d, J=2.7 Hz, 1H), 7.80 (dd, J=8.7, 2.7 Hz, 1H), 7.4-7.6 (m, 6H), 7.29 (d, J=8.7 Hz, 1H), 4.09 (d, J=17.0 Hz, 1H), 3.70 (d, J=17.0 Hz, 1H), 3.67 (s, 3H), 2.51 (s, 3H).

Synthetic Example 8 Methyl N-(5-cyano-2-pyridyl)-N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methylbenzoyl]carbamate (Compound of the present invention No. 5-071) Step 1: Production of N-(5-cyano-2-pyridyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl benzoic acid amide

In a solution of 0.39 g of 2-amino-5-cyanopyridine and 0.71 g of pyridine in 20 mL of dichloromethane, a solution of 1.31 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methylbenzoyl-chloride synthesized in Step 4 of Synthetic Example 1 in 20 mL of dichloromethane was added dropwise. After the completion of the addition dropwise, it was continued to stir at the same temperature further for 1 hour. After the completion of the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in 50 mL of ethyl acetate, precipitated insoluble material was removed through silica gel column, and the solvent was distilled off under reduced pressure. The residual solid was washed with diisopropyl ether to obtain 1.11 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.4-8.6 (m, 3H), 7.95-8.1 (m, 1H), 7.61 (s, 3H), 7.4-7.55 (m, 3H), 4.12 (d, J=17.1 Hz, 1H), 3.73 (d, J=17.1 Hz, 1H), 2.56 (s, 3H).

Step 2: Production of methyl N-(5-cyano-2-pyridyl)-N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methylbenzoyl]carbamate

In a suspension of 0.03 g of 55% oily sodium hydride suspended in 3 mL of tetrahydrofuran, a solution of 0.26 g of N-(5-cyano-2-pyridyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl benzoic acid amide in 3 mL of tetrahydrofuran was added under cooling with ice and with stirring and continued to stir at the same temperature for 10 minutes. After ceasing the generation of hydrogen gas, 0.07 g of methyl chloroformate was added, ice bath was removed and continued to stir further for 7 hours. After the completion of the reaction, the reaction mixture was poured in 10 mL of ice water, extracted with ethyl acetate (10 mL×2), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:2) to obtain 0.24 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.7-8.75 (m, 1H), 8.05-8.1 (m, 1H), 7.4-7.6 (m, 7H), 4.09 (d, J=17.1 Hz, 1H), 3.72 (s, 3H), 3.70 (d, J=17.1 Hz, 1H), 2.55 (s, 3H).

Synthetic Example 9 N-Acetyl-N-(6-chloro-2-pyridyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl benzoic acid amide (Compound of the present invention No. 5-073) Step 1: Production of N-(6-chloro-2-pyridyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl benzoic acid amide

In a solution of 0.10 g of 2-amino-6-chloropyridine and 0.16 g of pyridine in 5 mL of dichloromethane, a solution of 0.30 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methylbenzoyl-chloride synthesized in Step 4 of Synthetic Example 1 in 5 mL of dichloromethane was added at room temperature with stirring. After the completion of the addition dropwise, it was stirred at the same temperature further for 2.5 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in 50 mL of ethyl acetate, and precipitated insoluble material was removed through silica gel column, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:2) to obtain 0.25 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.29 (d, J=7.8 Hz, 1H), 8.23 (s, 1H), 7.74 (t, J=7.8 Hz, 1H), 7.5-7.6 (m, 6H), 7.13 (d, J=7.2 Hz, 1H), 4.11 (d, J=17.1 Hz, 1H), 3.73 (d, J=17.1 Hz, 1H), 2.55 (s, 3H).

Step 2: Production of N-acetyl-N-(6-chloro-2-pyridyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl benzoic acid amide

In a suspension of 0.10 g of 55% oily sodium hydride suspended in 15 mL of N,N-dimethylformamide, a solution of 0.30 g of N-(6-chloro-2-pyridyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl benzoic acid amide in 5 mL of N,N-dimethylformamide was added under cooling with ice and with stirring, and stirred at the same temperature for 10 minutes. After ceasing the generation of hydrogen gas, 0.30 g of acetyl chloride was added, ice bath was removed and continued to stir further for 5 minutes. After the completion of the reaction, the reaction mixture was poured in 20 mL of ice water, extracted with ethyl acetate (50 mL×1), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:2) to obtain 0.11 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.64 (t, J=7.8 Hz, 1H), 7.15-7.5 (m, 8H), 4.03 (d, J=17.2 Hz, 1H), 3.64 (d, J=17.2 Hz, 1H), 2.54 (s, 3H), 2.53 (s, 3H).

Synthetic Example 10 N-(6-Bromo-2-pyridyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-N-methyl-2-methyl benzoic acid amide (Compound of the present invention No. 5-075) Step 1: Production of N-(6-bromo-2-pyridyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl benzoic acid amide

In a solution of 0.13 g of 2-amino-6-bromopyridine and 0.16 g of pyridine in 5 mL of dichloromethane, a solution of 0.30 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methylbenzoyl-chloride synthesized in Step 4 of Synthetic Example 1 in 5 mL of dichloromethane was added at room temperature with stirring. After the completion of the addition dropwise, it was stirred at the same temperature further for 2 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in 50 mL of ethyl acetate, and precipitated insoluble material was removed through silica gel column, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:2) to obtain 0.25 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.32 (d, J=8.1 Hz, 1H), 8.21 (s, 1H), 7.2-7.7 (m, 8H), 4.11 (d, J=17.4 Hz, 1H), 3.73 (d, J=17.4 Hz, 1H), 2.55 (s, 3H).

Step 2: Production of N-(6-bromo-2-pyridyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-N-methyl-2-methyl benzoic acid amide

In a solution of 0.23 g of N-(6-bromo-2-pyridyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl benzoic acid amide in 5 mL of N,N-dimethylformamide, 0.02 g of 55% oily sodium hydride was added at room temperature with stirring, and stirred at the same temperature for 10 minutes. After ceasing the generation of hydrogen gas, 0.30 g of methyl iodide was added, and continued to stir further for 45 minutes. After the completion of the reaction, the reaction mixture was poured in 20 mL of ice water, extracted with ethyl acetate (50 mL×1), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:2) to obtain 0.18 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.45-7.55 (m, 3H), 7.3-7.5 (m, 3H), 7.05-7.3 (m, 3H), 4.06 (d, J=17.4 Hz, 1H), 3.60 (d, J=17.4 Hz, 1H), 3.49 (s, 3H), 2.37 (s, 3H).

Synthetic Example 11 N-Acetyl-N-(5-chloro-2-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl benzoic acid amide (Compound of the present invention No. 5-100) Step 1: Production of N-(5-chloro-2-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl benzoic acid amide

In a solution of 3.86 g of 2-amino-5-chloropyrimidine in 100 mL of pyridine, 10.0 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methylbenzoyl-chloride synthesized in Step 4 of Synthetic Example 1 was added at room temperature with stirring, and stirred at the same temperature for 23 hours. The solvent was distilled off under reduced pressure, the residue was dissolved in 30 mL of 1,4-dioxane, a solution of 3.02 g of potassium hydroxide in 20 mL of water was added and stirred at room temperature for 1.5 hour. After the completion of the reaction, the reaction mixture was diluted with 380 mL of water, precipitated crystal was filtered off, and washed with 150 mL of water. The resulting crude product was dissolved in 50 mL of ethyl acetate with heating, and 50 mL of 2N hydrochloric acid was added and stirred for 1 hour, and then 50 mL of toluene was added, and precipitated crystal was filtered off. Thereafter, the reaction mixture was washed with 50 mL of water, and then with 50 mL of toluene to obtain 7.95 g of the aimed product as white crystal.

Melting point 137.0 to 141.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.54 (s, 2H), 8.50 (s, 1H), 7.4-7.65 (m, 6H), 4.10 (d, J=17.3 Hz, 1H), 3.73 (d, J=17.3 Hz, 1H), 2.55 (s, 3H).

Step 2: Production of N-acetyl-N-(5-chloro-2-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl benzoic acid amide

In a solution of 0.20 g of N-(5-chloro-2-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl benzoic acid amide in 3 mL of tetrahydrofuran, 0.025 g of 55% oily sodium hydride was added under cooling with ice and with stirring and stirred at room temperature for 10 minutes. After ceasing the generation of hydrogen gas, 0.045 g of acetyl chloride was added under cooling with ice and with stirring, and continued to stir at the same temperature further for 1 hour. After the completion of the reaction, the reaction mixture was poured in 10 mL of ice water, extracted with ethyl acetate (10 mL×1), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (gradient of 1:9 to 3:7) to obtain 0.10 g of the aimed product as white crystal.

Melting point 175.0 to 177.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.56 (s, 2H), 7.3-7.55 (m, 6H), 4.03 (d, J=16.8 Hz, 1H), 3.63 (d, J=16.8 Hz, 1H), 2.59 (s, 3H), 2.53 (s, 3H).

Synthetic Example 12 N-(5-Chloro-2-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-N-methoxyacetyl-2-methyl benzoic acid amide (Compound of the present invention No. 5-106)

In a solution of 0.27 g of N-(5-chloro-2-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl benzoic acid amide synthesized in Step 1 of Synthetic Example 11, 0.08 g of triethylamine and a catalytic amount of 4-(dimethylamino)pyridine in 5 mL of tetrahydrofuran, 0.08 g of methoxyacetyl chloride was added at room temperature with stirring, and stirred at the same temperature for 0.5 hour. After the completion of the reaction, the solvent was distilled off under reduced pressure, the residue was passed through short-pass silica gel column that was eluated with ethyl acetate, and thereby insoluble material was removed. The solvent was distilled off under reduced pressure, and purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (3:7) to obtain 0.22 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.55 (s, 2H), 7.3-7.5 (m, 6H), 4.54 (s, 2H), 4.04 (d, J=17.4 Hz, 1H), 3.65 (d, J=17.4 Hz, 1H), 3.44 (s, 3H), 2.55 (s, 3H).

Synthetic Example 13 N-(5-Bromo-2-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-N-isobutyryl-2-methyl benzoic acid amide (Compound of the present invention No. 5-122) Step 1: Production of N-(5-bromo-2-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl benzoic acid amide

In a solution of 2.87 g of 2-amino-5-bromopyrimidine in 40 mL of pyridine, 6.00 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methylbenzoyl-chloride synthesized in Step 4 of Synthetic Example 1 was added at room temperature with stirring, and stirred at the same temperature for 2 days. The solvent was distilled off under reduced pressure, the residue was dissolved in 30 mL of 1,4-dioxane, a solution of 3.09 g of potassium hydroxide in 30 mL of water was added and stirred at room temperature for 3 hours. After the completion of the reaction, 20 mL of hydrochloric acid was added in the reaction mixture under cooling with ice and with stirring, extracted with ethyl acetate (50 mL×1), the organic phese was washed with 50 mL of 3N hydrochloric acid, and dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with neutral alumina column chromatography that was eluated with chloroform to obtain 5.52 g of the aimed product as white crystal.

Melting point 178.0 to 181.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ9.32 (s, 1H), 8.41 (s, 2H), 7.4-7.65 (m, 6H), 4.12 (d, J=17.4 Hz, 1H), 3.73 (d, J=17.4 Hz, 1H), 2.51 (s, 3H).

Step 2: Production of N-(5-bromo-2-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-N-isobutyryl-2-methyl benzoic acid amide

In a solution of 1.5 g of N-(5-bromo-2-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl benzoic acid amide, 0.42 g of triethylamine and 0.03 g of 4-(dimethylamino)pyridine in 50 mL of tetrahydrofuran, 0.42 g of isobutyryl chloride was added at room temperature with stirring and stirred at the same temperature for 18 hours. After the completion of the reaction, 50 mL of water was added in the reaction mixture, extracted with ethyl acetate (80 mL×1), 5 g of silica gel was added in the organic phase, stirred and filtered off, and then the solvent was distilled off under reduced pressure. The residue was subjected to crystallization from diethyl ether and hexane to obtain 0.87 g of the aimed product as white crystal.

Melting point 143.0 to 145.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.67 (s, 2H), 7.35-7.55 (m, 6H), 4.05 (d, J=17.1 Hz, 1H), 3.66 (d, J=17.1 Hz, 1H), 3.15-3.3 (m, 1H), 2.54 (s, 3H), 1.28 (d, J=6.8 Hz, 6H).

Synthetic Example 14 4-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl-N-methyl-N-(5-pyrimidinyl)benzoic acid amide (Compound of the present invention No. 5-164) Step 1: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl-N-(5-pyrimidinyl)benzoic acid amide

In a test tube for wicrowave reactor, a solution of 0.20 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoro methyl-4,5-dihydroisoxazol-3-yl]-2-methyl benzoic acid amide synthesized in Step 1 of Synthetic Example 19, 0.10 g of 5-bromopyrimidine, 4.8 mg of copper iodide, 0.21 g of potassium phosphate and 4.4 mg of N,N-dimethyl ethylene diamine in 1 mL of 1,4-dioxane was placed, and reacted by use of a microwave focused chemical synthesizer (Discover manufactured by CEM Corporation) at 120 W and 120° C. for 20 minutes. After the completion of the reaction, insoluble material was removed through silica gel column, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:1) to obtain 0.13 g of the aimed product as white crystal.

Melting point 207.0 to 211.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ9.09 (s, 2H), 9.04 (s, 1H), 7.4-7.7 (m, 7H), 4.11 (d, J=17.4 Hz, 1H), 3.73 (d, J=17.4 Hz, 1H), 2.56 (s, 3H).

Step 2: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl-N-methyl-N-(5-pyrimidinyl)benzoic acid amide

In a solution of 0.25 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl-N-(5-pyrimidinyl)benzoic acid amide in 4 mL of N,N-dimethylformamide, 0.36 g of methyl iodide and 0.35 g of potassium carbonate were added at room temperature with stirring, and stirred at 80° C. for 1 hour. After the completion of the reaction, 10 mL of water was added in the reaction mixture, and extracted with ethyl acetate (20 mL×1), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:2) to obtain 0.09 g of the aimed product as white crystal.

Melting point 197.0 to 200.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.96 (s, 1H), 8.51 (s, 2H), 7.3-7.6 (m, 6H), 4.04 (d, J=17.4 Hz, 1H), 3.66 (d, J=17.4 Hz, 1H), 3.50 (s, 3H), 2.36 (s, 3H).

Synthetic Example 15

Methyl N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methylbenzoyl]-N-(5-pyrimidinyl) carbamate (Compound of the present invention No. 5-169)

In a solution of 0.25 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl-N-(5-pyrimidinyl)benzoic acid amide synthesized in Step 1 of Synthetic Example 14, 0.15 g of triethylamine and a catalytic amount of 4-(dimethylamino)pyridine in 4 mL of tetrahydrofuran, 0.15 g of methyl chloroformate was added, and stirred at room temperature for 16 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, 10 mL of ethyl acetate was added and insoluble material was filtered off. The solvent was distilled off under reduced pressure and the residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:1) to obtain 0.14 g of the aimed product as white crystal.

Melting point 72.0 to 76.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ9.24 (s, 2H), 8.72 (s, 1H), 7.4-7.6 (m, 6H), 4.12 (d, J=17.4 Hz, 1H), 3.74 (d, J=17.4 Hz, 1H), 3.66 (s, 3H), 2.49 (s, 3H).

Synthetic Example 16 4-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl-N-methyl-N-(2-pyradinyl)benzoic acid amide (Compound of the present invention No. 5-131) Step 1: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl-N-(2-pyradinyl)benzoic acid amide

In a solution of 0.33 g of 2-aminopyradine in 10 mL of pyridine, 1.50 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methylbenzoyl-chloride synthesized in Step 4 of Synthetic Example 1 was added at room temperature with stirring, and stirred at room temperature for 20 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in 30 mL of ethyl acetate, and washed with 30 mL of 3N hydrochloric acid, and then the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with neutral alumina column chromatography that was eluated with chloroform to obtain 1.80 g of the aimed product as white crystal.

Melting point 139.0 to 144.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.32 (d, J=8.1 Hz, 1H), 8.21 (s, 1H), 7.2-7.7 (m, 8H), 4.11 (d, J=17.4 Hz, 1H), 3.73 (d, J=17.4 Hz, 1H), 2.55 (s, 3H).

Step 2: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl-N-methyl-N-(2-pyradinyl)benzoic acid amide

In a solution of 0.30 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl-N-(2-pyradinyl)benzoic acid amide in 3 mL of N,N-dimethylformamide, 0.04 g of 55% oily sodium hydride was added and stirred at the same temperature for 10 minutes. After ceasing the generation of hydrogen gas, 0.112 g of methyl iodide was added under cooling with ice and with stirring, and continued to stir at room temperature further for 20 hours. After the completion of the reaction, the reaction mixture was poured in 10 mL of ice water, extracted with ethyl acetate (10 mL×1), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:1) to obtain 0.109 g of the aimed product as yellow resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.5 (bs, 1H), 8.37 (dd, J=2.4, 1.2 Hz, 1H), 8.28 (d, J=2.4 Hz, 1H), 7.35-7.55 (m, 5H), 7.18 (d, J=8.1 Hz, 1H), 4.05 (d, J=17.3 Hz, 1H), 3.66 (d, J=17.3 Hz, 1H), 3.51 (s, 3H), 2.38 (s, 3H).

Synthetic Example 17 4-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-N-ethyl-2-methyl benzoic acid anilide (Compound of the present invention No. 5-002)

In a solution of 0.07 g of N-ethylaniline and 0.06 g of pyridine in 4 mL of dichloromethane, a solution of 0.22 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methylbenzoyl-chloride synthesized in Step 4 of Synthetic Example 1 in 4 mL of dichloromethane was added dropwise at room temperature with stirring. After the completion of the addition dropwise, it was continued to stir at the same temperature further for 10 minutes. After the completion of the reaction, the reaction mixture was poured in 5 mL of water, and 2N hydrochloric acid was added dropwise, and pH of the aqueous phase was adjusted to 2 to 3, and extracted with chloroform (10 mL×2). The organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (2:3) to obtain 0.24 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ6.9-7.5 (m, 11H), 3.9-4.05 (m, 3H), 3.58 (d, J=17.7 Hz, 1H), 2.38 (s, 3H), 1.2-1.3 (m, 3H).

Synthetic Example 18 N-Acetyl-N-(5-chloro-2-pyrimidinyl)-2-methyl-4-[5-(3,4,5-trichlorophenyl)-5-trifluoro-methyl-4,5-dihydroisoxazole-3-yl]benzoic acid amide (Compound of the present invention No. 5-170) Step 1: Production of 4-bromo-N-(5-chloro-2-pyrimidyl)-2-methyl banzoic acid amide

In a suspension of 4.0 g of 4-bromo-2-methyl benzoic acid in 30 mL of toluene, 1.9 mL of thionyl chloride and 3 drops of N,N-dimethylformamide were added, and stirred under reflux with heating for 3 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure to obtain 4.3 g of crude gray crystal of 4-bromo-2-methylbenzoyl-chloride. In a solution of 2.62 g of 2-amino-5-chloropyrimidine in 170 mL of pyridine, 4.3 g of 4-bromo-2-methylbenzoyl-chloride was added under cooling with ice and with stirring, and stirred under reflux with heating for 1.5 hour. After the completion of the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in 300 mL of ethyl acetate, and washed with 200 mL of 1N hydrochloric acid and 200 mL of water. The organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residual solid was washed with diisopropyl ether to obtain 2.97 g of the aimed product as white crystal.

Melting point 209.0 to 211.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.57 (s, 2H), 8.33 (bs, 1H), 7.35-7.5 (m, 3H), 2.52 (s, 3H).

Step 2: Production of N-(5-chloro-2-pyrimidyl)-4-formyl-2-methyl benzoic acid amide

In a solution of 0.37 g of 4-bromo-N-(5-chloro-2-pyrimidyl)-2-methyl banzoic acid amide in 10 mL of N,N-dimethylformamide in an autoclave, 0.12 g of sodium formate and 0.04 g of dichlorobis(triphenyl phosphine) palladium (II) were added, and stirred under atmosphere of 1.05 MPa of carbon monoxide at 120° C. for 3 hours. After the completion of the reaction, the reaction mixture was left and cooled to room temperature, the reaction mixture was poured in 50 mL of water, and extracted with ethyl acetate (25 mL×2). The combined organic phases were washed with water, and dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and then the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (gradient of 1:1 to 1:0) to obtain 0.03 g of the aimed product as white crystal.

Melting point 169.0 to 172.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ10.04 (s, 1H), 9.14 (bs, 1H), 8.44 (s, 2H), 7.78 (s, 1H), 7.77 (d, J=7.5 Hz, 1H), 7.62 (d, J=7.5 Hz, 1H), 2.56 (s, 3H).

Step 3: Production of N-acetyl-N-(5-chloro-2-pyrimidinyl)-4-formyl-2-methyl benzoic acid amide

In a solution of 35 mg of N-(5-chloro-2-pyrimidyl)-4-formyl-2-methyl banzoic acid amide, 51 mg of triethylamine and 2 mg of 4-(dimethylamino)pyridine in 5 mL of t-butylmethyl ether, 103 mg of acetic anhydride was added at room temperature and stirred at the same temperature for 4 hours. After the completion of the reaction, 10 mL of water was added in the reaction mixture, and extracted with ethyl acetate (15 mL×2). The combined organic phases were dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and then the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (gradient of 1:1 to 1:0) to obtain 26 mg of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ 9.94 (s, 1H), 8.57 (s, 2H), 7.66 (s, 1H), 7.57 (d, J=7.8 Hz, 1H), 7.43 (d, J=7.5 Hz, 1H), 2.61 (s, 3H), 2.58 (s, 3H).

Step 4: Production of N-acetyl-N-(5-chloro-2-pyrimidinyl)-4-hydroxyiminomethyl-2-methyl benzoic acid amide

In a solution of 26 mg of N-acetyl-N-(5-chloro-2-pyrimidinyl)-4-formyl-2-methyl banzoic acid amide in 4 mL of methanol and 1 mL of water, 10 mg of hydroxylamine hydrochloride was added at room temperature with stirring and stirred at the same temperature for 4 hours. After the completion of the reaction, 10 mL of water was added in the reaction mixture, and extracted with ethyl acetate (10 mL×2). The combined organic phases were dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and then the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:1) to obtain 30 mg of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃-DMSO-d₆, Me₄Si, 300 MHz) δ8.56 (s, 2H), 8.01 (s, 1H), 7.86 (bs, 1H), 7.37 (s, 1H), 7.2-7.35 (m, 2H), 2.61 (s, 3H), 2.53 (s, 3H).

Step 5: Production of N-acetyl-N-(5-chloro-2-pyrimidinyl)-2-methyl-4-[5-(3,4,5-trichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]benzoic acid amide

In a solution of 30 mg of N-acetyl-N-(5-chloro-2-pyrimidinyl)-4-hydroxyiminomethyl-2-methyl benzoic acid amide in 5 mL of 1,2-dimethoxyethane, 16 mg of N-chlorosuccinic acid imide was added and stirred at 40° C. for 30 minutes. Then the reaction mixture was left and cooled to room temperature, and 24 mg of 3,4,5-trichloro-1-(1-trifluoromethylethenyl)benzene, 10 mg of potassium hydrogen carbonate and 1 drop of water were added, and continued to stir at room temperature for 1.5 hour. After the completion of the reaction, the reaction mixture was poured in 10 mL of water, and extracted with ethyl acetate (10 mL×2). The combined organic phases were dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and then the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (gradient of 1:3 to 1:1) to obtain 11 mg of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.57 (s, 2H), 7.61 (s, 2H), 7.46 (s, 1H), 4.35 (s, 2H), 4.03 (d, J=17.4 Hz, 1H), 3.62 (d, J=17.4 Hz, 1H), 2.59 (s, 3H), 2.54 (s, 3H).

Synthetic Example 19 Methyl N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methylbenzoyl]carbamate (Compound of the present invention No. 2-003) Step 1: Production of N-[4-[5-(3,5-dichlorophenyl)-5-trifluoro methyl-4,5-dihydroisoxazole-3-yl]-2-methyl banzoic acid amide

In a mixture of 3.0 g of concentrated ammonia water and 15 mL of tetrahydrofuran, a solution of 3.0 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methylbenzoyl-chloride synthesized in Step 4 of Synthetic Example 1 in 20 mL of tetrahydrofuran was added dropwise under cooling with ice and with stirring. After the completion of the addition dropwise, it was continued to stir further for 18 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in 50 mL of ethyl acetate, washed with 50 mL of water, and dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to obtain 2.9 g of the aimed product as orange crystal.

Melting point 162.0 to 164.0° C.

¹H NMR (CDCl₃, Me₄Si, 400 MHz) δ7.45-7.55 (m, 6H), 6.40 (bs, 1H), 6.00 (bs, 1H), 4.09 (d, J=17.0 Hz, 1H), 3.71 (d, J=17.0 Hz, 1H), 2.49 (s, 3H).

Step 2: Production of methyl N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methylbenzoyl]carbamate

In a solution of 0.37 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl banzoic acid amide in 4 mL of dichloromethane, 0.13 g of oxazalyl chloride was added, and stirred under reflux with heating for 6 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in 2 mL of dichloromethane, and added in a solution of 0.03 g of methanol in 1 mL of dichloromethane, and stirred at room temperature for 15 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (gradient of 1:4 to 1:2) to obtain 0.37 g of the aimed product as colorless oily substance.

¹H NMR (CDCl₃, Me₄Si, 400 MHz) δ8.15 (bs, 1H), 7.35-7.6 (m, 6H), 4.08 (d, J=17.2 Hz, 1H), 3.79 (s, 3H), 3.71 (d, J=17.2 Hz, 1H), 2.45 (s, 3H).

Synthetic Example 20 N-[4-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methylbenzoyl]thiocarbamic acid-O-methyl (Compound of the present invention No. 2-011)

In a solution of 0.70 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methylbenzoyl-chloride synthesized in Step 4 of Synthetic Example 1 in 7 mL of tetrahydrofuran, 0.17 g of potassium thiocyanate was added, and stirred at 40° C. for 1 hour. After the completion of the reaction, the reaction mixture was left and cooled to room temperature, and insoluble material was filtered off, the filtrate was added in a solution of 0.15 g of methanol in 6 mL of tetrahydrofuran, and continued to stir at room temperature further for 18 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (gradient of 1:4 to 1:1) to obtain 0.54 g of the aimed product as yellow resinous substance.

¹H NMR (CDCl₃, Me₄Si, 400 MHz) δ8.91 (s, 1H), 7.45-7.6 (m, 5H), 7.44 (t, J=1.8 Hz, 1H), 4.15 (s, 3H), 4.09 (d, J=17.2 Hz, 1H), 3.71 (d, J=17.2 Hz, 1H), 2.50 (s, 3H).

Synthetic Example 21

Methyl N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methylbenzoyl]-N-methyl carbamate (Compound of the present invention No. 3-003)

In a solution of 0.29 g of methyl N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methylbenzoyl]carbamate synthesized in Synthetic Example 19 and 0.10 g of potassium carbonate in 5 mL of N,N-dimethylformamide, 0.11 g of methyl iodide was added, and stirred at room temperature for 16 hours. After the completion of the reaction, the reaction mixture was poured in 50 mL of ice water, and extracted with ethyl acetate (50 mL×1), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (gradient of 1:9 to 1:2) to obtain 0.29 g of the aimed product as white crystal.

Melting point 147.0 to 149.0° C.

¹H NMR (CDCl₃, Me₄Si, 400 MHz) δ7.45-7.55 (m, 4H), 7.43 (t, J=1.8 Hz, 1H), 7.21 (d, J=7.9 Hz, 1H), 4.08 (d, J=17.2 Hz, 1H), 3.69 (d, J=17.2 Hz, 1H), 3.64 (s, 3H), 3.37 (s, 3H), 2.33 (s, 3H).

Synthetic Example 22

Methyl N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methylbenzoyl]-N-(2,2,2-trifluoroethoxymethyl)carbamate (Compound of the present invention No. 3-032)

Step 1: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl-N-(hydroxymethyl)benzoic acid amide

In a solution of 7.00 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methyl benzoic acid amide synthesized in Step 1 of Synthetic Example 19 in 70 mL of 1,4-dioxane, 1.82 g of 37% formalin, 7.00 g of potassium carbonate and 15 mL of water were added at room temperature with stirring, and stirred at the same temperature for 3 hours. After the completion of the reaction, the reaction mixture was diluted by adding 200 mL of ethyl acetate, washed with water (50 mL×1), and then dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, filtered through silica gel, and the solvent was distilled off under reduced pressure to obtain 7.00 g of the crude product as white crystal.

Melting point 69.0 to 73.5° C.

Step 2: Production of N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl-N-(2,2,2-trifluoroethoxymethyl)benzoic acid amide

In a solution of 1.70 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl-N-(hydroxymethyl)benzoic acid amide in 20 mL of dichloromethane, 0.68 g of thionyl chloride was added at room temperature with stirring, and stirred at the same temperature for 2 hours. Then, the solvent was distilled off under reduced pressure, and the residue was dissolved in 10 mL of tetrahydrofuran. 1.50 g of 2,2,2-trifluoroethanol was added dropwise in a suspension of 0.33 g of 60% oily sodium hydride in 30 mL of tetrahydrofuran under cooling with ice and with stirring, and stirred at the same temperature for 10 minutes. Then, in this reaction mixture, the tetrahydrofuran solution of benzoic acid chloride prepared above was added dropwise under cooling with ice and with stirring. After the completion of the addition dropwise, it was continued to stir at room temperature for 1 hour. After the completion of the reaction, 50 mL of water was added in the reaction mixture, extracted with ethyl acetate (70 mL×1), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (2:3) to obtain 1.20 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 400 MHz) δ7.5-7.55 (m, 4H), 7.4-7.5 (m, 2H), 6.64 (t, J=6.4 Hz, 1H), 5.02 (d, J=7.2 Hz, 2H), 4.05-4.15 (m, 3H), 3.70 (d, J=17.4 Hz, 1H), 2.49 (s, 3H).

Step 3: Production of methyl 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methylbenzoyl]-N-(2,2,2-trifluoroethoxymethyl)carbamate

In a solution of 0.50 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl-N-(2,2,2-trifluoroethoxymethyl)benzoic acid amide in 10 mL of N,N-dimethylformamide, 0.0825 g of 60% oily sodium hydride was added under cooling with ice and with stirring, and stirred at room temperature for 10 minutes. Then, 0.268 g of methyl chloroformate was added, and continued to stir at the same teperature for 30 minutes. After the completion of the reaction, the reaction was poured in 50 mL of water, extracted with ethyl acetate (50 mL×1), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:1) to obtain 0.07 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 400 MHz) δ7.5-7.6 (m, 4H), 7.43 (t, J=2.0 Hz, 1H), 7.25 (d, J=8.0 Hz, 1H), 5.43 (s, 2H), 4.15 (q, J=8.6 Hz, 2H), 4.09 (d, J=17.2 Hz, 1H), 3.70 (d, J=17.2 Hz, 1H), 3.67 (s, 3H), 2.39 (s, 3H).

Synthetic Example 23

Methyl N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methylbenzoyl]-N-(2-tetrahydrofuranyl)carbamate (Compound of the present invention No. 3-077)

Step 1: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl-N-(2-tetrahydrofuranyl)benzoic acid amide

In a solution of 1.25 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methyl benzoic acid amide synthesized in Step 1 of Synthetic Example 19 and 0.32 g of 2,3-dihydrofuran in 30 mL of dichloromethane, 0.01 g of p-toluene sulfonic acid monohydrate was added at room temperature with stirring, and stirred at room temperature for 3 days. After the completion of the reaction, 30 mL of saturated sodium hydrogen carbonate aqueous solution was added in the reaction mixture, extracted with ethyl acetate (30 mL×2), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:1) to obtain 1.18 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.3-7.55 (m, 6H), 6.49 (d, J=8.1 Hz, 1H), 5.8-5.9 (m, 1H), 4.09 (d, J=17.1 Hz, 1H), 3.8-4.0 (m, 2H), 3.72 (d, J=17.1 Hz, 1H), 2.42 (s, 3H), 2.2-2.4 (m, 1H), 1.8-2.1 (m, 3H).

Step 2: Production of methyl N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methylbenzoyl]-N-(2-tetrahydrofuranyl)carbamate

In a suspension of 0.07 g of 55% oily sodium hydride in 10 mL of tetrahydrofuran, a solution of 0.49 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl-N-(2-tetrahydrofuranyl)benzoic acid amide in 5 mL of tetrahydrofuran was added dropwise under cooling with ice and with stirring. After the completion of the addition dropwise, it was stirred at at room temperature for 10 minutes. Then, 0.15 g of methyl chloroformate was added, and continued to stir at the same temperature further for 15 hours. After the completion of the reaction, the reaction was poured in 10 mL of water, extracted with ethyl acetate (20 mL×2), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (2:3) to obtain 0.13 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.4-7.6 (m, 5H), 7.30 (d, J=8.1 Hz, 1H), 6.23 (dd, J=7.5, 5.7 Hz, 1H), 4.1-4.25 (m, 1H), 4.09 (d, J=17.4 Hz, 1H), 3.85-3.95 (m, 1H), 3.70 (d, J=17.4 Hz, 1H), 3.50 (s, 3H), 2.52 (s, 3H), 2.15-2.4 (m, 3H), 1.9-2.1 (m, 1H).

Synthetic Example 24 Methyl N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-6-iodo-2-methylbenzoyl]carbamate (Compound of the present invention No. 2-019)

In a solution of 0.24 g of methyl N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methylbenzoyl]carbamate synthesized in Synthetic Example 19 and 0.12 g of N-iodosuccinimide in 3 mL of N,N-dimethylformamide, 0.0112 g of palladium (II) acetate was added, and stirred under nitrogen atmosphere at 100° C. for 4 hours. After the completion of the reaction, the reaction mixture was poured in a solution of 0.03 g of sodium thiosulfate in 30 mL of water, and extracted with ethyl acetate (30 mL×1), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (gradient of 0:1 to 3:2) to obtain 0.11 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 400 MHz) δ7.91 (bs, 1H), 7.90 (bs, 1H), 7.54 (bs, 1H), 7.50 (bs, 2H), 7.43 (t, J=1.8 Hz, 1H), 4.04 (d, J=17.2 Hz, 1H), 3.76 (s, 3H), 3.66 (d, J=17.2 Hz, 1H), 2.36 (s, 3H).

Synthetic Example 25 O,S-Diemthyl-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methylbenzoyl imidothiocarbamate (Compound of the present invention No. 8-001)

In a solution of 0.30 g of N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methylbenzoyl]thiocarbamic acid-O-methyl synthesized in Synthetic Example 20 and 0.12 g of potassium carbonate in 4 mL of N,N-dimethylformamide, 0.13 g of methyl iodide was added, and stirred at room temperature for 14 hours. After the completion of the reaction, the reaction mixture was poured in 50 mL of ice water, and extracted with ethyl acetate (50 mL×1), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (gradient of 1:4 to 1:1) to obtain 0.20 g of the aimed product as yellow resinous substance.

¹H NMR (CDCl₃, Me₄Si, 400 MHz) δ8.09 (d, J=8.2 Hz, 1H), 7.45-7.6 (m, 4H), 7.42 (t, J=1.8 Hz, 1H), 4.10 (d, J=17.2 Hz, 1H), 4.08 (s, 3H), 3.73 (d, J=17.2 Hz, 1H), 2.67 (s, 3H), 2.41 (s, 3H).

Synthetic Example 26 N-Carbamoyl-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl benzoic acid amide (Compound of the present invention No. 4-002)

In a solution of 0.36 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methyl benzoic acid amide synthesized in Step 1 of Synthetic Example 19 in 4 mL of dichloromethane, 0.13 g of oxalyl chloride was added and stirred under reflux with heating for 6 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in 5 mL of dichloromethane, and 0.11 g of concentrated ammonia water was added dropwise. After the completion of the addition dropwise, the mixture was stirred at room temperature for 15 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, and dissolved in 25 mL of ethyl acetate, washed with water, and dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residual solid was washed with chloroform to obtain 0.26 g of the aimed product as pale yellow crystal.

Melting point 201.0 to 205.0° C.

¹H NMR (CDCl₃, Me₄Si, 400 MHz) δ8.30 (bs, 2H), 7.5-7.6 (m, 5H), 7.44 (t, J=1.8 Hz, 1H), 5.38 (bs, 1H), 4.09 (d, J=17.2 Hz, 1H), 3.71 (d, J=17.2 Hz, 1H), 2.52 (s, 3H).

Synthetic Example 27 N-Chloroacetyl-N′-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methylbenzoyl]-N′-methyl urea (Compound of the present invention No. 4-006) Step 1: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl-N-methyl benzoic acid amide

In a mixture of 2.3 g of 40% methylamine aqueous solution and 10 mL of tetrahydrofuran, a solution of 1.0 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methylbenzoyl-chloride synthesized in Step 4 of Synthetic Example 1 in 10 mL of tetrahydrofuran was added dropwise under cooling with ice and with stirring. After the completion of the addition dropwise, it was continued to stir further for 18 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, the resiudue was dissolved in 100 mL of ethyl acetate, washed with 50 mL of water, then dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to obtain 1.0 g of the aimed product as pale yellow crystal.

Melting point 184.0 to 185.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.35-7.6 (m, 6H), 5.7-5.9 (m, 1H), 4.08 (d, J=17.1 Hz, 1H), 3.69 (d, J=17.1 Hz, 1H), 3.01 (d, J=4.8 Hz, 3H), 2.47 (s, 3H).

Step 2: Production of N-chloroacetyl-N′-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methylbenzoyl]-N′-methyl urea

In a solution of 0.86 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl-N-methyl benzoic acid amide in 10 mL of toluene, 0.36 g of chloroacetyl isocyanate was added, and stirred at 50° C. for 24 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (gradient of 0:1 to 3:2) to obtain 0.93 g of the aimed product as colorless oily substance.

¹H NMR (CDCl₃, Me₄Si, 400 MHz) δ12.27 (s, 1H), 7.45-7.65 (m, 4H), 7.42 (t, J=1.8 Hz, 1H), 7.27 (d, J=7.9 Hz, 1H), 4.46 (s, 2H), 4.07 (d, J=17.2 Hz, 1H), 3.69 (d, J=17.2 Hz, 1H), 3.07 (s, 3H), 2.36 (s, 3H).

Synthetic Example 28 N-Carbamoyl-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl-N-methyl benzoic acid amide (Compound of the present invention No. 4-003)

A solution of 0.40 g of N-chloroacetyl-N′-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methylbenzoyl]-N′-methyl urea synthesized in Synthetic Example 27 and 0.04 g of triethylamine in 4 mL of methanol was stirred at room temperature for 2 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (gradient of 1:4 to 4:1) to obtain 0.31 g of the aimed product as white crystal.

Melting point 181.0 to 183.0° C.

¹H NMR (CDCl₃, Me₄Si, 400 MHz) δ8.88 (bs, 1H), 7.5-7.6 (m, 4H), 7.43 (t, J=1.8 Hz, 1H), 7.28 (d, J=7.9 Hz, 1H), 5.76 (bs, 1H), 4.06 (d, J=17.2 Hz, 1H), 3.72 (d, J=17.2 Hz, 1H), 3.04 (s, 3H), 2.36 (s, 3H).

Synthetic Example 29 N-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methylbenzoyl]-N′-ethyl-N′-methoxycarbonyl urea (Compound of the present invention No. 4-011)

In a solution of 0.50 g of N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methyl benzoyl]-N′-ethyl urea synthesized similarly to Synthetic Example 26 in 4 mL of tetrahydrofuran, 4 mL of 1M tetrahydrofuran solution of lithium hexamethyl disilazane was added at −78° C. with stirring, and stirred at the same temperature for 30 minutes. Then, 0.12 g of methyl chloroformate was added in the reaction mixture at −78° C. with stirring. After the completion of the addition dropwise, it was continued to stir further for 18 hours while the temperature was slowly raised to room temperature. After the completion of the reaction, 30 mL of ice water was added, and extracted with ethyl acetate (30 mL×2). The organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (gradient of 0:1 to 1:2) to obtain 0.29 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 400 MHz) δ12.01 (s, 1H), 7.5-7.65 (m, 5H), 7.43 (t, J=1.8 Hz, 1H), 4.11 (d, J=17.2 Hz, 1H), 3.89 (s, 3H), 3.86 (q, J=7.1 Hz, 2H), 3.74 (d, J=17.2 Hz, 1H), 2.53 (s, 3H), 1.21 (t, J=7.1 Hz, 3H).

Synthetic Example 30 4-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-N-(dimethyl-aminomethylidene)-2-methyl benzamide (Compound of the present invention No. 8-006)

A mixture of 6.0 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl benzoic acid amide synthesized in Step 1 of Synthetic Example 19 and 50 mL of N,N-dimethylformamide dimethylacetal were stirred at 120° C. for 1.5 hour. After the completion of the reaction, the solvent was distilled off under reduced pressure. The residual solid was washed with ethyl acetate-hexane mixture (1:20) to obtain 6.2 g of the aimed product as pale yellow crystal.

Melting point 146.0 to 147.0° C.

¹H NMR (CDCl₃, Me₄Si, 400 MHz) δ8.60 (s, 1H), 8.11 (d, J=8.0 Hz, 1H), 7.45-7.55 (m, 4H), 7.4-7.45 (m, 1H), 4.10 (d, J=17.4 Hz, 1H), 3.71 (d, J=17.4 Hz, 1H), 3.21 (s, 3H), 3.19 (s, 3H), 2.64 (s, 3H).

Synthetic Example 31 4-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-N-(ethoxyimino-methyl)-2-methyl benzoic acid amide (Compound of the present invention No. 6-005)

in a solution of 0.25 g of ethoxyamine hydrochloride in 4 mL of water and 8 mL of acetic acid, a solution of 0.20 g of sodium hydroxide in 4 mL of water was added, and then 5 mL of 1,4-dioxane solution of 0.62 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-N-(dimethyl-aminomethylidene)-2-methyl benzamide synthesized in Synthetic Example 30 was added dropwise at room temperature with stirring. After the completion of the addition dropwise, it was continued to stir at the same temperature further for 2 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, 50 mL of ethyl acetate was added in the residue, and washed with water. The organic phase was dehydrated with and dried over saturated sodium chloride and then anhydrous sodium sulfate, the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (2:3) to obtain 0.44 g of the aimed product as white crystal.

Melting point 143.0 to 146.0° C.

¹H NMR (CDCl₃, Me₄Si, 400 MHz) δ8.59 and 8.50 (d, J=9.2 Hz, 1H), 7.78 and 7.70 (d, J=9.2 Hz, 1H), 7.5-7.65 (m, 6H), 4.05-4.2 (m, 3H), 3.71 (d, J=17.4 Hz, 1H), 2.54 (s, 3H), 1.28 (t, J=7.0 Hz, 3H).

Synthetic Example 32 (Z)-4-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-N-(methoxyiminomethyl)-2-methylbenzoic acid amide (Compound of the present invention No. 6-004)

After dissolving 1.8 g of a geometrical isomer of N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-N-(methoxy-iminomethyl)-2-methylbenzoic acid amide synthesized similarly to Synthetic Example 31 in 15 mL of acetonirile, the resulting solution was stirred at room temperature. It was continued to stir for 4 days, and then the solvent was distilled off under reduced pressure, the residual solid was re-crystallized from a small amount of acetonitrile to obtain 1.4 g of the aimed product (E/Z=2:98) as white crystal.

Melting point 167.0 to 169.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.49 (d, J=9.3 Hz, 1H), 7.77 (d, J=9.3 Hz, 1H), 7.45-7.65 (m, 6H), 4.09 (d, J=17.4 Hz, 1H), 3.90 (s, 3H), 3.71 (d, J=17.4 Hz, 1H), 2.53 (s, 3H).

Synthetic Example 33 4-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-N-(methoxyiminomethyl)-N-methyl-2-methylbenzoic acid amide (Compounds of the present invention Nos. 7-002 and 7-003)

In a solution of 0.20 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-N-(methoxy-iminomethyl)-2-methylbenzoic acid amide synthesized similarly to Synthetic Example 31 and 0.072 g of potassium hydroxide in 10 mL of N,N-dimethylformamide, 0.09 g of methyl iodide was added, and stirred at room temperature for 1 hour. After the completion of the reaction, the reaction mixture was poured in 20 mL of ice water, extracted with ethyl acetate (50 mL×1), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (2:3) to obtain 0.036 g of isomer (1) and 0.086 g of isomer (2) as the aimed products of colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz)

No. 7-002; 67.86 (s, 1H), 7.2-7.6 (m, 6H), 4.09 (d, J=18.0 Hz, 1H), 3.75 (s, 3H), 3.70 (d, J=18.0 Hz, 1H), 3.35 (s, 3H), 2.30 (s, 3H).

No. 7-003; 67.2-7.6 (m, 6H), 6.72 (s, 1H), 4.08 (d, J=18.0 Hz, 1H), 3.86 (s, 3H), 3.70 (d, J=18.0 Hz, 1H), 3.39 (s, 3H), 2.34 (s, 3H).

Synthetic Example 34 Methyl 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methylbenzoyl]-N-(methoxyiminomethyl) carbamate (Compounds of the present invention Nos. 7-004 and 7-005)

In a solution of 0.2 g of N-[4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-N-(methoxy-iminomethyl)-2-methylbenzoic acid amide synthesized similarly to Synthetic Example 31 and 1.0 g of potassium carbonate in 10 mL of N,N-dimethylformamide, 0.5 g of methyl chloroformate was added, and stirred at room temperature for 24 hours. After the completion of the reaction, the reaction mixture was poured in 20 mL of ice water, extracted with ethyl acetate (50 mL×1), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (2:3) to obtain 0.07 g of isomer (1) and 0.12 g of isomer (2) as the aimed products of colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz)

No. 7-004; 67.85 (bs, 1H), 7.5-7.6 (m, 4H), 7.4-7.45 (m, 1H), 7.25-7.3 (m, 1H), 4.08 (d, J=17.4 Hz, 1H), 3.65-3.9 (m, 4H), 3.34 (s, 3H), 2.29 (s, 3H).

No. 7-005; 67.5-7.6 (m, 4H), 7.4-7.5 (m, 1H), 7.25-7.3 (m, 1H), 6.72 (bs, 1H), 4.08 (d, J=17.4 Hz, 1H), 3.84 (s, 3H), 3.70 (d, J=17.4 Hz, 1H), 3.36 (s, 3H), 2.34 (s, 3H).

Synthetic Example 35 (Z)-4-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-ethyl-N-(methoxyiminomethyl)benzoic acid amide (Compound of the present invention No. 6-020) Step 1: Production of methyl 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-ethyl benzoate

In a solution of 0.50 g of methyl 2-bromo-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]benzoate and 0.03 g of 1,1′-bis(diphenylphosphino) ferrocene dichloropalladium (11), 2 mL a solution of 1.0M zinc diethyl in hexane was added under an atmosphere of nitrogen, and then stirred under reflux with heating for 1 hour. After the completion of the reaction, 30 mL of 1N hydrochloric acid was added in the reaction mixture, and extracted with ethyl acetate (40 mL×1). The organic phase was dehydrated with and dried over saturated sodium chloride and then anhydrous sodium sulfate, filtered through silica gel, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:4) to obtain 0.21 g of the aimed product as pale yellow resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.90 (d, J=8.4 Hz, 1H), 7.4-7.7 (m, 5H), 4.11 (d, J=17.4 Hz, 1H), 3.91 (s, 3H), 3.72 (d, J=17.4 Hz, 1H), 3.50 (q, J=7.5 Hz, 2H), 1.25 (t, J=7.5 Hz, 3H).

Step 2: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-ethyl benzoic acid amide

In a solution of 0.21 g of methyl 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-ethyl benzoate in 5 mL of etanol, a solution of 0.10 g of sodium hydroxide in 3 mL of water was added, and stirred under reflux with heating for 3 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, 10 mL of 1N hydrochloric acid was added, and extracted with ethyl acetate (40 mL×1). The organic phase was dehydrated with and dried over saturated sodium chloride and then anhydrous sodium sulfate, filtered through silica gel, and the solvent was distilled off under reduced pressure. The residue was dissolved in 10 mL of dichloromethane, and 0.10 g of oxalyl chloride and 0.03 g of N,N-dimethylformamide were added, and stirred at room temperature for 30 minutes. After the completion of the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in 5 mL of tetrahydrofuran, and 10 mL of concentrated ammonia water was added dropwise at room temperature with stirring. The completion of the addition dropwise, it was continued to stir further for 30 minutes. After the completion of the reaction, 30 mL of water was added in the reaction mixture, extracted with ethyl acetate (30 mL×1), the organic phase was dehydrated with and dried over saturated sodium chloride and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to obtain 0.18 g of the crude aimed product as yellow resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.4-7.6 (m, 6H), 5.70 (bs, 2H), 4.09 (d, J=17.4 Hz, 1H), 3.70 (d, J=17.4 Hz, 1H), 2.88 (q, J=7.8 Hz, 2H), 1.26 (t, J=7.8 Hz, 3H).

Step 3: Production of (Z)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-ethyl-N-(methoxyiminomethyl)benzoic acid amide

A mixture of 0.18 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-ethyl benzoic acid amide and 10 mL of N,N-dimethylformamide dimethylacetal was stirred under reflux with heating for 4 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in 5 mL of 1,4-dioxane, and added dropwise in a solution of 0.10 g of methoxyamine hydrochloride and 0.10 g of sodium hydroxide in 4 mL of water and 4 mL of acetic acid. After the completion of the addition dropwise, it was continued to stir at room temperature further for 30 minutes. After the completion of the reaction, 10 mL of water was added in the reaction mixture, and extracted with ethyl acetate (40 mL×1). The organic phase was dehydrated with and dried over saturated sodium chloride and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (2:3) to obtain 0.15 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.47 (d, J=9.0 Hz, 1H), 8.02 (s, 1H), 7.77 (d, J=9.0 Hz, 1H), 7.4-7.65 (m, 5H), 4.09 (d, J=17.4 Hz, 1H), 3.90 (s, 3H), 3.71 (d, J=17.4 Hz, 1H), 2.87 (q, J=7.8 Hz, 2H), 1.26 (t, J=7.8 Hz, 3H).

Synthetic Example 36 (Z)-4-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-difluoromethoxy-N-(ethoxyiminomethyl)benzoic acid amide (Compound of the present invention No. 6-023) Step 1: Production of 5-(3,5-dichlorophenyl)-3-(3-difluoromethoxy-4-nitrophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole

In a solution of 0.30 g of 5-(3,5-dichlorophenyl)-3-(3-hydroxy-4-nitrophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole in 20 mL of acetonitrile and 3 mL of water, 0.218 g of ethyl bromodifluoroacetate and 0.293 g of potassium carbonate were added, and stirred at 80° C. for 1 hour. After the completion of the reaction, the solvent was distilled off under reduced pressure, 10 mL of water was added in the residue, and extracted with ethyl acetate (20 mL×1). The organic phase was washed with water, and then dehydrated with and dried over saturated sodium chloride and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to obtain the crude aimed product as yellow resinous substance. The resulting product was used as such without purification for the next step.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.45-8.05 (m, 6H), 6.66 (t, J=72.3 Hz, 1H), 4.08 (d, J=17.4 Hz, 1H), 3.71 (d, J=17.4 Hz, 1H).

Step 2: Production of 3-(4-amino-3-difluoromethoxyphenyl)-5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole

In a mixture of 5.0 mL of water, 1.0 mL of acetic acid and 1.22 g of reduced iron, a solution of 2.0 g of 5-(3,5-dichlorophenyl)-3-(3-difluoromethoxy-4-nitrophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole in 15 mL of ethyl acetate was added dropwise at 75° C. under stirring with heating. After the completion of the addition dropwise, it was stirred at the same temperature for 2.5 hours. After the completion of the reaction, the reaction mixture was subjected to hot filtration through Celite, 20 ml of water was added in the filtrate, extracted with ethyl acetate (20 ml×2). The combined organic phases were washed with 10 ml of saturated sodium hydrogen carbonate aqueous solution, and then dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and then the solvent was distilled off under reduced pressure to obtain 1.7 g of the crude aimed product as yellow resinous substance. The resulting product was used as such without purification for the next step.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ6.7-7.5 (m, 6H), 6.50 (t, J=74.1 Hz, 1H), 4.23 (bs, 2H), 4.02 (d, J=17.4 Hz, 1H), 3.63 (d, J=17.4 Hz, 1H).

Step 3: Production of 5-(3,5-dichlorophenyl)-3-(3-difluoromethoxy-4-iodophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole

In a solution of 1.00 g of 3-(4-amino-3-difluoromethoxyphenyl)-5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole in a mixed solution of 10 mL of acetonitrile and 10 mL of water, 5 mL of concentrated hydrochloric acid was added, and a solution of 0.20 g of sodium nitrite in 2 mL of water was added dropwise slowly under cooling with ice and with stirring. After the completion of the addition dropwise, it was continued to stir at the same temperature further for 20 minutes. Then, a solution of 0.47 g of potassium iodide in 1 mL of water was added dropwise carefully. After the completion of the addition dropwise, it was continued to stir at room temperature further for 30 minutes. After the completion of the reaction, 0.041 g of urea was added in the reaction mixture, stirred at room temperature for 30 minutes, then a solution of 0.10 g of sodium sulfite in 5 mL of water was added, and extracted with ethyl acetate (20 mL×2). The combined organic phases were washed with water, and then dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that were eluated with ethyl acetate-hexane (1:9) to obtain 0.60 g of the aimed product as yellow resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.2-7.95 (m, 6H), 6.57 (t, J=73.2 Hz, 1H), 4.05 (d, J=17.4 Hz, 1H), 3.66 (d, J=17.4 Hz, 1H).

Step 4: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-difluoro-methoxy benzoic acid amide

In a solution of 0.30 g of 5-(3,5-dichlorophenyl)-3-(3-difluoromethoxy-4-iodophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole, 0.80 mL of 1,1,1,3,3,3-hexamethyldisilazane and 0.20 mL of diisopropylethylamine in 10 ml of N,N-dimethylformamide, 0.062 g of 1,1′-bis(diphenylphosphino) ferrocene and 0.013 g of palladium (II) acetate were added, and stirred under carbon monoxide atmosphere at 90° C. for 12 hours and then at room temperature for 3 days. After the completion of the reaction, 10 mL of 1N hydrochloric acid was added, and stirred for 10 minutes, extracted with ethyl acetate (10 mL×2). The combined organic phases were washed with water, and then dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that were eluated with ethyl acetate-hexane (2:3) to obtain 0.30 g of the aimed product as yellow resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.35-8.25 (m, 6H), 6.97 (bs, 1H), 6.70 (t, J=72.3 Hz, 1H), 6.27 (bs, 1H), 4.10 (d, J=17.1 Hz, 1H), 3.72 (d, J=17.1 Hz, 1H).

Step 5: Production of (Z)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-difluoromethoxy-N-(ethoxyiminomethyl)benzoic acid amide

A mixture of 0.15 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-difuoro-methoxy benzoic acid amide and 10 mL of N,N-dimethylformamide dimethylacetal was stirred at 120° C. for 1.5 hour. After the completion of the reaction, the residue was dissolved in 3 mL of 1,4-dioxane, a solution of 0.026 g of ethoxyamine hydrochloride in 3 mL of water was added dropwise. After the completion of the addition dropwise, it was continued to stir at room temperature further for 30 minutes. After the completion of the reaction, 10 mL of water was added in the reaction mixture, and extracted with ethyl acetate (10 mL×1). The organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that were eluated with ethyl acetate-hexane (1:2) to obtain 0.07 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ9.95 (d, J=9.0 Hz, 1H), 8.30 (d, J=9.0 Hz, 1H), 7.4-7.85 (m, 6H), 6.74 (t, J=72.0 Hz, 1H), 4.18 (q, J=7.2 Hz, 2H), 4.09 (d, J=17.7 Hz, 1H), 3.71 (d, J=17.7 Hz, 1H), 1.31 (t, J=7.2 Hz, 3H).

Synthetic Example 37 4-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-N-(methoxy-iminomethyl)-2-methoxymethyl benzoic acid amide (Compound of the present invention No. 6-031) Step 1: Production of methyl 2-bromomethyl-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]benzoate

In a solution of 3.25 g of methyl 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl benzoate in 15 mL of 1,2-dichloroethane, 1.34 g of N-bromosuccinimide and 0.19 g of 2,2′-azobisisobutyronitrile were added, and stirred under reflux with heating for 1 hour. After the completion of the reaction, the reaction mixture was left and cooled to room temperature, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:2) to obtain 3.40 g of the aimed product as brown resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.0-8.05 (m, 1H), 7.75 (s, 1H), 7.6-7.7 (m, 1H), 7.51 (s, 2H), 7.4-7.5 (m, 1H), 4.95 (s, 2H), 4.12 (d, J=17.4 Hz, 1H), 3.96 (s, 3H), 3.73 (d, J=17.4 Hz, 1H).

Step 2: Production of methyl 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methoxy-methyl benzoate

In a solution of 1.70 g of methyl 2-bromomethyl-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]benzoate in 20 mL of methanol, 0.41 g of potassium tert-butoxide was added, and stirred at room temperature for 23 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, and 20 mL of water was added in the reaction mixture, and extracted with ethyl acetate (20 mL×2). The combined organic phases were washed with 20 mL of 2N hydrochloric acid and then dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:4) to obtain 1.12 g of the aimed product as colorless resinous substance.

Step 3: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methoxymethyl benzoic acid

In a solution of 1.12 g of methyl 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methoxy-methyl benzoate in 30 mL of ethanol, a solution of 0.41 g of potassium hydroxide in 15 mL of water was added, and stirred under reflux with heating for 30 minutes. After the completion of the reaction, the reaction mixture was left and cooled to room temperature, and the solvent was distilled off under reduced pressure, and 10 mL of 2N hydrochloric acid was added in the residue, and extracted with ethyl acetate (20 mL×2). The combined organic phases were washed with water, and then the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain 1.04 g of the crude aimed product as white crystal. The resulting product was used as such without purification for the next step.

Step 4: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methoxymethyl benzoic acid amide

In a solution of 0.80 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methoxymethyl benzoic acid in 30 mL of dichloromethane, 0.23 g of oxalyl chloride and 0.06 g of N,N-dimethylforamide were added, and stirred at room temperature for 30 minutes. After the completion of the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in 5 mL of tetrahydrofuran, and a solution of 1.50 g of concentrated ammonia water in 10 mL of tetrahydrofuran was added dropwise at room temperature with stirring. After the completion of the addition dropwise, it was continued to stir further for 1 hour. After the completion of the reaction, the solvent was distilled off under reduced pressure, 10 mL of water was added in the residue, and extracted with ethyl acetate (20 mL×1). The organic phase was washed with 10 mL of 2N hydrochloric acid, and then dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that were eluated with ethyl acetate-hexane (1:1) to obtain 0.34 g of the aimed product as white crystal.

Melting point 186.0 to 188.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.87 (d, J=8.4 Hz, 1H), 7.65-7.75 (m, 2H), 7.50 (s, 2H), 7.4-7.45 (m, 1H), 7.33 (bs, 1H), 5.73 (bs, 1H), 4.61 (s, 2H), 4.11 (d, J=17.4 Hz, 1H), 3.72 (d, J=17.4 Hz, 1H), 3.45 (s, 3H).

Step 5: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-N-(methoxy-iminomethyl)-2-methoxymethyl benzoic acid amide

In a solution of 0.09 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methoxymethyl benzoic acid amide in 2 mL of tetrahydrofuran, 0.05 g of N,N-dimethylformamide dimethylacetal was added, and stirred at room temperature for 2 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, and the residue was dissolved in 2 mL of tetrahydrofuran, a solution of 0.02 g of methoxyamine hydrochloride in 2 mL of water was added dropwise. After the completion of the addition dropwise, it was continued to stir at room temperature further for 30 minutes. After the completion of the reaction, the solvent was distilled off under reduced pressure, 5 mL of water was added in the residue, and extracted with ethyl acetate (10 mL×1). The organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sulfuric acid, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that were eluated with ethyl acetate-hexane (1:4) to obtain 0.07 g of the aimed product as white crystal.

Melting point 132.0 to 134.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.63 and 10.34 (d, J=9.9 and 10.8 Hz, 1H), 7.7-7.95 (m, 4H), 7.51 (s, 2H), 7.4-7.45 (m, 1H), 4.53 and 4.55 (s, 2H), 4.11 (d, J=17.4 Hz, 1H), 3.81 and 3.91 (s, 3H), 3.72 (d, J=17.7 Hz, 1H), 3.51 and 3.53 (s, 3H).

Synthetic Example 38 4-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-(dimethyl aminomethyl)-N-(methoxyiminomethyl)benzoic acid amide (Compound of the present invention No. 6-032) Step 1: Production of methyl 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-(dimethyl-aminomethyl)benzoate

In a solution of 1.50 g of methyl 2-bromomethyl-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]benzoate in 20 mL of N,N-dimethylformamide, 0.48 g of dimethylamine hydrochloride and 1.48 g of triethylamine were added, and stirred at room temperature for 2 hours. After the completion of the reaction, 20 mL of water was added in the reaction mixture, and extracted with ethyl acetate (20 mL×2). The combined organic phases were dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that were eluated with ethyl acetate-hexane (1:3) to obtain 1.35 g of the aimed product as colorless resinous substance.

Step 2: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-(dimethyl-aminomethyl)benzoic acid

In a solution of 1.35 g of methyl 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-(dimethyl-aminomethyl)benzoate in 30 mL of ethanol, a solution of 0.48 g of potassium hydroxide in 15 mL of water was added, and stirred under reflux with heating for 30 minutes. After the completion of the reaction, the reaction mixture was left and cooled to room temperature, and 10 mL of 2N hydrochloric acid was added, and the solvent was distilled off under reduced pressure. The residue was dissolved in 20 mL of ethyl acetate, insoluble material was filtered off, and the solvent was distilled off under reduced pressure to obtain 1.05 g of the crude aimed product as white crystal. The resulting product was used as such without purification for the next step.

Step 3: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-(dimethylaminomethyl)benzoic acid amide

In a solution of 1.05 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-(dimethyl-aminomethyl)benzoic acid in 40 mL of dichloromethane, 0.58 g of oxalyl chloride and 0.06 g of N,N-dimethylforamide were added, and stirred at room temperature for 30 minutes. After the completion of the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in 15 mL of tetrahydrofuran, and a solution of 3.00 g of concentrated ammonia water in 15 mL of tetrahydrofuran was added dropwise under cooling with ice and with stirring. After the completion of the addition dropwise, it was continued to stir at room temperature further for 1 hour. After the completion of the reaction, the solvent was distilled off under reduced pressure, 20 mL of water was added in the residue, and extracted with ethyl acetate (20 mL×2). The organic phases were dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain 0.93 g of the aimed product as colorless resinous material. The resulting product was used as such without purification for the next step.

Step 4: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-(dimethyl-aminomethyl)-N-(methoxyiminomethyl)benzoic acid amide

In a solution of 0.30 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-(dimethylaminomethyl)benzoic acid amide in 6 mL of tetrahydrofuran, 0.16 g of N,N-dimethylformamide dimethylacetal was added, and stirred at room temperature for 3 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, and the residue was dissolved in 6 mL of tetrahydrofuran, a solution of 0.07 g of methoxyamine hydrochloride in 4 mL of water was added dropwise. After the completion of the addition dropwise, it was continued to stir at room temperature further for 30 minutes. After the completion of the reaction, the solvent was distilled off under reduced pressure, 10 mL of water was added in the residue, and extracted with ethyl acetate (20 mL×1). The organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that were eluated with ethyl acetate-hexane (1:2) to obtain 0.02 g of the aimed product as white crystal.

Melting point 144.0 to 146.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.09 (d, J=8.1 Hz, 1H), 7.82 (d, J=8.1 Hz, 1H), 7.55-7.65 (m, 2H), 7.52 (s, 2H), 7.4-7.45 (m, 1H), 4.11 (d, J=17.4 Hz, 1H), 3.88 (s, 3H), 3.72 (d, J=17.1 Hz, 1H), 3.54 (s, 2H), 2.28 (s, 6H).

Synthetic Example 39 2-Acetylamino-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-N-(methoxyiminomethyl)benzoic acid amide (Compound of the present invention No. 6-033) Step 1: Production of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-nitro benzoic acid amide

In a solution of 0.50 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-nitro benzoic acid in 10 mL of dichloromethane, 0.43 g of oxalyl chloride was added dropwise at room temperature with stirring. After the completion of the addition dropwise, it was continued to stir at the same temperature further for 1.5 hour. After the completion of the reaction, the solvent was distilled off under reduced pressure, and the residue was dissolved in 5 mL of tetrahydrofuran, and 15 mL of concentrated ammonia water was added dropwise under cooling with ice and with stirring. After the completion of the addition dropwise, it was continued to stir at room temperature further for 1 hour. After the completion of the reaction, the solvent was distilled off under reduced pressure, 20 mL of water was added in the residue, and extracted with ethyl acetate (20 mL×2). The organic phases were dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain 0.43 g of the crude aimed product as colorless crystal. The resulting product was used as such without purification for the next step.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.45-8.0 (m, 6H), 6.80 (bs, 2H), 4.10 (d, J=17.4 Hz, 1H), 3.20 (d, J=17.4 Hz, 1H).

Step 2: Production of 2-amino-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]benzoic acid amide

In a mixture of 10 mL of water, 2 mL of acetic acid and 0.52 g of reduced iron, a solution of 0.84 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-nitro benzoic acid amide in 10 mL of ethyl acetate was added dropwise at 75° C. with stirring. After the completion of the addition dropwise, it was stirred at the same temperature further for 2.5 hours. After the completion of the reaction, insoluble material was removed by hot filtration, 20 ml of water was added in the filtrate, and the organic phase was collected, and the aqueous phase was extracted with ethyl acetate (10 ml×2). The combined organic phases were washed with 10 ml of saturated sodium hydrogen carbonate aqueous solution, and then dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and then the solvent was distilled off under reduced pressure to obtain 0.80 g of the crude aimed product as yellow crystal. The resulting product was used as such without purification for the next step.

Melting point 190.0 to 193.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.35-7.5 (m, 6H), 6.9-6.95 (m, 2H), 6.00 (bs, 2H), 4.05 (d, J=17.4 Hz, 1H), 3.56 (d, J=17.4 Hz, 1H).

Step 3: Production of 2-acetylamino-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]benzoic acid amide

In a solution of 0.20 g of 2-amino-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]benzoic acid amide and 0.12 g of triethylamine in 5 mL of dichloromethane, 0.05 g of acetyl chloride was added under cooling with ice and with stirring, and stirred at room temperature for 40 minutes. After the completion of the reaction, 10 mL of ethyl acetate was added in the reaction mixture, and washed with 10 mL of water, 10 mL of saturated sodium hydrogen carbonate aqueous solution, and then 10 mL of saturated ammonium chloride aqueous solution in that order. The organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain 0.21 g of the crude aimed product as yellow crystal. The resulting product was used as such without purification for the next step.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ11.30 (s, 1H), 7.4-8.85 (m, 8H), 4.15 (d, J=17.4 Hz, 1H), 3.75 (d, J=17.4 Hz, 1H), 2.05 (s, 3H).

Step 4: Production of 2-acetylamino-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-N-(methoxyiminomethyl)benzoic acid amide

A mixture of 0.21 g of 2-acetylamino-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]benzoic acid amide and 10 mL of N,N-dimethylformamide dimethylacetal was stirred at room temperature for 1.5 hour. After the completion of the reaction, the solvent was distilled off under reduced pressure, and the residue was dissolved in 3 mL of 1,4-dioxane, a solution of 0.025 g of methoxyamine hydrochloride in 3 mL of water was added dropwise. After the completion of the addition dropwise, it was continued to stir at room temperature further for 30 minutes. After the completion of the reaction, the solvent was distilled off under reduced pressure, 5 mL of water was added in the residue, and extracted with ethyl acetate (10 mL×1). The organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that were eluated with ethyl acetate-hexane (1:2) to obtain 0.07 g of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ11.00 (bs, 1H), 8.90 (d, J=7.8 Hz, 1H), 8.85 (d, J=1.2 Hz, 1H), 7.45-7.8 (m, 6H), 4.15 (d, J=17.4 Hz, 1H), 3.95 (s, 3H), 3.75 (d, J=17.4 Hz, 1H), 2.25 (s, 3H).

Synthetic Example 40 4-[5-(3-Chloro-5-trifluoromethylphenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-N-(methoxyiminomethyl)-2-methyl benzoic acid amide (Compound of the present invention No. 6-037) Step 1: Production of 4-bromo-N-(dimethylaminomethylidene)-2-methyl benzoic acid amide

A mixture of 0.84 g of 4-bromo-2-methyl benzoic acid amide and 18 mL of N,N-dimethylformamide dimethylacetal was stirred at 70° C. for 30 minutes. After the completion of the reaction, the solvent was distilled off-under reduced pressure, and the residue was washed with 5 mL of hexane to obtain 0.67 g of the aimed product as white crystal.

Melting point 87.0 to 89.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.57 (s, 1H), 7.97 (d, J=8.1 Hz, 1H), 7.36 (s, 1H), 7.34 (d, J=8.1 Hz, 1H), 3.19 (s, 3H), 3.17 (s, 3H), 2.60 (s, 3H).

Step 2: Production of 4-bromo-N-(methoxyiminomethyl)-2-methyl benzoic acid amide

In a solution of 0.67 g of 4-bromo-N-(dimethylaminomethylidene)-2-methyl benzoic acid amide in 10 mL of 1,4-dioxane, a solution of 0.36 g of methoxyamine hydrochloride in 2 mL of water was added, and stirred at room temperature for 1 hour. After the completion of the reaction, the reaction mixture was diluted with 50 mL of ethyl acetate, washed with water, and dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain 0.70 g of the aimed product as white crystal.

Melting point 119.0 to 122.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.4-8.5 and 8.5-8.6 (m, 1H), 7.65-7.8 (m, 1H), 7.3-7.5 (m, 3H), 3.79 and 3.89 (s, 3H), 2.49 (s, 3H).

Step 3: Production of 4-formyl-N-(methoxyiminomethyl)-2-methyl benzoic acid amide

In a solution of 0.20 g of 4-bromo-N-(methoxyiminomethyl)-2-methyl benzoic acid amide in 5 ml of N,N-dimethylformamide, 0.065 g of sodium formate and 0.026 g of dichlorobis(triphenylphosphine) palladium (II) were added, and stirred under carbon monoxide atmosphere at 120° C. for 1.5 hour. After the completion of the reaction, the reaction mixture was left and cooled to room temperature, and poured in 30 mL of water, and extracted with ethyl acetate (20 mL×2). The combined organic phases were washed with water, and dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that were eluated with ethyl acetate-hexane (gradient of 1:3 to 1:1) to obtain 0.071 g of the aimed product as colorless oily substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ10.04 (s, 1H), 8.5-8.65 (m, 1H), 7.7-7.85 (m, 3H), 7.63 (d, J=7.8 Hz, 1H), 3.80 and 3.90 (s, 3H), 2.57 (s, 3H).

Step 4: Production of 4-hydroxyiminomethyl-N-(methoxyiminomethyl)-2-methyl benzoic acid amide

In a solution of 64 mg of 4-formyl-N-(methoxyiminomethyl)-2-methyl benzoic acid amide in 4 mL of methanol and 1 mL of water, 30 mg of hydroxyamine hydrochloride was added at room temperature with stirring, and continued to stir at the same temperature for 1.5 hour. After the completion of the reaction, 10 mL of water was added in the reaction mixture, and extracted with ethyl acetate (10 mL×2). The combined organic phases were dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that were eluated with ethyl acetate-hexane (1:1) to obtain 70 mg of the aimed product as white crystal.

Melting point 88.0 to 91.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.53 and 9.30 (d, J=10.2 Hz, 1H), 7.79 and 8.69 (d, J=10.2 Hz, 1H), 8.11 (s, 1H), 8.05 (bs, 1H), 7.4-7.55 (m, 3H), 3.85 and 3.90 (s, 3H), 2.51 (s, 3H).

Step 5: Production of 4-[5-(3-chloro-5-trifluoromethylphenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-N-(methoxyiminomethyl)-2-methyl benzoic acid amide

In a solution of 81 mg of 4-hydroxyiminomethyl-N-(methoxyiminomethyl)-2-methyl benzoic acid amide in 10 ml of 1,2-dimethoxyethane, 60 mg of N-chlorosuccinimide was added, and stirred at 70° C. for 45 minutes. Then, the reaction mixture was left and cooled to room temperature, and then 60 mg of 3-chloro-5-trifluoromethyl-1-(1-trifluoromethylethenyl)benzene, 40 mg of potassium hydrogen carbonate and 3 drops of water were added, and continued to stir at room temperature further for 15 hours. After the completion of the reaction, the reaction mixture was poured in 10 mL of water, and extracted with ethyl acetate (15 mL×2). The combined organic phases were dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that were eluated with ethyl acetate-hexane (gradient of 1:5 to 1:3) to obtain 13 mg of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.49 and 9.25 (d, J=10.2 Hz, 1H), 7.82 (s, 1H), 7.76 (s, 1H), 7.70 (s, 1H), 7.55-7.65 and 7.75-7.8 (m, 1H), 7.5-7.6 (m, 3H), 4.13 (d, J=17.4 Hz, 1H), 3.79 and 3.90 (s, 3H), 3.73 (d, J=17.4 Hz, 1H), 2.53 (s, 3H).

Synthetic Example 41 Methyl N-[2-methyl-4-[5-(3,4,5-trichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]benzoyl]carbamate (Compound of the present invention No. 2-026) Step 1: Production of 4-formyl-2-methyl benzoic acid amide

In 0.40 g of 4-formyl-2-methylbenzonitrile, 7 mL of concentrated sulfuric acid was added, and stirred at room temperature for 4.5 days. After the completion of the reaction, the reaction mixture was poured in 20 mL of ice water, extracted with ethyl acetate (15 mL×2). The combined organic phases were washed with water, and dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was washed with 5 mL of diisopropyl ether to obtain 0.26 g of the aimed product as white crystal.

Melting point 119.0 to 121.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ10.02 (s, 1H), 7.76 (s, 1H), 7.75 (d, J=7.8 Hz, 1H), 7.60 (d, J=7.8 Hz, 1H), 5.77 (bs, 2H), 2.57 (s, 3H).

Step 2: Production of methyl N-[4-formyl-2-methyl benzoyl]carbamate

In a solution of 80 mg of 4-formyl-2-methyl benzoic acid amide in 6 mL of dichloromethane, 75 mg of oxalyl chloride was added, and stirred under reflux with heating for 3 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, and the residue was dissolved in 5 mL of dichloromethane, and a mixed solution of 1.5 mL of methanol and 5 mL of dichloromethane was added, and stirred at room temperature for 30 minutes. After the completion of the reaction, the solvent was distilled off under reduced pressure.

The residue was purified with silica gel column chromatography that were eluated with ethyl acetate-hexane (gradient of 1:2 to 2:1) to obtain 41 mg of the aimed product as white crystal.

Melting point 115.0 to 118.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ10.01 (s, 1H), 7.89 (bs, 1H), 7.77 (s, 1H), 7.76 (d, J=7.8 Hz, 1H), 7.50 (d, J=7.8 Hz, 1H), 3.80 (s, 3H), 2.50 (s, 3H).

Step 3: Production of methyl N-[4-hydroxyiminomethyl-2-methylbenzoyl]carbamate

In a solution of 41 mg of methyl N-[4-formyl-2-methyl benzoyl]carbamate in 4 mL of methanol and 1 mL of water, 15 mg of hydroxylamine hydrochloride was added at room temperature with stirring, and continued to stir at the same temperature for 1.5 hour. After the completion of the reaction, 10 mL of water was added in the reaction mixture, and extracted with ethyl acetate (10 mL×2). The combined organic phases were dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain 45 mg of the aimed product as white crystal.

Melting point 141.0 to 143.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.0-8.15 (m, 3H), 7.3-7.45 (m, 3H), 3.85 (s, 3H), 2.47 (s, 3H).

Step 4: Production of methyl N-[2-methyl-4-[5-(3,4,5-trichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]benzoyl]carbamate

In a solution of 45 mg of methyl N-[4-hydroxyiminomethyl-2-methylbenzoyl]carbamate in 10 mL of 1,2-dimethoxyethane, 40 mg of N-chlorosuccinimide was added, and stirred at 60° C. for 45 minutes. Then, the reaction mixture was left and cooled to room temperature, and then 68 mg of 3,4,5-trichloro-1-(1-trifluoromethylethenyl)benzene, 40 mg of potassium hydrogen carbonate and 5 drops of water were added, and continued to stir at room temperature further for 15 hour. After the completion of the reaction, the reaction mixture was poured in 10 mL of water, and extracted with ethyl acetate (15 mL×2). The combined organic phases were dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and then the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (gradient of 1:2 to 1:1) to obtain 23 mg of the aimed product as colorless resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.86 (bs, 1H), 7.64 (s, 2H), 7.5-7.6 (m, 2H), 7.42 (d, J=8.1 Hz, 1H), 4.09 (d, J=17.4 Hz, 1H), 3.80 (s, 3H), 3.68 (d, J=17.4 Hz, 1H), 2.47 (s, 3H).

Synthetic Example 42 N-(5-Chloro-2-pyradinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-N-methyl-2-methyl benzoic acid amide (Compound of the present invention No. 5-173) Step 1: Production of N-(5-chloro-2-pyradinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl benzoic acid amide

In a solution of 0.17 g of 2-amino-5-chloropyradine in 5 mL of pyridine, 0.50 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methylbenzoyl-chloride synthesized in Step 4 of Synthetic Example 1 was added dropwise at room temperature with stirring, and stirred at the same temperature for 20 hours. After the completion of the reaction, 30 mL of 3N hydrochloric acid was added in the reaction mixture under cooling with ice and with stirring, and extracted with ethyl acetate (30 mL×1). The organic phase was washed with water, and then dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (3:7) to obtain 0.33 g of the aimed product as white crystal.

Melting point 242.0 to 243.0° C.

¹H NMR (CDCl₃-DMSO-d₆, Me₄Si, 300 MHz) δ11.44 (s, 1H), 9.23 (d, J=1.2 Hz, 1H), 8.53 (d, J=1.2 Hz, 1H), 7.55-7.8 (m, 6H), 4.40 (d, J=18.6 Hz, 1H), 4.29 (d, J=18.6 Hz, 1H), 2.42 (s, 3H).

Step 2: Production of N-(5-chloro-2-pyradinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-N-methyl-2-methyl benzoic acid amide

In a solution of 0.128 g of N-(5-chloro-2-pyradinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl benzoic acid amide in 3 mL of N,N-dimethylformamide, 0.016 g of 60% oily sodium hydride was added under cooling with ice and with stirring, and stirred at room temperature for 10 minutes. Then, 0.41 g of methyl iodide was added under cooling with ice and with stirring, and continued to stir at room temperature further for 20 hours. After the completion of the reaction, the reaction mixture was poured in 10 mL of ice water, extracted with ethyl acetate (10 mL×2), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:3) to obtain 0.066 g of the aimed product as yellow resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.45 (bs, 1H), 8.36 (d, J=1.5 Hz, 1H), 7.4-7.6 (m, 5H), 7.22 (d, J=8.4 Hz, 1H), 4.07 (d, J=17.5 Hz, 1H), 3.68 (d, J=17.5 Hz, 1H), 3.46 (s, 3H), 2.37 (s, 3H).

Synthetic Example 43 N-(5-Cyano-2-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-N-methyl-2-methyl benzoic acid amide (Compound of the present invention No. 5-171) Step 1: Production of N-(5-cyano-2-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl benzoic acid amide

In a solution of 0.20 g of N-(5-bromo-2-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl benzoic acid amide synthesized in Step 1 of Synthetic Example 13 in 3 mL of N,N-dimethylacetamide, 0.082 g of zinc cyanide, 0.011 g of zinc, 0.013 g of tris(dibenzylideneacetone)dipalladium and 0.015 g of 1,1′-bis(diphenylphosphino)ferrocene were added, and stirred under nitrogen atmosphere at 100° C. for 2 hours. After the completion of the reaction, the reaction mixture was left and cooled to room temperature, and 20 mL of concentrated ammonia water and 20 mL of water were added, and extracted with ethyl acetate (20 mL×2). The organic phases were washed with water, and dehydrated with and dried over saturated sodium chloride aqueous solution and anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:1) to obtain 0.15 g of the aimed product as white crystal.

Melting point 118.0 to 121.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.86 (s, 2H), 8.61 (s, 1H), 7.4-7.7 (m, 6H), 4.10 (d, J=17.5 Hz, 1H), 3.72 (d, J=17.5 Hz, 1H), 2.56 (s, 3H).

Step 2: Production of N-(5-cyano-2-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-N-methyl-2-methyl benzoic acid amide

In a solution of 0.075 g of N-(5-cyano-2-pyradinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl benzoic acid amide in 2 mL of N,N-dimethylformamide, 0.009 g of 60% oily sodium hydride was added under cooling with ice and with stirring, and stirred at room temperature for 10 minutes. Then, 0.025 g of methyl iodide was added under cooling with ice and with stirring, and continued to stir at room temperature for 2 hours. After the completion of the reaction, the reaction mixture was poured in 10 mL of ice water, extracted with ethyl acetate (10 mL×2), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (3:7) to obtain 0.039 g of the aimed product as yellow resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.55 (s, 2H), 7.3-7.55 (m, 5H), 7.07 (d, J=8.1 Hz, 1H), 4.07 (d, J=17.0 Hz, 1H), 3.70 (s, 3H), 3.67 (d, J=17.0 Hz, 1H), 2.38 (s, 3H).

Synthetic Example 44 N-(2-Chloro-2-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-N-methyl-2-methyl benzoic acid amide (Compound of the present invention No. 5-172) Step 1: Production of N-(2-chloro-2-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl benzoic acid amide

In a solution of 0.12 g of 5-amino-2-chloropyrimidine in 3 mL of pyridine, 0.36 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methylbenzoyl-chloride synthesized in Step 4 of Synthetic Example 1 was added at room temperature with stirring, and stirred at the same temperature for 18 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, 30 mL of 3N hydrochloric acid was added in the residue, and extracted with ethyl acetate (30 mL×1). The organic phase was washed with water, and then dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (2:3) to obtain 0.24 g of the aimed product as white crystal.

Melting point 231.0 to 234.0° C.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.98 (s, 2H), 7.71 (s, 1H), 7.4-7.65 (m, 6H), 4.10 (d, J=17.5 Hz, 1H), 3.72 (d, J=17.5 Hz, 1H), 2.54 (s, 3H).

Step 2: Production of N-(2-chloro-2-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-N-methyl-2-methyl benzoic acid amide

In a solution of 0.125 g of N-(2-chloro-5-pyrimidinyl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydro-isoxazole-3-yl]-2-methyl benzoic acid amide in 3 mL of N,N-dimethylformamide, 0.015 g of 60% oily sodium hydride was added under cooling with ice and with stirring, and stirred at room temperature for 10 minutes. Then, 0.040 g of methyl iodide was added under cooling with ice and with stirring, and continued to stir at room temperature for 2 hours. After the completion of the reaction, the reaction mixture was poured in 10 mL of ice water, extracted with ethyl acetate (10 mL×2), the organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with ethyl acetate-hexane (1:1) to obtain 0.030 g of the aimed product as yellow resinous substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ8.45 (bs, 2H), 7.35-7.6 (m, 5H), 7.18 (bs, 1H), 4.05 (d, J=17.0 Hz, 1H), 3.66 (d, J=17.0 Hz, 1H), 3.45 (bs, 3H), 2.36 (s, 3H).

Synthetic Example 45 Production of the Compound of the Present Invention with Parallel Organic Sythesizer Manufactured by Radleys Discovery Technologies

In a solution of 1.78 g of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methyl benzoic acid amide synthesized in Step 1 of Synthetic Example 19 in 15 mL of dichloromethane, 0.64 g of oxalyl chloride was added, and stirred under reflux with heating for 6 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure, the resiudual crude benzoylisocyanate was dissolved in 10 mL of dichloromethane.

In 5 reaction tubes for Carousel in which stirrers were placed, each 3.0 mmol of ethanol, 1-propanol, 2-propanol, 2-chloroethanol and 2-methoxyethanol were weighed, 2 mL of dichloromethane was added in each tube. The tubes were covered with lids and placed in a parallel organic synthesizer. In each reaction tube, 2 mL of a solution of the above-mentioned benzoylisocyanate in dichloromethane was added, and continued to stir at the same temperature for 18 hours. After the completion of the reaction, each reaction mixture was purified with medium pressure preparative liquid chromatography (medium pressure collection apparatus: YFLC-Wprep manufacturede by Yamazen Corporation) that was eluated with ethyl acetate-hexane (gradient of 1:9 to 1:1) to obtain the aimed products as colorless resinous substance. The products were confirmed by use of LC-MS (Waters LC-MS system, detector: ZMD, analysis condition: 254 nm, 80% CH₃CN-20% H₂O-0.1% HCOOH, ionization method: positive electrospray).

-   Ethyl     N-[4-[5-(3,4-dichlorophenyl)-5-trifluoromethyl-4,5-diroisoxazole-3-yl]-2-methyl     benzoyl]carbamate; 0.30 g, [M⁺+H]=488.98. -   N-[4-[5-(3,4-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl     benzoyl]carbamic acid-n-propyl; 0.30 g, [M⁺+H]=503.00. -   N-[4-[5-(3,4-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl     benzoyl]carbamic acid-1-propyl; 0.28 g, [M⁺+H]=502.97. -   N-[4-[5-(3,4-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl     benzoyl]carbamic acid-2-chloroethyl; 0.20 g, [M⁺+H]=522.84. -   N-[4-[5-(3,4-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl     benzoyl]carbamic acid-2-methoxyethyl; 0.28 g, [M⁺+H]=519.04.

Synthetic Example 46

Production of the Compound of the Present Invention with Parallel Organic Sythesizer Manufactured by Radleys Discovery Technologies

In 5 reaction tubes for Carousel in which stirrers were placed, each 0.15 g of N-[4-[5-(3,4-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl benzoyl]carbamic acid-n-butyl, N-[4-[5-(3,4-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl benzoyl]carbamic acid-2-propinyl, N-[4-[5-(3,4-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl benzoyl]carbamic acid-2-cyanoethyl, N-[4-[5-(3,4-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl benzoyl]carbamic acid-1-methoxycarbonylethyl and N-[4-[5-(3,4-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl benzoyl]carbamic acid-2-pyridylmethyl were weighed, 3 mL of N,N-dimethylformamide and 0.08 g of potassium carbonate were added in each tube. The tubes were covered with lids and placed in a parallel organic synthesizer. In each reaction tube, 0.08 g of methyl iodide was added, and continued to stir at the same temperature for 18 hours. After the completion of the reaction, each reaction mixture was purified with medium pressure preparative liquid chromatography (medium pressure collection apparatus: YFLC-Wprep manufacturede by Yamazen Corporation) that was eluated with ethyl acetate-hexane (gradient of 1:9 to 1:2) to obtain the aimed products as colorless resinous substance or white crystal. The products were confirmed by use of LC-MS (Waters LC-MS system, detector: ZMD, analysis condition: 254 nm, 80% CH₃CN-20% H₂O-0.1% HCOOH, ionization method: positive electrospray).

-   N-[4-[5-(3,4-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl     benzoyl]-N-methyl carbamic acid-n-butyl; 0.15 g, [M⁺+H]=531.06. -   N-[4-[5-(3,4-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl     benzoyl]-N-methyl carbamic acid-2-propinyl; 0.15 g, [M⁺+H]=513.04. -   N-[4-[5-(3,4-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl     benzoyl]-N-methyl carbamic acid-2-cyanoethyl; 0.04 g, [M⁺+H]=528.04. -   N-[4-[5-(3,4-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl     benzoyl]-N-methyl carbamic acid-1-methoxycarbonylethyl; 0.13 g,     [M⁺+H]=561.05. -   N-[4-[5-(3,4-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazole-3-yl]-2-methyl     benzoyl]-N-methyl carbamic acid-2-pyridylmethyl; 0.04 g,     [M⁺+H]=566.04.

Reference Example 1 3,5-Dichloro-4-fluoro-1-(1-trifluoromethylethenyl)benzene

In a solution of 2.00 g of 3,5-dichloro-4-fluoro-iodobenzene and 0.61 g of tert-butylmethyl ether in 18 mL of hexane, 5.3 mL of n-butyl lithium (1.54M hexane solution) was added dropwise at −10° C. with stirring, and stirred at the same temperature for 30 minutes. Then, a solution of 0.57 g of trimethoxyborane in 7 mL of tetrahydrofuran was added dropwise. After the completion of the addition dropwise, it was stirred at the same temperature further for 30 minutes and then the temperature was raised to room temperature. Then, in the reaction mixture, 1.80 g of 2-bromo-3,3,3-trifluoropropene, 1.90 g of potassium carbonate, 10 mL of water and 0.005 g of 1,3-bis(2,6-diisopropylphenyl)imidazole-2-ilidene (1,4-naphthoquinone) palladium (0) dimmer were added, and stirred under nitrogen atmosphere at 60° C. for 15 hours. After the completion of the reaction, the reaction mixture was left and cooled to room temperature, insoluble material was filtered off, and the organic phase was collected and the aqueous phase was extracted with 30 mL of ethyl acetate twice. The combined organic phases were washed with water, and dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with hexane to obtain 1.20 g of the aimed product as yellow oily substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.40 (d, J=6.3 Hz, 2H), 6.04 (s, 1H), 5.79 (s, 1H).

Reference Example 2 3-Chloro-5-trifluoromethyl-1-(1-trifluoromethylethenyl)benzene Step 1: Production of 3-bromo-5-chlorobenzotrifluoride

In a suspension of 3.0 g of 3-chloro-5-trifluoromethylaniline and 2.0 g of copper (II) chloride in 30 mL of acetonitrile, 1.9 g of nitrous acid-tert-butyl was added dropwise at room temperature with stirring. After the completion of the addition dropwise, it was continued to stir at the same temperature for 1 hour and then at 65° C. for 1 hour. After the completion of the reaction, the reaction mixture was left and cooled to room temperature, and insoluble material was filtered off, and 100 mL of 2N hydrochloric acid was added in the filtrate and extracted with diethyl ether (50 mL×2). The combined organic phases were washed with water, and dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to obtain 2.7 g of the crude aimed product as brown oily substance.

The resulting product was used as such without purification for the next step.

Step 2: Production of 3-chloro-5-trifluoromethyl-1-(1-trifluoromethylethenyl)benzene

In a solution of 2.60 g of 3-bromo-5-chlorobenzotrifluoride and 1.2 mL of tert-butylmethyl ether in 25 mL of hexane, 6.38 mL of n-butyl lithium (1.6M hexane solution) was added dropwise at −10° C. with stirring, and stirred at the same temperature for 30 minutes. Then, a solution of 1.09 g of trimethoxyborane in 10 mL of tetrahydrofuran was added dropwise. After the completion of the addition dropwise, it was stirred at the same temperature further for 10 minutes and then the temperature was raised to room temperature. Then, in the reaction mixture, 2.60 g of 2-bromo-3,3,3-trifluoropropene, 2.76 g of potassium carbonate, 15 mL of water and 0.0065 g of 1,3-bis(2,6-diisopropylphenyl)imidazole-2-ilidene (1,4-naphthoquinone) palladium (0) dimmer were added, and stirred under nitrogen atmosphere at 60° C. for 6 hours. After the completion of the reaction, the reaction mixture was left and cooled to room temperature, insoluble material was filtered off, and the organic phase was collected and the aqueous phase was extracted with 30 mL of ethyl acetate twice.

The combined organic phases were washed with water, and dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with hexane to obtain 1.50 g of the aimed product as orange oily substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.65 (s, 1H), 7.62 (s, 1H), 7.58 (s, 1H), 6.11 (s, 1H), 5.87 (s, 1H).

Reference Example 3 3-Chloro-4-fluoro-5-trifluoromethyl-1-(1-trifluoromethylethenyl)benzene Step 1: Production of 5-chloro-6-fluoro-3-nitrobenzotrifluoride

After azeotropically dehydrating 20.0 g of potassium fluoride and 2.0 g of tetramethylammonium chloride in 200 mL of toluene for 2 hours, toluene was distilled off, 100 mL of N,N-dimethylformamide and 8.0 g of 5,6-dichloro-3-nitrobenzotrifluoride were added, and stirred at 100° C. for 15 hours. After the completion of the reaction, the reaction mixture was left and cooled to room temperature, and 500 mL of water was added and extracted with diethyl ether (250 mL×2). The combined organic phases were dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to obtain 6.1 g of the crude aimed product as red-brown oily substance. The resulting product was used as such without purification for the next step.

Step 2: Production of 3-chloro-4-fluoro-5-trifluoromethylaniline

In a mixture of 7.0 g of reduced iron, 4 mL of acetic acid and 50 mL of water, a solution of 6.0 g of 5-chloro-6-fluoro-3-nitrobenzotrifluoride in 80 mL of acetic acid-ethyl acetate (1:1) was added dropwise at 80° C. with stirring over 30 minutes. After the completion of the addition dropwise, it was continued to stir at the same temperature further for 1 hour. After the completion of the reaction, the reaction mixture was left and cooled to room temperature, insoluble material was filtered off through Celite, the organic phase was collected and washed with 100 mL of water and then 100 mL of saturated sodium hydrogen carbonate aqueous solution. The organic phase was dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to obtain 6.0 g of the crude aimed product as red-brown oily substance. The resulting product was used as such without purification for the next step.

Step 3: Production of 3-chloro-2-fluoro-5-iodobenzotrifluoride

In 300 mL of 6N hydrochloric acid, 4.00 g of 3-chloro-4-fluoro-5-trifluoromethylaniline was added, and stirred at room temperature for 30 minutes. In the mixture, a solution of 1.42 g of sodium nitrite in 5 mL of water was added dropwise at such a rate that internal temperature would not exceed 5° C. After the completion of the addition dropwise, it was continued to stir at the same temperature further for 1 hour. In the reaction mixture, a solution of 4.70 g of potassium iodide in 15 mL of water was added dropwise at the same temperature with stirring. After the completion of the addition dropwise, it was continued to stir at the same temperature further for 1 hour and then at room temperature for 15 hours. After the completion of the reaction, the reaction mixture was extracted with 50 mL of diethyl ether twice. The combined organic phases were dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to obtain 2.70 g of the crude aimed product as yellow oily substance. The resulting product was used as such without purification for the next step.

Step 4: Production of 3-chloro-4-fluoro-5-trifluoromethyl-1-(1-trifluoromethylethenyl)benzene In a solution of 2.58 g of 3-chloro-2-fluoro-5-iodobenzotrifluoride and 0.68 g of tert-butylmethyl ether in 20 mL of hexane, 6.0 mL of n-butyl lithium (1.54M hexane solution) was added dropwise at −20° C. with stirring, and stirred at the same temperature for 30 minutes. Then, a solution of 0.88 g of trimethoxyborane in 10 mL of tetrahydrofuran was added dropwise. After the completion of the addition dropwise, it was stirred at the same temperature further for 30 minutes and then the temperature was raised to room temperature. Then, in the reaction mixture, 4.00 g of 2-bromo-3,3,3-trifluoropropene, 2.20 g of potassium carbonate, 15 mL of water and 0.03 g of 1,3-bis(2,6-diisopropylphenyl)imidazole-2-ilidene (1,4-naphthoquinone) palladium (0) dimmer were added, and stirred under nitrogen atmosphere at 60° C. for 6 hours. After the completion of the reaction, the reaction mixture was left and cooled to room temperature, insoluble material was filtered off, and the organic phase was collected and the aqueous phase was extracted with 30 mL of diethyl ether twice.

The combined organic phases were washed with water, and dehydrated with and dried over saturated sodium chloride aqueous solution and then anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified with silica gel column chromatography that was eluated with hexane to obtain 1.70 g of the aimed product as yellow oily substance.

¹H NMR (CDCl₃, Me₄Si, 300 MHz) δ7.69 (d, J=6.3 Hz, 1H), 7.58 (d, J=5.7 Hz, 1H), 6.10 (s, 1H), 5.83 (s, 1H).

The compounds of the present invention can be produced according to the above-mentioned production methods and working examples. The examples of the compounds produced similarly to Synthetic Examples 1 to 46 are shown in Tables 5 to 15 to which the present invention is not limited. In the meantime, in Tables, the indication “Et” means ethyl, hereinafter similarly thereto, “n-Pr” and “Pr-n” mean normal propyl, “i-Pr” and “Pr-i” mean isopropyl, “c-Pr” and “Pr-c” mean cyclopropyl, “n-Bu” and “Bu-n” mean normal butyl, “s-Bu” and “Bu-s” mean secondary butyl, “i-Bu” and “Bu-i” mean isobutyl, “t-Bu” and “Bu-t” mean tertiary butyl, “c-Bu” and “Bu-c” mean cyclobutyl, “n-Pen” and “Pen-n” mean normal pentyl, “c-Pen” and “Pen-c” mean cyclopentyl, “c-Hex” and “Hex-c” mean cyclohexyl, “Ph” means phenyl, “TMS” means trimethylsilyl, and in Tables, aromatic heterocyclic rings of D-1a to D-59b are the following structures, respectively

in Tables, saturated heterocyclic rings of E-5a to E-12c are the following structures, respectively,

In Tables, partially saturated heterocyclic ring of M-5c is the following structure

In Tables, T-13 to T-22 are the following structures, respectively

In addition, in Tables, the number showing the substitution position of substituents (X)_(m) and (Y)_(n) correspond to the position number indicated in the following strutural formulae. The indication “-” means no-substitution.

Further, in Tables, the indication of “Mw” shows the calculated value of molecular weight, the indication of “M⁺−H” shows the measured value of molecular ion peak, and “*1” means “resinous” and “*2” means “oily”.

TABLE 5

No. (X)_(m) (Y)_(n) R² R¹ Mw M⁺ + H 1-001 3,5-Cl₂ 2-CH₃ CH₂Ph C(O)OCH₃ 565.37 565.00 1-002 3,5-Cl₂ 2-CH₃ H C(O)OEt 489.27 488.98 1-003 3,5-Cl₂ 2-CH₃ Et C(O)OEt 517.32 517.07 1-004 3,5-Cl₂ 2-CH₃ H C(O)OPr-n 503.30 503.00 1-005 3,5-Cl₂ 2-CH₃ H C(O)OPr-i 503.30 502.97 1-006 3,5-Cl₂ 2-CH₃ CH₂C≡CH C(O)OPr-i 541.35 539.01* 1-007 3,5-Cl₂ 2-CH₃ C(O)CH₃ C(O)OPr-i 545.33 543.03* 1-008 3,5-Cl₂ 2-CH₃ C(O)OCH₃ C(O)OPr-i 561.33 559.03* 1-009 3,5-Cl₂ 2-CH₃ H C(O)OBu-n 517.32 517.07 1-010 3,5-Cl₂ 2-CH₃ H C(O)OBu-i 517.32 517.09 1-011 3,5-Cl₂ 2-CH₃ CH₃ C(O)OBu-i 531.35 531.18 1-012 3,5-Cl₂ 2-CH₃ H C(O)OBu-s(R) 517.32 517.05 1-013 3,5-Cl₂ 2-CH₃ CH₃ C(O)OBu-s(R) 531.35 529.05* 1-014 3,5-Cl₂ 2-CH₃ H C(O)OBu-s(S) 517.32 517.05 1-015 3,5-Cl₂ 2-CH₃ CH₃ C(O)OBu-s(S) 531.35 529.05* 1-016 3,5-Cl₂ 2-CH₃ CH₃ C(O)OBu-t 531.35 529.06* 1-017 3,5-Cl₂ 2-CH₃ H C(O)OCH₂Pr-c 515.31 515.11 1-018 3,5-Cl₂ 2-CH₃ H C(O)OBu-c 515.31 513.01* 1-019 3,5-Cl₂ 2-CH₃ H C(O)OPen-n 531.35 531.09 1-020 3,5-Cl₂ 2-CH₃ H C(O)OCH₂Bu-t 531.35 529.04* 1-021 3,5-Cl₂ 2-CH₃ H C(O)OPen-c 529.34 529.03 1-022 3,5-Cl₂ 2-CH₃ CH₃ C(O)OPen-c 543.36 541.05* 1-023 3,5-Cl₂ 2-CH₃ H C(O)OCH₂Pen-c 543.36 540.96* 1-024 3,5-Cl₂ 2-CH₃ H C(O)OHex-c 543.36 541.03* 1-025 3,5-Cl₂ 2-CH₃ H C(O)OCH₂Hex-c 557.39 555.03* 1-026 3,5-Cl₂ 2-CH₃ H C(O)OCH₂CH₂OCH₃ 519.30 519.04 1-027 3,5-Cl₂ 2-CH₃ H C(O)OCH₂CH₂OPh 581.37 581.07 1-028 3,5-Cl₂ 2-CH₃ H C(O)O(E-5a) 531.31 529.00* 1-029 3,5-Cl₂ 2-CH₃ H C(O)OCH₂(E-5a) 545.33 543.00* 1-030 3,5-Cl₂ 2-CH₃ H C(O)OCH₂(E-12c) 575.36 572.99* 1-031 3,5-Cl₂ 2-CH₃ H C(O)OCH₂CH₂SCH₃ 535.36 532.97* 1-032 3,5-Cl₂ 2-CH₃ H C(O)OCH₂CH₂SO₂CH₃ 567.36 567.01 1-033 3,5-Cl₂ 2-CH₃ H C(O)OCH₂CH₂N(CH₃)₂ 532.34 532.09 1-034 3,5-Cl₂ 2-CH₃ H C(O)OCH₂CH₂(T-14) 558.38 558.13 1-035 3,5-Cl₂ 2-CH₃ H C(O)OCH₂CH₂(T-18) 574.38 574.13 1-036 3,5-Cl₂ 2-CH₃ H C(O)OCH(CH₃)C(O)OCH₃ 547.31 547.04 1-037 3,5-Cl₂ 2-CH₃ CH₃ C(O)OCH(CH₃)C(O)OCH₃ 561.33 561.05 1-038 3,5-Cl₂ 2-CH₃ H C(O)O(E-6d) 573.34 570.99* 1-039 3,5-Cl₂ 2-CH₃ H C(O)OCH₂C(CH₃)═CH₂ 515.31 515.09 1-040 3,5-Cl₂ 2-CH₃ CH₃ C(O)OCH₂C(CH₃)═CH₂ 529.34 529.14 1-041 3,5-Cl₂ 2-CH₃ H C(O)OCH(Et)CH═CH₂ 529.34 527.03* 1-042 3,5-Cl₂ 2-CH₃ H C(O)OC(CH₃)₂CH═CH₂ 529.34 527.01* 1-043 3,5-Cl₂ 2-CH₃ H C(O)OCH₂(T-13) 555.37 553.03* 1-044 3,5-Cl₂ 2-CH₃ H C(O)OCH₂CCl═CH₂ 535.73 532.94* 1-045 3,5-Cl₂ 2-CH₃ H C(O)OCH₂C≡CH 499.27 499.03 1-046 3,5-Cl₂ 2-CH₃ H C(O)OCH₂(Ph—4-F) 569.33 569.07 1-047 3,5-Cl₂ 2-CH₃ H C(O)OCH₂(D-1a) 541.30 538.90* 1-048 3,5-Cl₂ 2-CH₃ H C(O)OCH₂(D-52a) 552.33 552.05 1-049 3,5-Cl₂ 2-CH₃ CH₃ C(O)OCH₂(D-52a) 566.36 566.04 1-050 3,5-Cl₂ 2-CH₃ H C(O)SCH₃ 491.31 490.89 1-051 3,5-Cl₂ 2-CH₃ CH₃ C(O)SPr-n 533.39 533.09 1-052 3,5-Cl₂ 2-CH₃ C(O)CH₃ C(O)OEt 531.31 528.98* 1-053 3,5-Cl₂ 2-CH₃ C(O)CH₂OCH₃ C(O)OPr-i 575.36 573.02* 1-054 3,5-Cl₂ 2-CH₃ H C(O)OCH₂CH₂S(D-52a) 597.05 598.09 1-055 3,5-Cl₂ 2-CH₃ H C(O)OCH₂CH(CH₃)NO₂ 547.05 545.91* 1-056 3,5-Cl₂ 2-CH₃ H C(O)OCH(CH₃)C(O)CH₃ 531.31 529.04* 1-057 3,5-Cl₂ 2-CH₃ H C(O)OCH₂CH₂-TMS 561.45 559.04* 1-058 3,5-Cl₂ 2-CH₃ H C(O)OCH₂CH₂CH₂-TMS 574.11 572.97* In Table above, the indication of “*” shows the measured value of molecular ion peak of M⁺ − H measured with negative mode.

TABLE 6

No. (X)_(m) R³ (Y)_(n) R¹ m.p. (° C.) 2-001 3,5-Cl₂ CF₃ — C(O)OEt *1 2-002 3,5-Cl₂ CF₃ — C(O)OPr-i *1 2-003 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ *2 2-004 3,5-Cl₂ CF₃ 2-CH₃ C(O)OBu-t *1 2-005 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₂CH₂OCH₂CH₂OCH₃ *1 2-006 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₂CH₂NHC(O)CH₃ 151.0-153.0 2-007 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₂CH₂(T-22) *1 2-008 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₂CH₂CN 170.0-172.0 2-009 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₂C(O)OCH₃ *1 2-010 3,5-Cl₂ CF₃ 2-CH₃ C(O)SPr-n 124.0-126.0 2-011 3,5-Cl₂ CF₃ 2-CH₃ C(S)OCH₃ *1 2-012 3,5-Cl₂ CF₃ 2-CH₃ C(S)SCH₃ *1 2-013 3,5-Cl₂ CF₃ 2-Cl C(O)OCH₃ *1 2-014 3,5-Cl₂ CF₃ 2-Br C(O)OCH₃ *1 2-015 3,5-Cl₂ CF₃ 2-I C(O)OCH₃ 166.0-168.0 2-016 3,5-Cl₂ CF₃ 2-I C(O)OPr-i *1 2-017 3,5-Cl₂ CF₃ 2-NO₂ C(O)OCH₃ 167.0-170.0 2-018 3,5-Cl₂ CF₃ 2-Ph C(O)OCH₃ *1 2-019 3,5-Cl₂ CF₃ 2-I—6-CH₃ C(O)OCH₃ *1 2-020 3,5-Cl₂ CF₂Cl 2-Cl C(O)OCH₃ *1 2-021 3-Cl—5-Br CF₃ 2-CH₃ C(O)OCH₃ *1 2-022 3,5-Br₂ CF₃ 2-CH₃ C(O)OCH₃ *1 2-023 3,5-(CF₃)₂ CF₃ 2-CH₃ C(O)OCH₃ *1 2-024 3,5-Cl₂ CF₃ 2-CF₃ C(O)OCH₃ *1 2-025 3,5-Cl₂ CF₃ 2-CH₂OCH₃ C(O)OCH₃ *1 2-026 3,4,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ *1 2-027 3,5-Cl₂ CF₃ 2-CH₃ C(S)OPr-i *1 2-028 3,5-Cl₂ CF₃ 2-CH₃ C(S)OBu-n *1 2-029 3,5-Cl₂ CF₃ 2-CH₃ C(S)OCH₂C≡CH *1 2-030 3,4,5-Cl₃ CF₃ — C(O)OEt *1

TABLE 7

No. (X)_(m) (Y)_(n) R² R¹ m.p. (° C.) 3-001 3,5-Cl₂ — CH₃ C(O)OEt *1 3-002 3,5-Cl₂ — CH₃ C(O)OPr-i *1 3-003 3,5-Cl₂ 2-CH₃ CH₃ C(O)OCH₃ 147.0-149.0 3-004 3,5-Cl₂ 2-CH₃ Et C(O)OCH₃ 100.0-102.0 3-005 3,5-Cl₂ 2-CH₃ n-Pr C(O)OCH₃ *1 3-006 3,5-Cl₂ 2-CH₃ i-Pr C(O)OCH₃ *1 3-007 3,5-Cl₂ 2-CH₃ CH₂OCH₃ C(O)OCH₃ 144.0-146.0 3-007(+) 99% e.e. [α]_(D) ^(21.4) + 64.25° (CH₃CN, c = 1.250) *1 3-007(−) 99% e.e. [α]_(D) ^(21.4) − 63.37° (CH₃CN, c = 1.190) *1 3-008 3,5-Cl₂ 2-CH₃ CH₂CN C(O)OCH₃ 170.0-171.0 3-009 3,5-Cl₂ 2-CH₃ CH₂C(O)OCH₃ C(O)OCH₃ *1 3-010 3,5-Cl₂ 2-CH₃ CH₂C≡CH C(O)OCH₃ 146.0-147.0 3-011 3,5-Cl₂ 2-CH₃ C(O)CH₃ C(O)OCH₃ 116.0-117.0 3-012 3,5-Cl₂ 2-CH₃ C(O)Bu-t C(O)OCH₃ *1 3-013 3,5-Cl₂ 2-CH₃ C(O)CH₂OCH₃ C(O)OCH₃ *1 3-014 3,5-Cl₂ 2-CH₃ C(O)OCH₃ C(O)OCH₃ *1 3-015 3,5-Cl₂ 2-CH₃ CH₃ C(O)OEt 133.0-135.0 3-016 3,5-Cl₂ 2-CH₃ CH₃ C(O)OPr-i *1 3-017 3,5-Cl₂ 2-CH₃ Et C(O)OPr-i *1 3-018 3,5-Cl₂ 2-CH₃ CH₂OCH₃ C(O)OPr-i *1 3-019 3,5-Cl₂ 2-CH₃ CH₃ C(O)OBu-n  91.0-93.0 3-020 3,5-Cl₂ 2-CH₃ CH₃ C(O)OCH₂CH₂OCH₃ *1 3-021 3,5-Cl₂ 2-CH₃ CH₃ C(O)OCH₂CH₂CN 171.0-172.0 3-022 3,5-Cl₂ 2-CH₃ CH₃ C(O)OCH₂C≡CH 185.0-187.0 3-023 3,5-Cl₂ 2-CH₃ CH₃ C(O)OCH₂(Ph—4-F) 132.0-133.0 3-024 3,5-Cl₂ 2-Cl CH₂OCH₃ C(O)OCH₃ 103.0-106.0 3-025 3,5-Cl₂ 2-Cl CH₂CN C(O)OCH₃ 185.0-187.0 3-026 3,5-Cl₂ 2-Br CH₂OCH₃ C(O)OCH₃ *1 3-027 3,5-Cl₂ 2-Br CH₂CN C(O)OCH₃ *1 3-028 3,5-Cl₂ 2-I CH₃ C(O)OCH₃ 170.0-172.0 3-029 3,5-Cl₂ 2-I CH₂OCH₃ C(O)OCH₃ 119.5-121.0 3-030 3,5-Cl₂ 2-I CH₂CN C(O)OCH₃ *1 3-031 3,5-Cl₂ 2-CH₃ CH₂OEt C(O)OCH₃ 112.0-114.0 3-032 3,5-Cl₂ 2-CH₃ CH₂OCH₂CF₃ C(O)OCH₃ *1 3-033 3,5-Cl₂ 2-CH₃ CH₂OC(O)CH₃ C(O)OCH₃ *1 3-034 3,5-Cl₂ 2-CH₃ CH₂OC(O)Bu-t C(O)OCH₃ *1 3-035 3,5-Cl₂ 2-CH₃ CH₂SCH₃ C(O)OCH₃ *1 3-036 3,5-Cl₂ 2-CH₃ CH₂SO₂CH₃ C(O)OCH₃ *1 3-037 3,5-Cl₂ 2-CH₃ CH₂SC(O)CH₃ C(O)OCH₃ *1 3-038 3,5-Cl₂ 2-CH₃ CH₂SC(S)OEt C(O)OCH₃ *1 3-039 3,5-Cl₂ 2-CH₃ CH₂NHC(O)OCH₃ C(O)OCH₃ *1 3-040 3,5-Cl₂ 2-CH₃ CH₂C(O)Ph C(O)OCH₃ *1 3-041 3,5-Cl₂ 2-CH₃ C(O)Et C(O)OCH₃ 135.0-136.0 3-042 3,5-Cl₂ 2-CH₃ C(O)Pr-n C(O)OCH₃ 149.0-151.0 3-043 3,5-Cl₂ 2-CH₃ C(O)Pr-i C(O)OCH₃ *1 3-044 3,5-Cl₂ 2-CH₃ C(O)CH₂Cl C(O)OCH₃ *1 3-045 3,5-Cl₂ 2-CH₃ C(O)CH₂SCH₃ C(O)OCH₃ *1 3-046 3,5-Cl₂ 2-CH₃ C(O)Ph C(O)OCH₃ *1 3-047 3,5-Cl₂ 2-CH₃ C(O)(Ph—4-Cl) C(O)OCH₃ *1 3-048 3,5-Cl₂ 2-CH₃ C(O)(Ph—4-CH₃) C(O)OCH₃ *1 3-049 3,5-Cl₂ 2-CH₃ C(O)(Ph—4-OCH₃) C(O)OCH₃ *1 3-050 3,5-Cl₂ 2-CH₃ C(O)(Ph—4-NO₂) C(O)OCH₃ *1 3-051 3,5-Cl₂ 2-CH₃ C(O)OCH₂Cl C(O)OCH₃ 112.0-114.0 3-052 3,5-Cl₂ 2-CH₃ C(O)OCH₂CH₂Cl C(O)OCH₃ *1 3-053 3,5-Cl₂ 2-CH₃ SCCl₃ C(O)OCH₃ *1 3-054 3,5-Cl₂ 2-CH₃ CH₂OCH₃ C(O)OEt *1 3-055 3,5-Cl₂ 2-CH₃ C(O)Et C(O)OEt *1 3-056 3,5-Cl₂ 2-CH₃ C(O)Bu-t C(O)OEt *1 3-057 3,5-Cl₂ 2-CH₃ C(O)CH₂OCH₃ C(O)OEt *1 3-058 3,5-Cl₂ 2-CH₃ C(O)OCH₃ C(O)OEt 121.0-122.0 3-059 3,5-Cl₂ 2-CH₃ CH₂CN C(O)OPr-i *1 3-060 3,5-Cl₂ 2-CH₃ C(O)Et C(O)OPr-i *1 3-061 3,5-Cl₂ 2-CH₃ C(O)Bu-t C(O)OPr-i 150.0-152.0 3-062 3,5-Cl₂ 2-CH₃ C(O)OEt C(O)OPr-i 121.0-122.0 3-063 3,5-Cl₂ 2-CH₃ Et C(O)OBu-t *1 3-064 3,5-Cl₂ 2-CH₃ CH₂OCH₃ C(O)OBu-t *1 3-065 3,5-Cl₂ 2-CH₃ CH₂Ph C(O)OBu-t *1 3-066 3,5-Cl₂ 2-CH₃ C(O)CH₃ C(O)OBu-t *1 3-067 3,5-Cl₂ 2-CH₃ C(O)Et C(O)OBu-t 150.0-152.0 3-068 3,5-Cl₂ 2-CH₃ C(O)CH₂CF₃ C(O)OBu-t *1 3-069 3,5-Cl₂ 2-CH₃ C(O)OCH₃ C(O)OBu-t 128.0-130.0 3-070 3,5-Cl₂ 2-CH₃ C(O)OCH₃ C(O)OCH₂CH₂OCH₃ *1 3-071 3,5-Cl₂ 2-CH₃ —CH₂CH₂OC(O)— *1 3-072 3,5-Cl₂ 2-CH₃ —C(O)C(CH₃)₂OC(O)— *1 3-073 3,5-Cl₂ 2-I CH₂OEt C(O)OCH₃ *1 3-074 3,5-Cl₂ 2-CH₃ CH₂OPr-i C(O)OCH₃ 110.0-111.0 3-075 3,5-Cl₂ 2-CH₃ CH₂OC(O)Et C(O)OCH₃ *1 3-076 3,5-Cl₂ 2-CH₃ CH₂OC(O)OCH₃ C(O)OCH₃ *1 3-077 3,5-Cl₂ 2-CH₃ E-5a C(O)OCH₃ *1 3-078 3,5-Cl₂ 2-CH₃ C(O)CH₂OEt C(O)OCH₃ *1 3-079 3,5-Cl₂ 2-CH₃ CH₂OEt C(O)OEt 114.0-115.0 3-080 3-Cl—5-Br 2-CH₃ CH₂OCH₃ C(O)OCH₃ *1 3-081 3,5-(CF₃)₂ 2-CH₃ C(O)Et C(O)OCH₃ 127.0-131.0 3-082 3,5-Cl₂ 2-CH₂OCH₃ CH₃ C(O)OEt 161.0-163.0 3-083 3,5-Cl₂ 2-CH₂OCH₃ C(O)CH₃ C(O)OCH₃ 155.0-159.0 3-084 3,5-(CF₃)₂ — CH₂OEt C(O)OCH₃ *1 3-085 3,5-(CF₃)₂ — CH₂OCH₂CF₃ C(O)OCH₃ *1

TABLE 8

No. (X)_(m) R³ (Y)_(n) R² R¹ m.p. (° C.) 4-001 3,5-Cl₂ CF₃ 2-I H C(O)NH₂ 177.0-180.0 4-002 3,5-Cl₂ CF₃ 2-CH₃ H C(O)NH₂ 201.0-205.0 4-003 3,5-Cl₂ CF₃ 2-CH₃ CH₃ C(O)NH₂ 181.0-183.0 4-004 3,5-Cl₂ CF₃ 2-CH₃ CH₃ C(O)NHC(O)CH₃ *1 4-005 3,5-Cl₂ CF₃ 2-CH₃ H C(O)NHC(O)CH₂Cl 159.0-161.0 4-006 3,5-Cl₂ CF₃ 2-CH₃ CH₃ C(O)NHC(O)CH₂Cl 184.0-185.0 4-007 3,5-Cl₂ CF₃ 2-CH₃ CH₃ C(O)NHC(O)CCl₃ *1 4-008 3,5-Cl₂ CF₃ 2-CH₃ CH₃ C(O)NHC(O)OCH₃ *1 4-009 3,5-Cl₂ CF₃ 2-CH₃ H C(S)NH₂ *1 4-010 3,5-Cl₂ CF₃ 2-CH₃ CH₃ C(O)NHC(O)Ph *1 4-011 3,5-Cl₂ CF₃ 2-CH₃ H C(O)N(Et)C(O)OCH₃ *1 4-012 3,5-Cl₂ CF₃ 2-CH₃ CH₂ C(O)N(Et)C(O)OCH₃ 169.0-171.0 4-013 3,5-Cl₂ CF₃ 2-CH₃ H C(O)NHOCH₃ 139.0-142.0 4-014 3,5-Cl₂ CF₃ 2-Cl H C(O)NH₂ 87.0-90.0 4-015 3,5-Cl₂ CF₃ 2-Br H C(O)NH₂ *1

TABLE 9

No. (X)_(m) R³ (Y)_(n) R² R¹ m.p. (° C.) 5-001 3,5-Cl₂ CF₃ 2-CH₃ CH₃ Ph *1 5-002 3,5-Cl₂ CF₃ 2-CH₃ Et Ph *1 5-003 3,5-Cl₂ CF₃ 2-CH₃ i-Pr Ph *1 5-004 3,5-Cl₂ CF₃ 2-CH₃ CH₃ Ph-4-F 175.0-178.0 5-005 3,5-Cl₂ CF₃ 2-CH₃ Et Ph-4-F 160.0-163.0 5-006 3,5-Cl₂ CF₃ 2-CH₃ CH₂CF₃ Ph-4-F 96.0-101.0 5-007 3,5-Cl₂ CF₃ 2-CH₃ CH₂OCH₃ Ph-4-F 140.0-143.0 5-008 3,5-Cl₂ CF₃ 2-CH₃ CH₂CN Ph-4-F 60.0-66.0 5.009 3,5-Cl₂ CF₃ 2-CH₃ CH₂CH═CH₂ Ph-4-F *1 5-010 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ Ph-4-F 61.0-66.0 5-011 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ Ph-4-F 89.0-94.0 5-012 3,5-Cl₂ CF₃ 2-CH₃ CH₃ D-52a *1 5-013 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ D-55a *1 5-014 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ D-55a *1 5-015 3,5-Cl₂ CF₃ 2-Cl CH₃ (D-55c)Cl 176.0-178.0 5-016 3,5-Cl₂ CF₃ 2-Cl C(O)CH₃ (D-55c)Cl *1 5-017 3,5-Cl₂ CF₃ 2-Cl C(O)OCH₃ (D-55c)Cl 114.0-121.0 5-018 3,5-Cl₂ CF₃ 2-CH₃ C(O)Et Ph-4-F *1 5-019 3,5-Cl₂ CF₃ 2-CH₃ C(O)Pr-c Ph-4-F *1 5-020 3,5-Cl₂ CF₃ 2-CH₃ C(O)Bu-i Ph-4-F *1 5-021 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₂OCH₃ Ph-4-F *1 5-022 3,5-Cl₂ CF₃ 2-CH₃ C(O)NH₂ Ph-4-F 209.0-211.0 5-023 3,5-Cl₂ CF₃ 2-CH₃ C(O)NHC(O)CH₂Cl Ph-4-F 141.0-144.0 5-024 3,5-Cl₂ CF₃ 2-CH₃ CH₃ Ph-4-NO₂ *1 5-025 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ Ph-4-NO₂ *1 5-026 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ Ph-4-NO₂ *1 5-027 3,5-Cl₂ CF₃ 2-CH₃ CH₃ Ph-4-CN *1 5-028 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ Ph-4-CN *1 5-029 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ Ph-4-CN *1 5-030 3,5-Cl₂ CF₃ 2-CH₃ CH₃ Ph-2,4-F₂ 171.0-173.0 5-031 3,5-Cl₂ CF₃ 2-CH₃ Et Ph-2,4-F₂ 168.0-169.0 5-032 3,5-Cl₂ CF₃ 2-CH₃ CH₂OCH₃ Ph-2,4-F₂ 155.0-158.0 5-033 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ Ph-2,4-F₂ *1 5-034 3,5-Cl₂ CF₃ 2-CH₃ C(O)Pr-i Ph-2,4-F₂ *1 5-035 3,5-Cl₂ CF₃ 2-CH₃ C(O)Bu-t Ph-2,4-F₂ *1 5-036 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ Ph-2,4-F₂ *1 5-037 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ Ph-2,5-F₂ *1 5-038 3,5-Cl₂ CF₃ 2-CH₃ C(O)Bu-t D-3a *1 5-039 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-8b)CH₃ *1 5-040 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ (D-8b)CH₃ *1 5-041 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ (D-8b)CH₃ *1 5-042 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-13b)CH₃ *1 5-043 3,5-Cl₂ CF₃ 2-CH₃ CH₃ D-14a *1 5-044 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ D-14a *1 5-045 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ D-14a *1 5-046 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-15a)CH₃ *1 5-047 3,5-Cl₂ CF₃ 2-CH₃ CH₃ D-21a *1 5-048 3,5-Cl₂ CF₃ 2-CH₃ CH₃ D-35a *1 5-049 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ D-35a *1 5-050 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ D-52a *1 5-051 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ D-52a *1 5-052 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-52d)Cl *1 5-053 3,5-Cl₂ CF₃ 2-CH₃ Et (D-52d)Cl *1 5-054 3,5-Cl₂ CF₃ 2-CH₃ CH₂OCH₃ (D-52d)Cl *1 5-055 3,5-Cl₂ CF₃ 2-CH₃ CH₂CN (D-52d)Cl *1 5-056 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ (D-52d)Cl *1 5-057 3,5-Cl₂ CF₃ 2-CH₃ C(O)Et (D-52d)Cl *1 5-058 3,5-Cl₂ CF₃ 2-CH₃ C(O)Pr-n (D-52d)Cl *1 5-059 3,5-Cl₂ CF₃ 2-CH₃ C(O)Bu-t (D-52d)Cl *1 5-060 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ (D-52d)Cl *1 5-061 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-52d)Br *1 5-062 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ (D-52d)Br *1 5-063 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ (D-52d)Br *1 5-064 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-52d)CF₃ *1 5-065 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ (D-52d)CF₃ *1 5-066 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ (D-52d)CF₃ *1 5-067 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-52d)NO₂ 103.0-106.0 5-068 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ (D-52d)NO₂ *1 5-069 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ (D-52d)NO₂ 163.0-165.0 5-070 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-52d)CN *1 5-071 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ (D-52d)CN *1 5-072 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-52e)Cl *1 5-073 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ (D-52e)Cl *1 5-074 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ (D-52e)Cl *1 5-075 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-52e)Br *1 5-076 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ (D-52e)Br *1 5-077 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ (D-52e)Br *1 5-078 3,5-Cl₂ CF₃ 2-CH₃ CH₃ D-53a 227.0-229.0 5-079 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ D-53a *1 5-080 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ D-53a *1 5-081 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-53e)Cl 167.0-169.0 5-082 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ (D-53e)Cl *1 5-083 3,5-Cl₂ CF₃ 2-CH₃ CH₃ D-54a *1 5-084 3,5-Cl₂ CF₃ 2-CH₃ CH₃ D-55a *1 5-085 3,5-Cl₂ CF₃ 2-CH₃ Et D-55a *1 5-086 3,5-Cl₂ CF₃ 2-CH₃ CH₂OCH₃ D-55a *1 5-087 3,5-Cl₂ CF₃ 2-CH₃ CH₂CN D-55a *1 5-088 3,5-Cl₂ CF₃ 2-CH₃ C(O)Et D-55a 133.0-136.5 5-089 3,5-Cl₂ CF₃ 2-CH₃ C(O)Pr-n D-55a *1 5-090 3,5-Cl₂ CF₃ 2-CH₃ C(O)Pr-i D-55a 168.5-170.0 5-091 3,5-Cl₂ CF₃ 2-CH₃ C(O)Bu-t D-55a 180.0-184.0 5-092 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-55c)Cl *1 5-093 3,5-Cl₂ CF₃ 2-CH₃ Et (D-55c)Cl *1 5-094 3,5-Cl₂ CF₃ 2-CH₃ CH₂OCH₃ (D-55c)Cl 156.0-158.0 5-095 3,5-Cl₂ CF₃ 2-CH₃ CH₂OEt (D-55c)Cl *1 5-096 3,5-Cl₂ CF₃ 2-CH₃ CH₂OC(O)CH₃ (D-55c)Cl *1 5-097 3,5-Cl₂ CF₃ 2-CH₃ CH₂CN (D-55c)Cl *1 5-098 3,5-Cl₂ CF₃ 2-CH₃ CH₂CH═CH₂ (D-55c)Cl *1 5-099 3,5-Cl₂ CF₃ 2-CH₃ CH₂C≡CH (D-55c)Cl *1 5-100 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ (D-55c)Cl 175.0-177.0 5-101 3,5-Cl₂ CF₃ 2-CH₃ C(O)Et (D-55c)Cl 98.0-100.0 5-102 3,5-Cl₂ CF₃ 2-CH₃ C(O)Pr-n (D-55c)Cl *1 5-103 3,5-Cl₂ CF₃ 2-CH₃ C(O)Pr-i (D-55c)Cl 131.0-133.0 5-104 3,5-Cl₂ CF₃ 2-CH₃ C(O)Pr-c (D-55c)Cl *1 5-105 3,5-Cl₂ CF₃ 2-CH₃ C(O)Bu-t (D-55c)Cl *1 5-106 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₂OCH₃ (D-55c)Cl *1 5-107 3,5-Cl₂ CF₃ 2-CH₃ C(O)Ph (D-55c)Cl *1 5-108 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ (D-55c)Cl 104.0-107.0 5-109 3,5-Cl₂ CF₃ 2-CH₃ C(O)OEt (D-55c)Cl *1 5-110 3,5-Cl₂ CF₃ 2-CH₃ C(O)OPr-n (D-55c)Cl *1 5-111 3,5-Cl₂ CF₃ 2-CH₃ C(O)OBu-i (D-55c)Cl *1 5-112 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₂Cl (D-55c)Cl *1 5-113 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₂CH₂OCH₃ (D-55c)Cl *1 5-114 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-55c)Br *1 5-115 3,5-Cl₂ CF₃ 2-CH₃ Et (D-55c)Br *1 5-116 3,5-Cl₂ CF₃ 2-CH₃ CH₂OCH₃ (D-55c)Br 137.0-142.0 5-117 3,5-Cl₂ CF₃ 2-CH₃ CH₂OC(O)CH₃ (D-55c)Br *1 5-118 3,5-Cl₂ CF₃ 2-CH₃ CH₂CN (D-55c)Br *1 5-119 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ (D-55c)Br 168.0-170.0 5-120 3,5-Cl₂ CF₃ 2-CH₃ C(O)Et (D-55c)Br 124.0-127.0 5-121 3,5-Cl₂ CF₃ 2-CH₃ C(O)Pr-n (D-55c)Br *1 5-122 3,5-Cl₂ CF₃ 2-CH₃ C(O)Pr-i (D-55c)Br 143.0-145.0 5-123 3,5-Cl₂ CF₃ 2-CH₃ C(O)Pr-c (D-55c)Br *1 5-124 3,5-Cl₂ CF₃ 2-CH₃ C(O)Bu-t (D-55c)Br *1 5-125 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₂OCH₃ (D-55c)Br *1 5-126 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ (D-55c)Br *1 5-127 3,5-Cl₂ CF₃ 2-CH₃ C(O)Et (D-55c)Br *1 5-128 3,5-Cl₂ CF₃ 2-CH₃ C(O)OPr-n (D-55c)Br *1 5-129 3,5-Cl₂ CF₃ 2-CH₃ C(O)OBu-i (D-55c)Br *1 5-130 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₂Cl (D-55c)Br *1 5-131 3,5-Cl₂ CF₃ 2-CH₃ CH₃ D-58a *1 5-132 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-58b)Br *1 5-133 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ (D-58b)Br *1 5-134 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ (D-58b)Br 87.0-89.0 5-135 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ (D-59b)Cl 163.0-166.0 5-136 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ (D-59b)Cl 169.0-171.0 5-137 3,5-Cl₂ CF₃ 2-I CH₃ (D-52d)Cl *1 5-138 3,5-Cl₂ CF₃ 2-I CH₃ (D-55c)Cl *1 5-139 3,5-Cl₂ CF₃ 2-I C(O)CH₃ (D-55c)Cl 196.0-199.0 5-140 3,5-Cl₂ CF₃ 2-I C(O)OCH₃ (D-55c)Cl 177.0-180.0 5-141 3,5-Cl₂ CF₃ 2-CH₃ i-Pr (D-55c)Cl 120.0-124.0 5-142 3,5-Cl₂ CF₃ 2-CH₃ CH₂C(O)CH₃ (D-55c)Cl *2 5-143 3,5-Cl₂ CF₃ 2-CH₃ CH₂C(O)OCH₃ (D-55c)Cl *2 5-144 3,5-Cl₂ CF₃ 2-CH₃ CH₂SCH₃ (D-55c)Cl *1 5-145 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₂Cl (D-55c)Cl *1 5-146 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₂OEt (D-55c)Cl *1 5-147 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₂SCH₃ (D-55c)Cl *1 5-148 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₂S(O)CH₃ (D-55c)Cl *1 5-149 3,5-Cl₂ CF₃ 2-CH₃ C(O)C(O)OEt (D-55c)Cl *1 5-150 3,5-Cl₂ CF₃ 2-CH₃ C(O)(D-52a) (D-55c)Cl *1 5-151 3,5-Cl₂ CF₃ 2-CH₃ C(O)(Ph-4-OCH₃) (D-55c)Cl 163.0-165.0 5-152 3,5-Cl₂ CF₃ 2-CH₃ C(O)(Ph-4-NO₂) (D-55c)Cl *1 5-153 3,5-Cl₂ CF₃ 2-CH₃ C(O)OPr-i (D-55c)Cl *1 5-154 3,5-Cl₂ CF₃ 2-CH₃ C(O)OBu-n (D-55c)Cl *1 5-155 3,5-Cl₂ CF₃ 2-CH₃ C(O)OBu-t (D-55c)Cl *1 5-156 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₂CH₂Cl (D-55c)Cl 66.0-68.0 5-157 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₂CH═CH₂ (D-55c)Cl 73.0-75.0 5-158 3,5-Cl₂ CF₃ 2-CH₃ C(O)OPh (D-55c)Cl *1 5-159 3,5-Cl₂ CF₃ 2-CH₃ C(O)N(CH₃)₂ (D-55c)Cl *1 5-160 3,5-Cl₂ CF₃ 2-CH₃ CH₂OEt (D-55c)Br *1 5-161 3,5-Cl₂ CF₃ 2-CH₃ CH₂CH═CH₂ (D-55c)Br *1 5-162 3,5-Cl₂ CF₃ 2-CH₃ C(O)Ph (D-55c)Br *1 5-163 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₂CH₂OCH₃ (D-55c)Br *1 5-164 3,5-Cl₂ CF₃ 2-CH₃ CH₃ D-57a 197.0-200.0 5-165 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ D-57a 68.0-74.0 5-166 3,5-Cl₂ CF₃ 2-CH₃ C(O)Et D-57a *1 5-167 3,5-Cl₂ CF₃ 2-CH₃ C(O)Pr-n D-57a *1 5-168 3,5-Cl₂ CF₃ 2-CH₃ C(O)Pr-i D-57a *1 5-169 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ D-57a 72.0-76.0 5-170 3,4,5-Cl₃ CF₃ 2-CH₃ C(O)CH₃ (D-55c)Cl *1 5-171 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-55c)CN *1 5-172 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-57b)Cl *1 5-173 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-58b)Cl *1 5-174 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ (D-58b)Cl 83.0-86.0 5-175 3,5-Cl₂ CF₃ 2-NO₂ C(O)CH₃ (D-55c)Cl *1 5-176 3,5-Cl₂ CF₃ 2-CH₃ CH₃ D-1a 108.0-112.0 5-177 3,5-Cl₂ CF₃ 2-CH₃ C(O)OBu-t D-1a *1 5-178 3,5-Cl₂ CF₃ 2-CH₃ CH₂OC(O)OCH₃ (D-55c)Cl *1 5-179 3,5-Cl₂ CF₃ 2-CH₃ Et (D-55c)CN *1 5-180 3,5-Cl₂ CF₃ 2-CH₃ CH₂OCH₃ (D-55c)CN *1 5-181 3,5-Cl₂ CF₃ 2-CH₃ CH₂OC(O)CH₃ (D-55c)CN *1 5-182 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ (D-55c)CN *1 5-183 3,5-Cl₂ CF₃ 2-CH₃ C(O)Pr-i (D-55c)CN 101.5-103.0 5-184 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ (D-55c)CN *1 5-185 3,5-Cl₂ CF₃ 2-CH₃ CH₂OCH₃ (D-57b)Cl *1 5-186 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ (D-57b)Cl *1 5-187 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ (D-57b)Cl *1 5-188 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-57d)Cl₂ *1 5-189 3,5-Cl₂ CF₃ 2-CH₃ CH₂OCH₃ (D-57d)Cl₂ 189.0-193.0 5-190 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ (D-57d)Cl₂ *1 5-191 3,5-Cl₂ CF₃ 2-CH₃ C(O)OCH₃ (D-57d)Cl₂ *1 5-192 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ D-58a *1 5-193 3,5-Cl₂ CF₃ 2-CH₃ CH₂OCH₃ (D-58b)Cl *1 5-194 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ (D-58b)Cl *1 5-195 3,5-Cl₂ CF₃ 2-CH₃ CH₃ (D-58b)CN *1 5-196 3,5-Cl₂ CF₃ 2-CH₃ CH₂OCH₃ (D-58b)CN *1 5-197 3,5-Cl₂ CF₃ 2-CH₃ C(O)CH₃ (D-58b)CN *1 5-198 3,5-Cl₂ CF₃ 2-CH₃ CH₂OCH₃ D-57a *1 5-199 3,5-Cl₂ CF₃ 2-CH₃ C(O)OBu-t Ph *1 5-200 3,5-(CF₃)₂ CF₃ — CH₃ (D-55c)Cl 178.0-179.0 5-201 3,5-(CF₃)₂ CF₃ — C(O)CH₃ (D-55c)Cl 176.0-179.0 5-202 3,5-(CF₃)₂ CF₃ — C(O)Pr-i (D-55c)Cl 134.0-136.0 5-203 3,5-(CF₃)₂ CF₃ — C(O)OCH₃ (D-55c)Cl 167.0-170.0 5-204 3,5-Cl₂ CF₃ 2-CH₃ CH₂CN (D-55c)CN *1 5-205 3,5-Cl₂ CF₃ 2-CH₃ C(O)Et (D-55c)CN *1 5-206 3,5-Cl₂ CF₃ 2-CH₃ CH₂CN D-57a 80.0-84.0

TABLE 10

No. (X)_(m) R³ (Y)_(n) R¹ m.p. (° C.) 6-001 3,5-Cl₂ CF₃ — CH═NOH 181.0-183.0 6-002 3,5-Cl₂ CF₃ 2-CH₃ CH═NOH 156.0-160.0 6-003 3,5-Cl₂ CF₃ 2-CH₃ CH═NOCH₃(E) *1 6-004 3,5-Cl₂ CF₃ 2-CH₃ CH═NOCH₃(Z) 167.0-169.0 6-004(R) 98% e.e. [α]_(D) ^(21.1) − 73.66° (CH₃CN, c = 1.250) *1 6-004(S) 97% e.e. [α]_(D) ^(20.1) + 71.70° (CH₃CN, c = 1.138) 157.0-158.0 6-005 3,5-Cl₂ CF₃ 2-CH₃ CH═NOEt 143.0-146.0 6-006 3,5-Cl₂ CF₃ 2-CH₃ CH═NOPr-n 109.0-111.0 6-007 3,5-Cl₂ CF₃ 2-CH₃ CH═NOPr-i *1 6-008 3,5-Cl₂ CF₃ 2-CH₃ CH═NOCH₂CH₂Cl 137.0-139.0 6-009 3,5-Cl₂ CF₃ 2-CH₃ CH═NOCH₂CF₃ *1 6-010 3,5-Cl₂ CF₃ 2-CH₃ CH═NOCH₂CH═CH₂ 123.0-124.0 6-011 3,5-Cl₂ CF₃ 2-CH₃ C(CH₃)═NOCH₃ 159.0-161.0 6-012 3,5-Cl₂ CF₃ 2-Cl CH═NOCH₃ 140.0-142.0 6-013 3,5-Cl₂ CF₃ 2-Cl CH═NOEt 126.0-129.0 6-014 3,5-Cl₂ CF₃ 2-Br CH═NOCH₃(Z) 146.0-149.0 6-015 3,5-Cl₂ CF₃ 2-Br CH═NOEt(Z) 134.0-137.0 6-016 3,5-Cl₂ CF₃ 2-I CH═NOCH₃(Z) *1 6-017 3,5-Cl₂ CF₃ 2-I CH═NOEt 126.0-129.0 6-018 3,5-Cl₂ CF₃ 2-CH₃ CH═NOEt(Z) 149.0-150.0 6-019 3,5-Cl₂ CF₃ 2-CH₃ (M-5c)CH₃ 179.0-181.0 6-020 3,5-Cl₂ CF₃ 2-Et CH═NOCH₃(Z) *1 6-021 3,5-Cl₂ CF₃ 2-CF₃ CH═NOEt(Z) 164.0-167.0 6-022 3,5-Cl₂ CF₃ 2-OCHF₂ CH═NOCH₃(Z) 137.0-141.0 6-023 3,5-Cl₂ CF₃ 2-OCHF₂ CH═NOEt(Z) *1 6-024 3,5-Cl₂ CF₃ 2-NO₂ CH═NOCH₃(Z) 229.0-233.0 6-025 3,5-Cl₂ CF₃ 2-CN CH═NOCH₃(Z) 188.0-190.0 6-026 3,5-Cl₂ CF₃ 2-Ph CH═NOCH₃ *1 6-027 3,5-Cl₂ CF₃ 2-(D-41a) CH═NOCH₃(Z) 172.0-174.0 6-028 3,5-Cl₂ CF₂Cl 2-Cl CH═NOCH₃ *1 6-029 3-Cl-5-Br CF₃ 2-CH₃ CH═NOCH₃ *1 6-030 3,5-(CF₃)₂ CF₃ 2-CH₃ CH═NOCH₃ *1 6-031 3,5-Cl₂ CF₃ 2-CH₂OCH₃ CH═NOCH₃ 132.0-134.0 6-032 3,5-Cl₂ CF₃ 2-CH2N(CH₃)₂ CH═NOCH₃ 144.0-146.0 6-033 3,5-Cl₂ CF₃ 2-NHC(O)CH₃ CH═NOCH₃(Z) 199.0-201.0 6-034 3,5-Cl₂ CF₃ 2-NHC(O)CH₃ CH═NOEt(Z) 204.0-205.0 6-035 3,5-Br₂ CF₃ 2-CH₃ CH═NOCH₃ *1 6-036 3,5-Br₂ CF₃ 2-CH₃ CH═NOEt *1 6-037 3-Cl-5-CF₃ CF₃ 2-CH₃ CH═NOCH₃ *1 6-038 3,5-Cl2-4-F CF₃ 2-CH₃ CH═NOCH₃ *1 6-039 3,4,5-Cl₃ CF₃ 2-CH₃ CH═NOCH₃ *1 6-040 3,4,5-Cl₃ CF₃ 2-CH₃ CH═NOEt *1 6-041 3-Cl-4-F-5-CF₃ CF₃ 2-CH₃ CH═NOCH₃ *1 6-042 3,5-Cl₂ CF₃ 2-CH₃ CH═NNHC(O)CH₃ 198.0-203.0 6-043 3,5-Cl₂ CF₃ 2-CH₃ CH═NNHC(O)CH₃ 209.0-211.0 6-044 3,5-Cl₂ CF₃ 2-CH₃ CH═NOCH₂C(O)OH *1 6-045 3,5-Cl₂ CF₃ 2-CH₃ CH═NOCH₂(Ph-4-NO₂) *1 6-046 3,5-Cl₂ CF₃ 2-NO₂ CH═NOEt 204.0-206.0 6-047 3,5-Cl₂ CF₃ 2-(Ph-4-Cl) CH═NOCH₃ *1 6-048 3,5-Cl₂ CF₃ 2-(D-2a) CH═NOCH₃ *1 6-049 3,5-Cl₂ CF₃ 2-(D-4a) CH═NOCH₃ *1 6-050 3,5-(CF₃)₂ CF₃ — CH═NOCH₃ 184.0-186.0 6-051 3,5-(CF₃)₂ CF₃ — CH═NOEt 86.0-94.0 6-052 3,4,5-Cl₃ CF₃ — CH═NOCH₃ *1 6-053 3,4,5-Cl₃ CF₃ — CH═NOEt 108.0-110.0 6-054 3,4,5-Cl₃ CF₃ — CH═NOPr-n 139.0-140.0 6-055 3,4,5-Cl₃ CF₃ — CH═NOPr-i *1

TABLE 11

No. (X)_(m) (Y)_(n) R² R¹ m.p. (° C.) 7-001 3,5-Cl₂ 2-CH₃ O CH₂OCH₃ CH═NOCH₃ *1 7-002 3,5-Cl₂ 2-CH₃ O CH₃ CH═NOCH₃ *1 (isomer1) 7-003 3,5-Cl₂ 2-CH₃ O CH₃ CH═NOCH₃ *1 (isomer2) 7-004 3,5-Cl₂ 2-CH₃ O C(O)OCH₃ CH═NOCH₃ *1 (isomer1) 7-005 3,5-Cl₂ 2-CH₃ O C(O)OCH₃ CH═NOCH₃ *1 (isomer2) 7-006 3,5-Cl₂ 2-CH₃ O CH₂OEt CH═NOCH₃ *1 7-007 3,5-Cl₂ 2-CH₃ O CH₂CN CH═NOCH₃ *1 7-008 3,5-Cl₂ 2-CH₃ O CH₂C≡CH CH═NOCH₃ *1 7-009 3,5-Cl₂ 2-CH₃ O CH₂OCH₃ CH═NOEt *1 7-010 3,5-Cl₂ — S H CH═NOCH₃ *1 7-011 3,5-Cl₂ — S H CH═NOEt *1 7-012 3,5-Cl₂ 2-CH₃ S H CH═NOCH₃ *1 7-013 3,5-Cl₂ 2-CH₃ O CH₂OCH₃ CH═NOCH₃ *1 (isomer1) 7-014 3,5-Cl₂ 2-CH₃ O CH₂OC(O)CH₃ CH═NOCH₃ *1 (isomer1) 7-015 3,5-Cl₂ 2-CH₃ O CH₂OC(O)CH₃ CH═NOCH₃ *1 (isomer2) 7-016 3,5-Cl₂ 2-CH₃ O CH₂SCH₃ CH═NOCH₃ *1 (isomer1) 7-017 3,5-Cl₂ 2-CH₃ O CH₂SCH₃ CH═NOCH₃ *1 (isomer2) 7-018 3,5-Cl₂ 2-CH₃ O CH₂C(O)OCH₃ CH═NOCH₃ *1 7-019 3,5-Cl₂ 2-CH₃ O CH₂(D-52a) CH═NOCH₃ *1 7-020 3,5-Cl₂ 2-CH₃ O CH₂CN CH═NOEt *1 7-021 3,5-Cl₂ 2-CH₃ O CH₂Si(CH₃)₃ CH═NOCH₃ *1 7-022 3,4,5-Cl₃ — S H CH═NOCH₃ *1 7-023 3,4,5-Cl₃ — S H CH═NOEt *1

TABLE 12

m.p. No. (X)_(m) R³ (Y)_(n) W R^(2a) R^(2b) (° C.) 8-001 3,5-Cl₂ CF₃ 2-CH₃ O OCH₃ SCH₃ *1 8-002 3,5-Cl₂ CF₃ 2-CH₃ O OCH₃ SCH₂OCH₃ *1 8-003 3,5-Cl₂ CF₃ 2-CH₃ O OCH₃ SC(O)CH₃ 109.0- 111.0 8-004 3,5-Cl₂ CF₃ — O N(CH₃)₂ H *1 8-005 3,5-Cl₂ CF₃ — S N(CH₃)₂ H 155.0- 159.0 8-006 3,5-Cl₂ CF₃ 2-CH₃ O N(CH₃)₂ H 146.0- 147.0 8-007 3,5-Cl₂ CF₃ 2-CH₃ O N(CH₃)₂ CH₃ *1 8-008 3,5-Cl₂ CF₂Cl 2-Cl O N(CH₃)₂ H *1 8-009 3,5-Br₂ CF₃ 2-CH₃ O N(CH₃)₂ H *1 8-010 3,5-(CF₃)₂ CF₃ 2-CH₃ O N(CH₃)₂ H *1 8-011 3,4,5-Cl₃ CF₃ 2-CH₃ O N(CH₃)₂ H *1 8-012 3,5-Cl₂ CF₃ 2-CH₃ S N(CH₃)₂ H *1 8-013 3,5-Cl₂ CF₃ 2-CH₃ O N(CH₃)₂ OCH₃ *1 8-014 3,5-Cl₂ CF₃ 2-CH₃ O N(CH₃)₂ SCH₃ *1 8-015 3,5-Cl₂ CF₃ 2-CH₃ O OEt SCH₃ 164.0- 166.0 8-016 3,5-Cl₂ CF₃ 2-CH₃ O OBu-n SCH₃ *1 8-017 3,5-Cl₂ CF₂ 2-CH₃ O OCH₂C≡CH SCH₃ *1

TABLE 13

No. (X)_(m) A¹ (Y)_(n) R² R¹ m.p. (° C.) 9-001 3,5-Cl₂ N 2-Cl H CH═NOCH₃ 178.0-181.0 9-002 3,5-Cl₂ N 2-Cl H C(O)OCH₃ *1

TABLE 14

No. (X)_(m) A¹ (Y)_(n) R^(2a) R^(2b) m.p. (° C.) 10-001 3,5-Cl₂ N 2-Cl N(CH₃)₂ H *1

TABLE 15

No. A¹ (Y)_(n) R² R¹ J m.p. (° C.) 11-001 C 2-CH₃ H C(O)CH₃ H 141.0-143.0 11-001 C 2-CH₃ H CH═NOCH₃ H 88.0-91.0 11-001 C 2-CH₃ C(O)CH₃ (D-55c)Cl H *1

Among the compounds of the present invention, ¹H NMR data of the compounds that the measured value of molecular ion peak, melting point or refractive index is not shown are shown in Table 16.

In the meantime, the indication of “(A)” in the table shows a condition in which tetramethylsilane is used as standard substance in chloroform-d solvent and measurement is carried out at 300 MHz (CDCl₃, Me₄Si, 300 MHz), and the indication “(B)” shows the measurement condition of (CDCl₃, Me₄Si, 400 MHz), the indication of “(C)” shows the measurement condition of (CDCl₃-DMSO-d₆, Me₄Si, 300 MHz), and the indication of “(D)” shows the measurement condition of (CDCl₃-DMSO-d₆, Me₄Si, 400 MHz).

TABLE 16 No. ¹H NMR 2-001 (A) δ8.57 (bs, 1H), 7.92 (d, J = 8.3 Hz, 2H), 7.77 (d, J = 8.3 Hz, 2H), 7.50 (d, J = 1.7 Hz, 2H), 7.42 (t, J = 1.7 Hz, 1H), 4.27 (q, J = 7.2 Hz, 2H), 4.12 (d, J = 17.1 Hz, 1H), 3.76 (d, J = 17.1 Hz, 1H), 1.31 (t, J = 7.2 Hz, 3H). 2-002 (A) δ8.54 (bs, 1H), 7.93 (d, J = 8.3 Hz, 2H), 7.77 (d, J = 8.3 Hz, 2H), 7.45-7.55 (m, 2H), 7.42 (t, J = 2.0 Hz, 1H), 4.95-5.15 (m, 1H), 4.13 (d, J = 17.1 Hz, 1H), 3.76 (d, J = 17.1 Hz, 1H), 1.30 (d, J = 6.6 Hz, 6H). 2-004 (B) δ7.68 (s, 1H), 7.45-7.6 (m, 4H), 7.43 (t, J = 1.8 Hz, 1H), 7.41 (d, J = 7.4 Hz, 1H), 4.08 (d, J = 17.2 Hz, 1H), 3.70 (d, J = 17.2 Hz, 1H), 2.46 (s, 3H), 1.46 (s, 9H). 2-005 (B) δ8.00 (bs, 1H), 7.45-7.6 (m, 5H), 7.43 (t, J = 1.8 Hz, 1H), 4.3-4.35 (m, 2H), 4.08 (d, J = 17.2 Hz, 1H), 3.71 (d, J = 17.2 Hz, 1H), 3.5-3.7 (m, 6H), 3.38 (s, 3H), 2.46 (s, 3H). 2-007 (B) δ7.85 (dd, J = 5.5, 3.1 Hz, 2H), 7.84 (bs, 1H), 7.75 (dd, J = 5.5, 3.1 Hz, 2H), 7.45-7.55 (m, 4H), 7.43 (t, J = 1.8 Hz, 1H), 7.42 (d, J = 7.9 Hz, 1H), 4.35-4.45 (m, 2H), 4.07 (d, J = 17.2 Hz, 1H), 3.98 (m, 2H), 3.69 (d, J = 17.2 Hz, 1H), 2.44 (s, 3H). 2-009 (B) δ8.37 (bs, 1H), 7.45-7.6 (m, 4H), 7.45 (d, J = 8.4 Hz, 1H), 7.43 (t, J = 1.8 Hz, 1H), 4.68 (s, 2H), 4.08 (d, J = 17.2 Hz, 1H), 3.77 (s, 3H), 3.71 (d, J = 17.2 Hz, 1H), 2.45 (s, 3H). 2-012 (B) δ9.81 (s, 1H), 7.5-7.65 (m, 5H), 7.44 (t, J = 1.8 Hz, 1H), 4.09 (d, J = 17.2 Hz, 1H), 3.72 (d, J = 17.2 Hz, 1H), 2.70 (s, 3H), 2.56 (s, 3H). 2-013 (B) δ8.45 (s, 1H), 7.71 (d, J = 1.7 Hz, 1H), 7.63 (dd, J = 8.1, 1.7 Hz, 1H), 7.52 (d, J = 8.1 Hz, 1H), 7.45-7.5 (m, 2H), 7.43 (t, J = 1.8 Hz, 1H), 4.07 (d, J = 17.2 Hz, 1H), 3.78 (s, 3H), 3.71 (d, J = 17.2 Hz, 1H). 2-014 (A) δ7.93 (bs, 1H), 7.89 (d, J = 1.8 Hz, 1H), 7.71 (dd, J = 7.8, 1.2 Hz, 1H), 7.4-7.55 (m, 4H), 4.06 (d, J = 17.4 Hz, 1H), 3.78 (s, 3H), 3.69 (d, J = 17.4 Hz, 1H). 2-016 (B) δ8.10 (d, J = 1.5 Hz, 1H), 7.79 (s, 1H), 7.74 (dd, J = 8.1, 1.5 Hz, 1H), 7.45-7.5 (m, 2H), 7.43 (t, J = 1.8 Hz, 1H), 7.36 (d, J = 8.1 Hz, 1H), 4.93 (sept, J = 6.2 Hz, 1H), 4.06 (d, J = 17.2 Hz, 1H), 3.68 (d, J = 17.2 Hz, 1H), 1.25 (d, J = 6.2 Hz, 6H). 2-018 (A) δ7.65-7.75 (m, 3H), 7.3-7.55 (m, 9H), 4.11 (d, J = 17.4 Hz, 1H), 3.73 (d, J = 17.4 Hz, 1H), 3.59 (s, 3H). 2-020 (A) δ8.28 (s, 1H), 7.71 (d, J = 1.5 Hz, 1H), 7.64 (dd, J = 8.1, 1.5 Hz, 1H), 7.54 (s, 1H), 7.51 (d, J = 1.5 Hz, 2H), 7.42 (t, J = 1.5 Hz, 1H), 4.11 (d, J = 17.4 Hz, 1H), 3.65-3.85 (m, 4H). 2-021 (A) δ7.83 (s, 1H), 7.65 (s, 1H), 7.5-7.6 (m, 4H), 7.43 (d, J = 8.7 Hz, 1H), 4.08 (d, J = 17.4 Hz, 1H), 3.80 (s, 3H), 3.68 (d, J = 17.4 Hz, 1H), 2.47 (s, 3H). 2-022 (A) δ8.15 (s, 1H), 7.7-7.75 (m, 1H), 7.70 (bs, 2H), 7.5-7.55 (m, 2H), 7.42 (d, J = 8.4 Hz, 1H), 4.07 (d, J = 17.4 Hz, 1H), 3.80 (s, 3H), 3.71 (d, J = 17.4 Hz, 1H), 2.45 (s, 3H). 2-023 (A) δ8.08 (s, 2H), 7.97 (s, 1H), 7.91 (s, 1H), 7.55-7.6 (m, 2H), 7.43 (d, J = 8.4 Hz, 1H), 4.20 (d, J = 17.4 Hz, 1H), 3.80 (s, 3H), 3.76 (d, J = 17.4 Hz, 1H), 2.47 (s, 3H). 2-024 (A) δ7.9-8.0 (m, 3H), 7.4-7.5 (m, 4H), 4.11 (d, J = 17.4 Hz, 1H), 3.73 (s, 3H), 3.72 (d, J = 17.4 Hz, 1H). 2-025 (A) δ9.73 (s, 1H), 7.65-7.9 (m, 3H), 7.4-7.55 (m, 3H), 4.57 (s, 2H), 4.10 (d, J = 17.4 Hz, 1H), 3.85 (s, 3H), 3.72 (d, J = 17.4 Hz, 1H), 3.51 (s, 3H). 2-027 (A) δ8.70 (s, 1H), 7.4-7.6 (m, 6H), 5.51 (qui, J = 6.6 Hz, 1H), 4.08 (d, J = 17.4 Hz, 1H), 3.70 (d, J = 17.4 Hz, 1H), 2.48 (s, 3H), 1.26 (d, J = 6.6 Hz, 6H). 2-028 (A) δ8.80 (s, 1H), 7.4-7.6 (m, 6H), 4.49 (t, J = 6.6 Hz, 2H), 4.08 (d, J = 17.4 Hz, 1H), 3.70 (d, J = 17.4 Hz, 1H), 2.39 (s, 3H), 1.5-1.7 (m, 2H), 1.2-1.45 (m, 2H), 0.90 (t, J = 7.5 Hz, 3H). 2-029 (A) δ8.90 (s, 1H), 7.4-7.65 (m, 6H), 5.15 (s, 2H), 4.10 (d, J = 17.4 Hz, 1H), 3.71 (d, J = 17.4 Hz, 1H), 2.45-2.6 (m, 4H). 2-030 (A) δ8.00 (s, 1H), 7.88 (d, J = 8.7 Hz, 2H), 7.77 (d, J = 8.7 Hz, 2H), 7.65 (s, 2H), 4.05-4.2 (m, 3H), 3.73 (d, J = 17.4 Hz, 1H), 1.35 (t, J = 7.2 Hz, 3H). 3-001 (A) δ7.69 (d, J = 8.7 Hz, 2H), 7.55 (d, J = 8.7 Hz, 2H), 7.45-7.55 (m, 2H), 7.43 (t, J = 2.0 Hz, 1H), 4.09 (d, J = 17.3 Hz, 1H), 4.07 (q, J = 7.1 Hz, 2H), 3.71 (d, J = 17.3 Hz, 1H), 3.36 (s, 3H), 1.06 (t, J = 7.1 Hz, 3H). 3-002 (A) δ7.69 (d, J = 8.3 Hz, 2H), 7.55 (d, J = 8.3 Hz, 2H), 7.45-7.55 (m, 2H), 7.43 (t, J = 1.8 Hz, 1H), 4.75-4.9 (m, 1H), 4.09 (d, J = 17.3 Hz, 1H), 3.51 (d, J = 17.3 Hz, 1H), 3.34 (s, 3H), 1.06 (d, J = 6.3 Hz, 6H). 3-005 (B) δ7.4-7.5 (m, 4H), 7.39 (t, J = 1.9 Hz, 1H), 7.14 (d, J = 7.8 Hz, 1H), 4.06 (d, J = 17.2 Hz, 1H), 3.82 (t, J = 9.4 Hz, 2H), 3.68 (d, J = 17.4 Hz, 1H), 3.59 (s, 3H), 2.30 (s, 3H), 1.69 (m, 2H), 0.96 (t, J = 7.4 Hz, 3H). 3-006 (B) δ7.4-7.6 (m, 5H), 7.2-7.3 (m, 1H), 4.87 (sep, J = 6.7 Hz, 1H), 4.09 (d, J = 17.2 Hz, 1H), 3.70 (d, J = 17.2 Hz, 1H), 3.56 (s, 3H), 2.39 (s, 3H), 1.45 (d, J = 7.0 Hz, 6H). 3-009 (B) δ7.45-7.55 (m, 5H), 7.43 (t, J = 1.8 Hz, 1H), 4.65 (s, 2H), 4.09 (d, J = 17.2 Hz, 1H), 3.82 (s, 3H), 3.70 (d, J = 17.2 Hz, 1H), 3.63 (s, 3H), 2.39 (s, 3H). 3-012 (B) δ7.4-7.6 (m, 6H), 4.09 (d, J = 17.2 Hz, 1H), 3.72 (s, 3H), 3.70 (d, J = 17.2 Hz, 1H), 2.45 (s, 3H), 1.37 (s, 9H). 3-013 (B) δ7.4-7.6 (m, 6H), 4.45 (s, 2H), 4.09 (d, J = 17.2 Hz, 1H), 3.77 (s, 3H), 3.72 (d, J = 17.2 Hz, 1H), 3.42 (s, 3H), 2.59 (s, 3H). 3-014 (B) δ7.4-7.6 (m, 6H), 4.10 (d, J = 17.2 Hz, 1H), 3.82 (s, 6H), 3.72 (d, J = 17.4 Hz, 1H), 2.53 (s, 3H). 3-016 (B) δ7.45-7.55 (m, 5H), 7.43 (t, J = 1.8 Hz, 1H), 4.89 (sep, J = 6.2 Hz, 1H), 4.07 (d, J = 17.2 Hz, 1H), 3.69 (d, J = 17.2 Hz, 1H), 3.36 (s, 3H), 2.33 (s, 3H), 1.01 (d, J = 6.2 Hz, 6H). 3-017 (B) δ7.45-7.55 (m, 5H), 7.43 (t, J = 1.8 Hz, 1H), 4.81 (sep, J = 6.3 Hz, 1H), 4.07 (d, J = 17.2 Hz, 1H), 3.93 (q, J = 7.0 Hz, 2H), 3.69 (d, J = 17.2 Hz, 1H), 2.34 (s, 3H), 1.29 (t, J = 7.0 Hz, 3H), 1.01 (d, J = 6.3 Hz, 6H). 3-018 (B) δ7.4-7.6 (m, 6H), 5.27 (s, 2H), 4.82 (sep, J = 6.3 Hz, 1H), 4.08 (d, J = 17.2 Hz, 1H), 3.70 (d, J = 17.2 Hz, 1H), 3.50 (s, 3H), 2.40 (s, 3H), 1.00 (d, J = 6.2 Hz, 6H). 3-020 (B) δ7.45-7.55 (m, 5H), 7.43 (t, J = 1.8 Hz, 1H), 4.1-4.15 (m, 2H), 4.08 (d, J = 17.2 Hz, 1H), 3.69 (d, J = 17.2 Hz, 1H), 3.39 (s, 3H), 3.3-3.35 (m, 2H), 3.26 (s, 3H), 2.33 (s, 3H). 3-026 (A) δ7.85 (d, J = 1.2 Hz, 1H), 7.68 (dd, J = 7.8, 2.0 Hz, 1H), 7.50 (bs, 2H), 7.44 (t, J = 2.0 Hz, 1H), 7.35 (d, J = 7.8 Hz, 1H), 5.33 (s, 2H), 4.05 (d, J = 17.4 Hz, 1H), 3.73 (s, 3H), 3.68 (d, J = 17.4 Hz, 1H), 3.52 (s, 3H). 3-027 (A) δ7.87 (d, J = 1.8 Hz, 1H), 7.70 (dd, J = 7.8, 1.8 Hz, 1H), 7.50 (bs, 2H), 7.44 (t, J = 2.0 Hz, 1H), 7.38 (d, J = 7.8 Hz, 1H), 4.81 (s, 2H), 4.07 (d, J = 17.4 Hz, 1H), 3.78 (s, 3H), 3.68 (d, J = 17.4 Hz, 1H). 3-030 (B) δ8.09 (d, J = 1.7 Hz, 1H), 7.73 (dd, J = 8.1, 1.7 Hz, 1H), 7.45-7.5 (m, 2H), 7.44 (t, J = 1.8 Hz, 1H), 7.29 (d, J = 8.1 Hz, 1H), 4.81 (s, 2H), 4.07 (d, J = 17.2 Hz, 1H), 3.78 (s, 3H), 3.69 (d, J = 17.2 Hz, 1H). 3-033 (B) δ7.45-7.55 (m, 4H), 7.43 (t, J = 1.8 Hz, 1H), 7.28 (d, J = 8.1 Hz, 1H), 5.86 (s, 2H), 4.09 (d, J = 17.2 Hz, 1H), 3.70 (d, J = 17.2 Hz, 1H), 3.68 (s, 3H), 2.39 (s, 3H), 2.13 (s, 3H). 3-034 (A) δ7.5-7.55 (m, 4H), 7.43 (t, J = 1.8 Hz, 1H), 7.26 (d, J = 7.8 Hz, 1H), 5.86 (s, 2H), 4.09 (d, J = 17.2 Hz, 1H), 3.70 (d, J = 17.2 Hz, 1H), 3.68 (s, 3H), 2.38 (s, 3H), 1.23 (s, 9H). 3-035 (B) δ7.5-7.55 (m, 4H), 7.43 (t, J = 1.8 Hz, 1H), 7.23 (d, J = 7.9 Hz, 1H), 5.01 (s, 2H), 4.07 (d, J = 17.2 Hz, 1H), 3.70 (d, J = 17.2 Hz, 1H), 3.65 (s, 3H), 2.38 (s, 3H), 2.33 (s, 3H). 3-036 (B) δ7.5-7.6 (m, 4H), 7.44 (t, J = 1.8 Hz, 1H), 7.33 (d, J = 8.1 Hz, 1H), 5.22 (s, 2H), 4.09 (d, J = 17.2 Hz, 1H), 3.71 (d, J = 17.2 Hz, 1H), 3.69 (s, 3H), 3.11 (s, 3H), 2.40 (s, 3H). 3-037 (A) δ7.45-7.55 (m, 4H), 7.43 (t, J = 1.8 Hz, 1H), 7.20 (d, J = 8.1 Hz, 1H), 5.37 (s, 2H), 4.09 (d, J = 17.2 Hz, 1H), 3.70 (d, J = 17.2 Hz, 1H), 3.67 (s, 3H), 2.39 (s, 3H), 2.34 (s, 3H). 3-038 (B) δ7.45-7.55 (m, 4H), 7.43 (t, J = 1.8 Hz, 1H), 7.23 (d, J = 8.0 Hz, 1H), 5.58 (s, 2H), 4.67 (d, J = 7.1 Hz, 2H), 4.08 (d, J = 17.2 Hz, 1H), 3.69 (d, J = 17.2 Hz, 1H), 3.65 (s, 3H), 2.36 (s, 3H), 1.43 (t, J = 7.1 Hz, 3H). 3-039 (B) δ7.5-7.55 (m, 4H), 7.43 (t, J = 1.8 Hz, 1H), 7.23 (d, J = 8.1 Hz, 1H), 5.86 (bs, 1H), 5.29 (d, J = 7.0 Hz, 2H), 4.09 (d, J = 17.2 Hz, 1H), 3.72 (s, 3H), 3.69 (d, J = 17.2 Hz, 1H), 3.67 (s, 3H), 2.35 (s, 3H). 3-040 (B) δ8.0-8.05 (m, 2H), 7.5-7.7 (m, 7H), 7.46 (d, J = 8.0 Hz, 1H), 7.43 (t, J = 1.8 Hz, 1H), 5.18 (s, 2H), 4.10 (d, J = 17.2 Hz, 1H), 3.71 (d, J = 17.2 Hz, 1H), 3.60 (s, 3H), 2.43 (s, 3H). 3-043 (B) δ7.45-7.6 (m, 5H), 7.43 (t, J = 1.8 Hz, 1H), 4.08 (d, J = 17.2 Hz, 1H), 3.77 (s, 3H), 3.70 (d, J = 17.2 Hz, 1H), 3.40 (sept, J = 6.8 Hz, 1H), 2.58 (s, 3H), 1.24 (d, J = 6.8 Hz, 6H). 3-044 (B) δ7.45-7.55 (m, 5H), 7.44 (t, J = 1.8 Hz, 1H), 4.63 (s, 2H), 4.08 (d, J = 17.2 Hz, 1H), 3.82 (s, 3H), 3.71 (d, J = 17.2 Hz, 1H), 2.62 (s, 3H). 3-045 (B) δ7.76 (d, J = 8.6 Hz, 1H), 7.5-7.6 (m, 4H), 7.44 (t, J = 1.8 Hz, 1H), 4.09 (d, J = 17.2 Hz, 1H), 3.78 (s, 3H), 3.77 (s, 2H), 3.71 (d, J = 17.2 Hz, 1H), 2.63 (s, 3H), 2.13 (s, 3H). 3-046 (B) δ7.8-7.9 (m, 2H), 7.45-7.7 (m, 8H), 7.43 (t, J = 1.8 Hz, 1H), 4.07 (d, J = 17.2 Hz, 1H), 3.72 (s, 3H), 3.69 (d, J = 17.2 Hz, 1H), 2.52 (s, 3H). 3-047 (A) δ7.81 (d, J = 8.4 Hz, 2H), 7.4-7.55 (m, 7H), 7.43 (t, J = 1.8 Hz, 1H), 4.09 (d, J = 17.2 Hz, 1H), 3.73 (s, 3H), 3.68 (d, J = 17.2 Hz, 1H), 2.52 (s, 3H). 3-048 (B) δ7.78 (d, J = 8.2 Hz, 2H), 7.5-7.6 (m, 5H), 7.43 (t, J = 1.8 Hz, 1H), 7.29 (d, J = 8.2 Hz, 2H), 4.07 (d, J = 17.2 Hz, 1H), 3.71 (s, 3H), 3.68 (d, J = 17.2 Hz, 1H), 2.52 (s, 3H), 2.43 (s, 3H). 3-049 (B) δ7.87 (d, J = 9.0 Hz, 2H), 7.45-7.55 (m, 5H), 7.43 (t, J = 1.8 Hz, 1H), 6.97 (d, J = 9.0 Hz, 2H), 4.07 (d, J = 17.2 Hz, 1H), 3.89 (s, 3H), 3.72 (s, 3H), 3.68 (d, J = 17.2 Hz, 1H), 2.52 (s, 3H). 3-050 (B) δ8.33 (d, J = 8.6 Hz, 2H), 8.00 (d, J = 8.6 Hz, 2H), 7.5-7.65 (m, 5H), 7.43 (t, J = 1.8 Hz, 1H), 4.08 (d, J = 17.2 Hz, 1H), 3.75 (s, 3H), 3.71 (d, J = 17.2 Hz, 1H), 2.55 (s, 3H). 3-052 (B) δ7.5-7.6 (m, 5H), 7.44 (t, J = 1.8 Hz, 1H), 4.43 (t, J = 5.7 Hz, 2H), 4.09 (d, J = 17.2 Hz, 1H), 3.84 (s, 3H), 3.70 (d, J = 17.2 Hz, 1H), 3.60 (t, J = 5.7 Hz, 2H), 2.55 (s, 3H). 3-053 (B) δ7.5-7.65 (m, 5H), 7.43 (t, J = 1.8 Hz, 1H), 4.10 (d, J = 17.2 Hz, 1H), 3.75 (s, 3H), 3.73 (d, J = 17.2 Hz, 1H), 2.51 (s, 3H). 3-054 (B) δ7.45-7.55 (m, 4H), 7.43 (t, J = 1.8 Hz, 1H), 7.25 (d, J = 7.9 Hz, 1H), 5.28 (s, 2H), 4.08 (d, J = 17.2 Hz, 1H), 4.06 (q, J = 7.1 Hz, 2H), 3.70 (d, J = 17.2 Hz, 1H), 3.51 (s, 3H), 2.40 (s, 3H), 1.01 (t, J = 7.1 Hz, 3H). 3-055 (B) δ7.5-7.6 (m, 5H), 7.43 (t, J = 1.8 Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 4.08 (d, J = 17.2 Hz, 1H), 3.70 (d, J = 17.2 Hz, 1H), 2.91 (q, J = 7.3 Hz, 2H), 2.59 (s, 3H), 1.19 (t, J = 7.3 Hz, 3H), 1.15 (t, J = 7.1 Hz, 3H). 3-056 (B) δ7.45-7.6 (m, 4H), 7.43 (t, J = 1.8 Hz, 1H), 7.38 (d, J = 8.4 Hz, 1H), 4.15 (q, J = 7.1 Hz, 2H), 4.08 (d, J = 17.2 Hz, 1H), 3.70 (d, J = 17.2 Hz, 1H), 2.45 (s, 3H), 1.38 (s, 9H), 1.18 (t, J = 7.1 Hz, 3H). 3-057 (B) δ7.5-7.65 (m, 5H), 7.43 (t, J = 1.8 Hz, 1H), 4.45 (s, 2H), 4.19 (q, J = 7.2 Hz, 2H), 4.08 (d, J = 17.2 Hz, 1H), 3.70 (d, J = 17.2 Hz, 1H), 3.43 (s, 3H), 2.59 (s, 3H), 1.15 (d, J = 7.2 Hz, 3H). 3-059 (B) δ7.2-7.6 (m, 6H), 4.8-5.0 (m, 1H), 4.77 (s, 2H), 4.09 (d, J = 17.2 Hz, 1H), 3.70 (d, J = 17.2 Hz, 1H), 2.36 (s, 3H), 1.06 (d, J = 6.4 Hz, 6H). 3-060 (B) δ7.5-7.6 (m, 5H), 7.44 (d, J = 8.1 Hz, 1H), 4.93 (sep, J = 6.2 Hz, 1H), 4.09 (d, J = 17.2 Hz, 1H), 3.71 (d, J = 17.2 Hz, 1H), 2.90 (q, J = 7.3 Hz, 2H), 2.58 (s, 3H), 1.20 (t, J = 7.3 Hz, 3H), 1.11 (d, J = 6.2 Hz, 6H). 3-063 (A) δ7.4-7.55 (m, 5H), 7.21 (d, J = 7.8 Hz, 1H), 4.08 (d, J = 17.1 Hz, 1H), 3.90 (q, J = 6.9 Hz, 2H), 3.70 (d, J = 17.1 Hz, 1H), 2.35 (s, 3H), 1.28 (t, J = 6.9 Hz, 3H), 1.19 (s, 9H). 3-064 (B) δ7.45-7.55 (m, 4H), 7.43 (t, J = 1.8 Hz, 1H), 7.29 (d, J = 8.1 Hz, 1H), 5.24 (s, 2H), 4.09 (d, J = 17.2 Hz, 1H), 3.70 (d, J = 17.2 Hz, 1H), 3.50 (s, 3H), 2.41 (s, 3H), 1.19 (s, 9H). 3-065 (A) δ7.15-7.5 (m, 11H), 5.02 (s, 2H), 4.07 (d, J = 17.1 Hz, 1H), 3.68 (d, J = 17.1 Hz, 1H), 2.33 (s, 3H), 1.14 (s, 9H). 3-066 (B) δ7.4-7.6 (m, 5H), 7.44 (t, J = 1.8 Hz, 1H), 4.09 (d, J = 17.2 Hz, 1H), 3.71 (d, J = 17.2 Hz, 1H), 2.58 (s, 3H), 2.53 (s, 3H), 1.30 (s, 9H). 3-068 (B) δ7.4-7.65 (m, 6H), 4.18 (d, J = 17.2 Hz, 1H), 3.75-3.9 (m, 2H), 3.71 (d, J = 17.2 Hz, 1H), 2.60 (s, 3H), 1.33 (s, 9H). 3-070 (B) δ7.5-7.6 (m, 5H), 7.44 (t, J = 1.8 Hz, 1H), 4.35-4.4 (m, 2H), 4.09 (d, J = 17.2 Hz, 1H), 3.84 (s, 3H), 3.70 (d, J = 17.2 Hz, 1H), 3.45-3.55 (m, 2H), 3.29 (s, 3H), 2.54 (s, 3H). 3-071 (B) δ7.45-7.6 (m, 4H), 7.43 (t, J = 1.8 Hz, 1H), 7.32 (d, J = 7.9 Hz, 1H), 4.53 (t, J = 8.2 Hz, 2H), 4.21 (t, J = 8.2 Hz, 2H), 4.08 (d, J = 17.2 Hz, 1H), 3.70 (d, J = 17.2 Hz, 1H), 2.37 (s, 3H). 3-072 (B) δ7.55-7.7 (m, 2H), 7.4-7.55 (m, 4H), 4.10 (d, J = 17.4 Hz, 1H), 3.72 (d, J = 17.4 Hz, 1H), 2.56 (s, 3H), 1.69 (s, 6H). 3-073 (B) δ8.08 (d, J = 1.7 Hz, 1H), 7.71 (dd, J = 8.1, 1.7 Hz, 1H), 7.50 (bs, 2H), 7.44 (t, J = 1.8 Hz, 1H), 7.26 (d, J = 8.1 Hz, 1H), 5.37 (s, 2H), 4.06 (d, J = 17.2 Hz, 1H), 3.37 (q, J = 7.0 Hz, 2H), 3.72 (s, 3H), 3.68 (d, J = 17.2 Hz, 1H), 1.26 (t, J = 7.0 Hz, 3H). 3-075 (B) δ7.5-7.55 (m, 4H), 7.43 (t, J = 1.8 Hz, 1H), 7.27 (d, J = 7.9 Hz, 1H), 5.87 (s, 2H), 4.09 (d, J = 17.2 Hz, 1H), 3.70 (d, J = 17.2 Hz, 1H), 3.67 (s, 3H), 2.40 (q, J = 7.5 Hz, 2H), 2.39 (s, 3H), 1.17 (t, J = 7.5 Hz, 3H). 3-076 (B) δ7.45-7.55 (m, 4H), 7.43 (t, J = 1.8 Hz, 1H), 7.27 (d, J = 8.1 Hz, 1H), 5.91 (s, 2H), 4.09 (d, J = 17.2 Hz, 1H), 3.84 (s, 3H), 3.70 (d, J = 17.2 Hz, 1H), 3.68 (s, 3H), 2.39 (s, 3H). 3-078 (B) δ7.55-7.65 (m, 5H), 7.43 (t, J = 1.8 Hz, 1H), 4.45 (s, 2H), 4.08 (d, J = 17.2 Hz, 1H), 3.77 (s, 3H), 3.70 (d, J = 17.2 Hz, 1H), 3.56 (q, J = 7.0 Hz, 2H), 2.59 (s, 3H), 1.18 (t, J = 7.0 Hz, 3H). 3-080 (A) δ7.66 (s, 1H), 7.45-7.6 (m, 4H), 7.2-7.3 (m, 1H), 5.28 (s, 2H), 4.08 (d, J = 17.4 Hz, 1H), 3.68 (d, J = 17.4 Hz, 1H), 3.66 (s, 3H), 3.50 (s, 3H), 2.40 (s, 3H). 3-084 (A) δ8.08 (s, 2H), 7.97 (s, 1H), 7.74 (d, J = 8.4 Hz, 2H), 7.63 (d, J = 8.4 Hz, 2H), 5.28 (s, 2H), 4.19 (d, J = 17.4 Hz, 1H), 3.65-3.8 (m, 6H), 1.24 (t, J = 7.2 Hz, 3H). 3-085 (A) δ8.09 (s, 2H), 7.78 (s, 1H), 7.74 (d, J = 8.4 Hz, 2H), 7.63 (d, J = 8.4 Hz, 2H), 5.38 (s, 2H), 4.05-4.3 (m, 3H), 3.76 (d, J = 17.4 Hz, 1H), 3.69 (s, 3H). 4-004 (B) δ11.65 (s, 1H), 7.5-7.65 (m, 4H), 7.44 (t, J = 1.8 Hz, 1H), 7.28 (d, J = 8.8 Hz, 1H), 4.09 (d, J = 17.2 Hz, 1H), 3.71 (d, J = 17.2 Hz, 1H), 3.07 (s, 3H), 2.49 (s, 3H), 2.37 (s, 3H). 4-007 (B) δ7.5-7.7 (m, 4H), 7.44 (d, J = 8.1 Hz, 1H), 7.34 (d, J = 7.9 Hz, 1H), 6.65 (bs, 1H), 4.09 (d, J = 17.2 Hz, 1H), 3.72 (d, J = 17.2 Hz, 1H), 3.15 (s, 3H), 2.40 (s, 3H). 4-008 (B) δ11.55 (s, 1H), 7.5-7.65 (m, 4H), 7.43 (t, J = 1.8 Hz, 1H), 7.28 (d, J = 7.9 Hz, 1H), 4.10 (d, J = 17.2 Hz, 1H), 3.84 (s, 3H), 3.72 (d, J = 17.2 Hz, 1H), 3.06 (s, 3H), 2.37 (s, 3H). 4-009 (B) δ9.96 (bs, 1H), 9.35 (bs, 1H), 7.45-7.65 (m, 6H), 7.43 (t, J = 1.8 Hz, 1H), 4.10 (d, J = 17.2 Hz, 1H), 3.73 (d, J = 17.2 Hz, 1H), 2.50 (s, 3H). 4-010 (B) δ12.92 (s, 1H), 7.95-8.05 (m, 2H), 7.45-7.7 (m, 7H), 7.44 (t, J = 1.8 Hz, 1H), 7.34 (d, J = 7.9 Hz, 1H), 4.12 (d, J = 17.2 Hz, 1H), 3.74 (d, J = 17.2 Hz, 1H), 3.17 (s, 3H), 2.41 (s, 3H). 4-015 (A) δ7.91 (s, 1H), 7.6-7.75 (m, 2H), 7.4-7.55 (m, 3H), 6.14 and 6.00 (s, 1H), 4.07 (d, J = 17.4 Hz, 1H), 3.69 (d, J = 17.4 Hz, 1H). 5-001 (A) δ6.8-7.7 (m, 11H), 3.99 (d, J = 17.1 Hz, 1H), 3.59 (d, J = 17.1 Hz, 1H), 3.51 (s, 3H), 2.36 (s, 3H). 5-003 (A) δ6.9-7.6 (m, 11H), 5.05-5.25 (m, 1H), 3.96 (d, J = 17.1 Hz, 1H), 3.56 (d, J = 17.1 Hz, 1H), 2.37 (s, 3H), 1.20 (d, J = 6.9 Hz, 6H). 5-009 (A) δ6.7-7.65 (m, 10H), 5.85-6.1 (m, 1H), 5.22 (s, 1H), 5.18 (d, J = 6.3 Hz, 1H), 4.50 (d, J = 6.3 Hz, 2H), 4.01 (d, J = 17.1 Hz, 1H), 3.62 (d, J = 17.1 Hz, 1H), 2.36 (s, 3H). 5-012 (A) δ8.38 (d, J = 4.8 Hz, 1H), 7.3-7.55 (m, 7H), 7.17 (d, J = 8.1 Hz, 1H), 7.04 (dd, J = 7.5, 4.8 Hz, 1H), 4.03 (d, J = 17.3 Hz, 1H), 3.64 (d, J = 17.3 Hz, 1H), 3.53 (s, 3H), 2.36 (s, 3H). 5-013 (A) δ8.64 (d, J = 5.1 Hz, 2H), 7.2-7.65 (m, 6H), 7.14 (t, J = 5.1 Hz, 1H), 4.01 (d, J = 17.4 Hz, 1H), 3.62 (d, J = 17.4 Hz, 1H), 2.59 (s, 3H), 2.54 (s, 3H). 5-016 (A) δ8.66 (s, 2H), 7.4-7.65 (m, 6H), 4.04 (d, J = 17.4 Hz, 1H), 3.65 (d, J = 17.4 Hz, 1H), 2.50 (s, 3H). 5-018 (A) δ7.4-7.65 (m, 5H), 7.0-7.3 (m, 5H), 4.05 (d, J = 17.1 Hz, 1H), 3.65 (d, J = 17.1 Hz, 1H), 2.60 (q, J = 7.5 Hz, 2H), 2.44 (s, 3H), 1.11 (t, J = 7.5 Hz, 3H). 5-019 (A) δ7.1-7.6 (m, 10H), 4.07 (d, J = 17.4 Hz, 1H), 3.67 (d, J = 17.4 Hz, 1H), 2.47 (s, 3H), 0.8-1.2 (m, 5H). 5-020 (A) δ7.4-7.5 (m, 5H), 7.2-7.3 (m, 1H), 7.0-7.2 (m, 4H), 4.05 (d, J = 17.4 Hz, 1H), 3.66 (d, J = 17.4 Hz, 1H), 2.45 (s, 3H), 2.45 (d, J = 6.6 Hz, 2H), 2.16 (qui, J = 6.6 Hz, 1H), 0.92 (d, J = 6.6 Hz, 6H). 5-021 (A) δ7.3-7.5 (m, 5H), 7.19 (d, J = 8.1 Hz, 1H), 6.9-7.1 (m, 4H), 4.52 (s, 2H), 4.02 (d, J = 17.4 Hz, 1H), 3.64 (d, J = 17.4 Hz, 1H), 3.46 (s, 3H), 2.43 (s, 3H). 5-024 (A) δ8.08 (d, J = 9.1 Hz, 2H), 7.05-7.5 (m, 8H), 4.03 (d, J = 17.3 Hz, 1H), 3.63 (d, J = 17.3 Hz, 1H), 3.51 (s, 3H), 2.37 (s, 3H). 5-025 (A) δ8.19 (d, J = 9.1 Hz, 2H), 7.2-7.5 (m, 8H), 4.02 (d, J = 17.3 Hz, 1H), 3.63 (d, J = 17.3 Hz, 1H), 2.52 (s, 3H), 2.49 (s, 3H). 5-026 (B) δ8.34 (d, J = 6.8 Hz, 2H), 7.4-7.6 (m, 8H), 4.10 (d, J = 17.2 Hz, 1H), 3.71 (d, J = 17.2 Hz, 1H), 3.65 (s, 3H), 2.50 (s, 3H). 5-027 (A) δ7.0-7.6 (m, 10H), 4.04 (d, J = 17.4 Hz, 1H), 3.65 (d, J = 17.4 Hz, 1H), 3.48 (s, 3H), 2.35 (s, 3H). 5-028 (A) δ7.64 (d, J = 8.1 Hz, 2H), 7.35-7.5 (m, 5H), 7.2-7.3 (m, 3H), 4.03 (d, J = 17.1 Hz, 1H), 3.64 (d, J = 17.1 Hz, 1H), 2.48 (s, 3H), 2.47 (s, 3H). 5-029 (A) δ7.25-7.8 (m, 10H), 4.10 (d, J = 17.4 Hz, 1H), 3.71 (d, J = 17.4 Hz, 1H), 3.64 (s, 3H), 2.48 (s, 3H). 5-034 (A) δ7.4-7.55 (m, 5H), 7.3-7.35 (m, 1H), 7.1-7.2 (m, 1H), 6.8-6.95 (m, 2H), 4.05 (d, J = 17.1 Hz, 1H), 3.67 (d, J = 17.1 Hz, 1H), 3.10 (sep, J = 6.6 Hz, 1H), 2.46 (s, 3H), 1.19 (d, J = 6.6 Hz, 6H). 5-035 (A) δ7.35-7.5 (m, 6H), 7.05-7.15 (m, 1H), 6.8-6.95 (m, 2H), 4.06 (d, J = 17.1 Hz, 1H), 3.67 (d, J = 17.1 Hz, 1H), 2.50 (s, 3H), 1.27 (s, 9H). 5-036 (A) δ7.25-7.6 (m, 7H), 6.99 (t, J = 8.1 Hz, 2H), 4.10 (d, J = 17.1 Hz, 1H), 3.70 (d, J = 17.1 Hz, 1H), 3.65 (s, 3H), 2.47 (s, 3H). 5-037 (A) δ7.5-7.6 (m, 4H), 7.4-7.45 (m, 2H), 7.1-7.25 (m, 2H), 7.0-7.1 (m, 1H), 4.10 (d, J = 17.4 Hz, 1H), 3.70 (d, J = 17.4 Hz, 1H), 3.66 (s, 3H), 2.47 (s, 3H). 5-038 (A) δ7.4-7.6 (m, 6H), 7.25-7.3 (m, 1H), 6.95-7.05 (m, 2H), 4.09 (d, J = 16.8 Hz, 1H), 3.71 (d, J = 16.8 Hz, 1H), 2.49 (s, 3H), 1.23 (s, 9H). 5-039 (A) δ7.25-7.6 (m, 7H), 4.09 (d, J = 16.8 Hz, 1H), 3.70 (d, J = 16.8 Hz, 1H), 3.36 (s, 3H), 2.35 (s, 6H). 5-040 (A) δ7.25-7.55 (m, 6H), 6.05 (s, 1H), 4.05 (d, J = 17.4 Hz, 1H), 3.67 (d, J = 17.4 Hz, 1H), 2.51 (s, 3H), 2.48 (s, 3H), 2.37 (s, 3H). 5-041 (A) δ7.4-7.6 (m, 6H), 6.11 (s, 1H), 4.08 (d, J = 16.8 Hz, 1H), 3.80 (s, 3H), 3.69 (d, J = 16.8 Hz, 1H), 2.49 (s, 3H), 2.47 (s, 3H). 5-042 (A) δ7.3-7.65 (m, 6H), 6.66 (s, 1H), 4.02 (d, J = 17.4 Hz, 1H), 3.75 (d, J = 17.4 Hz, 1H), 3.36 (s, 3H), 2.47 (s, 3H), 2.33 (s, 3H). 5-043 (A) δ7.1-7.6 (m, 8H), 6.05 (bs, 1H), 4.01 (d, J = 16.2 Hz, 1H), 3.62 (d, J = 16.2 Hz, 1H), 3.56 (s, 3H), 2.44 (s, 3H). 5-045 (A) δ7.4-7.65 (m, 8H), 6.40 (t, J = 2.2 Hz, 1H), 4.08 (d, J = 17.0 Hz, 1H), 3.76 (s, 3H), 3.69 (d, J = 17.0 Hz, 1H), 2.50 (s, 3H). 5-046 (A) δ6.85-7.6 (m, 8H), 4.04 (d, J = 17.4 Hz, 1H), 3.72 (s, 3H), 3.64 (d, J = 17.4 Hz, 1H), 3.50 (s, 3H), 2.31 (s, 3H). 5-047 (A) δ7.3-7.65 (m, 7H), 7.11 (d, J = 3.6 Hz, 1H), 4.11 (d, J = 17.4 Hz, 1H), 3.73 (d, J = 17.4 Hz, 1H), 3.51 (s, 3H), 2.36 (s, 3H). 5-048 (A) δ8.38 (s, 1H), 8.27 (d, J = 8.1 Hz, 1H), 7.5-7.6 (m, 4H), 7.27 (s, 1H), 4.13 (d, J = 17.4 Hz, 1H), 4.08 (s, 3H), 3.75 (d, J = 17.4 Hz, 1H), 2.79 (s, 3H). 5-049 (B) δ8.42 (s, 1H), 7.4-7.7 (m, 6H), 4.18 (s, 3H), 4.12 (d, J = 17.2 Hz, 1H), 3.73 (d, J = 17.2 Hz, 1H), 2.77 (s, 3H). 5-050 (A) δ8.35-8.45 (m, 1H), 7.15-7.75 (m, 9H), 4.02 (d, J = 17.1 Hz, 1H), 3.63 (d, J = 17.1 Hz, 1H), 2.52 (s, 3H), 2.49 (s, 3H). 5-051 (A) δ8.5-8.6 (m, 1H), 7.8-7.9 (m, 1H), 7.4-7.6 (m, 6H), 7.25-7.4 (m, 2H), 4.09 (d, J = 17.1 Hz, 1H), 3.69 (d, J = 17.1 Hz, 1H), 3.66 (s, 3H), 2.52 (s, 3H). 5-052 (A) δ8.33 (d, J = 2.5 Hz, 1H), 7.0-7.55 (m, 8H), 4.06 (d, J = 17.3 Hz, 1H), 3.66 (d, J = 17.3 Hz, 1H), 3.48 (s, 3H), 2.36 (s, 3H). 5-053 (A) δ8.32 (d, J = 2.4 Hz, 1H), 7.3-7.5 (m, 6H), 7.16 (d, J = 8.1 Hz, 1H), 6.93 (s, 1H), 4.06 (q, J = 7.2 Hz, 2H), 4.06 (d, J = 17.1 Hz, 1H), 3.68 (d, J = 17.1 Hz, 1H), 2.36 (s, 3H), 1.23 (t, J = 7.2 Hz, 3H). 5-054 (A) δ8.29 (d, J = 2.4 Hz, 1H), 7.3-7.6 (m, 6H), 7.1-7.25 (m, 2H), 5.33 (s, 2H), 4.06 (d, J = 17.1 Hz, 1H), 3.67 (d, J = 17.1 Hz, 1H), 3.40 (s, 3H), 2.42 (s, 3H). 5-055 (A) δ8.39 (s, 1H), 7.35-7.5 (m, 6H), 7.21 (d, J = 7.8 Hz, 1H), 6.7-6.9 (m, 1H), 4.97 (s, 2H), 4.06 (d, J = 17.1 Hz, 1H), 3.67 (d, J = 17.1 Hz, 1H), 2.35 (s, 3H). 5-056 (A) δ8.29 (d, J = 2.4 Hz, 1H), 7.6-7.7 (m, 1H), 7.15-7.5 (m, 7H), 4.04 (d, J = 17.4 Hz, 1H), 3.65 (d, J = 17.4 Hz, 1H), 2.52 (s, 3H), 2.51 (s, 3H). 5-057 (A) δ8.34 (d, J = 2.7 Hz, 1H), 7.65-7.75 (m, 1H), 7.35-7.5 (m, 5H), 7.15-7.5 (m, 2H), 4.04 (d, J = 17.4 Hz, 1H), 3.65 (d, J = 17.4 Hz, 1H), 2.77 (q, J = 7.2 Hz, 2H), 2.50 (s, 3H), 1.91 (t, J = 7.2 Hz, 3H). 5-058 (A) δ8.33 (d, J = 2.1 Hz, 1H), 7.6-7.7 (m, 1H), 7.35-7.5 (m, 5H), 7.15-7.35 (m, 2H), 4.04 (d, J = 17.4 Hz, 1H), 3.65 (d, J = 17.4 Hz, 1H), 2.71 (t, J = 7.5 Hz, 2H), 2.50 (s, 3H), 1.73 (sxt, J = 7.5 Hz, 2H), 0.97 (t, J = 7.5 Hz, 3H). 5-059 (A) δ8.36 (d, J = 2.1 Hz, 1H), 7.65-7.75 (m, 1H), 7.35-7.5 (m, 6H), 7.14 (d, J = 8.7 Hz, 1H), 4.07 (d, J = 17.4 Hz, 1H), 3.68 (d, J = 17.4 Hz, 1H), 2.51 (s, 3H), 1.21 (s, 9H). 5-061 (B) δ8.42 (d, J = 2.6 Hz, 1H), 7.3-7.65 (m, 7H), 7.19 (d, J = 8.0 Hz, 1H), 4.06 (d, J = 17.2 Hz, 1H), 3.66 (d, J = 17.4 Hz, 1H), 3.48 (s, 3H), 2.35 (s, 3H). 5-062 (B) δ8.4-8.45 (m, 1H), 7.80 (dd, J = 8.4, 2.2 Hz, 1H), 7.35-7.5 (m, 5H), 7.2-7.3 (m, 1H), 7.16 (d, J = 8.4 Hz, 1H), 4.04 (d, J = 17.2 Hz, 1H), 3.64 (d, J = 17.2 Hz, 1H), 2.52 (bs, 6H). 5-063 (B) δ8.60 (bs, 1H), 7.9-8.0 (m, 1H), 7.4-7.6 (m, 6H), 7.2-7.3 (m, 1H), 4.09 (d, J = 17.2 Hz, 1H), 3.65-3.75 (m, 4H), 2.52 (s, 3H). 5-064 (A) δ8.65 (bs, 1H), 7.77 (dd, J = 8.4, 2.1 Hz, 1H), 7.4-7.55 (m, 5H), 7.2-7.3 (m, 2H), 4.07 (d, J = 17.2 Hz, 1H), 3.68 (d, J = 17.2 Hz, 1H), 3.50 (s, 3H), 2.37 (s, 3H). 5-065 (A) δ8.59 (bs, 1H), 7.94 (dd, J = 8.4, 2.4 Hz, 1H), 7.2-7.5 (m, 7H), 4.03 (d, J = 17.2 Hz, 1H), 3.64 (d, J = 17.2 Hz, 1H), 2.55 (s, 3H), 2.53 (s, 3H). 5-066 (A) δ8.78 (bs, 1H), 8.06 (dd, J = 8.4, 2.1 Hz, 1H), 7.4-7.6 (m, 7H), 4.09 (d, J = 17.2 Hz, 1H), 3.70 (d, J = 17.2 Hz, 1H), 3.69 (s, 3H), 2.54 (s, 3H). 5-068 (A) δ9.06 (dd, J = 2.7, 0.6 Hz, 1H), 8.46 (dd, J = 9.0, 2.7 Hz, 1H), 7.58 (dd, J = 9.0, 0.6 Hz, 1H), 7.45-7.5 (m, 3H), 7.41 (t, J = 1.8 Hz, 1H), 7.36 (dd, J = 8.1, 1.5 Hz, 1H), 7.28 (d, J = 8.1 Hz, 1H), 4.05 (d, J = 17.2 Hz, 1H), 3.64 (d, J = 17.2 Hz, 1H), 2.58 (bs, 6H). 5-070 (A) δ8.65 (s, 1H), 7.75-7.85 (m, 1H), 7.4-7.65 (m, 6H), 7.24 (d, J = 7.8 Hz, 1H), 4.08 (d, J = 17.1 Hz, 1H), 3.69 (d, J = 17.1 Hz, 1H), 3.48 (s, 3H), 2.37 (s, 3H). 5-072 (A) δ7.05-7.55 (m, 9H), 4.06 (d, J = 17.2 Hz, 1H), 3.66 (d, J = 17.2 Hz, 1H), 3.49 (s, 3H), 2.37 (s, 3H). 5-074 (A) δ7.79 (t, J = 8.1 Hz, 1H), 7.25-7.5 (m, 8H), 4.09 (d, J = 17.2 Hz, 1H), 3.70 (d, J = 17.2 Hz, 1H), 3.68 (s, 3H), 2.51 (s, 3H). 5-076 (A) δ7.51 (t, J = 7.8 Hz, 1H), 7.25-7.5 (m, 7H), 7.25 (d, J = 7.8 Hz, 1H), 4.03 (d, J = 17.4 Hz, 1H), 3.64 (d, J = 17.4 Hz, 1H), 2.55 (s, 3H), 2.54 (s, 3H). 5-077 (A) δ7.63 (t, J = 7.8 Hz, 1H), 7.4-7.55 (m, 7H), 7.30 (d, J = 7.8 Hz, 1H), 4.08 (d, J = 17.4 Hz, 1H), 3.70 (d, J = 17.4 Hz, 1H), 3.68 (s, 3H), 2.52 (s, 3H). 5-079 (A) δ8.45-8.55 (m, 1H), 8.38 (d, J = 2.7 Hz, 1H), 7.2-7.5 (m, 8H), 4.02 (d, J = 17.4 Hz, 1H), 3.63 (d, J = 17.4 Hz, 1H), 2.50 (s, 3H), 2.46 (s, 3H). 5-080 (A) δ8.6-8.7 (m, 1H), 8.55 (d, J = 2.4 Hz, 1H), 7.35-7.65 (m, 8H), 4.10 (d, J = 17.1 Hz, 1H), 3.71 (d, J = 17.1 Hz, 1H), 3.64 (s, 3H), 2.49 (s, 3H). 5-081 (A) δ8.1 (bs, 1H), 7.0-7.5 (m, 8H), 4.03 (d, J = 16.8 Hz, 1H), 3.64 (d, J = 16.8 Hz, 1H), 3.48 (bs, 3H), 2.35 (s, 3H). 5-082 (B) δ8.32 (d, J = 2.8 Hz, 1H), 7.4-7.6 (m, 8H), 4.10 (d, J = 17.6 Hz, 1H), 3.71 (d, J = 17.6 Hz, 1H), 3.65 (s, 3H), 2.47 (s, 3H). 5-083 (A) δ8.46 (d, J = 6.1 Hz, 2H), 7.1-7.5 (m, 6H), 7.04 (d, J = 6.1 Hz, 2H), 4.04 (d, J = 17.3 Hz, 1H), 3.65 (d, J = 17.3 Hz, 1H), 3.48 (s, 3H), 2.36 (s, 3H). 5-084 (A) δ8.34 (d, J = 4.8 Hz, 2H), 7.45-7.55 (m, 2H), 7.4-7.45 (m, 2H), 7.25-7.3 (m, 1H), 7.06 (d, J = 7.8 Hz, 1H), 6.89 (t, J = 4.8 Hz, 1H), 4.05 (d, J = 17.4 Hz, 1H), 3.67 (s, 3H), 3.65 (d, J = 17.4 Hz, 1H), 2.37 (s, 3H). 5-085 (A) δ8.36 (d, J = 4.8 Hz, 2H), 7.4-7.55 (m, 4H), 7.2-7.3 (m, 1H), 7.05 (d, J = 7.8 Hz, 1H), 6.89 (t, J = 4.8 Hz, 1H), 4.27 (q, J = 7.1 Hz, 2H), 4.05 (d, J = 17.3 Hz, 1H), 3.65 (d, J = 17.3 Hz, 1H), 2.38 (s, 3H), 1.35 (t, J = 7.1 Hz, 3H). 5-086 (A) δ8.41 (d, J = 4.8 Hz, 2H), 7.4-7.55 (m, 4H), 7.2-7.3 (m, 1H), 7.07 (d, J = 8.1 Hz, 1H), 6.94 (t, J = 4.8 Hz, 1H), 5.63 (s, 2H), 4.04 (d, J = 17.0 Hz, 1H), 3.64 (d, J = 17.0 Hz, 1H), 3.52 (s, 3H), 2.48 (s, 3H). 5-087 (A) δ8.41 (d, J = 4.8 Hz, 2H), 7.3-7.55 (m, 5H), 7.11 (d, J = 7.8 Hz, 1H), 6.99 (t, J = 4.8 Hz, 1H), 5.14 (s, 2H), 4.07 (d, J = 17.3 Hz, 1H), 3.67 (d, J = 17.3 Hz, 1H), 2.38 (s, 3H). 5-089 (A) δ8.66 (d, J = 4.8 Hz, 2H), 7.3-7.5 (m, 6H), 7.16 (t, J = 4.8 Hz, 1H), 4.02 (d, J = 17.1 Hz, 1H), 3.63 (d, J = 17.1 Hz, 1H), 2.83 (t, J = 7.5 Hz, 2H), 2.55 (s, 3H), 1.7-1.85 (m, 2H), 1.00 (t, J = 7.5 Hz, 3H). 5-092 (A) δ8.3 (s, 2H), 7.35-7.55 (m, 4H), 7.2-7.35 (m, 1H), 7.05 (d, J = 8.1 Hz, 1H), 4.07 (d, J = 17.4 Hz, 1H), 3.67 (d, J = 17.4 Hz, 1H), 3.65 (s, 3H), 2.37 (s, 3H). 5-093 (A) δ8.29 (s, 2H), 7.4-7.6 (m, 4H), 7.30 (d, J = 8.1 Hz, 1H), 7.04 (d, J = 8.1 Hz, 1H), 4.24 (q, J = 7.2 Hz, 2H), 4.06 (d, J = 16.8 Hz, 1H), 3.66 (d, J = 16.8 Hz, 1H), 2.38 (s, 3H), 1.34 (t, J = 7.2 Hz, 3H). 5-095 (A) δ8.35 (s, 2H), 7.35-7.55 (m, 4H), 7.2-7.3 (m, 1H), 7.06 (d, J = 8.1 Hz, 1H), 5.65 (s, 2H), 4.06 (d, J = 17.1 Hz, 1H), 3.75 (q, J = 6.9 Hz, 2H), 3.66 (d, J = 17.1 Hz, 1H), 2.46 (s, 3H), 1.20 (t, J = 6.9 Hz, 3H). 5-096 (A) δ8.35 (s, 2H), 7.2-7.55 (m, 5H), 7.11 (d, J = 8.1 Hz, 1H), 6.12 (s, 2H), 4.07 (d, J = 17.4 Hz, 1H), 3.67 (d, J = 17.4 Hz, 1H), 2.54 (s, 3H), 2.09 (s, 3H). 5-097 (B) δ8.35 (s, 2H), 7.05-7.6 (m, 6H), 5.11 (s, 2H), 4.07 (d, J = 17.2 Hz, 1H), 3.67 (d, J = 17.2 Hz, 1H), 2.38 (s, 3H). 5-098 (A) δ8.30 (s, 2H), 7.25-7.55 (m, 5H), 7.05 (d, J = 8.1 Hz, 1H), 5.9-6.1 (m, 1H), 5.26 (dd, J = 17.4, 1.2 Hz, 1H), 5.16 (dd, J = 10.5, 1.2 Hz, 1H), 4.82 (d, J = 5.4 Hz, 2H), 4.06 (d, J = 17.1 Hz, 1H), 3.66 (d, J = 17.1 Hz, 1H), 2.41 (s, 3H). 5-099 (A) δ8.34 (s, 2H), 7.25-7.55 (m, 5H), 7.09 (d, J = 7.8 Hz, 1H), 4.98 (d, J = 2.4 Hz, 2H), 4.07 (d, J = 17.1 Hz, 1H), 3.67 (d, J = 17.1 Hz, 1H), 2.39 (s, 3H), 2.21 (t, J = 2.4 Hz, 1H). 5-102 (A) δ8.57 (s, 2H), 7.3-7.5 (m, 6H), 4.03 (d, J = 17.1 Hz, 1H), 3.67 (d, J = 17.1 Hz, 1H), 2.84 (t, J = 7.5 Hz, 2H), 2.53 (s, 3H), 1.75 (sxt, J = 7.5 Hz, 2H), 1.01 (t, J = 6.9 Hz, 3H). 5-104 (A) δ8.60 (s, 2H), 7.35-7.5 (m, 6H), 4.05 (d, J = 17.1 Hz, 1H), 3.66 (d, J = 17.1 Hz, 1H), 2.57 (s, 3H), 2.05-2.2 (m, 1H), 1.2-1.3 (m, 2H), 1.0-1.1 (m, 2H). 5-105 (A) δ8.45 (s, 2H), 7.35-7.55 (m, 6H), 4.07 (d, J = 17.1 Hz, 1H), 3.67 (d, J = 17.1 Hz, 1H), 2.54 (s, 3H), 1.36 (s, 9H). 5-107 (A) δ8.57 (s, 2H), 7.35-7.8 (m, 11H), 4.05 (d, J = 17.1 Hz, 1H), 3.66 (d, J = 17.1 Hz, 1H), 2.57 (s, 3H). 5-109 (A) δ8.72 (s, 2H), 7.4-7.6 (m, 6H), 4.16 (q, J = 7.2 Hz, 2H), 4.09 (d, J = 16.8 Hz, 1H), 3.71 (d, J = 16.8 Hz, 1H), 2.54 (s, 3H), 1.09 (t, J = 7.2 Hz, 3H). 5-110 (A)v8.72 (s, 2H), 7.4-7.6 (m, 6H), 4.09 (d, J = 17.4 Hz, 1H), 4.08 (d, J = 6.6 Hz, 2H), 3.70 (d, J = 17.4 Hz, 1H), 2.54 (s, 3H), 1.48 (sxt, J = 6.6 Hz, 2H), 0.77 (t, J = 6.6 Hz, 3H). 5-111 (A) δ8.72 (s, 2H), 7.4-7.6 (m, 6H), 4.08 (d, J = 17.1 Hz, 1H), 3.90 (d, J = 6.6 Hz, 2H), 3.70 (d, J = 17.1 Hz, 1H), 2.54 (s, 3H), 1.77 (sep, J = 6.6 Hz, 1H), 0.76 (d, J = 6.6 Hz, 6H). 5-112 (A) δ8.72 (s, 2H), 7.4-7.6 (m, 6H), 5.67 (s, 2H), 4.09 (d, J = 17.4 Hz, 1H), 3.70 (d, J = 17.4 Hz, 1H), 2.56 (s, 3H). 5-113 (A) δ8.71 (s, 2H), 7.4-7.6 (m, 6H), 4.2-4.3 (m, 2H), 4.09 (d, J = 17.4 Hz, 1H), 3.71 (d, J = 17.4 Hz, 1H), 3.35-3.45 (m, 2H), 3.23 (s, 3H), 2.54 (s, 3H). 5-114 (B) δ8.38 (s, 2H), 7.05-7.55 (m, 6H), 4.06 (d, J = 17.2 Hz, 1H), 3.66 (d, J = 17.2 Hz, 1H), 3.64 (s, 3H), 2.36 (s, 3H). 5-115 (A) δ8.37 (s, 2H), 7.25-7.55 (m, 5H), 7.03 (d, J = 8.1 Hz, 1H), 4.24 (q, J = 6.9 Hz, 2H), 4.06 (d, J = 17.1 Hz, 1H), 3.66 (d, J = 17.1 Hz, 1H), 2.37 (s, 3H), 1.34 (t, J = 6.9 Hz, 3H). 5-117 (A) δ8.44 (s, 2H), 7.3-7.55 (m, 5H), 7.11 (d, J = 8.1 Hz, 1H), 6.12 (s, 2H), 4.07 (d, J = 17.4 Hz, 1H), 3.67 (d, J = 17.4 Hz, 1H), 2.44 (s, 3H), 2.09 (s, 3H). 5-118 (A) δ8.44 (s, 2H), 7.50 (s, 3H), 7.3-7.45 (m, 2H), 7.10 (d, J = 8.1 Hz, 1H), 5.10 (s, 2H), 4.08 (d, J = 16.8 Hz, 1H), 3.69 (d, J = 16.8 Hz, 1H), 2.37 (s, 3H). 5-121 (A) δ8.67 (s, 2H), 7.3-7.5 (m, 6H), 4.04 (d, J = 17.4 Hz, 1H), 3.65 (d, J = 17.4 Hz, 1H), 2.83 (t, J = 7.5 Hz, 2H), 2.53 (s, 3H), 1.78 (sxt, J = 7.5 Hz, 2H), 1.01 (t, J = 7.5 Hz, 3H). 5-123 (A) δ8.69 (s, 2H), 7.35-7.5 (m, 6H), 4.05 (d, J = 17.1 Hz, 1H), 3.66 (d, J = 17.1 Hz, 1H), 2.57 (s, 3H), 2.05-2.15 (m, 1H), 0.8-1.1 (m, 4H). 5-124 (A) δ8.53 (s, 2H), 7.35-7.55 (m, 6H), 4.07 (d, J = 17.4 Hz, 1H), 3.68 (d, J = 17.4 Hz, 1H), 2.54 (s, 3H), 1.36 (s, 9H). 5-125 (A) δ8.64 (s, 2H), 7.3-7.55 (m, 6H), 4.53 (s, 2H), 4.04 (d, J = 17.1 Hz, 1H), 3.65 (d, J = 17.1 Hz, 1H), 3.44 (s, 3H), 2.55 (s, 3H). 5-126 (B) δ8.38 (s, 2H), 7.35-7.6 (m, 6H), 4.04 (d, J = 17.2 Hz, 1H), 3.73 (s, 3H), 3.66 (d, J = 17.2 Hz, 1H), 2.54 (s, 3H). 5-127 (A) δ8.81 (s, 2H), 7.4-7.6 (m, 6H), 4.17 (q, J = 7.2 Hz, 2H), 4.09 (d, J = 17.1 Hz, 1H), 3.71 (d, J = 17.1 Hz, 1H), 2.54 (s, 3H), 1.10 (t, J = 7.2 Hz, 3H). 5-128 (A) δ8.81 (s, 2H), 7.4-7.6 (m, 6H), 4.0-4.2 (m, 3H), 3.70 (d, J = 16.8 Hz, 1H), 2.54 (s, 3H), 1.49 (sxt, J = 7.5 Hz, 2H), 0.77 (t, J = 7.5 Hz, 3H). 5-129 (A) δ8.81 (s, 2H), 7.4-7.6 (m, 6H), 4.08 (d, J = 16.8 Hz, 1H), 3.90 (d, J = 6.6 Hz, 2H), 3.70 (d, J = 16.8 Hz, 1H), 2.54 (s, 3H), 1.77 (sep, J = 6.6 Hz, 1H), 0.76 (d, J = 6.6 Hz, 6H). 5-130 (A) δ8.81 (s, 2H), 7.4-7.6 (m, 6H), 5.67 (s, 2H), 4.09 (d, J = 17.4 Hz, 1H), 3.70 (d, J = 17.4 Hz, 1H), 2.55 (s, 3H). 5-132 (A) δ8.46 (bs, 1H), 8.45 (d, J = 1.3 Hz, 1H), 7.45-7.55 (m, 4H), 7.43 (t, J = 1.8 Hz, 1H), 7.22 (d, J = 8.1 Hz, 1H), 4.07 (d, J = 17.2 Hz, 1H), 3.68 (d, J = 17.2 Hz, 1H), 3.45 (s, 3H), 2.36 (s, 3H). 5-133 (A) δ8.40 (d, J = 1.2 Hz, 1H), 8.34 (d, J = 1.8 Hz, 1H), 7.45-7.55 (m, 3H), 7.42 (t, J = 1.8 Hz, 1H), 7.34 (dd, J = 8.4, 1.2 Hz, 1H), 7.25 (d, J = 7.8 Hz, 1H), 4.04 (d, J = 17.2 Hz, 1H), 3.65 (d, J = 17.2 Hz, 1H), 2.60 (s, 3H), 2.51 (s, 3H). 5-137 (B) δ8.25-8.3 (m, 1H), 8.0-8.1 (m, 1H), 7.5-7.7 (m, 5H), 7.42 (t, J = 1.8 Hz, 1H), 7.2-7.25 (m, 1H), 4.03 (d, J = 17.2 Hz, 1H), 3.65 (d, J = 17.2 Hz, 1H), 3.45 (s, 3H). 5-138 (A) δ8.63 (s, 2H), 8.03 (s, 1H), 7.35-7.65 (m, 5H), 4.01 (d, J = 17.1 Hz, 1H), 3.62 (d, J = 17.1 Hz, 1H), 2.56 (s, 3H). 5-142 (A) δ8.22 (s, 2H), 7.51 (bs, 3H), 7.42 (bs, 1H), 7.2-7.35 (m, 2H), 5.02 (bs, 2H), 4.08 (d, J = 17.4 Hz, 1H), 3.68 (d, J = 17.4 Hz, 1H), 2.43 (s, 3H), 2.31 (s, 3H). 5-143 (A) δ8.26 (s, 2H), 7.51 (bs, 3H), 7.42 (bs, 1H), 7.2-7.35 (m, 2H), 4.95 (bs, 2H), 4.07 (d, J = 17.4 Hz, 1H), 3.82 (s, 3H), 3.68 (d, J = 17.4 Hz, 1H), 2.44 (s, 3H). 5-144 (A) δ8.33 (s, 2H), 7.25-7.55 (m, 5H), 7.04 (d, J = 8.1 Hz, 1H), 5.36 (s, 2H), 4.06 (d, J = 17.4 Hz, 1H), 3.66 (d, J = 17.4 Hz, 1H), 2.43 (s, 3H), 2.29 (s, 3H). 5-145 (A) δ8.57 (s, 2H), 7.3-7.5 (m, 6H), 4.73 (s, 2H), 4.03 (d, J = 17.1 Hz, 1H), 3.64 (d, J = 17.1 Hz, 1H), 2.56 (s, 3H). 5-146 (A) δ8.55 (s, 2H), 7.35-7.5 (m, 6H), 4.53 (s, 2H), 4.04 (d, J = 17.1 Hz, 1H), 3.5-3.7 (m, 3H), 2.56 (s, 3H), 1.13 (t, J = 6.9 Hz, 3H). 5-147 (A) δ8.54 (s, 2H), 7.35-7.5 (m, 6H), 4.03 (d, J = 17.1 Hz, 1H), 3.88 (s, 2H), 3.64 (d, J = 17.1 Hz, 1H), 2.56 (s, 3H), 2.28 (s, 3H). 5-148 (A) δ8.55 (s, 2H), 7.35-7.5 (m, 6H), 4.66 (dd, J = 14.1, 3.3 Hz, 1H), 4.20 (dd, J = 14.1, 3.3 Hz, 1H), 4.02 (d, J = 17.1 Hz, 1H), 3.62 (d, J = 17.1 Hz, 1H), 2.87 (s, 3H), 2.55 (s, 3H). 5-149 (A) δ8.57 (s, 2H), 7.35-7.6 (m, 6H), 4.38 (q, J = 7.2 Hz, 2H), 4.04 (d, J = 17.1 Hz, 1H), 3.65 (d, J = 17.1 Hz, 1H), 2.58 (s, 3H), 1.37 (t, J = 7.2 Hz, 3H). 5-150 (A) δ8.53 (s, 2H), 8.42 (d, J = 4.1 Hz, 1H), 8.04 (d, J = 8.0 Hz, 1H), 7.8-7.9 (m, 2H), 7.35-7.55 (m, 6H), 4.05 (d, J = 17.0 Hz, 1H), 3.66 (d, J = 17.0 Hz, 1H), 2.62 (s, 3H). 5-152 (A) δ8.56 (s, 2H), 8.25 (d, J = 8.8 Hz, 2H), 7.92 (d, J = 8.8 Hz, 2H), 7.4-7.65 (m, 6H), 4.05 (d, J = 17.0 Hz, 1H), 3.66 (d, J = 17.0 Hz, 1H), 2.57 (s, 3H). 5-153 (A) δ8.72 (s, 2H), 7.45-7.6 (m, 5H), 7.43 (t, J = 1.8 Hz, 1H), 4.85-5.0 (m, 1H), 4.09 (d, J = 17.1 Hz, 1H), 3.70 (d, J = 17.1 Hz, 1H), 2.54 (s, 3H), 1.08 (d, J = 6.3 Hz, 6H). 5-154 (A) δ8.72 (s, 2H), 7.5-7.6 (m, 5H), 7.43 (t, J = 1.8 Hz, 1H), 4.05-4.15 (m, 3H), 3.69 (d, J = 16.5 Hz, 1H), 2.54 (s, 3H), 1.35-1.5 (m, 1H), 1.1-1.2 (m, 3H), 0.80 (t, J = 7.2 Hz, 3H). 5-155 (A) δ8.73 (s, 2H), 7.5-7.6 (m, 5H), 7.44 (t, J = 1.8 Hz, 1H), 4.09 (d, J = 17.1 Hz, 1H), 3.71 (d, J = 17.1 Hz, 1H), 2.55 (s, 3H), 1.28 (s, 9H). 5-158 (A) δ8.76 (s, 2H), 7.0-7.65 (m, 11H), 4.07 (d, J = 17.1 Hz, 1H), 3.68 (d, J = 17.1 Hz, 1H), 2.59 (s, 3H). 5-159 (A) δ8.42 (s, 2H), 7.2-7.5 (m, 6H), 4.07 (d, J = 17.4 Hz, 1H), 3.68 (d, J = 17.4 Hz, 1H), 3.10 (s, 6H), 2.53 (s, 3H). 5-160 (A) δ8.43 (s, 2H), 7.0-7.55 (m, 6H), 5.65 (s, 2H), 4.06 (d, J = 17.4 Hz, 1H), 3.75 (q, J = 6.6 Hz, 2H), 3.67 (d, J = 17.4 Hz, 1H), 2.45 (s, 3H), 1.20 (t, J = 6.6 Hz, 3H). 5-161 (A) δ8.38 (s, 2H), 7.0-7.55 (m, 6H), 5.9-6.1 (m, 1H), 5.1-5.35 (m, 2H), 4.82 (d, J = 5.4 Hz, 2H), 4.07 (d, J = 17.1 Hz, 1H), 3.68 (d, J = 17.1 Hz, 1H), 2.41 (s, 3H). 5-162 (A) δ8.64 (s, 2H), 7.3-7.8 (m, 11H), 4.05 (d, J = 17.4 Hz, 1H), 3.66 (d, J = 17.4 Hz, 1H), 2.56 (s, 3H). 5-163 (A) δ8.80 (s, 2H), 7.4-7.6 (m, 6H), 4.2-4.3 (m, 2H), 4.09 (d, J = 17.4 Hz, 1H), 3.70 (d, J = 17.4 Hz, 1H), 3.35-3.45 (m, 2H), 3.23 (s, 3H), 2.54 (s, 3H). 5-166 (A) δ9.08 (s, 1H), 8.53 (s, 2H), 7.2-7.55 (m, 6H), 4.03 (d, J = 17.2 Hz, 1H), 3.40 (d, J = 17.2 Hz, 1H), 2.83 (q, J = 7.2 Hz, 2H), 2.46 (s, 3H), 1.21 (t, J = 7.2 Hz, 3H). 5-167 (A) δ9.08 (s, 1H), 8.53 (s, 2H), 7.4-7.5 (m, 5H), 7.23 (d, J = 8.1 Hz, 1H), 4.03 (d, J = 17.4 Hz, 1H), 3.64 (d, J = 17.4 Hz, 1H), 2.77 (t, J = 7.2 Hz, 2H), 2.46 (s, 3H), 1.73 (sxt, J = 7.2 Hz, 2H), 0.98 (t, J = 7.2 Hz, 3H). 5-168 (A) δ9.09 (s, 1H), 8.54 (s, 2H), 7.4-7.6 (m, 5H), 7.26 (d, J = 7.8 Hz, 1H), 4.04 (d, J = 17.4 Hz, 1H), 3.65 (d, J = 17.4 Hz, 1H), 3.22 (sep, J = 6.9 Hz, 1H), 2.48 (s, 3H), 1.25 (d, J = 6.9 Hz, 6H). 5-175 (A) δ8.79 (s, 2H), 7.4-8.4 (m, 6H), 4.12 (d, J = 17.1 Hz, 1H), 3.75 (d, J = 17.1 Hz, 1H), 2.24 (s, 3H). 5-177 (A) δ7.3-7.55 (m, 7H), 6.35-6.45 (m, 1H), 6.2-6.3 (m, 1H), 4.08 (d, J = 17.4 Hz, 1H), 3.69 (d, J = 17.4 Hz, 1H), 2.48 (s, 3H), 1.28 (s, 9H). 5-178 (A) δ8.34 (s, 2H), 7.25-7.55 (m, 5H), 7.10 (d, J = 7.8 Hz, 1H), 6.17 (s, 2H), 4.05 (d, J = 17.4 Hz, 1H), 3.79 (s, 3H), 3.65 (d, J = 17.4 Hz, 1H), 2.44 (s, 3H). 5-179 (A) δ8.53 (s, 2H), 7.3-7.55 (m, 5H), 7.03 (d, J = 7.8 Hz, 1H), 4.30 (q, J = 7.2 Hz, 2H), 4.08 (d, J = 17.4 Hz, 1H), 3.69 (d, J = 17.4 Hz, 1H), 2.39 (s, 3H), 1.38 (t, J = 7.2 Hz, 3H). 5-180 (A) δ8.61 (s, 2H), 7.4-7.55 (m, 4H), 7.31 (d, J = 8.0 Hz, 1H), 7.09 (d, J = 8.0 Hz, 1H), 5.63 (s, 2H), 4.06 (d, J = 17.0 Hz, 1H), 3.66 (d, J = 17.0 Hz, 1H), 3.52 (s, 3H), 2.48 (s, 3H). 5-181 (A) δ8.62 (s, 2H), 7.3-7.55 (m, 5H), 7.12 (d, J = 8.4 Hz, 1H), 6.17 (s, 2H), 4.08 (d, J = 17.4 Hz, 1H), 3.69 (d, J = 17.4 Hz, 1H), 2.45 (s, 3H), 2.10 (s, 3H). 5-182 (A) δ8.83 (s, 2H), 7.3-7.55 (m, 6H), 4.03 (d, J = 17.2 Hz, 1H), 3.64 (d, J = 17.2 Hz, 1H), 2.62 (s, 3H), 2.58 (s, 3H). 5-184 (A) δ8.94 (s, 2H), 7.4-7.6 (m, 6H), 4.08 (d, J = 17.2 Hz, 1H), 3.79 (s, 3H), 3.66 (d, J = 17.2 Hz, 1H), 2.57 (s, 3H). 5-185 (A) δ8.55 (bs, 2H), 7.4-7.55 (m, 6H), 4.95 (bs, 2H), 4.05 (d, J = 17.4 Hz, 1H), 3.70 (d, J = 17.4 Hz, 1H), 3.40 (bs, 3H), 2.40 (s, 3H). 5-186 (A) δ8.35 (s, 2H), 7.2-7.5 (m, 6H), 4.40 (d, J = 17.4 Hz, 1H), 3.65 (d, J = 17.4 Hz, 1H), 2.60 (s, 3H), 2.45 (s, 3H). 5-187 (A) δ8.60 (s, 2H), 7.4-7.6 (m, 6H), 4.10 (d, J = 17.4 Hz, 1H), 3.70 (d, J = 17.4 Hz, 1H), 3.65 (s, 3H), 2.45 (s, 3H). 5-188 (A) δ8.21 and 8.62 (s, 1H), 7.0-7.7 (m, 6H), 3.9-4.15 (m, 1H), 3.64 and 3.73 (d, J = 17.4 Hz, 1H), 3.15 and 3.43 (s, 3H), 2.44 and 2.48 (s, 3H). 5-190 (A) δ8.36 (s, 1H), 7.3-7.6 (m, 6H), 4.05 (d, J = 17.4 Hz, 1H), 3.67 (d, J = 17.4 Hz, 1H), 2.52 (s, 3H), 2.49 (s, 3H). 5-191 (A) δ8.55 (s, 1H), 7.35-7.65 (m, 6H), 4.12 (d, J = 17.4 Hz, 1H), 3.73 (d, J = 17.4 Hz, 1H), 3.69 (s, 3H), 2.48 (s, 3H). 5-192 (A) δ8.3-8.6 (m, 3H), 7.2-7.45 (m, 6H), 4.00 (d, J = 17.4 Hz, 1H), 3.60 (d, J = 17.4 Hz, 1H), 2.60 (s, 3H), 2.50 (s, 3H). 5-193 (A) δ8.40 (s, 1H), 8.35 (s, 1H), 7.25-7.5 (m, 6H), 5.30 (s, 2H), 4.05 (d, J = 17.4 Hz, 1H), 3.65 (d, J = 17.4 Hz, 1H), 3.40 (s, 3H), 2.40 (s, 3H). 5-194 (A) δ8.35 (s, 1H), 8.30 (s, 1H), 7.2-7.6 (m, 6H), 4.25 (d, J = 17.4 Hz, 1H), 3.65 (d, J = 17.4 Hz, 1H), 2.60 (s, 3H), 2.50 (s, 3H). 5-195 (A) δ9.13 (s, 1H), 8.68 (s, 1H), 7.3-7.65 (m, 6H), 4.11 (d, J = 17.4 Hz, 1H), 3.72 (d, J = 17.4 Hz, 1H), 3.44 (s, 3H), 2.39 (s, 3H). 5-197 (A) δ8.78 (s, 1H), 8.52 (s, 1H), 7.25-7.55 (m, 6H), 4.03 (d, J = 17.4 Hz, 1H), 3.64 (d, J = 17.4 Hz, 1H), 2.60 (s, 3H), 2.56 (s, 3H). 5-198 (A) δ9.01 (s, 1H), 8.65 (s, 2H), 7.1-7.55 (m, 6H), 5.07 (s, 2H), 4.05 (d, J = 17.4 Hz, 1H), 3.66 (d, J = 17.4 Hz, 1H), 3.43 (s, 3H), 2.40 (s, 3H). 5-199 (A) δ7.25-7.6 (m, 11H), 4.09 (d, J = 17.4 Hz, 1H), 3.71 (d, J = 17.4 Hz, 1H), 2.51 (s, 3H), 1.20 (s, 9H). 5-204 (A) δ8.64 (s, 2H), 7.35-7.55 (m, 5H), 7.10 (d, J = 8.0 Hz, 1H), 5.15 (s, 2H), 4.08 (d, J = 17.5 Hz, 1H), 3.68 (d, J = 17.5 Hz, 1H), 2.40 (s, 3H). 5-205 (A) δ8.82 (s, 2H), 7.35-7.55 (m, 6H), 4.04 (d, J = 17.5 Hz, 1H), 3.65 (d, J = 17.5 Hz, 1H), 2.93 (q, J = 7.6 Hz, 2H), 2.58 (s, 3H), 1.27 (t, J = 7.6 Hz, 3H). 6-003 (B) δ8.58 (d, J = 14.2 Hz, 1H), 7.85 (d, J = 14.2 Hz, 1H), 7.4-7.6 (m, 6H), 4.09 (d, J = 17.4 Hz, 1H), 3.78 (s, 3H), 3.70 (d, J = 17.4 Hz, 1H), 2.51 (s, 3H). 6-007 (B) δ8.49 (d, J = 9.0 Hz, 1H), 7.77 (d, J = 9.0 Hz, 1H), 7.5-7.65 (m, 5H), 7.44 (t, J = 1.8 Hz, 1H), 4.36 (qui, J = 6.4 Hz, 1H), 4.09 (d, J = 17.4 Hz, 1H), 3.71 (d, J = 17.4 Hz, 1H), 2.54 (s, 3H), 1.26 (d, J = 6.4 Hz, 6H). 6-009 (A) δ8.45 (d, J = 9.0 Hz, 1H), 7.87 (bs, 1H), 7.5-7.65 (m, 5H), 7.44 (t, J = 1.8 Hz, 1H), 4.31 and 4.45 (q, J = 9.0 Hz, 2H), 4.09 (d, J = 17.4 Hz, 1H), 3.71 (d, J = 17.4 Hz, 1H), 2.54 (s, 3H). 6-016 (A) δ8.54 (d, J = 9.0 Hz, 1H), 8.18 (s, 1H), 7.7-7.8 (m, 2H), 7.4-7.6 (m, 4H), 4.06 (d, J = 17.4 Hz, 1H), 3.91 (s, 3H), 3.68 (d, J = 17.4 Hz, 1H). 6-026 (A) δ7.99 (d, J = 9.0 Hz, 1H), 7.77 (d, J = 9.0 Hz, 1H), 7.66 (s, 1H), 7.3-7.6 (m, 10H), 4.11 (d, J = 17.4 Hz, 1H), 3.73 (d, J = 17.4 Hz, 1H), 3.59 (s, 3H). 6-028 (A) δ8.30 and 9.17 (d, J = 10.2 Hz, 1H), 7.82 and 8.59 (d, J = 10.2 Hz, 1H), 7.85-7.95 (m, 1H), 7.75-7.80 (m, 1H), 7.66 (d, J = 7.8 Hz, 1H), 7.51 (s, 2H), 7.43 (s, 1H), 4.09 (d, J = 17.4 Hz, 1H), 3.80 and 3.92 (s, 3H), 3.73 (d, J = 17.4 Hz, 1H). 6-029 (A) δ8.50 and 8.59 (d, J = 10.2 Hz, 1H), 7.77 and 7.87 (d, J = 10.2 Hz, 1H), 7.66 (s, 1H), 7.5-7.65 (m, 5H), 4.07 (d, J = 17.4 Hz, 1H), 3.39 and 3.79 (s, 3H), 3.67 (d, J = 17.4 Hz, 1H), 2.52 (s, 3H). 6-030 (A) δ8.48 and 8.58 (d, J = 10.2 Hz, 1H), 8.08 (s, 2H), 7.97 (s, 1H), 7.76 and 7.87 (d, J = 10.2 Hz, 1H), 7.45-7.65 (m, 3H), 4.20 (d, J = 17.4 Hz, 1H), 3.79 and 3.89 (s, 3H), 3.76 (d, J = 17.4 Hz, 1H), 2.53 (s, 3H). 6-035 (A) δ8.49 and 8.59 (d, J = 10.2 Hz, 1H), 7.65-7.8 (m, 2H), 7.70 (s, 2H), 7.5-7.65 (m, 3H), 4.07 (d, J = 17.4 Hz, 1H), 3.78 and 3.90 (s, 3H), 3.68 (d, J = 17.4 Hz, 1H), 2.53 (s, 3H). 6-036 (A) δ8.52 and 8.58 (d, J = 9.9 Hz, 1H), 7.65-7.95 (m, 4H), 7.45-7.65 (m, 3H), 3.95-4.25 (m, 3H), 3.70 (d, J = 17.4 Hz, 1H), 2.54 (s, 3H), 1.28 (t, J = 6.9 Hz, 3H). 6-038 (A) δ8.48 and 9.23 (d, J = 9.9 Hz, 1H), 7.7-7.85 (m, 1H), 7.5-7.65 (m, 5H), 4.08 (d, J = 17.4 Hz, 1H), 3.79 and 3.89 (s, 3H), 3.68 (d, J = 17.4 Hz, 1H), 2.53 (s, 3H). 6-039 (A) δ8.48 and 8.58 (d, J = 9.9 Hz, 1H), 7.7-7.85 (m, 1H), 7.64 (s, 2H), 7.5-7.6 (m, 3H), 4.10 (d, J = 17.4 Hz, 1H), 3.79 and 3.89 (s, 3H), 3.69 (d, J = 17.4 Hz, 1H), 2.53 (s, 3H). 6-040 (A) δ8.51 and 8.59 (d, J = 9.9 Hz, 1H), 7.7-7.85 (m, 1H), 7.64 (s, 2H), 7.5-7.6 (m, 3H), 4.02 and 4.14 (d, J = 7.2 Hz, 2H), 4.08 (d, J = 17.4 Hz, 1H), 3.69 (d, J = 17.4 Hz, 1H), 2.53 (s, 3H), 1.26 and 1.28 (t, J = 7.2 Hz, 3H). 6-041 (A) δ8.48 and 9.23 (d, J = 9.9 Hz, 1H), 7.7-7.95 (m, 3H), 7.5-7.65 (m, 3H), 4.13 (d, J = 17.4 Hz, 1H), 3.79 and 3.89 (s, 3H), 3.70 (d, J = 17.4 Hz, 1H), 2.53 (s, 3H). 6-044 (A) δ8.68 (bs, 1H), 7.88 (bs, 1H), 7.35-7.65 (m, 6H), 4.68 (s, 2H), 4.08 (d, J = 17.4 Hz, 1H), 3.70 (d, J = 17.4 Hz, 1H), 2.53 (s, 3H). 6-045 (A) δ8.50 (d, J = 9.6 Hz, 1H), 8.20 (d, J = 8.4 Hz, 2H), 7.80 (bs, 1H), 7.55 (d, J = 8.4 Hz, 2H), 7.4-7.65 (m, 6H), 5.10 and 5.20 (s, 2H), 4.10 (d, J = 17.4 Hz, 1H), 3.70 (d, J = 17.4 Hz, 1H), 2.55 (s, 3H). 6-047 (A) δ7.9-8.1 (m, 1H), 7.75-7.8 (m, 1H), 7.67 (s, 1H), 7.4-7.6 (m, 7H), 7.25-7.35 (m, 2H), 4.11 (d, J = 17.4 Hz, 1H), 3.73 (d, J = 17.4 Hz, 1H), 3.67 (s, 3H). 6-048 (A) δ8.45 (d, J = 9.3 Hz, 1H), 7.87 (d, J = 9.3 Hz, 1H), 7.45-7.75 (m, 7H), 7.44 (bs, 1H), 6.52 (bs, 1H), 4.11 (d, J = 17.4 Hz, 1H), 3.76 (s, 3H), 3.71 (d, J = 17.4 Hz, 1H). 6-049 (A) δ8.21 (d, J = 9.6 Hz, 1H), 7.95 (d, J = 9.6 Hz, 1H), 7.65-7.8 (m, 2H), 7.60 (d, J = 9.6 Hz, 1H), 7.4-7.55 (m, 5H), 7.10 (d, J = 6.0 Hz, 1H), 4.11 (d, J = 17.4 Hz, 1H), 3.73 (d, J = 17.4 Hz, 1H), 3.69 (s, 3H). 6-052 (A) δ8.86 (d, J = 9.6 Hz, 1H), 7.75-8.0 (m, 5H), 7.65 (s, 2H), 4.11 (d, J = 17.4 Hz, 1H), 3.94 (s, 3H), 3.70 (d, J = 17.4 Hz, 1H). 6-055 (A) δ8.87 and 8.60 (d, J = 9.3 Hz, 1H), 7.90 (d, J = 9.0 Hz, 2H), 7.75-7.85 (m, 3H), 7.65 (s, 2H), 4.40 (qui, J = 6.0 Hz, 1H), 4.12 (d, J = 17.4 Hz, 1H), 3.73 (d, J = 17.4 Hz, 1H), 1.2-1.35 (m, 6H). 7-001 (A) δ7.25-7.55 (m, 6H), 6.89 and 6.91 (s, 1H), 5.22 and 5.25 (s, 2H), 4.09 (d, J = 17.4 Hz, 1H), 3.79 and 3.80 (s, 3H), 3.70 (d, J = 17.4 Hz, 1H), 3.38 and 3.39 (s, 3H), 2.40 and 2.43 (s, 3H). 7-006 (A) δ7.3-7.6 (m, 6H), 6.90 (s, 1H), 5.25 (s, 2H), 4.09 (d, J = 17.1 Hz, 1H), 3.79 (s, 3H), 3.71 (d, J = 17.1 Hz, 1H), 3.57 (q, J = 7.2 Hz, 2H), 2.40 (s, 3H), 1.20 (t, J = 7.2 Hz, 3H). 7-007 (A) δ7.25-7.6 (m, 6H), 6.60 (s, 1H), 4.84 (s, 2H), 4.09 (d, J = 17.4 Hz, 1H), 3.95 (s, 3H), 3.71 (d, J = 17.4 Hz, 1H), 2.36 (s, 3H). 7-008 (A) δ7.25-7.6 (m, 6H), 6.68 (s, 1H), 4.73 (s, 2H), 4.09 (d, J = 17.4 Hz, 1H), 3.87 (s, 3H), 3.70 (d, J = 17.4 Hz, 1H), 2.37 (s, 3H), 2.27 (s, 1H). 7-009 (A) δ7.3-7.6 (m, 6H), 6.88 (s, 1H), 5.24 (s, 2H), 4.08 (d, J = 17.4 Hz, 1H), 4.05 (q, J = 6.9 Hz, 2H), 3.70 (d, J = 17.4 Hz, 1H), 3.88 (s, 3H), 2.40 (s, 3H), 1.22 (t, J = 6.9 Hz, 3H). 7-010 (A) δ9.15 and 9.80 (d, J = 8.7 Hz, 1H), 8.31 and 9.08 (d, J = 8.7 Hz, 1H), 7.8-7.95 (m, 2H), 7.65-7.8 (m, 2H), 7.51 (s, 2H), 7.44 (bs, 1H), 4.09 (d, J = 17.4 Hz, 1H), 3.86 and 3.97 (s, 3H), 3.71 (d, J = 17.4 Hz, 1H). 7-011 (A) δ9.15 and 9.81 (d, J = 8.7 Hz, 1H), 8.30 and 9.08 (d, J = 9.5 Hz, 1H), 7.85-7.95 (m, 2H), 7.65-7.8 (m, 2H), 7.51 (s, 2H), 7.43 (bs, 1H), 4.21 (q, J = 7.2 Hz, 2H), 4.09 (d, J = 17.4 Hz, 1H), 3.71 (d, J = 17.4 Hz, 1H), 1.33 (t, J = 7.2 Hz, 3H). 7-012 (A) δ9.42 (d, J = 9.6 Hz, 1H), 8.26 (d, J = 9.6 Hz, 1H), 7.35-7.6 (m, 6H), 4.07 (d, J = 17.4 Hz, 1H), 3.92 (s, 3H), 3.69 (d, J = 17.4 Hz, 1H), 2.44 (s, 3H). 7-013 (A) δ7.3-7.6 (m, 6H), 6.90 (s, 1H), 5.20 (s, 2H), 4.10 (d, J = 17.4 Hz, 1H), 3.80 (s, 3H), 3.70 (d, J = 17.4 Hz, 1H), 3.40 (s, 3H), 2.40 (s, 3H). 7-014 (A) δ7.25-7.65 (m, 7H), 5.69 (bs, 2H), 4.08 (d, J = 17.4 Hz, 1H), 3.78 (s, 3H), 3.70 (d, J = 17.4 Hz, 1H), 2.35 (s, 3H), 2.08 (s, 3H). 7-015 (A) δ7.25-7.65 (m, 6H), 6.90 (s, 1H), 5.77 (s, 2H), 4.08 (d, J = 17.4 Hz, 1H), 3.81 (s, 3H), 3.70 (d, J = 17.4 Hz, 1H), 2.39 (s, 3H), 2.09 (s, 3H). 7-016 (A) δ7.25-7.65 (m, 6H), 6.68 (s, 1H), 5.13 (s, 2H), 4.08 (d, J = 17.4 Hz, 1H), 3.82 (s, 3H), 3.69 (d, J = 17.4 Hz, 1H), 2.38 (s, 3H), 2.25 (s, 3H). 7-017 (A) δ7.79 (bs, 1H), 7.25-7.65 (m, 6H), 5.03 (bs, 2H), 4.08 (d, J = 17.4 Hz, 1H), 3.77 (s, 3H), 3.70 (d, J = 17.4 Hz, 1H), 2.34 (s, 6H). 7-018 (A) δ7.3-7.6 (m, 6H), 6.68 (bs, 1H), 4.78 (s, 2H), 4.08 (d, J = 17.4 Hz, 1H), 3.80 (s, 3H), 3.79 (s, 3H), 3.69 (d, J = 17.4 Hz, 1H), 2.41 (s, 3H). 7-019 (A) δ8.56 (bs, 1H), 7.95 (s, 1H), 7.05-7.75 (m, 9H), 5.25 (s, 2H), 4.10 (d, J = 17.4 Hz, 1H), 3.70 (d, J = 17.4 Hz, 1H), 3.65 (s, 3H), 2.40 (s, 3H). 7-020 (A) δ7.55-7.6 (m, 2H), 7.51 (bs, 2H), 7.44 (t, J = 1.8 Hz, 1H), 7.33 (d, J = 8.0 Hz, 1H), 6.59 (s, 1H), 4.84 (s, 2H), 4.19 (q, J = 7.2 Hz, 2H), 4.08 (d, J = 17.4 Hz, 1H), 3.69 (d, J = 17.4 Hz, 1H), 2.37 (s, 3H), 1.34 (t, J = 7.2 Hz, 3H). 7-021 (A) δ7.2-7.55 (m, 6H), 6.60 (s, 1H), 4.11 (d, J = 17.4 Hz, 1H), 3.77 (s, 3H), 3.69 (d, J = 17.4 Hz, 1H), 3.52 (s, 2H), 2.36 (s, 3H), 0.15 (s, 9H). 7-022 (A) δ9.79 (d, J = 9.1 Hz, 1H), 8.29 (d, J = 9.1 Hz, 1H), 7.88 (d, J = 8.7 Hz, 2H), 7.72 (d, J = 8.7 Hz, 2H), 7.64 (s, 2H), 4.10 (d, J = 17.5 Hz, 1H), 3.97 (s, 3H), 3.71 (d, J = 17.5 Hz, 1H). 7-023 (A) δ9.81 (d, J = 9.3 Hz, 1H), 8.29 (d, J = 9.3 Hz, 1H), 7.89 (d, J = 8.4 Hz, 2H), 7.72 (d, J = 8.4 Hz, 2H), 7.64 (s, 2H), 4.21 (q, J = 7.2 Hz, 2H), 4.10 (d, J = 17.4 Hz, 1H), 3.71 (d, J = 17.4 Hz, 1H), 1.33 (t, J = 7.2 Hz, 3H). 8-002 (A) δ8.04 (d, J = 8.1 Hz, 1H), 7.5-7.6 (m, 4H), 7.43 (t, J = 1.8 Hz, 1H), 5.07 (s, 2H), 4.10 (d, J = 17.2 Hz, 1H), 4.09 (s, 3H), 3.72 (d, J = 17.2 Hz, 1H), 3.38 (s, 3H), 2.68 (s, 3H). 8-004 (A) δ8.66 (s, 1H), 8.32 (d, J = 8.7 Hz, 2H), 7.71 (d, J = 8.7 Hz, 2H), 7.52 (s, 2H), 7.43 (s, 1H), 4.12 (d, J = 17.4 Hz, 1H), 3.73 (d, J = 17.4 Hz, 1H), 3.25 (s, 3H), 3.22 (s, 3H). 8-007 (A) δ7.90 (d, J = 8.6 Hz, 1H), 7.4-7.55 (m, 5H), 4.09 (d, J = 17.4 Hz, 1H), 3.70 (d, J = 17.4 Hz, 1H), 3.16 (s, 3H), 3.13 (s, 3H), 2.62 (s, 3H), 2.35 (s, 3H). 8-008 (A) δ8.61 (s, 1H), 7.96 (d, J = 7.5 Hz, 1H), 7.66 (s, 1H), 7.62 (d, J = 8.1 Hz, 1H), 7.53 (s, 2H), 7.43 (s, 1H), 4.13 (d, J = 17.4 Hz, 1H), 3.71 (d, J = 17.4 Hz, 1H), 3.22 (s, 3H), 3.18 (s, 3H), 2.35 (s, 3H). 8-009 (A) δ8.59 (s, 1H), 8.11 (d, J = 8.1 Hz, 1H), 7.7-7.75 (m, 3H), 7.53 (d, J = 8.1 Hz, 1H), 7.51 (s, 1H), 4.09 (d, J = 17.4 Hz, 1H), 3.74 (d, J = 17.4 Hz, 1H), 3.20 (s, 3H), 3.19 (s, 3H), 2.64 (s, 3H). 3.18 (s, 3H), 2.35 (s, 3H). 8-010 (A) δ8.60 (s, 1H), 8.05-8.15 (m, 3H), 7.96 (s, 1H), 7.53 (d, J = 8.1 Hz, 1H), 7.51 (s, 1H), 4.21 (d, J = 17.4 Hz, 1H), 3.76 (d, J = 17.4 Hz, 1H), 3.20 (s, 3H), 3.18 (s, 3H), 2.65 (s, 3H). 8-011 (A) δ8.59 (s, 1H), 8.10 (d, J = 8.1 Hz, 1H), 7.65 (s, 2H), 7.50 (d, J = 8.1 Hz, 1H), 7.48 (s, 1H), 4.09 (d, J = 17.4 Hz, 1H), 3.74 (d, J = 17.4 Hz, 1H), 3.20 (s, 3H), 3.18 (s, 3H), 2.64 (s, 3H). 8-012 (A) δ8.70 (s, 1H), 7.67 (d, J = 7.8 Hz, 1H), 7.51 (bs, 2H), 7.4-7.55 (m, 3H), 4.06 (d, J = 17.4 Hz, 1H), 3.69 (d, J = 17.4 Hz, 1H), 3.31 (s, 3H), 3.20 (s, 3H), 2.48 (s, 3H). 8-013 (A) δ7.91 (d, J = 8.1 Hz, 1H), 7.4-7.55 (m, 5H), 4.09 (d, J = 17.4 Hz, 1H), 3.92 (s, 3H), 3.70 (d, J = 17.4 Hz, 1H), 3.07 (s, 6H), 2.64 (s, 3H). 8-014 (A) δ7.97 (d, J = 7.9 Hz, 1H), 7.4-7.6 (m, 5H), 4.10 (d, J = 17.1 Hz, 1H), 3.71 (d, J = 17.1 Hz, 1H), 3.24 (s, 6H), 2.66 (s, 3H), 2.44 (s, 3H). 8-016 (A) δ8.07 (d, J = 8.1 Hz, 1H), 7.4-7.6 (m, 5H), 4.47 (t, J = 6.6 Hz, 2H), 4.10 (d, J = 17.4 Hz, 1H), 3.69 (d, J = 17.4 Hz, 1H), 2.67 (s, 3H), 2.41 (s, 3H), 1.7-1.9 (m, 2H), 1.4-1.55 (m, 2H), 0.99 (t, J = 7.2 Hz, 3H). 8-017 (A) δ8.13 (d, J = 8.1 Hz, 1H), 7.4-7.6 (m, 5H), 5.05 (bs, 2H), 4.10 (d, J = 17.4 Hz, 1H), 3.70 (d, J = 17.4 Hz, 1H), 2.68 (s, 3H), 2.60 (bs, 1H), 2.46 (s, 3H). 9-002 (A) δ9.84 (bs, 1H), 8.80 (d, J = 1.8 Hz, 1H), 8.11 (d, J = 1.8 Hz, 1H), 7.50 (d, J = 1.8 Hz, 2H), 7.46 (t, J = 1.8 Hz, 1H), 4.11 (d, J = 17.4 Hz, 1H), 3.87 (s, 3H), 3.74 (d, J = 17.4 Hz, 1H). 10-001 (A) δ8.72 (d, J = 1.8 Hz, 1H), 8.69 (s, 1H), 8.09 (d, J = 1.8 Hz, 1H), 7.50 (s, 2H), 7.4-7.45 (m, 1H), 4.08 (d, J = 17.4 Hz, 1H), 3.73 (d, J = 17.4 Hz, 1H), 3.24 (s, 3H), 3.19 (s, 3H).

Test Examples

Next, usefulness of the compound of the present invention as a pesticide is specifically explained in the following Test Examples to which the present invention is not limited.

Test Example 1 Insecticidal Test Against Cabbage Moth

A 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 500 ppm. To the chemical solution was dipped leaves of cabbage for about 10 seconds, and after air-drying, they were placed in a laboratory dish, then 5-cabbage moth (Plutella xylostella) in the stage of second instar larva per the dish were released therein, and the dish was covered with a lid and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 6 days was counted and a rate of dead insects was calculated by the following calculation equation. Incidentally, the test was carried out with two districts.

Rate of dead insects (%)=(Number of dead insects/Number of released insects)×100

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 1-001*, 1-002*, 1-003*, 1-004*, 1-005*, 1-006*, 1-007*, 1-008*, 1-009, 1-010*, 1-011, 1-012*, 1-013*, 1-014*, 1-015, 1-016*, 1-017*, 1-018*, 1-019 to 1-025, 1-026*, 1-027 to 1-030, 1-031*, 1-032*, 1-033 to 1-035, 1-036*, 1-037*, 1-038, 1-039*, 1-040 to 1-043, 1-044*, 1-045*, 1-046, 1-047*, 1-048*, 1-049*, 1-050*, 1-051, 1-052*, 1-053*, 1-054*, 1-055*, 1-056*, 1-057*, 1-058, 2-001, 2-002, 2-003*, 2-004*, 2-005*, 2-006*, 2-007*, 2-008*, 2-009*, 2-010*, 2-011*, 2-012*, 2-013**, 2-014**, 2-015*, 2-016*, 2-017*, 2-018**, 2-019, 2-020**, 2-021**, 2-022**, 2-023**, 2-024**, 2-025**, 2-026**, 2-027**, 2-028, 2-029*, 2-030, 3-001, 3-002, 3-003*, 3-004*, 3-005*, 3-006*, 3-007*, 3-007(+)**, 3-007(−), 3-008*, 3-009*, 3-010*, 3-011*, 3-012*, 3-013*, 3-014*, 3-015*, 3-016*, 3-017*, 3-018*, 3-019, 3-020*, 3-021*, 3-022*, 3-023, 3-024**, 3-025**, 3-026**, 3-027**, 3-028*, 3-029**, 3-030**, 3-031**, 3-032**, 3-033*, 3-034**, 3-035*, 3-036*, 3-037**, 3-038*, 3-039**, 3-040*, 3-041*, 3-042*, 3-043*, 3-044**, 3-045*, 3-046*, 3-047**, 3-048**, 3-049**, 3-050**, 3-051**, 3-052*, 3-053*, 3-054*, 3-055*, 3-056*, 3-057*, 3-058*, 3-059*, 3-060*, 3-061*, 3-062*, 3-063*, 3-064*, 3-065, 3-066*, 3-067*, 3-068*, 3-069*, 3-070*, 3-071, 3-072, 3-073**, 3-074**, 3-075**, 3-076**, 3-077**, 3-078**, 3-079**, 3-080**, 3-081**, 3-082*, 3-083**, 3-084**, 3-085, 4-001*, 4-002*, 4-003*, 4-004*, 4-005*, 4-006*, 4-007*, 4-008**, 4-009*, 4-010**, 4-011**, 4-012**, 4-013**, 4-014**, 4-015**, 5-001, 5-002*, 5-003*, 5-004*, 5-005*, 5-006*, 5-007*, 5-008*, 5-009*, 5-010*, 5-011*, 5-012*, 5-013*, 5-014*, 5-015**, 5-016**, 5-017**, 5-018*, 5-019*, 5-020*, 5-021*, 5-022*, 5-023*, 5-024*, 5-025*, 5-026*, 5-027*, 5-028*, 5-029*, 5-030**, 5-031**, 5-032**, 5-033**, 5-034**, 5-035**, 5-036**, 5-038*, 5-039*, 5-040*, 5-041*, 5-042, 5-043*, 5-044*, 5-045*, 5-046*, 5-047, 5-048, 5-049*, 5-050*, 5-051*, 5-052*, 5-053*, 5-054**, 5-055**, 5-056**, 5-057**, 5-058**, 5-059**, 5-060*, 5-061**, 5-062**, 5-063**, 5-064**, 5-065**, 5-066**, 5-067**, 5-068**, 5-069**, 5-070**, 5-071**, 5-072**, 5-073**, 5-074**, 5-075**, 5-076**, 5-077**, 5-078*, 5-079*, 5-080*, 5-081*, 5-082*, 5-083*, 5-084*, 5-085*, 5-086*, 5-087**, 5-088*, 5-089, 5-090**, 5-091*, 5-092*, 5-093**, 5-094*, 5-095**, 5-096**, 5-097**, 5-098**, 5-099**, 5-100*, 5-101*, 5-102**, 5-103**, 5-104**, 5-105**, 5-106**, 5-107**, 5-108*, 5-109**, 5-110**, 5-111**, 5-112**, 5-113**, 5-114**, 5-115**, 5-116**, 5-117**, 5-118**, 5-119**, 5-120**, 5-121**, 5-122**, 5-123**, 5-124**, 5-125**, 5-126**, 5-127**, 5-128**, 5-129**, 5-130**, 5-131**, 5-132**, 5-133**, 5-134**, 5-135*, 5-136*, 5-137**, 5-138**, 5-139**, 5-140**, 5-141**, 5-142*, 5-143*, 5-144*, 5-145**, 5-146**, 5-147**, 5-148**, 5-149**, 5-150**, 5-151**, 5-152**, 5-153**, 5-154**, 5-155**, 5-156**, 5-157**, 5-158**, 5-160**, 5-161*, 5-162**, 5-163**, 5-164**, 5-165**, 5-166**, 5-167**, 5-168**, 5-169**, 5-170**, 5-171**, 5-172**, 5-173**, 5-174**, 5-175**, 5-176*, 5-177*, 5-178**, 5-180**, 5-182**, 5-183**, 5-184**, 5-185*, 5-186*, 5-187*, 5-190, 5-191, 5-192**, 5-193**, 5-194**, 5-195**, 5-196**, 5-197**, 5-198**, 5-199*, 5-200 to 5-203, 5-204**, 5-205**, 5-206**, 6-001, 6-002*, 6-003**, 6-004**, 6-004(R)**, 6-004(S)**, 6-005**, 6-006**, 6-007**, 6-008**, 6-009**, 6-010**, 6-012**, 6-013**, 6-014**, 6-015**, 6-016**, 6-017**, 6-018**, 6-019*, 6-020**, 6-021**, 6-022**, 6-023*, 6-024**, 6-025**, 6-026**, 6-027**, 6-028**, 6-029**, 6-030**, 6-031**, 6-032, 6-033**, 6-034**, 6-035**, 6-036**, 6-037**, 6-038**, 6-039**, 6-040**, 6-041**, 6-042*, 6-043*, 6-044, 6-045*, 6-046**, 6-047*, 6-048*, 6-050**, 6-051**, 6-052**, 6-053**, 6-054**, 6-055**, 7-001**, 7-002**, 7-003**, 7-004**, 7-005**, 7-006**, 7-007**, 7-008**, 7-009**, 7-010**, 7-011**, 7-012**, 7-013**, 7-014**, 7-015**, 7-016**, 7-017**, 7-018**, 7-019**, 7-020**, 7-021**, 7-022**, 7-023**, 8-001*, 8-002**, 8-003**, 8-004, 8-005, 8-006*, 8-007**, 8-012, 8-013**, 8-014, 8-016, 8-017*, 9-001**, 9-002.

In the interim, the indication of “*” shows that the insecticidal test was carried out by use of a chemical solution of a concentration of 100 ppm, and the indication “**” shows that the insecticidal test was carried out by use of a chemical solution of a concentration of 10 ppm.

Test Example 2 Insecticidal Test Against Common Cutworm

A 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 500 ppm. To the chemical solution was dipped leaves of cabbage for about 10 seconds, and after air-drying, they were placed in a laboratory dish, then 5-common cutworm (Spodoptera litura) in the stage of second instar larva per the dish were released therein, and the dish was covered with a lid and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 6 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with two districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 1-001*, 1-002*, 1-003*, 1-004*, 1-005*, 1-006*, 1-007*, 1-008*, 1-009, 1-010*, 1-011, 1-012*, 1-013*, 1-015, 1-016*, 1-017*, 1-018*, 1-020, 1-021, 1-023, 1-026*, 1-027 to 1-030, 1-033, 1-034, 1-036*, 1-037*, 1-039*, 1-040 to 1-043, 1-044*, 1-045*, 1-046, 1-047*, 1-048*, 1-049*, 1-050*, 1-051, 1-052*, 1-053*, 1-054*, 1-055*, 1-056*, 1-057*, 1-058, 2-003*, 2-004*, 2-005*, 2-006*, 2-009*, 2-010*, 2-011*, 2-012*, 2-013**, 2-014**, 2-015*, 2-016*, 2-017*, 2-020**, 2-021**, 2-022**, 2-023**, 2-024**, 2-025**, 2-026**, 2-027**, 2-028, 2-029*, 2-030, 3-002, 3-003*, 3-004*, 3-005*, 3-006*, 3-007*, 3-007(+)**, 3-007(−), 3-008*, 3-009*, 3-010*, 3-011*, 3-012*, 3-013*, 3-014*, 3-015*, 3-016*, 3-017*, 3-018*, 3-019, 3-020*, 3-021*, 3-022*, 3-023, 3-024**, 3-025**, 3-026**, 3-027**, 3-028*, 3-029**, 3-030**, 3-031**, 3-032**, 3-033*, 3-034**, 3-035*, 3-036*, 3-037**, 3-038*, 3-039**, 3-040*, 3-041*, 3-042*, 3-043*, 3-044**, 3-045*, 3-046*, 3-047**, 3-048**, 3-049**, 3-050**, 3-051**, 3-052*, 3-053*, 3-054*, 3-055*, 3-056*, 3-057*, 3-058*, 3-059*, 3-060*, 3-061*, 3-062*, 3-063*, 3-064*, 3-065, 3-066*, 3-067*, 3-068*, 3-069*, 3-070*, 3-071, 3-073**, 3-074**, 3-075**, 3-076**, 3-077**, 3-078**, 3-079**, 3-080**, 3-081**, 3-082**, 3-083**, 3-084*, 3-085, 4-001*, 4-002*, 4-003*, 4-004*, 4-005*, 4-006*, 4-007*, 4-008**, 4-009*, 4-010**, 4-011**, 4-012**, 4-013**, 4-014**, 4-015**, 5-001*, 5-002*, 5-003*, 5-004*, 5-005*, 5-006*, 5-007*, 5-008*, 5-009*, 5-010*, 5-011*, 5-012*, 5-013*, 5-014*, 5-015**, 5-016**, 5-017**, 5-018*, 5-019*, 5-020*, 5-021*, 5-023*, 5-024*, 5-025*, 5-026*, 5-027*, 5-028*, 5-029*, 5-030**, 5-031**, 5-032**, 5-033**, 5-034**, 5-035**, 5-036**, 5-037**, 5-038*, 5-039*, 5-040*, 5-041*, 5-042, 5-043*, 5-044*, 5-045*, 5-046*, 5-047, 5-048, 5-049*, 5-050*, 5-051*, 5-052*, 5-053**, 5-054**, 5-055**, 5-056**, 5-057**, 5-058**, 5-059**, 5-060*, 5-061**, 5-062**, 5-063**, 5-064**, 5-065**, 5-066**, 5-067**, 5-068**, 5-069**, 5-070**, 5-071**, 5-072**, 5-073**, 5-074**, 5-075**, 5-076**, 5-077**, 5-078*, 5-079*, 5-080*, 5-081*, 5-082*, 5-083*, 5-084*, 5-085*, 5-086*, 5-087**, 5-088*, 5-089, 5-090**, 5-091*, 5-092*, 5-093**, 5-094*, 5-095**, 5-096**, 5-097**, 5-098**, 5-099**, 5-100*, 5-101*, 5-102**, 5-103**, 5-104**, 5-105**, 5-106**, 5-107**, 5-108*, 5-109**, 5-110**, 5-111**, 5-112**, 5-113**, 5-114**, 5-115**, 5-116**, 5-117**, 5-118**, 5-119**, 5-120**, 5-121**, 5-122**, 5-123**, 5-124**, 5-125**, 5-126**, 5-127**, 5-128**, 5-129**, 5-130**, 5-131**, 5-132**, 5-133**, 5-134**, 5-135*, 5-136*, 5-137**, 5-138**, 5-139**, 5-140**, 5-141**, 5-142*, 5-143*, 5-144**, 5-145**, 5-146**, 5-147**, 5-148**, 5-149**, 5-150**, 5-151**, 5-152**, 5-153**, 5-154**, 5-155**, 5-156**, 5-157**, 5-158**, 5-159**, 5-160**, 5-161*, 5-162*, 5-163**, 5-164**, 5-165**, 5-166**, 5-167**, 5-168**, 5-169**, 5-170**, 5-171**, 5-172**, 5-173**, 5-174**, 5-175**, 5-177*, 5-178**, 5-180**, 5-182**, 5-183**, 5-184**, 5-185*, 5-186*, 5-187*, 5-192**, 5-193**, 5-194**, 5-195**, 5-196**, 5-197**, 5-198**, 5-199*, 5-201, 5-202, 5-204**, 5-205**, 5-206**, 6-001, 6-002*, 6-003**, 6-004**, 6-004(R)**, 6-004(S)**, 6-005**, 6-006**, 6-007**, 6-008**, 6-009**, 6-010**, 6-011**, 6-012**, 6-013**, 6-014**, 6-015**, 6-016**, 6-017**, 6-018**, 6-019*, 6-020**, 6-021**, 6-022**, 6-023*, 6-024**, 6-027**, 6-028**, 6-029**, 6-030**, 6-031**, 6-033**, 6-034**, 6-035**, 6-036**, 6-037**, 6-038**, 6-039**, 6-040**, 6-041**, 6-042*, 6-043*, 6-045*, 6-046**, 6-047*, 6-048*, 6-049**, 6-050**, 6-051**, 6-052**, 6-053**, 6-054**, 6-055**, 7-001**, 7-002**, 7-003**, 7-004**, 7-005**, 7-006**, 7-007**, 7-008**, 7-009**, 7-010**, 7-011**, 7-012**, 7-013**, 7-014**, 7-015**, 7-016**, 7-017**, 7-018*, 7-019**, 7-020**, 7-021**, 7-022**, 7-023**, 8-001*, 8-002**, 8-003**, 8-004, 8-005, 8-006*, 8-007**, 8-012, 8-013**, 8-014, 8-015**, 8-016, 8-017*, 9-001**, 9-002.

In the interim, the indication of “*” shows that the insecticidal test was carried out by use of a chemical solution of a concentration of 100 ppm, and the indication “**” shows that the insecticidal test was carried out by use of a chemical solution of a concentration of 10 ppm.

Test Example 3 Insecticidal Test Against Beet Armyworm

A 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 100 ppm. To the chemical solution was dipped leaves of cabbage for about 10 seconds, and after air-drying, they were placed in a laboratory dish, then 5-beet armyworm (Spodoptera exigua) in the stage of second instar larva per the dish were released therein, and the dish was covered with a lid and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 6 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with two districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 1-001, 1-005, 2-003, 2-015, 3-003, 3-007, 3-008, 3-010 to 3-012, 3-026, 3-029 to 3-033, 3-041 to 3-043, 3-045, 3-046, 3-052, 3-058, 3-070, 3-073 to 3-079, 4-001, 5-004, 5-007, 5-010, 5-015 to 5-017, 5-033, 5-045, 5-052, 5-054, 5-057, 5-060, 5-061, 5-070, 5-081, 5-084, 5-092 to 5-094, 5-096, 5-097, 5-100 to 5-108, 5-110, 5-112 to 5-116, 5-119 to 5-122, 5-126, 5-127, 5-130, 5-131, 5-139, 5-140, 5-160, 5-164 to 5-169, 5-173, 5-174, 5-180, 5-182 to 5-184, 5-192, 5-194, 6-004, 6-005, 6-018, 7-001, 7-006, 7-010, 7-012.

Test Example 4 Insecticidal Test Against Oriental Tea Tortix

A 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 100 ppm. To the chemical solution was dipped leaves of cabbage for about 10 seconds, and after air-drying, they were placed in a laboratory dish, then 5-oriental tea tortix (Homona magnanima) in the stage of second instar larva per the dish were released therein, and the dish was covered with a lid and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 6 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in

Test Example 1 Incidentally, the Test was Carried Out with Two Districts

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 1-002, 1-005, 1-007, 1-008, 1-053, 2-004, 2-015, 2-016, 2-020, 2-022, 3-003, 3-007, 3-007(+), 3-015, 3-018, 3-026, 3-028, 3-029, 3-031, 3-032, 3-055, 3-059 to 3-062, 3-066 to 3-069, 3-073, 3-074, 3-076, 3-079, 3-081, 4-001 to 4-005, 4-009, 4-014, 4-015, 5-001, 5-004, 5-007, 5-010, 5-011, 5-013, 5-017 to 5-019, 5-021, 5-028, 5-029, 5-034, 5-044, 5-045, 5-069, 5-079, 5-080, 5-083, 5-096, 5-100, 5-104, 5-106 to 5-110, 5-112, 5-113, 5-117, 5-120, 5-121, 5-123, 5-125, 5-127, 5-130, 5-131, 5-139, 5-140, 5-145, 5-146, 5-148, 5-149, 5-152, 5-164 to 5-169, 5-171, 5-174, 5-178 to 5-184, 5-192, 5-198, 5-204 to 5-206, 6-003, 6-004, 6-004(S), 6-005, 6-009, 6-012, 6-016 to 6-018, 6-020, 6-021, 6-027, 6-051 to 6-055, 7-001, 7-006, 7-007, 7-009 to 7-015, 7-019, 7-022, 7-023, 8-013.

Test Example 5 Insecticidal Test Against Corn Earworm

A 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 100 ppm. To the chemical solution was dipped leaves of cabbage for about 10 seconds, and after air-drying, they were placed in a laboratory dish, then 1-corn earworm (Helicoverpa armigera) in the stage of second instar larva per the dish were released therein, and the dish was covered with a lid and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 6 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with twelve districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 1-001 to 1-008, 1-010, 1-012, 1-014, 1-016, 1-017, 1-026, 1-030, 1-031, 1-036, 1-037, 1-041, 1-045, 1-047, 1-050, 1-052 to 1-054, 2-003 to 2-006, 2-009 to 2-018, 2-020 to 2-027, 2-029, 3-003 to 3-007, 3-007(+), 3-008 to 3-018, 3-022, 3-024 to 3-064, 3-066 to 3-070, 3-073 to 3-081, 3-084, 3-085, 4-001 to 4-015, 5-001 to 5-021, 5-023 to 5-041, 5-043 to 5-046, 5-049 to 5-141, 5-144 to 5-175, 5-177 to 5-187, 5-192 to 5-206, 6-003, 6-004, 6-004(R), 6-004(S), 6-005 to 6-007, 6-009, 6-010, 6-012 to 6-018, 6-020 to 6-029, 6-031, 6-033 to 6-037, 6-039, 6-040, 6-043, 6-046, 6-048 to 6-055, 7-001 to 7-023, 8-001 to 8-003, 8-006, 8-007, 8-013, 8-015, 8-017, 9-001, 9-002.

Test Example 6 Insecticidal Test Against Peach Fruit Moth

A 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 100 ppm. To the chemical solution was dipped apple young fruits on which peach fruit moth (Carpocina sasakii) laid eggs (20-egg/fruit) for about 10 seconds, and after air-drying, they were placed in a laboratory dish, and the dish was covered with a lid and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 20 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with two districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 3-011, 3-033, 3-076, 5-090, 5-164, 6-004, 6-005, 6-018.

Test Example 7 Insecticidal Test Against Frankliniella occidentalis

A wet filter paper was laid in a styrol cup having an inner diameter of 7 cm, a leaf of a common bean cut out so as to have the same diameter was laid theron, and 10-Frankliniella occidentalis with first instar larva per leaf was inoculated thereon. A 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 500 ppm. The chemical solution was sprayed with a rotating spray tower in an amount of 2.5 ml per styrol cup, and the styrol cups were covered with lids and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 2 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with two districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 1-001 to 1-037, 1-039 to 1-058, 2-003 to 2-011, 2-013 to 2-029, 3-001 to 3-007, 3-007(+), 3-007(−), 3-008 to 3-083, 4-001, 4-003 to 4-015, 5-001 to 5-021, 5-023 to 5-187, 5-192 to 5-199, 5-204 to 5-206, 6-002 to 6-004, 6-004(S), 6-005 to 6-023, 6-025, 6-027 to 6-033, 6-035 to 6-041, 6-043 to 6-048, 6-050 to 6-055, 7-001 to 7-023, 8-001 to 8-007, 8-012 to 8-017, 9-001, 9-002.

Test Example 8 Insecticidal Test Against Thrips palmi

A wet filter paper was laid in a styrol cup having an inner diameter of 7 cm, a leaf of a common bean cut out so as to have the same diameter was laid theron, and 10-Thrips palmi in the stage of adult per leaf was inoculated thereon. A 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 100 ppm. The chemical solution was sprayed with a rotating spray tower in an amount of 2.5 ml per styrol cup, and the styrol cups were covered with lids and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 2 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with two districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 1-001 to 1-018, 1-020 to 1-022, 1-026, 1-028, 1-031, 1-037, 1-039, 1-040, 1-044, 1-045, 1-049 to 1-053, 1-055, 1-056, 2-002 to 2-005, 2-009 to 2-011, 2-013 to 2-017, 2-019 to 2-027, 2-029, 3-001 to 3-007, 3-007(+), 3-008 to 3-064, 3-066 to 3-071, 3-073 to 3-081, 3-083, 4-001 to 4-005, 4-008, 4-009, 4-011 to 4-015, 5-001 to 5-021, 5-023 to 5-037, 5-039 to 5-083, 5-085 to 5-146, 5-148 to 5-158, 5-160 to 5-172, 5-174 to 5-187, 5-192 to 5-199, 5-204 to 5-206, 6-001 to 6-004, 6-004(S), 6-005 to 6-018, 6-020 to 6-023, 6-025, 6-027 to 6-029, 6-031, 6-035 to 6-037, 6-039, 6-040, 6-045, 6-046, 6-050 to 6-055, 7-001, 7-003 to 7-023, 8-001 to 8-007, 8-013, 8-015, 8-017, 9-001, 9-002.

Test Example 9 Insecticidal Test Against Eysarcoris lewisi

A 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 500 ppm. To the chemical solution was dipped leave sheaths of rice for about 10 seconds, and after air-drying, they were placed in a test tube, then 5-Eysarcoris lewisi in the stage of first instar larva per the test tube were released therein, and the test tube was covered with a sponge and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 2 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with two districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 1-001 to 1-010, 1-012 to 1-014, 1-016 to 1-019, 1-021, 1-026, 1-027, 1-031 to 1-033, 1-036, 1-039, 1-044, 1-045, 1-047 to 1-050, 1-052 to 1-054, 1-056, 2-003 to 2-005, 2-010, 2-011, 2-013 to 2-017, 2-020 to 2-027, 2-029, 3-003 to 3-018, 3-020, 3-021, 3-024 to 3-037, 3-039, 3-041 to 3-064, 3-066 to 3-070, 3-073 to 3-081, 4-001, 4-002, 4-005, 4-007, 4-009, 5-001 to 5-019, 5-021, 5-023, 5-025 to 5-031, 5-033 to 5-035, 5-038, 5-040, 5-043 to 5-046, 5-050 to 5-053, 5-055, 5-056, 5-058, 5-060, 5-061, 5-065, 5-067 to 5-072, 5-078 to 5-088, 5-090 to 5-131, 5-133, 5-134, 5-137 to 5-140, 5-142, 5-145 to 5-160, 5-162 to 5-171, 5-174, 5-175, 5-178, 5-180, 5-182 to 5-184, 5-186, 5-192 to 5-194, 5-198, 5-204 to 5-206, 6-003 to 6-010, 6-012 to 6-018, 6-020, 6-022, 6-027 to 6-029, 6-031, 6-035 to 6-041, 6-052, 7-001, 7-006, 7-007, 7-009, 7-010, 7-012 to 7-017, 7-019, 7-020, 7-022, 8-001, 8-006, 8-007, 8-012, 8-013, 9-002.

Test Example 10 Insecticidal Test Against Brown Rice Planthopper

A 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 500 ppm. To the chemical solution was dipped leave sheaths of rice for about 10 seconds, and after air-drying, they were placed in a test tube, then 5-brown rice planthopper (Nilaparvata lugens) in the second instar larva per the test tube were released therein, and the test tube was covered with a sponge and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 6 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with two districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 1-001 to 1-018, 1-021, 1-022, 1-028, 1-033, 1-040, 1-045, 1-049, 1-050, 1-052, 1-053, 2-002 to 2-004, 2-009 to 2-011, 2-013 to 2-016, 2-020 to 2-029, 3-002 to 3-007, 3-007(+), 3-008 to 3-020, 3-024 to 3-036, 3-039, 3-041 to 3-046, 3-048 to 3-064, 3-066 to 3-070, 3-073 to 3-081, 4-001, 4-002, 4-004, 4-005, 4-009, 4-013 to 4-015, 5-001 to 5-006, 5-008, 5-011 to 5-017, 5-027, 5-031, 5-032, 5-035, 5-038, 5-040, 5-043 to 5-045, 5-050, 5-079, 5-080, 5-083 to 5-117, 5-119 to 5-131, 5-138 to 5-142, 5-144 to 5-151, 5-153, 5-154, 5-156 to 5-158, 5-160, 5-162 to 5-171, 5-174, 5-175, 5-177, 5-178, 5-180, 5-182 to 5-184, 5-192 to 5-194, 5-198, 5-199, 5-204 to 5-206, 6-002 to 6-004, 6-004(S), 6-005 to 6-010, 6-012 to 6-020, 6-022, 6-027 to 6-031, 6-035 to 6-041, 6-050*, 6-052, 6-053*, 6-054*, 6-055*, 7-001 to 7-023, 8-001, 8-006, 8-007, 8-012, 8-013, 9-001, 9-002. “*” means the compound tested at 100 ppm.

Test Example 11 Insecticidal Test Against Bemisia argentifolii

A wet filter paper was laid in a styrol cup having an inner diameter of 7 cm, a leaf of a tomato cut out on which Bemisia argentifolii laid eggs (10-egg/leaf) was laid thereon. A 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 500 ppm. The chemical solution was sprayed with a rotating spray tower in an amount of 2.5 ml per styrol cup, and the styrol cups were covered with lids and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 6 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with two districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention No. 1-002 to 1-014, 1-016 to 1-026, 1-028, 1-029, 1-036, 1-039, 1-041, 1-042, 1-044 to 1-046, 1-049, 1-050, 1-052, 1-053, 1-056, 1-057, 2-003, 2-004, 2-009 to 2-011, 2-013 to 2-018, 2-020 to 2-028, 3-003 to 3-005, 3-007, 3-011 to 3-020, 3-022, 3-024, 3-026, 3-028 to 3-034, 3-041 to 3-064, 3-066 to 3-070, 3-073 to 3-081, 4-002, 5-001, 5-002, 5-009, 5-010, 5-012 to 5-021, 5-033, 5-035, 5-040, 5-041, 5-044, 5-045, 5-050, 5-051, 5-056 to 5-058, 5-060, 5-062, 5-063, 5-065, 5-066, 5-068, 5-071 to 5-074, 5-076 to 5-080, 5-082 to 5-091, 5-093, 5-096, 5-098, 5-100, 5-102 to 5-113, 5-116, 5-117, 5-119 to 5-131, 5-133, 5-139, 5-140, 5-144 to 5-158, 5-162 to 5-171, 5-174, 5-175, 5-177 to 5-184, 5-192 to 5-194, 5-197, 5-198, 5-204 to 5-206, 6-002 to 6-004, 6-004(S), 6-005 to 6-010, 6-012 to 6-023, 6-025, 6-027 to 6-031, 6-035 to 6-041, 6-043, 6-052, 6-053, 7-001, 7-003 to 7-017, 7-019, 7-020, 7-022, 7-023, 8-003, 8-006, 8-007, 8-012, 9-001, 9-002.

Test Example 12 Insecticidal Test Against Green Peach Aphid

A wet cotton wool was laid in a laboratory dish having an inner diameter of 3 cm, a leaf of a cabbage cut out so as to have the same diameter was laid theron, and 4-green peach aphid (Myzus persicae) in the stage of no-wing adult was left. After 1 day, a 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 500 ppm, and the chemical solution was sprayed with a rotating spray tower (2.5 mg/cm²), and the laboratory dish was covered with lids and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 6 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with two districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 1-002 to 1-014, 1-016 to 1-018, 1-020, 1-021, 1-024, 1-026 to 1-028, 1-031 to 1-033, 1-040, 1-045, 1-046, 1-048, 1-050, 1-052, 1-053, 1-055, 2-003 to 2-005, 2-009 to 2-011, 2-013 to 2-017, 2-020 to 2-028, 2-029*, 2-030, 3-001 to 3-006, 3-007(+), 3-008, 3-010 to 3-020, 3-022 to 3-035, 3-037 to 3-039, 3-041 to 3-048, 3-050 to 3-064, 3-066 to 3-070, 3-073 to 3-081, 4-001, 4-004, 4-006, 4-009, 4-014, 5-002, 5-005, 5-008 to 5-021, 5-026, 5-034, 5-035, 5-039, 5-040, 5-044 to 5-046, 5-053, 5-056, 5-058, 5-063 to 5-066, 5-069, 5-072 to 5-080, 5-082, 5-084 to 5-090, 5-094, 5-096, 5-098 to 5-115, 5-117 to 5-131, 5-133, 5-134, 5-138, 5-139, 5-146 to 5-150, 5-152 to 5-157, 5-163 to 5-174, 5-177, 5-178, 5-180, 5-182 to 5-184, 5-192 to 5-194, 5-198, 5-199, 5-204 to 5-206, 6-002 to 6-010, 6-016 to 6-018, 6-020, 6-026 to 6-029, 6-035 to 6-041, 6-049, 6-052, 6-055, 7-001 to 7-003, 7-005 to 7-010, 7-013 to 7-017, 7-019 to 7-023, 8-001 to 8-004, 8-006, 8-007, 8-013, 8-015, 8-017, 9-002. “*” means the compound tested at 100 ppm.

Test Example 13 Insecticidal Test Against Japanese Mealybug

A wet filter paper was laid in a styrol cup having an inner diameter of 7 cm, a leaf of a common bean cut out so as to have the same diameter was laid theron, and 10-Japanese mealybug (Planococcus kraunhiae) in the first instar larva per leaf was inoculated thereon. A 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 500 ppm. The chemical solution was sprayed with a rotating spray tower in an amount of 2.5 ml per styrol cup, and the styrol cups were covered with lids and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 6 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with two districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 1-002 to 1-014, 1-016 to 1-019, 1-021, 1-022, 1-024, 1-026, 1-027, 1-031, 1-036, 1-037, 1-040, 1-041, 1-045, 1-047, 1-049, 1-050, 1-052, 1-053, 1-057, 2-003 to 2-005, 2-008, 2-010, 2-011, 2-013 to 2-018, 2-020 to 2-028, 3-003 to 3-005, 3-007, 3-008, 3-010 to 3-021, 3-023 to 3-026, 3-028, 3-029, 3-031, 3-032, 3-034, 3-041 to 3-046, 3-049, 3-051, 3-052, 3-054 to 3-062, 3-064, 3-066 to 3-070, 3-073 to 3-081, 3-083, 4-006, 4-009, 4-011, 5-002, 5-004, 5-006, 5-009 to 5-017, 5-019 to 5-021, 5-024, 5-026, 5-032, 5-037, 5-040, 5-044, 5-045, 5-052, 5-054, 5-057, 5-061 to 5-064, 5-067, 5-068, 5-073 to 5-079, 5-081, 5-082, 5-084, 5-086, 5-088 to 5-090, 5-092, 5-094 to 5-097, 5-099 to 5-114, 5-116, 5-117, 5-119 to 5-129, 5-138 to 5-140, 5-142, 5-146 to 5-154, 5-156 to 5-158, 5-160, 5-162 to 5-171, 5-173 to 5-185, 5-192 to 5-194, 5-196 to 5-198, 5-206, 6-002 to 6-010, 6-012 to 6-018, 6-020 to 6-023, 6-025 to 6-031, 6-035 to 6-041, 6-047, 6-048, 6-052, 7-001, 7-003, 7-005 to 7-017, 7-019 to 7-022, 8-003, 8-004, 8-007, 8-012, 8-016, 8-017, 9-001, 9-002.

Test Example 14 Insecticidal Test Against Cucurbit Leaf Beetle

A 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 500 ppm. To the chemical solution was dipped leaves of cucumber for about 10 seconds, and after air-drying, they were placed in a laboratory dish, then 5-cucurbit leaf beetle (Aulacophora femoralis) in the stage of second instar larva per the dish were released therein, and the dish was covered with a lid and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 6 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with two districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 1-001 to 1-058, 2-001 to 2-018, 2-020 to 2-029, 3-001 to 3-070, 3-072 to 3-083, 4-001 to 4-015, 5-001 to 5-021, 5-023 to 5-178, 5-180, 5-183 to 5-187, 5-192 to 5-198, 5-204 to 5-206, 6-001 to 6-031, 6-033 to 6-049, 6-052, 7-001 to 7-017, 7-019 to 7-023, 8-001 to 8-007, 8-012 to 8-017, 9-001, 9-002.

Test Example 15 Insecticidal Test Against Serpentine Leaf Miner

A 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 500 ppm. To the chemical solution was dipped leaves of common bean on which serpentine leaf miner (Liriomyza trifolii) laid eggs (10 eggs/leaf) for about 10 seconds, and after air-drying, they were placed on a wet filter paper laid in a styrol cup having an inner diameter of 7 cm, and the styrol cup was covered with a lid and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 6 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with two districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 1-002 to 1-010, 1-012, 1-014, 1-016 to 1-019, 1-021, 1-026, 1-028, 1-029, 1-031 to 1-033, 1-036, 1-039, 1-042, 1-044, 1-045, 1-047, 1-050, 1-052, 1-053, 1-055, 1-056, 2-003 to 2-006, 2-008 to 2-011, 2-013 to 2-018, 2-020 to 2-026, 3-003, 3-004, 3-007, 3-008, 3-010 to 3-016, 3-018, 3-020 to 3-022, 3-024 to 3-039, 3-041 to 3-064, 3-066 to 3-070, 3-073 to 3-081, 3-083, 4-001 to 4-009, 4-013, 5-001, 5-004, 5-008, 5-012 to 5-017, 5-019, 5-021, 5-027, 5-040, 5-041, 5-043 to 5-046, 5-049 to 5-053, 5-055, 5-067, 5-068, 5-070 to 5-074, 5-078 to 5-092, 5-094 to 5-097, 5-100 to 5-106, 5-108 to 5-114, 5-117, 5-119 to 5-128, 5-130, 5-131, 5-135, 5-139, 5-140, 5-145 to 5-152, 5-154 to 5-158, 5-163 to 5-171, 5-173 to 5-184, 5-186, 5-192 to 5-194, 5-198, 5-206, 6-002 to 6-004, 6-004(S), 6-005 to 6-018, 6-020 to 6-024, 6-026 to 6-031, 6-035 to 6-041, 6-043, 6-044, 6-052, 7-001 to 7-017, 7-019, 7-020, 7-022, 7-023, 8-001 to 8-003, 8-006, 8-007, 8-012, 8-014, 9-001, 9-002.

Test Example 16 Insecticidal Test Against Two-Spotted Spider Mite

A wet filter paper was laid in a styrol cup having an inner diameter of 7 cm, a leaf of a common bean cut out so as to have the same diameter was laid theron, and 10 larvae of two-spotted spider mite (Tetranychus urticae) per leaf was inoculated thereon. A 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 500 ppm. The chemical solution was sprayed with a rotating spray tower in an amount of 2.5 ml per styrol cup, and the styrol cups were covered with lids and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 6 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with two districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 1-001 to 1-010, 1-012 to 1-014, 1-016 to 1-019, 1-021, 1-026, 1-027, 1-031 to 1-033, 1-042, 1-044 to 1-049, 1-052, 1-053, 1-055, 1-056, 2-003 to 2-006, 2-009 to 2-017, 2-020 to 2-027, 3-003 to 3-024, 3-026, 3-028, 3-029, 3-031 to 3-033, 3-035, 3-036, 3-039, 3-041 to 3-046, 3-051 to 3-064, 3-066 to 3-070, 3-073 to 3-081, 4-001 to 4-007, 4-009, 4-014, 4-015, 5-002 to 5-005, 5-009 to 5-011, 5-013, 5-014, 5-018, 5-019, 5-021, 5-039, 5-044 to 5-046, 5-049, 5-052, 5-072, 5-078 to 5-080, 5-084, 5-088, 5-100, 5-102, 5-103, 5-108, 5-115, 5-131, 5-138 to 5-140, 5-145 to 5-148, 5-157, 5-164 to 5-177, 5-192 to 5-194, 5-196, 5-198, 5-203, 5-206, 6-003, 6-004, 6-004(S)**, 6-005 to 6-022, 6-025, 6-027 to 6-031, 6-034 to 6-041, 6-043, 6-050*, 6-051*, 6-052, 6-053*, 6-054*, 6-055*, 7-001 to 7-020, 7-022, 7-023, 8-001, 8-003, 8-006, 8-007, 8-012, 8-013, 9-002. “*” means the compound tested at 100 ppm.“**” means the compound tested at 10 ppm.

Test Example 17 Insecticidal Test Against Pink Citrus Rust Mite

A wet filter paper was laid in a styrol cup having an inner diameter of 7 cm, a leaf of a mandarin orange cut out so as to have the same diameter was laid theron, and 10 larvae of pink citrus rust mite (Aculops pelekassi) per leaf was inoculated thereon. A 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 100 ppm. The chemical solution was sprayed with a rotating spray tower in an amount of 2.5 ml per styrol cup, and the styrol cups were covered with lids and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 6 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with two districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 1-003, 1-005, 1-008, 1-053, 2-003, 2-015, 2-016, 3-004, 3-007, 3-008, 3-010, 3-012, 3-028, 3-031 to 3-033, 3-041 to 3-043, 3-045, 3-046, 3-054, 3-056 to 3-058, 3-074 to 3-079, 4-001, 5-013, 5-081, 5-084, 5-090, 5-092 to 5-097, 5-100 to 5-106, 5-108, 5-115, 5-119, 5-145 to 5-149, 5-156, 5-157, 5-164 to 5-169, 5-171, 6-004, 6-005, 6-009, 6-018, 6-053, 6-054, 7-001.

Test Example 18 Insecticidal Test Against Broad Mite

A wet filter paper was laid in a styrol cup having an inner diameter of 7 cm, a leaf of a common bean cut out so as to have the same diameter was laid theron, and 10 adults of broad mite (Polyphagotarsonemus latus) per leaf was inoculated thereon. A 10% emulsifiable concentrate (depending on the compounds, 10% wettable powder was applied for the test) of the compound of the present invention was diluted with water containing a spreading agent to prepare a chemical solution with a concentration of 100 ppm. The chemical solution was sprayed with a rotating spray tower in an amount of 2.5 ml per styrol cup, and the styrol cups were covered with lids and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 2 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with two districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 2-015, 3-041, 3-043, 3-077 to 3-079, 5-092, 5-165.

Test Example 19 Insecticidal Test Against Ctenocephalides fells

After 400 μl of acetone solution in which 4 mg of the compound of the present invention was dissolved in 40 ml of acetone (concentration 100 ppm) was coated on the bottom face and side face of a laboratory dish having an inner diameter of 5.3 cm, acetone was vaporized to prepare a thin film of the compound of the present invention on the inner wall of the laboratory dish. As the surface area of the inner wall is 40 cm², the treated dosage is 1 μg/cm². 10 adults of Ctenocephalides felis (male and female are mixed) were left in the laboratory dish, covered with lid and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 4 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with one district. As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 2-003*, 2-015*, 3-004*, 3-007*, 3-008, 3-010 to 3-012, 3-025*, 3-026*, 3-027*, 3-028*, 3-029*, 3-030*, 3-031, 3-033*, 3-041*, 3-042*, 3-043*, 3-058*, 3-074, 3-079, 5-001, 5-002*, 5-012, 5-013, 5-084, 5-092*, 5-093*, 5-094*, 5-095*, 5-096*, 5-097*, 5-100*, 5-101*, 5-102*, 5-103*, 5-104*, 5-105*, 5-106*, 5-108*, 5-109*, 5-113*, 5-114*, 5-115*, 5-116*, 5-118*, 5-119*, 5-120*, 5-122*, 5-126*, 5-131*, 6-002, 6-004 to 6-011, 6-016, 6-018, 7-001, 7-003, 7-005, 7-009.

In the interim, the indication of “*” shows that the insecticidal test was carried out by use of a chemical solution of a concentration of 0.1 μg/cm².

Test Example 20 Insecticidal Test Against American Dog Tick

After 4001 of acetone solution in which 4 mg of the compound of the present invention was dissolved in 40 ml of acetone (concentration 100 ppm) was coated on the bottom face and side face of two laboratory dishes having an inner diameter of 5.3 cm, acetone was vaporized to prepare a thin film of the compound of the present invention on the inner wall of the laboratory dish. As the surface area of the inner wall is 40 cm², the treated dosage is 1 μg/cm². 10-American dog tick (Dermacentor variabilis) (male and female are mixed) in the stage of protonymph were left in the laboratory dishes, two laboratory dishes together were sealed with a tape so that ticks do not escape, and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 4 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with one district.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 2-003*, 2-015*, 3-004*, 3-007*, 3-008*, 3-010*, 3-011, 3-012*, 3-025*, 3-026*, 3-027*, 3-028*, 3-029*, 3-030*, 3-031*, 3-033*, 3-041*, 3-042*, 3-043*, 3-058*, 3-074*, 3-079*, 5-001, 5-002**, 5-012, 5-013*, 5-052*, 5-061*, 5-063*, 5-084*, 5-092*, 5-093*, 5-094*, 5-095*, 5-096*, 5-097*, 5-100*, 5-101*, 5-102*, 5-103*, 5-104*, 5-105*, 5-106*, 5-108*, 5-109*, 5-113, 5-114*, 5-115*, 5-116*, 5-118*, 5-119*, 5-120*, 5-122*, 5-126*, 5-131*, 6-002*, 6-004*, 6-005*, 6-006*, 6-007*, 6-008*, 6-009*, 6-010*, 6-011*, 6-016*, 6-018*, 6-024*, 6-026*, 7-001*, 7-003*, 7-005*, 7-009*.

In the interim, the indication of “*” shows that the insecticidal test was carried out by use of a chemical solution of a concentration of 0.1 μg/cm².

Test Example 21 Insecticidal Test Against German Cockroach

A chemical solution having a concentration of 1 μg/μl was prepared by diluting the compound of the present invention with acetone. The chemical solution was coated on the abdominal region of male adults of German cockroach (Blattella germanica) in an amount of 11 per cockroach, and the treated cockroaches were contained at a thermostat chamber at 25° C. A number of dead insect(s) after 2 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with five districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 2-003, 3-007, 3-031, 3-032, 3-041, 3-074, 3-077, 5-094, 5-100 to 5-103, 5-108, 6-004, 6-009, 6-018, 7-001, 7-004.

Test Example 22 Insecticidal Test Against Musca domestica

A chemical solution having a concentration of 1 μg/μl was prepared by diluting the compound of the present invention with acetone. The chemical solution was coated on the abdominal region of female adults of Musca domestica in an amount of 11 per fly, and the treated flies were contained at a thermostat chamber at 25° C. A number of dead insect(s) after 2 days was counted and a rate of dead insects was calculated by the calculation equation similar to that in Test Example 1. Incidentally, the test was carried out with ten districts.

As a result, the following compounds showed an insecticidal rate of 80% or more among the compounds tested.

The compounds of the present invention: No. 5-234.

Test Example 23 Insecticidal Test Against Corn Earworm (Comparative Example 1)

A 10% emulsifiable concentrate of the compound of the present invention or comparative compound was diluted with water containing a spreading agent to prepare a chemical solution with a prescribed concentration. To the chemical solution was dipped leaves of cabbage for about 10 seconds, and after air-drying, they were placed in a laboratory dish, then 7-corn earworm (Helicoverpa armigera) in the stage of third instar larva per the dish were released therein, and the dish was covered with a perforated lid and contained at a thermostat chamber at 25° C. Artificial feed (1 cm³) was added after 2 days of treatment, and a number of dead insect(s) after 6 days was counted and a rate of dead insects was calculated by the following calculation equation. In the meantime, the test was carried out with two areas.

Rate of dead insects (%)=(Number of dead insects/Number of released insects)×100

The rate of dead insects in each prescribed concentration of the compounds tested is shown in Table 17.

TABLE 17 Conentration (ppm) Tasted Compound 33 10 3 1 0.3 Compound of the present invention No. 100 100 50.0 7.1 3-033 Comparative Compound A 92.9 28.6 0 0 Comparative Compound A: WO 2005/085216, Compound No. 6-077

Test Example 24 Insecticidal Test Against Oriental Tea Tortix (Comparative Example 2)

A 10% emulsifiable concentrate of the compound of the present invention or comparative compound was diluted with water containing a spreading agent to prepare a chemical solution with a prescribed concentration. To the chemical solution was dipped leaves of cabbage for about 10 seconds, and after air-drying, they were placed in a laboratory dish, then 7-oriental tea tortix (Homona magnanima) in the stage of third instar larva per the dish were released therein, and the dish was covered with a perforated lid and contained at a thermostat chamber at 25° C. A number of dead insect(s) after 6 days was counted and a rate of dead insects was calculated by the following calculation equation. In the meantime, the test was carried out with two areas.

Rate of dead insects (%)=(Number of dead insects/Number of released insects)×100

The rate of dead insects in each prescribed concentration of the compounds tested is shown in Table 18.

TABLE 18 Conentration (ppm) Tasted Compound 100 33 10 3 1 0.3 0.1 Compound of the present 100 100 92.9 57.1 14.3 invention No. 5-165 Comparative Compound B 100 64.3 7.1 0 0 Comparative Compound B: WO 2005/085216, Compound No. 5-309

INDUSTRIAL APPLICABILITY

The isoxazoline-substituted benzamide compounds according to the present invention are extremely useful compounds showing an excellent pesticidal activity, particularly an insecticidal and acaricidal activity, and causing little adverse effect against non-targeted beings such as mammals, fishes and useful insects.

LENGTHY TABLES The patent application contains a lengthy table section. A copy of the table is available in electronic form from the USPTO web site (http://seqdata.uspto.gov/?pageRequest=docDetail&DocID=US20140135496A1). An electronic copy of the table will also be available from the USPTO upon request and payment of the fee set forth in 37 CFR 1.19(b)(3). 

1-17. (canceled)
 18. 4-Hydroxyiminomethyl substituted benzamide compound of formula (2) or a salt thereof:

wherein A¹ is carbon atom or nitrogen atom, J is hydrogen atom or halogen atom, W is oxygen atom or sulfur atom, Y is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R⁴, —OR⁵, —N(R⁷)R⁶ or —C(S)NH₂, when n is 2, each Y may be identical with or different from each other, R¹ is —C(R^(1b))═NOR^(1a), —C(O)OR^(1c), —C(O)SR^(1c), —C(S)OR^(1c), —C(O)N(R^(1e))R^(1d), —C(S)N(R^(1e))R^(1d), phenyl, phenyl substituted with (Z)_(p1), D-3, D-8, D-10, D-11, D-13 to D-15, D-17, D-22, D-35, D-52 to D-58 or D-59, R^(1a) is C₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₈cycloalkyl C₁-C₄alkyl, C₃-C₆alkenyl or C₃-C₆alkynyl, R^(1b) is hydrogen atom or C₁-C₆alkyl, R^(1c) is C₁-C₆alkyl, C₁-C₄alkyl arbitrarily substituted with R¹⁴ or C₃-C₆cycloalkyl, R^(1d) is hydrogen atom, —C(O)R¹⁵, —C(O)OR¹⁵ or —C(O)SR¹⁵, R^(1e) is hydrogen atom or C₁-C₆alkyl, R² is C₁-C₆alkyl, —CH₂R^(14a), E-5, E-24, C₃-C₆alkynyl, —C(O)R¹⁵, —C(O)OR¹⁵, —C(O)SR¹⁵, —C(S)OR¹⁵, —C(S)SR¹⁵, —C(O)C(O)OR¹⁵, phenyl or phenyl substituted with (Z)_(p1), further when R¹ is —C(R^(1b))═NOR^(1a), —C(O)OR^(1c), —C(O)SR^(1c), —C(S)OR^(1c), —C(O)N(R^(1e))R^(1d) or —C(S)N(R^(1e))R^(1d), R² may be hydrogen atom, when R¹ is phenyl, phenyl substituted with (Z)_(p1), D-3, D-8, D-10, D-11, D-13 to D-15, D-17, D-22, D-35, D-52 to D-58 or D-59, R² may be C₁-C₆haloalkyl or C₃-C₆alkenyl, or R² together with R¹ may form ═C(R^(2b))R^(2a), R^(2a) is C₁-C₆alkoxy or di(C₁-C₆alkyl)amino, R^(2b) is C₁-C₆alkyl or C₁-C₆alkylcarbonylthio, D-3, D-8, D-10, D-11, D-13 to D-15, D-17, D-22, D-35, D-52 to D-58 and D-59 are aromatic heterocyclic rings of the following formulae, respectively

Z is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylsulfonyloxy, C₁-C₆haloalkylsulfonyloxy, C₁-C₆alkylthio, C₁-C₆haloalkylthio, C₁-C₆alkylsulfinyl, C₁-C₆haloalkylsulfinyl, C₁-C₆alkylsulfonyl, C₁-C₆haloalkylsulfonyl, C₁-C₆alkoxycarbonyl, —C(O)NH₂ or —C(S)NH₂, when p1, p2 or p3 is an integer of 2 or more, each Z may be identical with or different from each other, further, when two Zs are adjacent, the adjacent two Zs may form 5-membered or 6-membered ring together with carbon atoms to which the two Zs are bonded by forming —OCH₂O— or —OCH₂CH₂O—, in this case, hydrogen atoms bonded to each carbon atom forming the ring may be arbitrarily substituted with halogen atom, E-5 and E-24 are saturated heterocyclic rings of the following formulae, respectively,

R⁴ is C₁-C₆alkoxy or C₁-C₆haloalkoxy, R⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl, R⁶ is —CHO, C₁-C₆alkylcarbonyl, C₁-C₆haloalkylcarbonyl, C₁-C₆alkoxycarbonyl, C₁-C₆alkylthiocarbonyl, C₁-C₆alkoxythiocarbonyl, C₁-C₆alkyldithiocarbonyl, C₁-C₆alkylsulfonyl or C₁-C₆haloalkylsulfonyl, R⁷ is hydrogen atom or C₁-C₆alkyl R¹³ is C₁-C₆alkyl or C₁-C₆haloalkyl, R¹⁴ is cyano, C₃-C₆cycloalkyl, C₁-C₆alkoxy, C₁-C₄alkoxy, C₁-C₆alkylsulfonyl, —NHC(O)R³², —NHC(O)OR³², C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R^(14a) is cyano, —OR²⁵, —NHC(O)OR³², —S(O)_(r)R²⁷, C₁-C₆alkylcarbonyl, C₁-C₆alkoxycarbonyl or phenyl, R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkyl arbitrarily substituted with R³¹, C₃-C₆cycloalkyl, C₂-C₆alkenyl, C₂-C₆alkynyl, phenyl, phenyl substituted with (Z)_(p1), D-52, D-53 or D-54, R²⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxy C₁-C₄alkyl, benzyl, C₃-C₆alkenyl, C₃-C₆alkynyl, —C(O)R³² or —C(O)OR³², R²⁷ is C₁-C₆alkyl, C₁-C₆haloalkyl, C(O)R³² or —C(S)OR³², R³¹ is C₃-C₆cycloalkyl, C₁-C₄alkoxy, C₁-C₄haloalkoxy, C₁-C₄alkylsulfonyl or phenyl, R³² is C₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkyl or phenyl, n is an integer of 0 to 2, p1 is an integer of 1 to 3, p2 and p3 are an integer of 0 to 2, p4 and p5 are an integer of 0 or 1, q3 and q4 are 0, r is an integer of 0 or 2, and t is an integer of 0 or
 1. 19. 4-Hydroxyiminomethyl substituted benzamide compound or the salt thereof according to claim 18, wherein A¹ is carbon atom, W is oxygen atom, Y is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, —OR⁵ or —N(R⁷)R⁶, R¹ is —CH═NOR^(1a), R^(1a) is C₁-C₆alkyl, R² is hydrogen atom, —CH₂R^(14a), C₃-C₆alkynyl or C₁-C₆alkoxycarbonyl, R⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl, R⁶ is —CHO, C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R^(14a) is cyano or —OR²⁵, R²⁵ is C₁-C₄alkyl, C₁-C₄haloalkyl or —C(O)OR³², and R³² is C₁-C₆alkyl.
 20. 4-Hydroxyiminomethyl substituted benzamide compound or the salt thereof according to claim 18, wherein A¹ is carbon atom, W is oxygen atom, Y is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, —OR⁵ or —N(R⁷)R⁶, R¹ is —C(O)OR^(1c), R^(1c) is C₁-C₆alkyl or C₃-C₆cycloalkyl, R² is hydrogen atom, C₁-C₆alkyl, —CH₂R^(14a), E-5, —C(O)R⁵, C₁-C₆alkoxycarbonyl, C₁-C₆haloalkoxycarbonyl or C₁-C₆haloalkylthio, R⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl, R⁶ is —CHO, C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R^(14a) is cyano, —OR²⁵, or —NHC(O)OR³², R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxy C₁-C₄alkyl, C₁-C₄alkylthio C₁-C₄alkyl or C₃-C₆cycloalkyl, R²⁵ is C₁-C₄alkyl, C₁-C₄haloalkyl or —C(O)OR³², R³² is C₁-C₆alkyl, n is an integer of 0 or 1, and q3 is
 0. 21. 4-Hydroxyiminomethyl substituted benzamide compound or the salt thereof according to claim 18, wherein A¹ is carbon atom, W is oxygen atom, Y is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, —OR⁵ or —N(R⁷)R⁶, R¹ is —C(O)N(R^(1e))R^(1d), R^(1d) is hydrogen atom, —C(O)R¹⁵ or —C(O)OR¹⁵, R^(1e) is hydrogen atom or C₁-C₆alkyl, R² is hydrogen atom or C₁-C₆alkyl, R⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl, R⁶ is —CHO, C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R¹⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl, and n is an integer of 0 or
 1. 22. 4-Hydroxyiminomethyl substituted benzamide compound or the salt thereof according to claim 18, wherein A¹ is carbon atom, W is oxygen atom, Y is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, —OR⁵ or —N(R⁷)R⁶, R¹ is phenyl substituted with (Z)_(p1), D-52, D-55, D-56, D-57 or D-58, R² is C₁-C₆alkyl, —CH₂R^(14a), C₃-C₆alkynyl, —C(O)R¹⁵, —C(O)OR¹⁵ or —C(O)C(O)OR¹⁵, Z is halogen atom, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₆alkoxy, C₁-C₆haloalkoxy, C₁-C₆alkylthio, C₁-C₆alkylsulfinyl or C₁-C₆alkylsulfonyl, when p1, p2 or p3 is an integer of 2 or more, each Z may be identical with or different from each other, R⁵ is C₁-C₆alkyl or C₁-C₆haloalkyl, R⁶ is —CHO, C₁-C₆alkylcarbonyl or C₁-C₆alkoxycarbonyl, R^(14a) is cyano or —OR²⁵, R¹⁵ is C₁-C₆alkyl, C₁-C₆haloalkyl, C₁-C₄alkoxy C₁-C₄alkyl, C₁-C₄alkylthio C₁-C₄alkyl, C₁-C₄alkylsulfinyl C₁-C₄alkyl, C₁-C₄alkylsulfonyl C₁-C₄alkyl, C₃-C₆cycloalkyl, C₂-C₆alkenyl, C₂-C₆alkynyl, phenyl, phenyl substituted with (Z)_(p), or D-52, R²⁵ is C₁-C₄alkyl, C₁-C₄ haloalkyl, —C(O)R³² or —C(O)OR³², R³² is C₁-C₆alkyl or C₃-C₆cycloalkyl, n is an integer of 0 or 1, and t is
 0. 